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Salinosporamide A (1) is a secondary metabolite that was isolated in 2003 by 
Fenical and co-workers from marine actinomycete bacteria of Salinospora strain 
CNB-392. Salinosporamide A is a highly potent and specific inhibitor of the 20S 
proteasome. The proteasome, a multicatalytic proteolytic complex that regulates 
protein degradation within the cells, is receiving considerable attention as a target for 
treating cancer. Salinosporamide A is currently undergoing clinical trials as potential 
drug for cancer treatment. It contains a densely functionalised fused 
y-lactam--lactone bicyclic ring structure, with five contiguous stereocentres. Due to 
the impressive biological activity, as well as its complex chemical structure, this 





This thesis describes the investigations undertaken towards the synthesis of 1. 
After studies on several different approaches, a concise formal synthesis was 
achieved. This route employed a sequential Ni-catalysed reductive aldol 
cyclisation-lactonisation reaction in the construction of the 'y-lactam core of 1, which 
contained the required stereochemistry. This approach represents an attractive 
method to install the C2 side-chain with simultaneous protection of the C5 oxygen 
and saves several steps over alternative routes. The product of the 
cyclisation-lactonisation sequence (489) was readily transformed into an 
intermediate in the synthesis of 1 by Corey and co-workers (26), which had been 
converted into salinosporamide A in four steps. 
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CHAPTER 1 	 Introduction 
1. Introduction 
Salinosporamide A (1) is a secondary metabolite that was isolated in 2003 by 
Fenical and co-workers from the marine actinomycete bacteria of Salinospora strain 
CNB-3 92 (Figure 1.1).' Salinosporamide A is structurally related to omuralide (2), a 
transformation product of the soil microbial metabolite (+)-lactacystin (3) isolated by 
Omura et al. in 1991.2  Omuralide was the first specific 20S proteasome inhibitor 
identified. The proteasome is a multicatalytic proteolytic complex that regulates 
protein degradation within cells and is receiving considerable attention as a target for 
treating cancer. Omuralide (2) has an 10 5 0 value of 49 nM when tested against 
purified 20S proteasome, but salinosporamide A (1) was found to be approximately 
35 times more potent than omuralide, with an 10 50 value of 1.3 nM in the same assay. 
Salinosporamide A also exhibited high in vitro cytotoxicity with a mean G1 5 0 value 
of less than 10 nM when tested against the NCI's 60 cell-line panel. 20S Proteasome 
inhibitors are of interest for the treatment of several types of cancer and the drug 
Velcade® (bortezomib) (4) has been approved by the FDA for the treatment of 
multiple melanoma. 3 Salinosporamide A (NPI-0052) is currently in phase I human 
clinical trials for the treatment of multiple myeloma and other cancers. 4 
ci 	 Me 
Me 
1 	 2 
saiinosporamide A 	(+)-ioctacystin--iactone 
(omuralide) 
Me 	NH 'S -,,—,NHAc 	 OH 





N 	" OH 
0 	 Me 
Me 	 Me 
3 4 
(+)-lactacystin 	 bortezomib 
Figure 1.1 Salinosporamide A, omuralide, lactacystin and bortezomib 
The synthesis of proteasome inhibitors such as omuralide and salinosporamide A 
is therefore of great pharmaceutical value, since it would allow greater quantities to 
be produced which would permit more extensive testing, as well as the synthesis of 
analogues. The aim of this project was to investigate synthetic approaches to 
salinosporamide A, the most interesting 20S proteasome inhibitor recently isolated. 
1 
CHAPTER 1 	 Introduction 
1.1. Ubiquitin-mediated proteolysis and proteasome 
inhibitors 
1.1.1. The discovery of ubiquitin-mediated proteolysis 
While there had been great interest and much research on understanding how the 
cell controls the synthesis of certain proteins, control of the degradation of proteins 
had for a long time not received so much attention. The first system known for 
protein degradation in eukaryotic cells was the lysosomal apparatus, a 
membrane-enclosed vacuole containing multiple acid proteases and other hydrolases. 
It was long believed to be the only site for protein breakdown but, from studies 
initiated in the fifties, it was established that the bulk of cytosolic proteins are 
hydrolysed by a distinct pathway which is highly specific and requires ATP and the 
26S proteasome. Knowledge in this area developed rather slowly but in the early 
nineties the studies were greatly simplified thanks to the availability of proteasome 
inhibitors. 5 Avram Hersko, Aaron Ciechanover and Ernie Rose were awarded the 
Nobel Prize in chemistry in 2004 for their studies of this system. 6 
Ubiquitination is the process, present both in the nucleus and the cytosol, 
whereby proteins are marked for degradation by covalent linkage to the protein 
ubiquitin. This process requires the initial ATP-dependent activation of ubiquitin's 
terminal carboxy group by the ubiquitin-activating enzyme, El (Figure 1.2). The 
activated ubiquitin is then transferred to the ubiquitin carrier proteins, E2s. There is 
some selectivity in this step but the great selectivity of this process comes from the 
ubiquitin ligases, or E3s, which reorganise one or a set of protein substrates and 
catalyse the transfer of the activated ubiquitin from the E2 to the substrate, forming 
processively a chain of ubiquitin molecules. A chain composed of four or more 
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Figure 1.2 Mechanism of the E1/E21E3-catalysed attachment of ubiquitin to 
proteins' 
The 26S proteasome is an ATP-dependent proteolytic complex, formed by two 
19S (890 kDa) "cap" complexes, which provide the specificity and regulation, and 
the central 20S proteosome (720 kDa), where proteins are degraded. The 19S 
complexes contain binding sites for ubiquitinated proteins, enzymes that 
depolymerise the ubiquitin chain, and six different ATPases that unfold the substrate 
and make the entry to the 20S complex easier. The barrel-shaped 20S proteasome is 
formed from four stacked rings that enclose a central chamber where proteolysis 
occurs. This proteasome uses the hydroxyl group of a terminal threonine residue as 
the catalytic nucleophile that attacks and breaks peptide bonds. A protein, once taken 
up by the proteasome, is completely degraded into small peptides of 3-20 residues 
that are further hydrolysed into amino acids by other peptidases. The isolation of the 
active sites within the 20S complex away from cytosolic proteins and the restriction 






1.1.2. Biological functions of the ubiquitin mediated proteolysis 
The availability of proteasomal inhibitors with increasing specificity and potency 
has helped greatly in understanding the role of the proteasomal-ubiquitin protein 
degradation in many biological processes. 5 Since the late 1980s a number of 
physiologically important substrates involved in this proteolysis pathway have been 
identified. Only as an illustration, a few examples will be briefly described. 
1kB was the first substrate of the ubiquitin-proteasome pathway Identified with 
the help of proteasome inhibitors. 9 It is an inhibitor of transcription factor NF-KB, 
which activates the expression of many genes encoding inflammatory mediators. The 
signal for the initiation of the inflammatory response is the rapid destruction of the 
inhibitory protein IiB. Consequently, proteasome inhibitors, by stabilising 1KB, 
maintain NF-KB in the inhibited state and prevent production of the inflammatory 
proteins. 3 
The proteasome is also involved in degradation of numerous proteins regulating 
the cell cycle. Inhibition of the proteasomal activity was reported to stop the cell 
cycle at different stages. Several studies demonstrated that cancer cells are usually 
more sensitive to proteasome inhibitors than normal cells. The use of proteasome 
inhibitors also demonstrated that the proteasomal-ubiquitin pathway has a decisive 
effect on cell death and survival: several substrates of this proteolytic pathway are 
short-lived proteins which are critical for cell progression and transcriptional 
regulation, and they can therefore become the key players in the control of the cell 
death program. 10 
Proteasome inhibitors have been associated with suppression of angiogenesis." 
Cancerous' tissues stimulate angiogenesis and that leads to increased tumour 
formation and possible metastases. Many of the factors involved in angiogenesis are 
regulated by the proteasome. 
The ability of proteasome inhibitors to inhibit cell growth and selectively induce 
apoptosis in cancer cells, together with the ability to inhibit angiogenesis, renders 
these agents attractive candidates as anticancer drugs. The development of 
proteasome inhibitors in cancer treatment is therefore one of the fastest growing 
fields in modern biomedical science. 8 
rd 
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1.1.3. Proteasome inhibitors and mode of action 
More than 90% of cell protein degradation occurs through the 
ubiquitin-proteasomal pathway. The proteasome is the main component of this 
mechanism and the regulation of its activity is very important for an enormous 
number of essential biological processes. For that reason, compounds that inhibit or 
modulate proteasomal activity have great biological importance. Proteasome 
inhibitors can be used as tools to investigate regulation of the ubiquitin-proteasomal 
system, and also as leads for possible drug development. They are generally 
classified based on the pharmacophore with preference for the proteasome's active 
site, the hydroxyl group of an N-terminal threonine. They are also classified based on 
the specificity and the reversibility of binding. 12 
Peptide aldehydes (Scheme 1.1) were the first proteasome inhibitors to be 
developed and are still the most widely used inhibitors. Aldehyde inhibitors enter the 
cell rapidly and their effect is reversible. They have fast dissociation rates, are 
rapidly oxidised into inactive acids by cells and are easily transported out of the cell. 
Consequently, the effects of these inhibitors can be rapidly reversed by removal of 
the inhibitor. 
Peptides with a vinyl sulfone are another class of proteosomal inhibitor. These 
bind to proteasomes irreversibly but are less reactive than aldehydes. Vinyl sulfones 
act as conjugate addition acceptors for the hydroxyl group of the proteasome's 
catalytic threonine, forming a covalent bond. 
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Peptide boronates (Scheme 1.2) are much more potent inhibitors than aldehydes 
and vinyl sulfones. Although boronates are considered reversible inhibitors, the 
inhibition is practically irreversible over the duration of several hours. Their high 
inhibition efficiency, high selectivity (they do not inhibit other cellular proteases) 
and low dissociation rates render these chemical compounds the focus of intense 
research. The boronate derivative bortezomib (4) has already passed through clinical 
trials and represents a new drug against multiple myelanoma. 4 
Apart from synthetic peptide inhibitors, there are a variety of natural compounds, 
like peptide epoxyketones and -lactones. Epoxyketones act by an interesting and 
unique mechanism. They react with both the hydroxyl and amino groups of the 
catalytic N-terminal threonine of the proteasome. Due to their unique mechanism, 
they are the most selective inhibitors of the proteasome known. 
Peptide boronates 
0 	 OH 
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Scheme 1.2 Peptide boronates and peptide epoxyketones proteasome 
inhibitors 
Lactacystin, omuralide and salinosporamide A are 13-lactone inhibitors and their 
mode of action and reactivity will be explained in more detail in the next section. 
CHAPTER 1 	 Introduction 
1.1.3.1. Lactacystin, omuralide and salinoporamide A. Mode of action 
and Struótu re-Activity Relationships (SAR) studies 
In 1991, Omura's group isolated and characterised (+)-lactacystin (3), a 
secondary metabolite derived from a Streptomyces bacterial strain. 2 It was initially 
considered a neurotrophic agent but has since found application in models of 
arthritis, ischemia, and asthma. By further interpretation of the biological activity, 
Fenteany discovered that its molecular target was the 20S proteasome.' 3 Experiments 
done by Fenteany and co-workers as well as the crystallographic work of Huber 14 
clearly defined the mode of inhibition of (+)-lactacystin and explained its high 
potency and selectivity. 
(+)-Lactacystin was shown to be in fact a pro-drug for the active inhibitor 
omuralide (2), which is the only species to enter the cell. 15 (+)-Lactacystin 
spontaneously eliminates N-acetylcysteine in a reversible manner to produce the 3-
lactone. Once inside the cell, omuralide either: (i) is hydrolysed by water to give the 
carboxylic acid 5; (ii) reacts with glutathione to form the glutathione derivative 
(lactathione) 6 which acts as a reservoir of the drug; or (iii) binds to the 20S 
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Scheme 1.3 Formation of omuralide (2) from (+)-Iactacystin 3 and its 






The electrophilic centre of the inhibitor is the -lactone. Omuralide binds to the 
20S proteasome through a covalent bond in the form of an ester between the C4 
carbonyl and the hydroxyl group of an N-terminal threonine residue in the active site. 
Although the inhibitor is covalently bound the resultant ester is subject to hydrolysis 
and the inhibition is therefore reversible, with enzymatic activity restored in a matter 
of hours. 8 
The synthesis of (+)-lactacystin has received widespread attention since its 
isolation in 1991. The first synthesis of 2 was reported by Corey and co-workers in 
1992. 17  Many refinements to the synthesis have been reported by the Corey group, 
allowing (+)-lactacystin to be synthesised via omuralide and allowing the synthesis 
of C2 and CS analogues.' 6 It was found that replacing the C2 methyl group with 
larger alkyl substituents increased the potency of proteasome inhibition relative to 
omuralide but that alteration of the isopropyl group at the CS position resulted in a 
loss of activity. 18  The f3-lactone has been shown to be essential for biological activity 
through synthesis of the '3R diastereoisomer' (8) of (+)-lactacystin (3) which is 
unable to form the -lactone but shares all of the other structural features.' 9 This 
compound was found to be inactive which is consistent with the mechanism of 
inhibition. 
0 










Figure 1.3 Lactacystin, omuralide and salinosporamide A analogues 
Salinosporamide A not only represents a more attractive synthetic target than 
omuralide due to its increased biological activity, but it is also a more challenging 
one. It is even more densely flinctionalised than omuralide, containing five 
contiguous stereogenic centres. Salinosporamide A shares the key y-lactam-f3-lactone 
pharmacophore with omuralide but differs in the C2, C3 and CS substituents. It 
contains a cloroethyl group at C2, it is methylated at C3 creating a second quaternary 
8 
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stereogenic centre and carries a cyclohexenyl group at C5 in place of the isopropyl 
group of omuralide. It is this unique substitution that, collectively, makes 
salinosporamide A approximately 35 times more potent that omuralide in proteasome 
inhibition. 
Given the structural similarities between omuralide and salinosporamide A, a 
similar binding mode with the proteasome could be expected, namely attack of the 
Thrl-OH of the proteasome to the f3-lactone carbonyl, opening the ring and forming 
an ester. This was confirmed by a crystal structure analysis of salinosporamide A in 




Figure 1.4 Crystal structure analysis of salinosporamide A (1) in complex with 
the 20S proteasome 2° 
The -lactone is therefore recognised as the key pharmacophore, but the 
enhanced potency of salinosporamide A must be due to certain substituents of the 
bicyclic ring. Therefore, full structure-activity relationship (SAR) studies of 
salinosporamide A were undertaken. 2 ' Table 1.1 outlines some biological data of in 
vivo (cytotoxicity against multiple myeloma cell line RPMI 8226) and in vitro 
proteasome inhibition. This SAR study together with the analysis of the crystal 
structure of salinosporamide A (1) and of the des-chioro analogue (10, Figure 1.3) in 
complex with the proteasome, provided explanations for its enhanced potency. 20  This 
des-chloro analogue 10 (salinosporamide B) was isolated, in smaller quantities, from 
the same microbial strain. 
-
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The fact that the cyclohexenyl group of 1 does not result in a loss of activity 
(Table 1.1) contradicts the SAR data obtained for omuralide (2) by Corey and co-
workers and suggests that salinosporamide A may interact with the proteasome in a 
different manner to omuralide. The C5 isopropyl analogue of salinosporamide A (9, 
Figure 1.3, vide supra) has been synthesised by the Corey group 22  and was found to 
be 2.5 times more potent than 2 but less active than 1 against the purified 
proteasome. 23 Various C5 analogues were synthesised by modifying the cyclohexene 
substituent but all were found to be less potent than the parent compound (Table 1. 1, 
entries 3-5). The hydrogen bonds formed between C5-OH and the proteasome also 
have an important role in causing inhibition. Epimerisation of this centre or oxidation 
to the ketone results in analogues without proteosomal inhibition (entry 6). 
It was observed that the C3 methyl group points toward a small pocket and 
interacts weakly with the protein. Both a hydrogen atom and a methyl group fit into 
this pocket, but an analogue containing an ethyl group at this position does not 
inhibit the proteasome (entry 7). The ethyl group is too big and causes steric 
interactions that do not allow binding. 
Modification from 
Biological activities 
sahnosporamide A (1) (1050 
nM) 
2= CH2CH20, R3= Me, R1= Cytotoxicity 	Proteasome 
RPMI 8226 
cyclohexenyl) Inhibition (MM) 
None (1) 8.2 ± 2.0 	 21 ± 3 
2 Omuralide (2) 3300 ±1600 540 ± 60 
3 cyclohexyl 52± 13 	250±30 
o:;:Q 




6 epi-C-5(OH) >20000 >20000 
7 R3 =CH2CH3 1900±400 3300±200 
8 R2 = CH2CH2Br 7.4 ± 1.6 14 ± 2 
9 R2 = CH2 CH2I 6.8 ± 0.8 13 ± 3 
10 R2 epi-CH2CH20 1900±300 2500 ±500 
11 R2 =CH2CH3 6100 ±3300 640 ±60 





The hydrolysis of the -lactone was also evaluated. In aqueous solutions 
salinosporamide A hydrolyses to the acid 11 which rapidly eliminates HCl to give 
the bicyclic product 12, as illustrated in Scheme 1.4. 
CI 	
1120 	 NH 	 HCI 	 NH 
1 	 11 	 12 
Scheme 1.4: Formation of the bicyclic tetrahydrofuran derivative 12 following 
displacement of the C2-chloro substituent 
A potential problem with salinosporamide A as a pharmaceutical agent is 
therefore it's instability in aqueous solution at pH 7 (t 1 12=5-10 mi. In an attempt to 
get round this problem, Corey and co-workers have synthesised -lactam 13 which is 
stable at pH 7 for at least 24 hours (Figure 1.5) 24  This is proposed to compensate for 
the decreased potency of proteasome inhibition exhibited for this compound. 




Figure 1.5 /3-Lactam 13 
Salinosporamide A (1) contains a chloroethyl group at the C2 position; the 
des-chloro analogue of salinosporamide A, salinosporamide B (Figure 1.3), is found 
to be 500-fold less cytotoxic than salinosporamide A against the human colon 
HCT-116 cancer cell line. 25 . Substitution of chlorine with bromine or iodine (Table 
1.1, entries 8 and 9) gave analogues of similar potency. The C2 epimer (entry 10) 
also resulted in a marked decreased potency. 
The chloride substituent is proposed to be responsible for the increase in potency 
by ensuring that the covalent attachment to the proteasome is irreversible. It is 
suggested a two-step binding mechanism, in which -lactone ring opening (14) is 





at C3, forming a bicyclic tetrahydrofuran derivative (15) (Scheme 1.5). For 
omuralide (2), the formation of the ester bond with the proteasome is reversible 
because the hydroxyl at C3 is free and can attack the carbonyl again, but this is not 
possible for salinosporamide A. 
CI 	 Proteasome 	 c' 	- HCI 4N H 
bH 	 OH 
1 	 14 	 15 
Scheme 1.5 Salinosporamide A binds irreversibly 
Cleavage of the acyl ester by a nucleophilic water molecule is challenged by the 
spatial arrangement of C3-0 in the tetrahydrofuran derivative. Proteasome activity is 
only slowly recovered after 7 days in mice treated with 1, which could be attributed 
to red blood cell turnover. 4 
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1.2. Previous syntheses of salinosporamide A 
The discovery of proteasome inhibitors has facilitated a greater understanding of 
the mechanism of the proteasome and an increased awareness of its biological 
importance. They have shown the proteasome as a viable target for drug 
development. 
Because of the potent biological activity, as well as its complex structure, 
salinosporamide A (1) has generated considerable interest in the synthetic 
community. Corey completed the first total synthesis in 200426.  Since then, other 
total syntheses (Danishefsky, 27 Macherla,28 Pattenden29 (racemic) and 
Romo30(racemic)) and a formal synthesis (Langlois)31' 32  have been reported. The 
remainder of this section will review the synthetic strategies towards the natural 
product. 
1.2.1. Corey's Synthesis 
The first total synthesis of salinosporamide A was achieved by Corey and 
co-workers in 2004,26  following on from extensive work by the group on the 
synthesis of (+)-lactacystin, omuralide and related analogues. 11,33,34  This synthesis is 
outlined in Scheme 1.6 
(S)-Tbreonine methyl ester was treated with 4-methoxybenzoyl chloride to give 
the N-acylated product 16 which cyclised to an ozaxoline in the presence ofp-TsOH. 
Stereoselective alkylation of the oxazoline with benzyloxymethyl chloride afforded a 
new oxazoline 17, with the required stereochemistry at the tetrasubstituted C4 
carbon. Selective reductive ring-opening of 17 using NaBH 3CN/HOAc gave the 
N-PMB-protected amino alcohol 18. This intermediate was acylated in a one-flask 
sequence: temporary protection of the secondary alcohol with a trimethylsilyl group, 
N-acylation with acryloyl chloride, followed by desilylation, to yield the N-acrylyl-
N-PMB derivative 19 in 96% yield. Oxidation of 19 with Dess-Martin periodinane 35 
produced keto-acrylamide 20. 
The key formation of the 'y-lactam was successfully achieved via a 
Baylis-Hillman cyclisation, operation that installs the stereocentre at C3. Using 















diastereomer of the y-lactam with high diastereoselectivity (9:1). Silylation of the 
cyclised products allowed separation of the two diastereomers and desired 21 was 
isolated in 95% yield. Subsequent tributyltin-mediated radical-chain cyclisation of 21 
gave the syn-fused 'y-lactam 22, setting up the desired stereochemical relationship at 
C2 and C3. Cleavage of the benzyl ether and oxidation of the resulting primary 
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Reagents and conditions: (a) p-TsOH, toluene, reflux, 12 h, 80%; (b) LDA, 
THF-HMPA, —78 °C then CICH 2013ri, 4 h, 69%; (c) NaCNBH 3 , AcOH, 40 °C, 12 h, 90; 
(d) TMSC1, Et20, 23 °C, 12 h; (e) Acryloyl Chloride, 'Pr 2NEt, CH202, 1 h, 0 °C then 
H, Et20, 23 °C, I h, 96%; (0 Dess-Martin periodinane, 23 °C, 1 h, 96%; (g) 
Quinuclidine, DME, 0 °C, 7 d, 90%; (h) BrCH 2S1(CH3)2C1, Et3N, DMAP, CH 202, 0 °C, 
30 mm, 95%; (i) Bu3Snl-I, AIBN, Benzene, reflux, .8 h, 89%; (j) Pd-C, EtOH, H 2  0 
atm), 18 h, 95%;. (k) Dess-Martin periodinane, 23 °C, 1 h, 95%; (1) 24, THF, —78 °C, 5 
h, 88%; (m)KF, KHCO 3 , H202, THF-MeOH (1:1), 23°C, 18 h, 92%; (n)CAN, MeCN -
H20; (3:1), 0 °C, 1 h, 83%; (o) 3N LiOH-THF (3:1), 5 °C, 4 d; (p) BOPCI, pyridine, 
CH2Cl2, 23 °C, 1 h; (q) Ph 3 PCI2 , MeCN, pyridine, 23 °C, 1 h, 65% (3 steps). 
Scheme 1.6: First total synthesis of 1 
The next step was the installation of the 2-cyclohexenyl group via an 
organometallic addition of 2-cyclohexenylzinc chloride  36  (24) into aldehyde 23. This 
reaction proceeded with excellent diastereoselectivity (20:1), setting up the desired 
stereochemical relationship at C5 and C6 (Scheme 1.6). 
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Tamao-Fleming oxidation 37  of 25 afforded trio! 26. This intermediate was 
successfully converted into 1 in four final steps: cleavage of the PMB group using 
CAN (83% yield), hydrolysis of the methyl ester employing LiOH, f3-lactone 
formation with BOPC1, and finally chlorination of the primary alcohol with 
triphenyiphosphine dichloride (65% yield over three steps). 
The Baylis-Hilman cyclisation step was revised by Corey and co-workers in 2005 
to give complete diastereoselectivity (dr >99:1).22 23 In this new methodology, 
keto-acrylamide 20 was reacted with the Kulinkovich 38 reagent 27, formed from 
reaction of four equivalents of Ti('PrO)4 with seven equivalents of 
cyclopentylmagnesium chloride (Scheme 1.7). The reaction mixture was treated then 
with iodine to form the a-iodomethyl-y-lactam 28. Finally, the addition of 




















CO2Me HO CO2Me 
•28 	-' 	 29 
Reagents and conditions: (a) Ti(Oi-Pr) 4 (4 eq), c-05H9MgCI (7 eq), t-BuOMe, —40 °C, 
30 mm, 12 (5 eq), -40 °C, 2 h then 0 °C, 2 h.; (b) NEt 3 , CH 20 2, 30 mm, 83%. 
Scheme 1.7 Improved Iactam formation 
This new methodology was also employed in the synthesis of 
3-methyl-2-epi-omuralide Keto acrylamide 30 was added to the Kulinchovich 
reagent in a similar procedure but the cyclised titanium-containing intermediate 
formed wasthen quenched with 1 N HC1, an operation that afforded 'y-lactam 31 in 
95 % yield and as a single diastereomer (Scheme 1.8). 
15 
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Reagents and conditions: (a) Ti(Oi-Pr) 4 (4 eq), c-0 5H9MgCI (7 eq), (-BuOMe, —40 °C 
to -20 °C, then 1 N aq HCI, 95%. 
Scheme 1.8 Synthesis of 3-methyl-2-epi-omuralide 32 
It was surprising that y-lactam 31 was obtained with a anti relationship between 
the methyl substituent at C2 and the hydroxyl group at C3. The Ti-mediated 
cyclisations of y,E-unsaturated ketones 40 have been proposed to occur through a 
bicyclic organotitanium intermediate such as 33 (Scheme 1.9). However, the anti 
arrangement in 7-lactam 31 of substituents at C2 and C3 suggested that the 
cyclisation occurs via a monocyclic intermediate such as 34. The formation of 34 
could be explained via a two-step mechanism involving transfer of (RO) 2Ti from the 
Kulinchovich reagent 27 to the acrylamide ct,f3-double bond of 30, followed, by 
radical addition 41  of that intermediate to the methyl ketone, which is chelated through 
MgC1 with the methyl ester carbonyl. 
0 
A ,PMBMe 
RO Me .1-1 	
l"01BS 









Scheme 1.9 Bicyclic organotitanium intermediate vs radical mechanism 
Novel methodology for the methyl ester cleavage, -lactone formation and the 
chlorination procedure was also reported.22' 23  A novel sequence of three reactions 
was developed and applied in the transformation of dihydroxylactam 35 to the 
salinosporamide-omuralide hybrid 9 (Scheme 1.10). The cleavage of the methyl ester 
was a challenging step due to the strong steric hindrance of the CO 2Me carbonyl and 
the tendency of 35 to undergo retroaldol cleavage and other undesired reactions. A 
new reagent was successfully developed, (Me 2TeA1Me)2, readily generated by 
16 
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heating tellurium powder and A1Me 3 in toluene for 6 h and cooling the product to 
room temperature .42  This reagent selectively attacks the methyl group of the methyl 
ester, instead of the carbonyl, and it can operate under mild conditions in terms of 
temperature and basicity. 
Without further purification, the resulting carboxylic acid was reacted with 
Ph3PC12 in dry 1:1 MeCN-pyridine to give directly 36 in 89% yield. This efficient 
operation combined the side chain chlorination with a novel method 
of -lactonisation in a single step. Finally, desilylation afforded the salinosporamide-
omuralide hybrid 9. 
0 	 0 	 0 






35 	 36 	 9 
Reagents and conditions: (a) [MeTeA1Me] 2 Toluene, 23 °C, 12 h; (b) PPh 3 Cl2 , 
CH202 , pyridine, 12 h, 89%; (c) NEt 3 •3HF, THF, 23 °C, 4 h, 92%. 
Scheme 1.10 Completion of the synthesis of salinosporamide-omuralide 
hybrid 9 via a novel sequence of three reactions 
Corey's total synthesis of salinosporamide A via a Baylis-Hillman cyclisation to 
construct y-lactam 29 was achieved in 8.7% overall yield over eighteen steps. This 
was improved with a less time consuming, very efficient and completely 
diastereoselective cyclisation reaction employing the Kulinkovich reagent 27, 
methodology that allows the synthesis of salinosporamide A in eightteen steps and an 
improved 9.1% overall yield. 
1.2.2. Danishefsky's synthesis 
The second total synthesis of 1 was published by Danishefsky in 2005.27  This 
synthetic route afforded salinosporamide A from 37 in twenty-eight steps and in 
1.8% overall yield . It started from the pyroglutamate derivative 37 derived from L-
glutamic acid (Scheme 1.1 The strong facial bias of this bicyclo[2.2.0] 
compound 37 allowed the creation of the stereocentre at C3 through treatment with 





This was followed by alkylation at C2 with -benzyloxy iodoethane, with attack now 
from the n-face, to give lactam 38 as a 14:1 mixture of diastereoisomers. 
Acylation at C4 would be achieved via conversion of the vinyl group into a 
carbonate ester acylating agent. Ozonolysis of 38 and reductive treatment with 
sodium borohydride produced alcohol 39. Carbonate formation and aminal cleavage 
using TfOH afforded alcohol 40, which was subjected to Jones oxidation to the 
carboxylic acid, tert-butyl ester formation and imidate formation with Meerwein's 
reagent (Et 3 0BF4) to produce 41. 
0 	 0 	
0 	 0 
Ph 
Ph a-b d-e BnO 	 NH 
OH o 	 /O 
Ph c BnO.,' 	N—_' 	. BnO/{N1( 
OH 	 OCO2Et 
37 	 38 	 39 	 40 
f-h 
0 	 OEt 	 OEt 






43 	 42 	 41 
Reagents and conditions: (a) vinylmagnesium bromide, TMSCI, Cul, —78 °C, 75%; (b) 
[(2-iodoethoxy)methyl]benzene, LDA, THF, rt, 77%, dr = 14:1; (c) 0 3 , CH2Cl 2-MeOH 
(3:1), -78 °C then NaBH 4, 0 °C (86%); (d) C1CO 2Et, pyridine, rt, 96%; (e) TfOH, 
THF-H20 (9:1), rt, 100%; (f) Jones reagent, acetone, rt; (g) Me 2NCH(0t-Bu)2, toluene, 
reflux, 72% over 2 steps; (h) Et 30BF4 , K2CO3,  CH202, rt, 88%; (i) LHMDS, THF, 
-20T, 82%; U) I M HC1 aq, THF, 0 °C, 90%; (k) PMBCI, NaH, DMF, rt, 61%; (1) 
Pd(OH) 2-C, H2, EtOH, rt, 100%. 
Scheme 1.11 Danishefsky's synthesis (I) 
With the lactam functionality thus masked, internal acylation of C4 with the 
pendant carbonate occurred in good yield using LHMDS, forming intermediate 42. 
In this step, the stereogenic centre at C4 was constructed. The lactam was unmasked 
under acidic conditions, the amide was then protected with PMBC1 and the benzyl 
ether was cleaved to give lactam 43. 
Nucleophilic lactone ring-opening of 43 with a phenylselenium anion generated 
from (PhSe)2 and NaBH4 followed by benzyl ester formation of the resulting 





oxidation/elimination sequence afforded a mixture of the expected alcohol 45 (72%), 
along with aldehyde 46 (22%). Upon purification, the unoxidised material was 
converted into aldehyde 46 via a Dess-Martin periodinane 35 oxidation (89% in three 
steps from 44). 
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Reagents and conditions: (a) PhSeSePh, NaBH 4, EtOH, 60 °C; (b) BnBr, K2CO3, 
DMF, rt, 72% over 2 steps; (c) 30% H 202 aq, THF, rt; (d) toluene, 100 °C, 72% 45 + 
22% 46 over 2 steps; (e) Dess-Martin periodinane, CH 202 , ii, 92% (89% in three steps 
from 44); (1) PhSeBr, AgBF 4, BnOH, CH202 , —20 to 0 °C, 74% as an anomeric mixture 
(12:1); (g) AIBN, nBu 3SiiH, toluene, 100 °C, 98%; (h) NaBH 4, THF-EtOH (3:1), rt, 
85%; (i) Dess-Martin periodinane, CH 202 , ii, 95%; U) cyclohexenyl zinc chloride 24, 
THF, —78 °C; (k) CAN, CH 202-H20, 0 °C, 90%; (1) Na, liq NH 3 , —78 °C; (m) NaBH 4 , 
THF-H20 (2:1), rt, 97% over two steps; (n) BC1 3, CH202, 0 °C; (o) BOPCI, NEt 3 , 
CH202, rt; (p) PPh 3 Cl 2 , pyridine, CH 2 Cl2, rt, 51% over 3 steps. 
Scheme 1.12 Danishefsky's synthesis (II) 
Treatment of 46 with phenylselenium bromide and AgBF 4 in the presence of 
benzyl alcohol gave acetal 47, setting up the desired stereochemical relationship at 
C2 and C3. Subsequent radical deselenenylation of 47 yielded 48, which contains the 
desired C3 methyl substituent. Selective reduction of the benzyl ester of 48 to the 
alcohol followed by a Dess Martin oxidation 35  afforded aldehyde 49. Stereoselective 
introduction of the cyclohexenyl group was conducted using Corey's procedure 26 : 
N 
HO n-p 
51 	 1 
C1 	 NH HO 	CO2t";ZH 
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treatment of the PMB protected y-lactam 49 with the cyclohexenyl zinc reagent 24, 
produced 50 with an excellent yield and diastereoselectivity. It was reported that the 
use of this methodology on the corresponding imidate aldehyde derived from 42 
(Scheme 1.11) instead of on 49 resulted in poor diastereoselectivity (78% yield, 4:3, 
configuration not determined). This showed that the PMB group played a critical role 
in diastereo selection in this novel addition. 
Removal of the PMB group, followed by reductive opening of the benzyl 
glycoside, gave rise to triol 51. Lewis acidic cleavage of the tert-butyl ester was 
effected through treatment with BC1 3 , and the crude trihydroxy acid was then 
subjected to lactonisation-chlorination to provide salinosporamide A (1). 
1.2.3. Pattenden Racemic Synthesis 
Pattenden and co-workers reported in 2006 a racemic synthesis of 
salinosporamide A, outlined in Scheme 1.13. 29  In this route, (±)-1 was obtained from 
52 in fourteen steps and 11.5% overall yield. 
Protection of known ketone 52 44  as an acetal was followed by ester hydrolysis 
and coupling of the resulting acid with dimethyl 2-aminomalonate to afford amide 
53. This intermediate was transformed into amide y-lactam (±)54 via a 
diastereoselective acid catalysed intramolecular cyclisation. When a solution of 53 in 
acetic acid/water (4:1) was heated at 65 °C for 4 days, deprotection of the dioxolane 
and in situ cyclisation occurred, leading to a single diastereomer of (±)-54. 
The tertiary alcohol of (±)-54 was then TMS-protected and the lactam nitrogen 
was protected with a PMB group, forming (±)-55. The ester anti to the protected 
alcohol was then selectively reduced to the aldehyde using lithium superhydride. The 
cyclohexenyl side chain was inserted into (±)-56 following Corey's procedure, 26 










0 CO Me 	 0 
d 	BnO a-c 	BnO 	
CO2Me 	
Me.')...CO2Me











0 	 0 
BnO 	
N- PMB 
	g BnO 	 N PMB 
	
Me ..... ... CHO 	 Me ........ CO2Me 
TMSO CO2Me 	 TMSO CO2Me 
(a)-56 	 (±)-55 
HO : 	I-n 	C1 	 NH HO CO2MOH
(±)-58 	 (01 0 
Reagents and conditions: (a) ethylene glycol, p-TsOH, benzene, 110 °C, 14 h; (b) 2M 
NaOH, EtOH, 70 °C, 3 h; (c) dimethyl aminomalonate•HC1, HOBt, EDCHCI, CH 202 , 
NMM, 0 °C to rt (82% over 3 steps); (d) 4:1 AcOH—H 20, 65 °C, 4 d (71%); (e) excess 
TMSOTf, 2,6-lutidine, CH202 , —78 °C to 0 °C, then 1 M HC1 (9 1%); (f) PMB-Br, NaH, 
DMF, 0 °C to rt, 14 h (82%); (g) Super-hydride (1.0 M in THF), CH 2Cl2 , —78 °C, 3 h 
(78%); (h) 2-cyclohexenyizinc chloride 24, THF, —78 °C (87%); (I) BCI 3 •DMS, CH202 , 
24 h, 0 °C to rt; (j) 48% HF in H 20-MeCN (1:9), rt, 22 h; (k) CAN, MeCN, H 20 (3:1), 0 
°C, 1 h (87% over 3 steps); (1) [MeTeAIMe 2] 2, toluene, rt, 24 h; (m) BOP-CI, CH 2Cl2 , 
pyridine, rt, 3 h; (n) PPh 3 Cl2, MeCN, pyridine, ii, 4 h (45% over 3 steps). 
Scheme 1.13 Pattenden's synthesis 
Cleavage of the benzyl ether and trimethylsilyl ether, followed by deprotection of 
the PMB group on the lactam nitrogen afforded Corey intermediate (±)58,26  which 
was then converted into (±)-salinosporamide A following reported methods. 22,23,42 
1.2.4. Lang lois's formal synthesis 
In 2006, Langlois and co-workers reported a formal synthesis of Salinosporamide 
A.31' 
32 
 As it has been shown, Corey's synthesis involved the highly functionalised 
a-methylene-lactam 29 as a key intermediate (Figure 1.6). Langlois first published a 
route to (±)-59, a closely related scaffold which contains all the required 
functionality to be transformed into racemic salinosporamide A. Their synthetic 
strategy was based on a regio- and stereoselective N-methylnitrone cycloaddition. 
21 
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OBn 	Me. ... ...... OBn 
HO CO2Me HO CO2Me 
29 	 (t)-59 
Figure 1.6 a-Methylene-Iactam key intermediates 29 and (±)-59 
Selective alkylation of methyl pyroglutamate 60 with chloromethylbenzylether 
was successfully achieved using LHMDS (Scheme 1.14). N-Boc protection afforded 
intermediate 61. This protection improved the reactivity of the lactam carbonyl, 
allowing efficient classical introduction of the double bond to give 62. A 
stereoselective methylcuprate addition was then performed (product obtained as a 
single diastereomer), followed by reintroduction of the double bond, yielding 63. A 
regio- and stereoselective 1,3-dipolar cycloaddition of N-methylnitrone with 63 was 
achieved affording (±)-64 in 57% yield. In this step the 0 hydroxyl group and the 
precursor for the C2 exo-methylene group are introduced. The cleavage of the 
isoxaline N-O bond was performed chemoselectively by hydrogenolysis using 
Peariman's catalyst, without affecting the O-benzyl group. Finally, methylation with 
an excess of iodomethane and treatment with triethylamine afforded the target 
intermediate (±)-59. 
0 	 0 	 0 
a-b 	 N 
_Boc 	 ,.JL. Oc 
ç 	 \\ N 
OBn 	 ' OBn 
60 CO2Me 	 61 CO2Me 62 CO2 Me 
4, d-e 
0 	 0 	 0 
Boc Boc 
N 9 	 ______ A\NMe. H OBn 	Me 	 Boc —OBn 	 OBfl 
HO CO2Me Me CO2Me MCO2Me 
(±)-59 	 (±)-64 	 63 
Reagents and conditions: (a) LHMDS, THF, BnOCH 2CI (53%); (b) (1300 20, DMAP, 
MeCN (100%); (c) (i) LHMDS, THF, PhSeCI; (ii) H 202, CH2Cl 2 , pyridine (89%); (d) 
Me2CuLi, THF, TMSCI (83%); (e) (i) LHMDS, THF, PhSeCI; (ii) H 202, CH202 , 
pyridine (75%); (f) N-methylnitrone, toluene, reflux (57%); (g) (i) H 2, Pd(OH)2 , 
EtOAc-MeOH (72%); (ii) Mel, THF, Et3N (65%). 
Scheme 1.14 Racemic formal synthesis 
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A second publication by Langlois reported an asymmetric route to 1. To obtain 
enantiopure 29 and 59 (Figure 1.6), (5)-methyl 2-hydroxymethylpyroglutamate 67 
was chosen as the chiral precursor (Scheme 1.15). This compound has been prepared 
before from bicyclic nitrile 65. 45  Selective O-benzylation of 67 was successfully 
achieved using 2-benzyloxy-1-methylpyridinium triflate (68), leading to 69 in 75% 
yield. From intermediate 69, the synthesis of enantiopure 59 (Figure 1.6) is 
achievable, because the subsequent steps of the racemic synthesis (Scheme 1.14) 
cannot produce racemisation. 
BnO +N 
0 	 +C1_ 
	 0 	 TfOH Me1 	0 




	 _  NH 
CO2H 	 H
....
OH 	 H OBn 
CN 	 CO2Me CO2Me 
65 66 	 67 	 69 
Reagents and conditions: (a) 6N HCI, reflux (98%); (b) CH 2N2, Et20 (67%); (c) 68, 
MgO, PhCF3 , reflux (75%). 
Scheme 1.15 Langlois' formal synthesis 
This chemistry was also employed for the synthesis of Corey's intermediate 29. 
Starting from PMB-protected 69, the double bond introduction (Scheme 1.14) was 
achieved in a very low yield. Therefore 69 was transformed into the N-Boc 
derivative 59, which was followed by removal of the Boc protecting group and PMB 
protection, to afford pyrrolinone 70 (Scheme 1.16). 
The N-methylnitrone cycloaddition with 70 occurred with the expected 
regioselectivity, but slightly lower stereoselectivity (ratio 4:1), giving the desired 
diastereomer 72 in 54 % yield (14% of 71). After hydrogenolysis (73), 
N-methylation using iodomethane and elimination in a biphasic mixture of aqueous 
Na2CO3, and CH 2Cl2 afforded the target a-methylenelactam 29. This route represents 
a formal synthesis of the natural product salinosporamide A from 67 in eighteen 
steps and 4% overall yield. 
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Reagents and conditions: (a) CF 3 CO2H, CH2C12 (100%); (b) CsCO 3 , PMBBr, DMF 
(57%); (c) N-methylnitrone, toluene, reflux (14% for 71, 54% for 72); (d) H 2, Pd(OH)2, 
EtOAc-MeOH (64%); (e) (i) Mel, MeOH; (ii) Na 2CO3 , CH202 (90%). 
Scheme 1.16: Langlois' formal synthesis 
1.2.5. Romo's synthesis 
A racemic synthesis of salinosporamide A was published by Romo and 
co-workers in March 2007. 0  In this publication, they reported new methodology to 
form the bicyclic core of the natural product, via an intramolecular bis-cyclisation 
process which forms the C-C and the C-O bonds simultaneously (Scheme 1.17). This 
bis-cyclisation process permitted the synthesis of the (±)-bicyclic--lactone with the 
required relative configuration. Potential enolisation and subsequent racemisation at 
C2 was not problematic since, due to the conformationally controlled acidity of 3-
kètoamides owing to A" 3 strain,  46  retention of this stereocentre occurred. This route 











 Me 	 7~4 
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Me 
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Scheme 1.17: Racemic formal synthesis 
In this synthesis, N-PMB serine ally! ester 77 was obtained in two steps from 
benzyl proteted serine 76 and then coupled with heteroketene dimer 78, providing 
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79, which afforded ketoacid 80 after Pd-mediated ester deprotection (Scheme 1.18). 
Bis-cyclisation of 80 gave bicyclic--lactones (±)-82 and (±)-83 in 25-35% yield, in 
favour of the relative configuration of salinosporamide A (dr 2-3:1). This was a 
much lower yield than the ones obtained in bis-cyclisation reactions with 
C4-unsubstituted substrates, most likely due to increased steric crowding. 
Deprotection of the benzyl ether allowed enrichment of the major diastereomer 
(±)-84 to 6-10:1 after purification. A modified Moffat oxidation  47  using EDCI and 
dichloroacetic acid, followed by addition of 2-cyclohexenyl zinc chloride gave two 
diastereomeric alcohols (dr 3.5:1) in 33% yield. Finally, PMB deprotection of (±)-85 
permitted isolation of diastereomerically pure (±)-salinosporamide A. 
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Reagents and conditions: (a) p-anisaldehyde, MeOH, NaBH 4; (b) p-TsOH, allyl 
alcohol (74%, 2 steps); (c) THF, 60 °C, 36 h (80%); (d) Pd(PPh 3)4, morpholine (75%); 
(e) DIPEA, PPY, CH2Cl2, —10 °C, 6 h (25-35 %, dr 2-3:1); (f) H 2, Pd/C, THF, 25 °C 
(98%); (g) EDCI, DMSO, C1 2CHCO2H; (h) 2-cyclohexenyizinc chloride 24, THF, 
—78 CC (33%, 2 steps, dr 3.5:1); (i) CAN, MeCNIH 20 (49%, major diast.). 
Scheme 1.18 Racemic formal synthesis 
1.2.6. Mac herla's synthesis 
Another enaritioselective synthesis of salinosporamide A was reported by 
Macherla and co-workers in 2007.28  This synthesis starts with a MsC1-mediated 
amide coupling of 86 and 87 to give protected f3-ketoamide 88 (Scheme 1.19). 
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Oxazolidine 87 serves both as a group to induce chirality in the aldol cyclisation 
performed in a later step and as a protecting group. Deprotection of the ketone 
generated 3-ketoamide 89 as a mixture of epimers at the a-carbon containing the 
allyl group. 
The next step generated key intermediate 90, via a novel enantioselective 
intramolecular aldol cyclisation that uses the self-regeneration of stereocentres 
principle 48  to generate simultaneously chiral stereocentres C2 and C3. 13-Ketoamide 
89 was treated with t-BuOK to give rise to 90 in 64% yield and 70% d.e., along with 
minor diastereomers and dehydration product. The chirality of C4 stereocentre was 
maintained in the reaction. 
The highly functionalised intermediate 90 was then transformed into 91 (and its 
diastereomer, 5:1 ratio) via oxidative cleavage of the allyl group with 0s0 4/NMO 
followed by treatment with Na10 4 and then treatment with BnBr in the presence of 
t-BuOK. The methyl ester of 91 was reduced to the alcohol and reoxidised to the 
aldehyde 92 using a TPAP/NMO oxidation 49 . The use of Corey's methodology26 to 
install the cyclohexene ring on 92 was not successful in this system and Brown's 
allylboration chemistry 5° had to be used instead. Aldehyde 92 was reacted with 
B-2-cyclohexen-1-yl-9-BBN (93) to give the expected syn addition product 94, 
having the desired stereochemistry at C6, but the required stereocentre at CS would 
have to be regenerated later. 
The benzyl acetal in 94 was opened and transformed into the benzoyl protected 
alcohol 96. This transformation aimed to obtain a protecting group that would 
withstand the strong acidic conditions of the aminal deprotection (1,3-propanedithiol, 
HC1, TfOH), because if the benzyl alcohol was deprotected, it could not be 
differentiated later in the synthesis from the other primary alcohol (ClS in 96). 
Oxidation of the C15 alcohol was only possible after protection of the C5 hydroxyl 
group. It was found out that TMS protection of CS hydroxyl followed by a 2-step 
oxidation afforded the corresponding carboxylic acid 97. 
Deprotection of the benzoyl group of 97 was followed by 13-lactone formation 
with BOPC1 and chlorination of the primary alcohol with Ph 3PCJ2 afforded 98, the 





Martin periodinane 35 , which was stereoselectively reduced by a ketoreductase 
enzyme to afford the desired (—)-1. 
The synthesis of salinosporamide A was achieved in twenty-four steps and 0.2% 
overall yield. The key formation of 90 was accomplished via an impressive 
enantioselective intramolecular aldol cyclisation, but protecting group manipulations 
and the regeneration of the C5 stereocentre added extra steps and lowered the yield 
of this synthetic route. 
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Reagents and conditions: (a) MsCI, Et 3N, CH202, 0 °C to ii, o/n (66%); (b) 
CeC67H20, Na!, MeCN, 60 °C, 4 h (84%); (c) t-BuOK, uHF, rt, 15 mm (64%, 70% 
de); (d) 0s0 4, NMO, H20/THF, 3 h then Na104, 2 h, (99%); (e) BnBr, t-BuOK, THF, 6 
h, 76%; (f) L1BH 4, THF, 24 h (94%); (g) TPAP (cat.), NMO, CH 202, 18 h (79%); (h) 
THF, —78 °C to ii, 11.5 h (80%); (i) HCl, THF, 60 °C, 10 h; (j) NaBH 4 , THFIH20, 30 
mm (81%, 2 steps); (k) BzCI, Et 3N, CH2C12, 10 h (87%); (I) 1,3-propanedithiol, HCI, 
CF3 CH20H, 60 °C, 4 h (94%); (m) TMSCI, Et 3N, CH2C1 2, 12 h (53%); (n) Dess-Martin 
periodinane, CH 202, 2 h; (o) NaH2PO4, NaC102, 2-methyl-2-butene, t-BuOHIH 20, 0 
°C, 1.5 h (63%, 2 steps); (p) K2CO3, MeOH, 15 h; (q) BOPCI, pyridine, MeCN, 2 h 
(60%, 2 steps); (r) Ph 3PCI 2 , pyridine, MeCN, 18 h (57%); (s) Dess-Martin periodmnane, 
CH202, 2 h (60%); (t) KRED-EXP-B1Y, NAD+, GDH-103, glucose, pH 6.9, 3 7-3 9 °C, 
40 mm (56%). 
Scheme 1.19 Macher/a's total synthesis 
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1.3. Objectives 
The outstanding biological activity of salinosporamide A together with the 
challenge of synthesising the densely functionalised and compact structure prompted 
us to investigate a synthetic route to this natural product. The ultimate aim of this 
project was to develop a synthesis of salinosporamide A which is efficient, 
stereocontrolled and amenable to the preparation of significant quantities of the 
natural product. 
Our objective was to integrate the development of new catalytic reaction 
methodologies into the synthesis of 1. In'parallel studies conducted by other PhD 
students within our group, the development of copper-, cobalt-, and nickel-catalysed 
reductive aldol cyclisations resulting in the production of -hydroxylactones and l-
hydroxylactams was being undertaken (Scheme 1.20). The successful application of 
a suitable variant of these methodologies within a complex setting, such as in a total 
synthesis of!, would serve to demonstrate the utility of this chemistry. 
] 0 _ 
o 	 metal 	I 	H 	OM 
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99 	 100 	 101 
Scheme 1.20 Reductive a/dol cyclisation methodology 
To examine the feasibility of the use of this approach in our system, an amide 
represented by 102 would be first prepared (Scheme 1.21). With this substrate, the 
conditions for the reductive aldol cyclisation would be investigated, aiming to obtain 
y-lactam 103 with good yields and diastereoselectivities. We envisaged this advanced 
intermediate could be converted into salinosporamide A (1) in a few straightforward 
operations. 
O 	 Reductive 	 0 




102 	 103 
Scheme 1.21 Reductive a/dol cyc/isation approach 
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However, at the inception of our studies these methodologies were not available. 
Therefore, we would initially focus our efforts on a racemic synthetic approach that 
looked to be concise, allowing rapid assembly of much of the functionality of 1 
(Scheme 1.22). The first target of this route was the synthesis of a y-lactam such as 
104. Three key transformations would be then performed on this substrate: selective 
reduction to the aldehyde of the diester functionality, insertion of the cyclohexenyl 
side chain and alkylation at C2. If these three operations were successful, a few final 
transformations would afford (±)-1. 
Organometallic 
Selective 	 addition 
o 	reduction o 
PG 	 PG] 
N 	 N 
Me........ CO2R 	Me ........ CHO 
HO CO2R 	 PGO CO2 R 
104 	 105  
Alkylation 
PG 	 PGO, 
- - - 	Me,.S__1I1 - - - 
- - - 
OH 




Scheme 1.22 Initial investigations to (±)-1 
If this route was successful, we hoped to investigate the development of an 
asymmetric variant. With this approach we would also learn about the chemical 
behaviour of these y—lactam intermediates and this knowledge could also be applied 
eventually into the route developed with the reductive aldol cyclisation approach. 
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2. Racemic approach based on amidomalonate aldol 
cyclisations 
When this project began, the methodology studies on the catalysed reductive 
aldol cyclisation were simultaneously initiated. Until that methodology was 
developed, efforts were focused on another synthetic approach, the development of 
which is described herein. 
2.1. Retrosynthetic analysis 
Our first approach to salinosporamide A is outlined in Scheme 2.1. 
Disconnection of the -lactone of 1, transformation of the chlorine atom on the ethyl 
side chain and deprotection of the lactam nitrogen atom lead back to intermediate 
107. It was envisioned that the hydroxyethyl side chain of 107 could be inserted, 
after protecting group manipulations, via an enolate alkylation on 106. Introduction 
of the side chain at C2 at a late stage in the synthesis would facilitate the preparation 
of derivatives of 1. 
Disconnection of the cyclohexenyl side chain of 106 reveals aldehyde 105 and 
cyclohexenyl zinc reagent 24, methodology that had been successfully developed by 
Corey and co-workers in their total synthesis of 1.26  This reaction constructs 
stereoselectively the two contiguous stereogenic centres at C5 and at C6. It was 
anticipated that aldehyde 105 could be prepared by selective mono-reduction of the 
diester functionality of 104. Our initial efforts targeted the construction of a y-lactam 
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Me 	CO2R 	 Me' 	... CH + 
HO CO2R 	 PGO CO2R 
104 	 105 	 24 
Scheme 2.1 First retrosynthetic analysis of salinosporamide A (1) 
2.2. Results and discussion 
2.2.1. Synthesis of the y-Iactam 
Inspection of the literature revealed that a y-lactam of general structure 104 had 
been prepared previously. 51 Pyrrolidinone 110 was obtained via an acid catalysed 
reaction of N-PMP diethyl aminomalonate 109 with diketene 108 (Scheme 2.2). 
y-Lactam 110 was then transformed into -lactam 111, which was proposed as a 
suitable intermediate in the synthesis of -lactam antibiotics such as thienamycin 








Me 	 ''CO2Et 
+ EtO. OEt 	
Me')— ... CO2Et 
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OH 	 H2N 
1 113 	 12 
Reagents and conditions: (a) HOAc, reflux, 72%; (b) 12, EtONa, 62%. 
Scheme 2.2 Reported example of the synthesis of 110 using diketene 
Diketene (108) is a reactive and versatile compound which is best known as a 
reagent for the preparation of acetoacetic acid derivatives (Scheme 2.3). It is a 
strained molecule which is readily ring-opened and therefore it frequently appears to 
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react as acetylketene (114). 	It is known that aliphatic amines are rapidly 
acetoacetylated by diketene, without the need for a catalyst. Therefore, in this 
example, reaction of amine 109 with diketene presumably forms acetoacetamide 115, 
which provides y-lactam 110 via an acid catalysed aldol cyclisation. 
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Scheme 2.3 Synthesis of 110 
It was therefore decided to exploit this procedure in the preparation of the 
y-lactam, which would be the starting point of our synthetic route. For this purpose, 
three aminomalonate derivatives were first prepared. The synthesis of N-PMP diethyl 
ester malonate 109 was successfully achieved reacting p-anisidine (117) and diethyl 
bromomalonate (116) in refluxing Et 20. Following the reaction, a simple 













Reagents and conditions: (a) Et20, 2 h heating under reflux, 14 h rt, 85%. 
Scheme 2.4 Synthesis of amine 109 
N-PMB-protected aminomalonates 119 and 121 were also prepared (Scheme 
2.5). The use of a PMB protecting group on the nitrogen was desirable, because 
although similar conditions are employed for the deprotection of both PMP and PMB 
groups (CAN reagent), the PMB group is much more readily cleaved than the PMP 
group. 54  In addition to this, Corey employed a N-PMB protecting group in the 
organometallic addition into aldehyde 23 (Scheme 1.6) to introduce the cyclohexenyl 
side chain. 26 
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Diethyl bromomalonate (116) and p-methoxybenzyl amine (118) were reacted in 
the presence of Et 3N to yield amine 119 (52%), although with a lower yield than that 
obtained for the N-PMP equivalent. Similarly, 118 was reacted with dimethyl 
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o 	o 0 	0 
120 	 118 121 3540% 
Reagents and conditions: (a) Et3N (1 eq), MeCN, 0 °C to rt, 14 h. 
Scheme 2.5 Synthesis of N-PMB protected amines 119 and 121 
We proceeded then to study the formation of the y-lactam. Two procedures were 
investigated. Initially, we conducted the reported procedure, which involved reaction 
of diketene with the aminomalonate. 5 ' Due to the fact that diketene is now difficult to 
access from commercial sources, we decided to modify slightly the original 
procedure, by generating diketene in situ. Therefore, acetyl chloride was treated with 
Et3N, followed by addition of amine 121, to successfully afford y-lactam 123. 
Scheme 2.6 outlines the mechanism of this reaction. One equivalent of Et 3N reacts 
with acetyl chloride (122), eliminating HC1 and forming ketene (124). A 
substoichiometric quantity of base then reacts with some of this ketene to form an 
ammonium enolate (125), which attacks ketene present in the media to give diketene 
108. Then, in the presence of DMAP as a catalyst, amine 121 reacts with diketene, 
forming the uncyclised amide 127, which spontaneously cyclises to form y-lactam 
123 in good yield. 
33 










Me- 	. " CO2Me 
0 0 	 HO CO2 Me 












+ 	 _ 00 0) 	
)-Ii( 
121 0 0 	Me 't N 
0 
II NEt3 	 (_,NEt3 	
DMAP 	 MeO...OMe 
124 	125 	 126 	 108 	 127 	o 	o 
Reagents and conditions: (a) Et3N (1.1 eq), DMAP (0.2 eq), CH 2Cl2 , 
0 °C to rt, 14 h, 70-80%. 
Scheme 2.6 Mechanism of the formation of Iactam 123 
• 	The second procedure investigated involved the reaction of an aminomalonate 
with dioxinone 129. In 1952, Carroll and Bader described the acid catalysed reaction 
of diketene and acetone forming the dioxinone (Scheme 2.7). Subsequently, they - 
reported that 129, when pyrolysèd, decomposes into acetylketene (114) and acetone, 
via a retro-Diels—Alder fragmentation. 
55  Clemens reported in 1985 the pyrolysis of 
129 in the presence of nucleophiles as a general purpose acetoacetylation 
procedure. 56  Dioxinone 129 is a commercially available liquid, which is easily 
handled and stored, and the acetylation reactions are rapid and provide only volatile 
products. 
Me Me 	 1 	1 
0 	H 	 >< Nuc 	
0 0 o _____ 
+ Me 	
o 9 10 Me 	 Me 0 	 [Me C] 	 Nuc 
108 	128 	 129 	 114 	 130 
Scheme 2.7 Synthesis and use of dioxinone 129 
We were pleased to find that 'y-lactams 110 and 131 were readily prepared by 
mixing dioxinone 129 and the corresponding amine (109 or 119) in refluxing toluene 
(Scheme 2.8). Under the reflux conditions, the amine reacts with the acetylketene 
(114) formed in the reaction, to give an acetoacetamide which spontaneously affords 





Me 	Me 	 HN- PG 	
0 
a 	 PG 
Me O + EtO
OEt 	
Me... ... CO2Et Yly 
0 	 HO CO2Et 







I )c 1 + 	 PG EtO OEt 	 EtO OEt 
j 	0 0 	 o o 
109 PG=PMP 	 132 PG=PMP 114 	 119 PG=PMB 133 PG=PMB 
Reagents and conditions: (a) Toluene, 110 °C, 14 h. 
Scheme 2.8 Synthesis of tlactams 110 and 131 using dioxinone 129 
This procedure was very easily performed and afforded the desired cyclised 
products in good yields. Due to this efficiency and practicality, it became our 
preferred method for the synthesis of the 'y-lactam. It was decided to use amines 
y-lactams 110 and 131 in parallel studies in the development of the synthesis, since 
amines 109 and 119 were obtained in higher yields than amine 121. Moreover, the 
use of these two y-lactams would keep consistency in the ester moiety, and only the 
nitrogen protecting group would vary. It was assumed that having an ethyl ester 
instead of a methyl ester as the intermediates in Corey's synthesis would not have an 
important effect in the synthetic route. 
2.2.2. Regioselective reduction of the ester and cyclohexenyl 
insertion 
With the 'y-lactam in hand, the next step was the selective reduction of the ester 
anti to C3 hydroxyl to the aldehyde (Scheme 2.9). By having the aldehyde anti to the 
tertiary alcohol (135), the side chain at C5 would be correctly inserted at this 
position. It was anticipated that protection of C3 hydroxyl with a suitably bulky 
group (134) would be sufficient to direct reduction of the ester anti to it. The ester 
syn to the alcohol (136) is necessary in order to form the 3-lactone of 
salinosporamide A. 
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Scheme 2.9 Selective reduction of the diester functionality 
Several protection attempts using trimethylsilyl triflate or tert-butyldimethylsilyl 
triflate were unsuccessful, with none or very little desired product obtained. Finally, 
it was found that y-lactams 130 and 131 were successfully protected with TMSC1 to 
give the protected silyl ethers 137 and 138, as shown in Scheme 2.10. 
0 	 0 
PG 	 a 	
N- PG 
Me ........ CO2 Et 	 Me ........ CO2 Et 
HO CO2Et 	 TMSO CO2 Et 
130 PG = PMP 	 137 PG = PMP 92% 
131 PG=PMB 138 PG=PMB 85% 
Reagents and conditions: (a) TMSCI (1.5 eq), DMAP (0.2 eq), Et 3N (3 eq), 
CH2Cl2, 0 °C to rt, 14 h. 
Scheme 2.10 TMS protection of C3 hydroxyl 
Initial investigations on the selective mono-reduction to the aldehyde, and 
subsequent addition of the side chain, were done employing the PMP-derivative. A 
selective reduction of diester 137 to yield an a-formyl ester was achieved using a 
method described by Burton. 57  In 1993, the Burton group reported the transformation 
of 139 to predominantly •trans-1,4-dialdehyde 140 via a stereoselective low-
temperature reduction with an excess of DIBAL—H (Scheme 2.11). 
MeO2CCO2Me 	 MeO2C CHO 	+ Me02CCHO 
a-b  
Me02C CO2 Me 	 OHC CO2Me 	Me02C CHO 
139 	 140 (90:10) 63% 	.141 
Reagents and conditions: (a) DIBAL—H (4 eq), CH 2Cl 2 , —78 °C, 3 h; (b) 
HCI (aq), —65 °C, 63%. 
Scheme 2.11 Burton's stereoselective reduction using DIBAL—H 
36 
CHAPTER 2 	 Racemic Approaches 
After some investigation, the optimal conditions for the reduction of 137 were 
found to be a slow addition of 3.5 equivalents of DIBAL—H to a solution of the ester 
in CH2C12 at —78 °C. This reaction did in fact provide a mono-aldehyde product with 
high selectivity, and minimal traces of over-reduced or doubly reduced products 
were detected in the unpurified mixture. Initially, we assumed that reduction had 
occurred anti- to the bulky trimethylsilyloxy group to provide the desired aldehyde. 
In fact, reduction had occurred in the undesired sense to provide aldehyde 144 
(Scheme 2.13, vide infra). 
This outcome was discovered with the next transformation, the insertion of the 
cyclohexenyl side chain, which was done according to Corey's procedure. 26 
2-Cyclohexenyl tributyltin was first prepared, via a 1,4-palladium catalysed addition 
of tributyltin hydride into 1 ,3-cyclohexadiene (Scheme 2.12). Initially, this reaction 
was carried out following the reported method,36' 58  which utilises Pd(PPh 3)4 in THE 
However, it was discovered that the reaction also proceeds using only 0.5 mol% of 
the less expensive Pd2(dba)3 and 4 mol% of PPh 3 . Toluene was observed to be a 
better solvent than THE After stirring overnight, the catalyst was removed by 
filtration of the reaction mixture through a silica plug and distillation of the crude 
product under high vacuum gave allyistannane 143 (85% purity)'. 
SnBu3 
Oaa 
142 	 143 
Reagents and conditions: (a) Bu3 SnH (1 eq), Pd 2(dba)3 (0.5 mol%), PPh 3 
(4 mol%), toluene, rt, 14 h, 52%. 
Scheme 2.12 Synthesis of 2-cyclohexenyl tributyltin 143 
Subsequently, 2-cyclohexenyl tributyltin 143 was transmetallated at —78 °C, first 
with n-BuLi and then with zinc chloride, forming a solution of 2-cyclohexenyl zinc 
chloride 24. A solution of aldehyde 144 in THF at —78 °C was transferred into a 
solution of the zinc chloride reagent, which provided homoallylic alcohol 145 in 83% 
yield (Scheme 2.13). 
'The purity of 143 was assessed by 'H NMR spectroscopy, calculating the amount of Bu 3 SnH 
remaining in the sample by integration of the expected 15H from 3 x CH 2 CH 2CH2CH3 . 
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Reagents and conditions: (a) DIBAL—H (3.5 e, CH202 , —78 °C, 1.5 h, 
69%; (b) 2-cyclohexenyl zinc chloride 24 (2.5 eq), THF, —78 °C, 4 h, 83%. 
Scheme 2.13 Synthesis of undesired addition product 145 
Alcohol 145 was isolated as a crystalline solid and it was possible to establish its 
connectivity and relative stereochemistry using X-ray crystallography (Figure 2. 1), 
which unfortunately, revealed unambiguously that reduction of 137 had occurred in 
the undesired sense. Presumably, prior coordination of DIBAL—H to the oxygen 
atom of the TMS ether was responsible for the outcome of these reactions (chelate 
146, Scheme 2.13). Although not expected, similar effects have been observed by 
Evans and co-workers in carbonyl addition reactions of silyloxyaldehydes using 
aluminium Lewis acids. 59 
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Figure 2.1 X-ray crystal structure of 145 
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Therefore, a reducing agent without this coordinating ability was required, in the 
hope that the steric hindrance would this time be the determining factor for the 
selectivity of the reaction. A range of alternative procedures for selective 
monoreduction of 137 were evaluated and it was discovered that NaBH 4ILiC1 in 
THF/EtOH6° was efficient in this regard to provide alcohol 147 in 90% yield 
(Scheme 2.14). Re-oxidation of 147 with either Dess-Martin periodinane 35 or under 
Swern conditions 61  provided aldehyde 148, which showed slight differences in its 'H 
NMR spectra to aldehyde 144. The introduction of the 2-cyclohexenyl chain was 
carried out following the same procedure as with undesired aldehyde 144, to provide 
desired homoallylic alcohol 149 in 85 % yield (Scheme 2.14). 
( N _ PMP a 	 N ,PMP b 	(IL N _PMP c 	 PM 
CO2 EI 	Me..j\-__(  ... CI-120H 	Me..i—..CHO 
TMSO CO2 Et 	 TMSO CO2 Et 	 TMSO CO2Et 	 TMSO CO2 Et 
137 	 147 	 148 	 149 
Reagents and conditions: (a) NaBH 4 (5.5 eq), LiCI (5.5 eq), THF, EtOH, 
0°C to rt, 14 h, 90%; (b) (COCI) 2 (2.1 eq), DMSO (4.2 eq), Et3N (4.2 eq), 
CH2Cl2 , —78 °C, 3 h, 90%; (c) 2-cyclohexenyl zinc chloride 24 (2.5 eq), 
THF, —78 °C, 4 h, 84%. 
Scheme 2.14 Synthesis of desired addition product 149 
The X-ray crystal structure of alcohol 149 was obtained, which further confirmed 
that reduction of 137 had occurred in the desired sense, in addition to showing that 




Figure 2.2 X-ray crystal structure of 149 
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Once the optimal conditions for the mono-reduction and subsequent insertion of 
the cyclohexenyl group were found, these were applied to the PMB-derivative 138. 
Selective reduction of 138 to the alcohol was successfully achieved (Scheme 2.15), 
but in slightly lower yields (68%) than those for the PMP 'y-lactam. This was due to 
formation of the diol, product of reduction of both esters, before starting diester 138 
was consumed. The cyclohexenyl side chain was inserted following the same 
procedure employed for 148 with good yield and high diastereoselectivity. An X-ray 
crystal structure of 151 was not obtained, but by analogy with the PMP-derivatives, it 
was assumed that alcohol 151 had the desired relative stereochemistry. 
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)L PMB 	a-b 	 .PMB 	c 	 )t PM8 
N- 
	
c 	N' 	I 
Me.......CO2Et 	 Me ........ CHO 
TMSO CO2Et 	 TMSO CO2Et 	 TMSO CO2 Et 
138 	 150 	 151 
Reagents and conditions: (a) NaBH4 (2 eq), LiCI (2 eq), THF, EtOH, 
0 °C to rt, 14 h, 68%; (b) (COd) 2 (2.1 eq), DMSO (4.2 eq), Et 3N (4.2 eq), 
CH202 , -78 °C, 4 h, 78%; (c) 2-cyclohexenyl zinc chloride 24 (2.5 eq), 
THF, -78 °C, 4 h, 71%. 
Scheme 2.15 Synthesis of PMB protected alcohol 151 
2.2.3. Introduction of the C2 substituent 
Focus was turned then to the installation of the side chain at C2 via enolate 
alkylation. The best available precedent for this transformation was found in the total 
synthesis of omuralide (2) by the Donohoe group. 62  In their route, -hydroxylactam 
152 was alkylated with Mel using LDA as base to provide 153 in 63% yield, along 
with the undesired diastereomer 154 in 10% yield (Scheme 2.16). 
0 	 0 	 0 
1 ,BOC 	 Me 	IL Boc 	Me., )L Boc  
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Me 	a + 
OAc I OAc I OAc 
HO CO2Et 	 CO2EI 	 CO2Et 
152 	 153 63% 	 154 10% 
Reagents and conditions: (a) LDA (2.4 eq), HMPA (15 eq), Me! 
(9.3 eq), THF, —78 °C. 
Scheme 2.16 Donohoe's a/ky/at/on at C2 in the synthesis of omuralide 
40 
CHAPTER 2 	 Racemic Approaches 
y-Lactam 152 had the C5 hydroxyl group acetate protected but a free C3 
hydroxyl group. Surprisingly, no alkylation of the acetate ester was observed. 
However, we believed that the free C3 hydroxyl group was required to avoid 
undesired elimination to form the corresponding a,3-unsaturated lactam. The tertiary 
alcohol would be deprotonated under the basic conditions of the reaction and 
therefore a minimum of two equivalents of base was needed for the formation of the 
enolate. 
In light of this precedent, we desired access to a 3-hydroxylactam 157 (Scheme 
2.17), in which the C5 secondary alcohol is protected and the C3 tertiary alcohol 
unprotected. Protection of the secondary alcohol of 149 was first attempted. 
Unfortunately, this hydroxyl group proved to be extremely unreactive, presumably 
due to steric crowding, and many attempts to install a suitable protecting group (such 
as acetate, benzyl, pivaloate, TBS etc) were fruitless. It was therefore decided to 
deprotect the C3 hydroxyl group and attempt a selective protection of the secondary 
over the tertiary alcohol. Diol 156 was easily obtained from 149 using CSA in EtOH. 
However, all efforts to protect selectively the secondary alcohol were unsuccessful 
and forcing conditions resulted in reprotection of the tertiary alcohol. 
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Scheme 2.17 Unsuccessful attempts to /3-hydroxylactam 157 
The protection of the secondary alcohol of the PMB derivative 151 also proved to 
be very challenging. Protection with a benzyl, pivaloate, TBS or TES group under 
several conditions were investigated but all attempts met with failure. However, 
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protection as the acetate ester was successful, and subsequent deprotection of the 








TMSO CO2Et 	 TMSO CO2 Et HO CO2 Et 
151 	 158 	 159 
Reagents and conditions: (a) Ac20 (3 eq), Et3N (5 eq), DMAP (0.8 eq), 
CH2C12 , 0 °C to rt, 14 h, 90%. (b) CSA (2 eq), EtOH, ii, 0.5 h, 91%. 
Scheme 2.18 Successful transformations to alkylation substrate 159 
y-Lactam 159 was ready for alkylation. Although it displays differences to the 
compound that Donohoe and co-workers had successfully alkylated in their synthesis 
of omuralide (152),62  most notably in a denser, more sterically crowded substitution 
pattern and a different nitrogen protecting group, we felt that there might be enough 
similarities to provide a good chance of success. 
Donohoe's procedure involved the addition of methyl iodide (9.3 equivalents) to 
a solution of LDA (2.4 equivalents) at —78 °C, followed by the addition of a solution 
of alcohol 152 and HMPA (15 equivalents) in THF (Scheme 2.16). Additives such as 
HMPA, DMPU or TMEDA are often used as a cosolvent in reactions with 
organolithium reagents because they coordinate to the lithium cations, breaking up 
oligomers of lithium species and leaving a more reactive monomeric carbanion 
available for the reaction. 63  Because HMPA is highly toxic (it is a reported 
carcinogen), the use of DMPU or TMEDA is preferred. The influence of LiC1 on the 
structure and reactivity of lithium enolates has also been reported. 64 
When we initiated the investigation of the alkylation reaction we decided to 
initially employ the very reactive Me! as alkylating agent, in order to test the 
reaction. Failure with this electrophile was likely to mean failure with a more 
complex alkylating agent required to give the desired chioroethyl side-chain. 
Numerous conditions were attempted: various multiple equivalents of LDA, 
NaHMDS or KHMDS as base, with or without HMPA or DMPU, with or without 
LiC1 additive; but no evidence for the desired product 160 was obtained (Scheme 
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2.19). In some cases, only unreacted starting material was recovered, while in others, 
complex mixtures of products were obtained. 
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Scheme 2.19 Alkylation reaction trials with substrate 159 
Model Studies 
Analysis of the NMR spectra of the alkylation reactions performed on 159 
proved to be complicated; furthermore, valuable 2-cyclohexenyl tributyltin 143 was 
being consumed during the study. Therefore, we decided to prepare a structurally 
less complex substrate, aiming for a more experimentally convenient preparation and 
also in order to facilitate the analysis of the NMR spectra. A thorough study of the 
alkylation reaction would then be undertaken on these derivatives. After finding the 
optimal conditions for the alkylation reaction, these would be applied to 159, which 
would allow the synthesis of our natural product. 
In one of the synthetic routes to omuralide (2) developed by Corey's group, the 
reaction of aldehyde 161 with isopropylmagnesium bromide 162 afforded alcohol 
163 stereospecifically and in very good yields (Scheme 2.20). In this 
transformation, the reaction of isopropenylmagnesium bromide with TMSC1 at 
-40 °C is slower than with the aldehyde; attack of the Grignard reagent forms an 
alkoxide, which is rapidly silylated, avoiding a retroaldol cleavage. The isopropenyl 
group was then reduced to give the isopropyl side chain required for the synthesis of 
2. 
Me 	 PMB 
BrMg 1 
 Me Me)i 
	
Me 	 Me 
_CHO 	 Me 	 Me 
	
H ~4 ~-. OH. 
TBSO CO2 Et 	 TMSO CO2Et 	 0 
161 	 163 	 2 
Reagents and conditions: (a) 162, TMSCI, THF, —40 °C, 0.5 h, 97%. 
Scheme 2.20 Corey's insertion of the isopropenyl group in the synthesis of 
omuralide 
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Consequently, for our model system we decided to insert an isopropyl group at 
C5 instead of the cyclohexenyl group, since this was an efficient and simple reaction, 
performed with a commercially available reagent. Moreover, if the route was 
successful, we would be preparing an omuralide-salinosporamide hybrid, compound 
that had also been recently synthesised by Corey. 23  Isopropenyl magnesium bromide 
was reacted with aldehyde 150, in the presence of TMSC1 to obtain alcohol 164 in 
good yield (Scheme 2.21). CS of alcohol 164 was expected to have the desired 
stereochemistry, by analogy with Corey's reaction. 
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Reagents and conditions: (a) TMSCI (5 eq), 162 (3 eq), THF, -78 °C, 3 h, 76%. 
Scheme 2.21 Introduction of the isopropenyl side chain 
As previously described, before attempting the alkylating reaction, alcohol 164 
needed to be transformed into a -hydroxy1actam with a free C3 hydroxyl group and 
the CS hydroxyl group protected. Acetate protection of the secondary alcohol of 164 
was readily achieved using acetic anhydride and pyridine as base (Scheme 2.22). It 
should be noted that, protection attempts using other protecting groups, such as 
benzyl or pivaloate, were fruitless. Deprotection of the TMS group of 165 in the 
presence of CSA was completed overnight, affording isopropenyl derivative 166, 
which was then ready for alkylation. 
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I 	 b 
Me)—t_--<'Me 	 Me'.)—j----<Me . 	 Me" P
PM 
Me 
TMSO CO2 Et 	 IMSO CO2 Et 	 HO CO2EI 
164 	 165 	 166 
Reagents and conditions: (a) Ac 20 (6 eq), pyridine (3.5 eq), DMAP (0.2 
eq), CH2Cl2, 0 °C to rt, 14 h, 92%; (b) CSA (4 eq), EtOH, rt, 14 h, 83%. 
Scheme 2.22 Obtention of/3-hydroxylactam 166 
44 
CHAPTER 2 	 Racemic Approaches 
Hydrogenation of 166 using Pd/C afforded the new alcohol 167 containing the 
isopropyl group, albeit in low yield (Scheme 2.23). 
	
('N'J 	 a 	
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Reagents and conditions: (a) H2, PdJC (0.7 eq), EtOH, rt, 18 h, 50%. 
Scheme 2.23 Hydrogenation of 166 reveals the isopropyl side chain 
The investigation of the reaction was initiated employing alcohol 167 and again 
utilising the very reactive Mel as the alkylating agent. Numerous conditions were 
attempted. Firstly, Donohoe's conditions 62  were repeated, procedure that involved 
the addition of a solution of the alcohol to a solution of LDA and Mel; however, 
none of the desired methylated product was observed. This reaction was repeated 
without HMPA or using DMPU instead of HMPA. The use of other bases, such as 
KHMDS and LTMP, was also examined. An attempt was made altering the order of 
addition, therefore adding a solution of alcohol 167 into a solution of LDA, to form 
the enolate, followed by addition of Mel. The reaction was also performed using allyl 
iodide instead of methyl iodide. However, all efforts to obtain the alkylated product 
were unsuccessful (Scheme 2.24). 














169 R = Allyl 
Scheme 2.24 Alkylation reaction trials with substrate 167 
Several variables had been studied for this reaction but, in general, the procedure 
involved the addition of a base (typically LDA) to a solution of 167, the reaction 
mixture was then stirred at —78 °C for 30-60 mm, followed by the addition of Mel. In 
none of the conditions attempted desired alkylated product 168 was formed; 
however, a methylated product was obtained as a major product (50-75%). Careful 
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analysis of these reactions revealed the formation of a methylated compound, which 
displayed spectroscopic data consistent with the structure represented by enamide 
172 (Scheme 2.25). We assumed that 172 was formed as a result of alkoxide 170 
undergoing elimination of the acetate to provide ring-opened acetoacetamide 171, 
which is then methylated under the reaction conditions. The 'H NMR spectrum 
showed a doublet at high chemical shift (6.7 ppm) and there was no signal for the 
methyl of the acetate group. This doublet was assigned to the proton on the double 
bond formed in the elimination of the acetate group (H A). When the ' 3C NMR 
spectrum was examined, we observed a new quaternary carbon at 205.3 ppm, which 
was assigned to the newly formed methyl ketone. The 'H NMR spectrum of this 
substrate showed in fact that 172 was a mixture of two compounds, due to the 
formation of either the double bond ZIE isomers or to a mixture of two amide 
rotamers. 
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Scheme 2.25 Fragmentation of 167: acetate elimination and ring opening 
When repeating the reaction in the absence of methyl iodide, the non-alkylated 
amide 171 was obtained (also as a mixture of two isomers or rotamers), thus 
demonstrating that the alkylation at C2 occurred in a second step, after the 
elimination and ring opening. The reaction was also performed using allyl iodide 
instead of methyl iodide and it afforded the analogous allylated amide. 
The C2 alkylation of the isopropenyl derivative 166 was also investigated. The 
same combinations of conditions (different bases, addition of HMPA or DMPU, 
order of addition) were explored, however, all attempts failed to give the desired 
product (173). In this occasion, a methylated product, with spectroscopic data 
consistent with acetoamide 174 was isolated (Scheme 2.26). This product is a result 
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of a similar elimination and ring-opening process, followed by alkylation, to the one 
detailed for the formation of 172 (Scheme 2.25). 
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Scheme 2.26 Failure in the preparation of 173 and formation of 174 
Employing the model substrates, we had identified the fragmentation process that 
was occurring under the reaction conditions. Despite this discouraging result, it was 
necessary to verify whether a similar ring-opened product was obtained when 
performing the reaction on y-lactam 159, the substrate with all the required 
functionalities for the synthesis of (±)-1. 
The alkylation reactions attempted on 159 produced a slightly more complex 
mixture of products than 167and 166. However, now that we were able to recognise 
the pattern of the fragmentation product in the 'H NMR spectrum, it was confirmed 
that the same ring-opening process was clearly taking place and compound 175 was 
being formed (Scheme 2.27). 
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Scheme 2.27 Final attempt of the alkylation on 159 
Although for C2 alkylation we had opted to target substrates containing a free 
alcohol at 0 to avoid hydroxide elimination, clearly this feature was resulting in the 
undesired ring-opening/acetate elimination described above. Therefore for 
comparative purposes, we attempted the alkylation of 158, which has the 0 alcohol 
TMS protected (Scheme 2.28). Unreacted starting material was recovered when only 
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1.2 equivalents of base were employed. However, when using an excess of LDA (2.2 
eq) in HMPA/THF for enolisation, followed by addition of Mel (9 equivalents), 177 
was obtained in a rapid reaction, which is the product of methylation of the acetate 
ester. There was no evidence of methylation at C2, or elimination of the 
trimethylsilyloxy substituent. 
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Scheme 2.28 Acetate methylation of 158 
The reaction was also performed on 165, and acetate methylation occurred again. 
Therefore, protection of the secondary alcohol at C5 with a non-enolisable protecting 
group was necessary. However, as previously described all efforts to protect the C5 
hydroxyl group of 151 and also of 164 with any other group than acetate were 
unsuccessful. 
The alkylation reaction was also performed with N-PMP diol 156 and ,T -lactam 
138 (Scheme 2.29), but mostly starting material was recovered in both cases. 
Comparing our substrates with Donohoe's (152, Scheme 2.29),62  we wondered why 
the enolate formation and alkylation was unfavoured in our system. Although the 
presence of the C3 methyl made a more dense structure, we believed that the main 
difference with our system was the protecting group on the amide nitrogen. A 
possible explanation for the failure of these reactions was the lower reactivity of the 









Me 	CO2Et 	 , Me 
I OAc 
TMSO CO2Et 	 HO CO2Et 
138 	 152 
Scheme 2.29 Comparison of our substrates with Donohoe's 
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The N-Boc T-lactam derivative could potentially be prepared, but Danishefsky 
reported 27  that the success of Corey's procedure 26  for the insertion of the 
cyclohexenyl side chain is very dependent on the protecting group of the amide. 
Therefore, a Boc group could be not beneficial for that step. The PMB group could 
have also been replaced by a Boc group only prior to the alkylation reaction, but this 
would mean adding extra steps to the synthesis. 
2.3. Conclusions 
We employed an easy and efficient way to prepare y-lactams of general structure 
104. A selective mono-reduction of the ester to the aldehyde, followed by insertion 
of the cyclohexenyl side chain into the aldehyde were successfully performed. 
The next key step in the synthetic sequence was the introduction of the side chain 
at C2. Unfortunately, all efforts to induce the formation of the enolate and 
subsequent reaction with the alkylating agent were fruitless, and the desired alkylated 
product was not obtained. When the reaction was performed on 3-hydroxy y—lactam 
substrates protected at C5, a fragmentation process ocurred. Throughout the study, 
we had no evidence for the formation of the amide enolate. It was speculated that 
changing the protecting group on the nitrogen could make the enolate more reactive. 
The investigation of the racemic synthetic route proved more challenging than 
originally expected. Therefore, although we had managed to prepare compounds 
with much of the functionality required for salinosporamide A (1), the unsuccessful 
C2 alkylation studies prompted us to consider alternative strategies. Although we 
were not able to complete the route, with this approach we gained valuable insight 
into the reactivity and chemical behaviour of the y-lactam substrates. This knowledge 
was fundamental for the development of the rest of the project. Most importantly, we 
were able to readily apply Corey's method for the insertion of the cyclohexenyl chain 
in the final approach, whereby we achieved the formal synthesis. 
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3. Reductive aldol cyclisation approach 
A series of metal-catalysed reductive aldol cyclisation reactions for the formation 
of 3-hydroxylactones and -hydroxylactams in a highly diastereoselective fashion 
had been developed in our laboratories. 65-67  The studies carried out on the application 
of this methodology for the introduction of the T-lactam moiety in salinosporamide A 
will be described in this chapter. 
3.1. Aims 
Disconnection of the 13-lactone and the cyclohexenyl group of 1, along with 
appropriate functional group manipulations/interconversions lead back to y-lactam 
103. We envisaged that y-lactam 103 could be synthesised from an amide enolate 
such as 178, via an intramolecular aldol reaction with the methyl ketone moiety 
(Scheme 3.1). A crucial advantage over the previous approach is that the reductive 
aldol cyclisation is expected to afford the y-lactam intermediate 103 having the side 



















Scheme 3.1 Formation of the !actam via an intramolecular a/do! reaction 
In order to obtain f3-hydroxylactam 103 in an intramolecular aldol fashion, the 
main challenge was to regioselectively form the amide enolate over the ketone 
enolate. Control of the regioselectivity of the enolisation was essential, because 
under traditional aldol reaction conditions ketone enolate 180 would be the first to 
form, due to a higher acidity of the protons and also to a lower steric hindrance. 
(Scheme 3.2). 
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Scheme 3.2 Favoured formation of ketone enolate 180 under classical aldol 
conditions 
We reasoned that the best approach to overcome this selectivity problem would 
be a reductive aldol protocol, which utilises an a,-unsaturated amide as a latent 
enolate. Reductive enolate formation of (x,-unsaturated amide 102, followed by 
aldol reaction with the methyl ketone, would provide access to the target y-lactam 
103, as represented in Scheme 3.3. 
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Scheme 3.3 Reductive aldol approach for the preparation of lactam 103 
Important advances have been made in the field of the reductive aldol chemistry 
in recent years. This technique has become an important tool in organic synthesis and 
the application of this methodology in synthesis of natural products has already been 
possible, as it will be described in the next section. Although the intramolecular aldol 
reaction of enones with ketones or aldehydes for the formation of carbocyclic rings 
had been widely described in the literature, when this project was started there were 
no examples of reductive aldol cyclisations of a,-unsaturated amides to afford 
lactams. With this observation, our group initiated a programme for the development 
of d-block catalysed reductive aldol cyclisation of (x,13-unsaturated  amides and, 
although not relevant to this project of a,13-unsaturated  esters, to yield heterocyclic 
products. The aim was to subsequently apply this methodology into the synthesis of 
the 3-hydroxy-y-lactam moiety of salinosporamide A. 
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3.2. The reductive aldol reaction 
The aldol reaction 
The aldol reaction is an extraordinarily important carbon-carbon bond-forming 
tool in organic synthesis, and is considered the, most important method for the 
construction of -hydroxy carbonyl compounds.  68  The addition of an' enolisable 
carbonyl to a ketone or, more typically, to an aldehyde (due to its higher 
electrophilicity) affords a 3-hydroxy carbonyl compound, forming a new C-C bond 
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Scheme 3.4 The a/do! reaction 
The classic aldol reaction is a highly atom efficient process but the chemo- and 
regio selectivity in the formation of enolates from unsymmetrical precursors has 
represented a big challenge. The development of the asymmetric aldol reaction has 
been one of the most important topics in modern catalysis and the control of its 
stereoselectivity has now reached impressive levels. In natural product synthesis, 
control of the absolute stereochemistry when creating new stereocentres is 
fundamental and that is the reason why the asymmetric aldol reaction has been 
extensively used for the construction of complex molecules over the last three 
decades. 69 
In the early days of asymmetric synthesis, studies were limited to stepwise aldol 
approaches that utilised preformed enolates. 70 Two methods were extensively 
developed: the use of stoichiometric amounts of chirality in the form of auxiliaries or 
ligands (asymmetric modification of the enolate or of the electrophile) and the 
catalytic approach using chiral Lewis acids. 
Crimmins 71 , Evans72, Oppolzer73 , Massamune74 , Paterson  75 and Denmark 76 
groups have been the main contributors to the methodology employing chiral 
auxiliaries or highly efficient catalysts to generate aldol products with high 
enantioselectivity. 
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In order to avoid the use of stoichiometric amounts of chiral promoters, the 
catalytic version of the enantioselective aldol reaction was investigated. This 
methodology required a reaction catalyst to initiate and mediate the reaction. 
Therefore, the catalyst represented the vehicle for influencing reaction 
stereoselection. This reaction design needed the identification of a suitable latent 
enolate that would not react with the electrophile without the presence of the 
activating agent. Mukaiyama 77 first recognised enolsilanes as the requisite latent 
enolate equivalents to which the addition of a chiral metal-based Lewis acid would 
promote the asymmetric catalysed aldol reaction (Scheme 3.5). Since the discovery 
of the Mukaiyama aldol reaction, there has been a great progress in the development 
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Scheme 3.5 Lewis acid catalysed a/do! reaction 
Although achieving high levels of diastereo- and enantioselectivity, these 
strategies always require the transformation of one of the reagents prior to the aldol 
addition. Ideally, catalytic methodologies should employ unmodified substrates. The 
direct catalytic asymmetric aldol reaction has been extensively developed in recent 
years, but these methodologies are still limited to the use of symmetric ketones, 
ketones possessing a single set of acidic hydrogens, or ketones which incorporate 
hydroxyl directing groups. 79 
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The reductive aldol reaction 
The use of enones represents an alternative way of achieving a selective enolate 
formation. Stork established that tandem enone reduction-enolate alkylation is an 
effective method to control the regiochemistry in enolate-mediated C-C bond 
formations (Scheme 3 . 6) . 80 
0 	 OLi 	 OLi 
R 	 R2 	
LDA 	
+ R2 	R' 	 R2 
190 	 191 	 192 
0 	 H-M 	 H OM 




Scheme 3.6 Control of the enolisation regioselectivity using enones as latent 
enolates equivalents 
The hydrometallation of aj3-unsaturated carbonyl compounds has proven to be a 
mild and versatile method for enolate formation, being amenable to catalysis. 81 The 
reductive aldol reaction involves the direct metal-catalysed reductive addition of 
a,f3-unsaturated carbonyl compounds with aldehydes or ketones (Scheme 3.7). 
OH 0 
0 	 Me 0 	 tal-H 
R 	+ 	 x 	then H3O 	
R X 
Me 
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Scheme 3.7 Transition metal-catalysed reductive aldol reaction 
• The first example of a reductive aldol coupling was reported by Revis and Hilty 
in 1987.82  They demonstrated that the reaction of a,3-unsaturated esters with ketones 
or aldehydes in the presence of substoichiometric amounts of RhC1 3 3H20 (0.09 
mol%) and trimethylsilane (1.3 mol%) represents a general and mild method to form 
3-si1oxy esters (Scheme 3.8). The coupling proceeded well for several types of 
ketones and also for acetaldehyde. As nucleophiles, only esters were employed, since 
methyl vinyl ketone did not couple to acetone, and silyl enol ether (200) was formed 
instead. 
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Reagents and conditions: (a) cat RhC1 3 3H20, Me3 S1H, rt, 95%. 
Scheme 3.8 First example of a catalytic reductive aldol reaction 
Silyl ketene acetal (201) was prepared independently and reacted with acetone in 
the presence of a substoichiometric quantity of RhC1 3 3H20, but only traces of the 
aldol product were formed. This eliminated the possibility of the Rh species acting as 
a Lewis acid in the reaction, thus supporting the conjugate reduction followed by 
aldol reaction mechanism. 
Since the Revis and Hilty report, there have been numerous advances in the 
reductive aldol reaction, employing a broad variety of transition metal catalysts and 
reaction conditions. The reductive aldol reaction has already been fully reviewed in 
the literature; 81' 83, 84 the rest of this section will therefore focus on developments in 
the field that are directly related to this project. Two aspects will be covered: 
methodologies that have been successfully applied towards the synthesis of natural 
products and the methodologies reported for the formation of carbocyclic rings, 
which constitute the precedents for the methodology studies carried out in our group. 
In 1990, Matsuda made an important contribution in the rhodium-catalysed 
reductive aldol reaction, reporting the first coupling of a,-unsaturated ketones with 
aldehydes, to form f3-siloxy ketone aldols, using Rb 4(CO) 1 2 as catalyst. 85 
Nevertheless, Morken has been one of the main contributors to the Rh-catalysed 
reductive aldol reaction. As little was known about the mechanism, his aim was to 
find the most efficient catalyst system. A high-throughput evaluation of 192 
independent catalytic systems was performed . 86 The reaction chosen for the 
screening was the reaction of methyl acrylate with benzyldehyde. He examined four 
complexes, Co(acac) 2 2H20, [Pd(allyl)Cl]2, [Ir(COD)Cl] 2 and [Rh(COD)Cl] 2, six 
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hydride sources and seven chiral ligands. The combination of {Rh(COD)Cl] 2 , 
C12MeSiH and Me-DuPhos (204) was found to be the most successful one (Scheme 
3.9), providing diastereoselectivities of up to 23:1 (syn:anti) and relatively high 
yields (15-82%). 
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Scheme 3.9 Morken's catalytic stereoselective reductive aldol reaction 
Morken also reported the first example of a catalytic asymmetric reductive aldol 
reaction. 87  Coupling of methyl acrylate with benzaldehyde in the presence of 
Rh(BINAP) as catalyst and Et 2MeSiH as reductant, afforded a syn selective (1.7:1, 
37% yield) reaction in which the syn aldol product was obtained in 91% ee and the 
anti in 88% ee. It was discovered that the yields were much more favourable using 
phenyl acrylate (207) (Scheme 3.10). 
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72% yield, 3.4:1 syn:ariti 
206 	 207 	 208 (88% ee) 	 209 (34% ee) 
Reagents and conditions: (a) 2.5 mol% [(COD)RhCI] 2 , 6.5 mol% 
R-BINAP, Et2MeSiH; (b) H30t 
Scheme 3.10 First Rh-catalysed asymmetric reductive aldol reaction 
With the advances made in the Rh-catalysed reductive aldol reaction its 
application in total synthesis was now possible. Morken applied this methodology in 
the synthesis of the C10-C24 ketone fragment of the inostamycin family of 
compounds (Figure 3. 1).88  These compounds are known to possess anti-HIV and 
anticancer activity. 
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Figure 3.1 Compounds of the Inostamycin family 
The Rh-catalysed asymmetric reductive aldol reaction between propionaldehyde 
(210) and phenyl crotonate (211) afforded the corresponding 3-hydroxy ester 212 in 
76% yield and with 4.3:1 syn diastereoselectivity and 88% enantiomeric excess 
(Scheme 3.11). This intermediate was then used for, the synthesis of the C1O-C24 
ketone fragment 213. 
Me 
0 	 0 
OH 	 OTES 
a 
MeL + Me 	 OPh 	
Me 	 Me10 
El 	 El 
TES 
210 	 211 	 212 76%,4.3:1 syn:anfi 	 213 
88%ee 
Reagents and conditions: (a) 2.5 mol% [Rh(COD)C11 2 , 5.5 mol% 
S-BINAP, Et2MeSiH (1.2eq), C1(CH 2)C1, ii; then H 30, 76%. 
Scheme 3.11 Synthesis of the C10-C24 ketone fragment of the inostamycin 
family 
In 2001, Morken and co-workers reported that Ir(I) salts, when complexed to an 
appropriate 2,6-bis(oxazolinyl)pyridine (pybox) ligand (Figure 3.2), are able to 
catalyse reductive aldol reactions to give the products in good yields, good 






Figure 3.2 Pybox ligands employed in the Ir-catalysed asymmetric reaction 
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An initial survey of the impact of ligand architecture revealed that the nature of 
the pybox ligand substitution has a significant impact on stereoselectivity. These 
investigations identified the aminoindanol-derived indane pybox 218 as the best 
ligand with regards to both enantio- and diastereoselectivity. 
Therefore, ligand 218 was successfully used in the iridium-based catalytic 
reductive aldol reaction of various aldehydes. This catalyst system showed 
remarkable enantioselectivity with benzaldehyde and a-alkoxy aldehydes, however 
poor reaction with simple aldehydes. It was also observed that oxygenation adjacent 
to the aldehydes enhances reactivity relative to non-oxygenated aliphatic substrates 
(Table 3.1). 
+ R'H 	 OMe 
219a-e 	 220 
(I) 2.5 mol% [Ir(COD)CI] 2 







Aldehyde 	Yield (%) 	 syn:anti 	ee (syn) 
C 
H Fh 
68 	221a 6.6:1 	94 
2 EflC...JL 49 	221b 9.9:1 	96 
3 TESC)L 47 	221c 8.2:1 	96 
Me  .. J( <5 	221d - 	 - 
EnC 'H 
65 	221e 2.7:1 	82 
Table 3.1 Ir-Pybox catalysed asymmetric reductive aldol reaction 
Morken applied this methodology in the total synthesis of borrelidin (222), a 
potential anti-cancer agent. 90 The structure of borrelidin is characterised by an 
18-membered macrolactone carrying a cyclopentane carboxylic acid and a unique 
conjugated cyanodiene (Figure 3.3). 
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Me Me Me 
OH 
4 3 
10 	OH 	 0 
222 
Figure 3.3 Borrelidin 
Reductive aldol methodology was used to establish the stereogenic centres at C3, 
C4, C 1 and Cli. Both steps in which this methodology was used went in good 
yield, with high diastereoselectivity and good to excellent enantioselectivity (Scheme 
3.12). 
OH 0 	 OTBS 
a 	 !L. PMBO l 
PMBO,)I.... + OMe 
HOMe 
	
Me 	 Me Me 
223 	 220 	 224 	76% yield 225 
6:1 d. r.; > 90%ee 
OH 0 	 OTBS 





1OMe H +  
Me 	 Me Me 
226 	 220 	 227 	84% yield 	 228 
6:1 d. r.; > 98%ee 
Reagents and conditions: (a) 2.5 mol% [Ir(COD)CI] 2, Ligand 218, 7.5 mol%, 
Et2MeSiH, rt; (b) TBSOTf, 2,6-lutidine, 90%; (c) DIBAL—H, 79%; (d) 
Dess-Martin periodinane, 92%; (e) CBr 4, PPh3 , 94%; (f) n-BuLi, Mel, 97%; (g) 
Cp2ZrHC1, (ii) 12,  89%; (h) TBSOTf, 2,6-lutidine, 99%; (i) DIBAL—H, 94%; 
PPh3 , 12, 96%; (k) pseudoephedrine propionamide, LDA, 93%; (1) LAB, 
93%; (m) PPh 3 , '2,  95%. 
Scheme 3.12 Application of the Ir-Pybox catalysed asymmetric reductive aldol 
reaction in the synthesis of borrelidin 
Fragments 225 and 228 were coupled in a modified Negishi coupling. Alkyl 
iodide 228 was converted to the dialkyl zinc and reacted with vinyl iodide 225 
yielding intermediate 229, which ultimately allowed the synthesis of borrelidin 
(Scheme 3.13). 
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Me Me Me 	 - 
OTBS 	 OTBS 	 OTBS 





Me Me 	 Me Me 
228 	 225 	 229 OBn 
Reagents and conditions: (a) (i) t-BuLi, ZnCl 2, ( ii) Pd(PPh3)4 , 225, (58%). 
Scheme 3.13 Synthesis of borrelidin 222 
Motherwell reported in 2004 a Rh-catalysed intramolecular reductive aldol 
reaction of aldehyde-enoate derivatives. 9 ' 6-Oxo-enoates were cyclised with 
RhC1(PPh 3)3 or RhH(PPh3)4 as the Rh source (1 mol%) and Et 3 SiH (2.1 eq) as the 
hydride source, in toluene. Aldol products were obtained with syn-selectivity when 
using RhC1(PPh3)3 , but RhH(PPh3 )4 showed higher catalytic activity and high 
anti-selectivity, except for the cyclisation of 232 (Table 3.2). 




OS1Et3 	231 	RhCI(PPh 3 ) 3 	81 	3:1 
H 	 CO2Me 	
RhH(PPh3)4 	81 	1:11 
CO2 Me 
0 
3 	Me 	 232 	




Me 	 RhH(PPh3 )4 	62 	6.4:1 
234 	
OSiEt3 
5 	 235 
	
RhCI(PPh3)3 	93 	2.2:1 
6 Me7 	- CO2Me 	
Me_
RhH(PPh3)4 	61 	1:11 
Me Me 
Table 3.2 Rh-catalysed reductive cyclisation of 6-oxo-enoates derivatives 
They also applied this methodology in the synthesis of the highly potent anti-HIV 
carbocyclic nucleosides (-)-carbovir (239) and (-)-abacavir (240).92  The Rh-catalysed 
reductive aldol reaction allowed access to key intermediate 237 from 
cis-cyclopentane 236 (Scheme 3.14). Protected triol 237 was converted into 
protected tetraol 238, which is a key intermediate in the synthesis of the carbocyclic 
nucleosides. 
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CO2 Me 	 CO2Me 	
Ac 
o=<j
a Et .% 
	
3SiO/'7 	 AcO...../( - 
00 	 00 	 cb 
Me Me 	 Me 	 Me Me 
5.4:4.0:2.0: 1.1 (81% yield) 





239 (-)-carbovir HN 
NN 
HO 	 N 	N 	NH2 
240 (-)-abavir 
Reagents and conditions: (a) 1 mol% RhH(PPh 3)4 , Et3 S1H (2.1 eq), toluene, 50°C. 
Scheme 3.14 Use of the Rh-catalysed reductive a/do! cyclisation 
We can then conclude that, due to the development of the reductive aldol 
reaction, the application of this methodology to the synthesis of natural products has 
been possible, with inter- and also intramolecular examples. In the remaining part of 
this section, we will describe methodologies for intramolecular reductive aldol 
reactions to form carbocyclic rings, which are therefore relevant to the methodology 
of our project. 
In 1989, Mukaiyama reported the first cobalt-catalysed cross coupling reaction of 
a,13-unsaturated nitriles, amides and esters with aldehydes using phenylsilane as a 
hydride source to give the corresponding 3-hydroxy nitriles, amides or esters. 93 
Krische, in 2001, reported the first examples of intramolecular reductive aldol 
reactions catalysed by cobalt.  94  The optimised conditions for this transformation 
proved general for five-, six- and seven-membered ring formation. The aldol 
products were obtained in moderate to excellent yield (35-87%) and in all cases, 
irrespective of yield, only the syn-diastereomer was observed (Scheme 3.15). Studies 
into the mechanism of this cycloreduction were also performed. 8t ' 95 
0 	
a 	 o 	OH 	242a n=1,R 1 =Ph 	70% 
R1 	
0 	 242b n=2.R'=Ph 87% 
242c n = 2, R 1 = p-CF3Ph 72% 
242d n = 2, R 1 = 2-Na ph 68% 
242e n = 2, R' = Me 	38% 
214a-e 	 242a-e 
Reagents and conditions: (a) 5 mol% Co(dpm)2, PhSil-13 (1.2 eq), CI(CH 2)2C1, 20 °C. 
Scheme 3.15 First example of a Co-catalysed intramolecular reductive a/do! 
cyclisation 
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Krische played a major role in the development of Rh based catalyst systems in 
the reductive aldol reaction. In 2002, he reported the first example of inter- and 
intramolecular reductive aldol reaction of enones in which the enolates were 
generated using elemental hydrogen as reductant. 96 
Generally, the accepted mechanism for the Rh-catalysed alkene hydrogenation 
has three steps: oxidative addition of LRh(I) to elemental hydrogen, followed by 
alkene hydrometalation forming LRh(III)(a1kyl)(hydrido) intermediates and, finally, 
alkyl-hydrogen reductive elimination to give the saturated product and regenerate 
LRh(I). If the double bond is part of an enone, an enolate will be generated. 
Therefore they hypothesised that if there was an electrophile, the alkyl-rhodium 
intermediate could be trapped, in competition with alkyl-hydrogen reductive. 
elimination (Scheme 3.16). 




L0Rh'OTf + H, 	 I —r 
. 






(C-H reductive 	R 1 	 H VII VI elimination) III 
H 
L0 - 	F a OH 
Rh° ' 
R 1 	 0 noIate 
0 
addition 
V 	(0-H reductive 	R1  
elimination) iv 
Scheme 3.16 Proposed catalytic cycle of the reductive generation of enolates 
under hydrogenative conditions 
• With this theory, they attempted the hydrogenative cycloreduction of monoenone 
monoaldehydes. A variety of Rh sources and phosphines were screened but when 
using Rli(COD) 2OTf/PPh3, equal proportions of syn-aldol cycloreduction product 
(244) and 1,4-reduction product (245) were obtained (Scheme 3.17). Bearing in mind 
the proposed mechanism, they speculated that deprotonation of (hydrido)Rh species I 
or III would diminish the 1,4-reduction. Indeed, when the reactions were performed 
using potassium acetate 244 and 245 were obtained in 59% and 21% yield, 
respectively. A higher Lewis acidity of the metal was another important factor, since 
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when (p-CF3Ph)3P was used as ligand, together with the base, the yield of 244 was 
increased to 89%, obtaining only 0.1% of 245. 
Ph1JJ L H 	 W 	 + Ph_ 	 H 
243 	 244 89% (10:1 syn:anti) 	245 0.1% 
Reagents and conditions: (a) 10 mol% [Rh(COD) 2]OTf, 24 mol% 
(p-CF3 Ph)3P, H2 (I atm), 30% KOAc, C1(CH 2)C1, rt, 89%. 
Scheme 3.17 Rh-catalysed hydrogenative a/do! cyc!oreduction 01243 
Using these conditions, cycloreduction of aromatic, heteroaromatic, and aliphatic 
enone substrates yielded the five- and six-membered ring -hydroxy ketone products 
in good to excellent yields (65-90%) and with high syn diastereoselectivities (up to 
24:1) (Table 3.3). 
10 mol% [Rfl(COD)2]OTf 
a 	 24 mol% (p-CF3Ph)3P 




o OH 	 0 
R1 	
+ 	R' 
247a-f 	 248a-f 
Yield product (%) Yield 
Substrate (syn:ant:) 1,4-reduction (%) 
I ti 	2, R' 	p-MeOPh 74 (5:1) 247a 3 
2 n = 2, R 1 = 2-naphthyl 90(10:1) 247b 1 
3 n=2,R2-thiopheny1 76(19:1) 247c 2 
4 n = 2, R' = 2-fuiyl 70 (6:1) 247d 10 
5 n1,R'Ph 71(24:1) 247e 1 
6 n = 2, R 1 = Me 65 (1:5) 247f - 
Table 3.3 Rh-catalysed hydrogenative a/dol cycloreduction of enOne 
aldehydes 
The fact that 1,4-reduction had been practically eliminated led to the formulation 
of another possible mechanism and explanation of the role of the base (Scheme 
3.18) .97  It was believed that Rh-monohydride was being formed via heterolytic 
cleavage of hydrogen (oxidative addition and reductive elimination by the base). 
Therefore, if enone hydrometalation occurred via a Rh-monohydride complex, the 
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fesulting enolate would lack an extra hydride ligand and could not go under C-H 
reductive elimination (II vs VI, Scheme 3.1 8).98  After enolate addition, III follows 
the catalytic cycle, suffering oxidative addition to form Rh(III) enolate IV that 
liberates the desired aldol product and Rh-monohydride, which reenters the cycle. - FIX (base) 	
TfO H 	
[0 	 0 
I I R1 H " _ R V H 	 O  /Rh' O Rh addition) 
HOAc 	



















R' Lá (Oxidative 
IV 	 addition) 
(0-H reductive  
elimination) 
Scheme 3.18 Formal heterolytic activation of hydrogen mitigates competitive 
conjugate reduction by enabling monohydride catalytic cycle 
Keto-enones were also cyclised using Rh(COD) 2OTf/PPh3 and in the presence of 
K2CO3 as base, yielding the aldol products with good yields and exclusive 
cis-selectivity (cis:trans > 95:5) (Scheme 3.19).98  Based on this system, there have 
been several other reports of Rh-catalysed reductive aldol reactions from the Krische 
group. 99 
10 mol% [Rh(COD) 2]OTf 
24 mol% Ph 3P 
0 	 H2 (1 atm), KOAC (80 mol%) 	o 	OH 
Jt 0 	Me 	CI(CH2)2C1,25°Cor8O°C 
R,  iT R1() 
249.,-f'-..(' 	 250a.f 
OH 	 0 OH 	 o OH 
&
,Me a Me X 	 C):D 






o OH Me 
250d 74% 	 250e 75% 	 250f 70% 
Scheme 3.19 Catalytic hydrogenative cycloreduction of keto-enones 
rsvl 
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In 2003, Krische reported a reductive aldol cyclisation of monoenone 
monoketones using catecholborane. In this intramolecular reaction, the reduction of 
either the enone or the ketone was avoided. The desired cyclised products were 
obtained in good yields and high levels of syn-diastereoselectivity (>99:1) (Scheme 
3.20). 100 





251 	 253 
Reagents and conditions: (a) Catecholborane 252 (115 mol%), THF, 
25 °C, 89%. 
Scheme 3.20 Catecholborane mediated a/dol cycloreduction of monoenone 
monoketones 
Baba and co-workers reported a reductive aldol reaction of enones with 
aldehydes utilising InBr3 and hydrosilanes as the hydride source. 101 In 2004 Hosomi 
and co-workers reported a similar indium catalysed reductive aldol cyclisation of 
enones with ketones, employing In(OAc) 3 and PhSiH3 (Scheme 3.21).b02 
0 	0 	 OHOMe 
a 	
PhjJ 
251 	 253 90% (syn:anti >99:1) 
Reagents and conditions: (a) In(OAc) 3 (10 mol%), PhSiH 3 (1.2 eq), 
THF, EtOH, reflux. 
Scheme 3.21 Indium catalysed reductive aldo/ reaction of keto-enones. 
The Cu-catalysed reductive aldol reaction has also made a major contribution to 
the development of the intramolecular reductive aldol reaction forming carbocyclic 
rings. The copper hydride species [Ph 3PCuH]6 (Stryker's reagent),  103  is a well 
characterised, stoichiometric source of hydride which chemoselectively reduces 
conjugate systems, being inert toward isolated olefins. In 1998 Chiu and co-workers 
were able to develop the first example of an intramolecular reductive aldol reaction 
using Stryker's reagent. Working on the synthesis of pseudolaric acid A, keto-enone 
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254 was successfully cyclised using [Ph 3PCuH] 6, to yield two bicyclic diastereomers, 
255 (66%) and 256 (16%) (Scheme 3.22).104 
Me 	 Me- 
0 	 0 
 Me 
HO,,, , 	 HO 
CO2 Et 	?CO2 Et 
H 	 a 
+ 
M9 Me 	 Me 
254 	 25566% 	 25616% 
Reagents and conditions: (a) [Ph 3PCuH] 6 (2 eq), toluene, —23 °C. 
Scheme 3.22 First example of an intramolecular reductive a/dol reaction using 
Stryker's reagent 
In. 2001, Chiu reported a more in-depth investigation of the intramolecular 
reductive aldol cyclisation reaction promoted by stoichiometric Stryker's reagent 
(Scheme 3.23).b05  When the reactions were performed at low temperatures (-40 to 
-25 °C), to avoid dehydration, -hydroxyketones were obtained with good to 






Reagents and conditions: (a) [Ph 3 PCuH] 6 (2 eq), toluene, —40 °C 
Scheme 3.23 Reductive a/dol cyclisation of enediones by Stryker's reagent 
This methodology was applied to the synthesis of lucinone (261) (Scheme 
3.24).b06 Enedione 259 was transformed quantitatively and stereoselectively into 260 
using two hydride equivalents of the Stryker's reagent in toluene at 0 °C to room 
temperature. 
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Me 	 Me 
Me 
Me OH 




260 	Me 	 261 (lucinone) Me 
Reagents and conditions: (a) [Ph 3PCuH] 6 (2 eq), toluene, 0 °C, 99%; (b) 
cat 0s04, K3Fe(CN)6, 38%. 
Scheme 3.24 Synthesis of lucinone 
The use of copper salts and organosilanes to form copper hydride species had 
been reported for conjugate reductive reactions by Mori and Hosomi in 1997.107 
Buchwald 108 and Lipshutz' 09 had been great contributors in this area, reporting 
several excellent methods for enantioselective conjugate reductions. 
In 2000, Lipshutz reported the catalytic reductive aldol reaction of enones and 
aldehydes using Stryker' s reagent (5 mol%) in the presence of a silyl hydride (1.5 eq) 
such as dimethyiphenylsilane (Me 2PhSiH), tetramethyldisiloxane (HMe 2 SiOSiMe2H) 
or polymethyihydrosiloxane (PMHS), to regenerate it. 110 This was a one pot- two 
step reaction and provided 3-hydroxyketones in high yield. In the first step, silyl enol 
ethers were formed. In the second step, Lewis acids such as BF 3 or TiC14 were used 
to promote the aldol reaction. 
Chiu reported, in 2004, the development of the intramolecular catalytic Cu-
catalysed reductive aldol reaction using Strykers reagent (10 mol%) as the Cu source 
and PMHS (2.0 eq) as a hydride source. 83, ill A variety of alkynediones were 
cyclised using these conditions, to afford the cyclic f-hydroxy bicycloalkenones with 
similar or improved yields that with the stoichiometric reaction. An example is 






OH a or b 
MeXj3 
CO2Me 
Stoichiometric 	263 (48%) 







Reagents and conditions: (a) [Ph 3PCuH] 6 (1.5 eq), toluene, —40 °C. (b) 
[Ph3PCuH] 6  0 0 mol%), PMHS (2 eq), toluene, —40 °C. 
Scheme 3.25 Reductive a/dol cyc/isations catalysed by Stryker's reagent 
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These were the precedents in the literature on intramolecular reductive aldol 
cyclisations when our group became interested in developing the reductive aldol 
methodology for the preparation of heterocyclic products. In the next section, the 
development within the group on this methodology will be described. 
3.3. Development of the reductive aldol cyclisation in the 
Lam group 
3.3.1. Copper-catalysed reductive aldol cyclisation 
In 2004, with the aim of developing a methodology that ultimately allowed the 
synthesis of salinosporamide A, an investigation on the reductive aldol cyclisation of 
a,J3-unsaturated amides and, although not related to our project, a , 13-unsaturated 
esters was initiated in our group. As a result of these studies, in 2005 we reported the 
first intramolecular copper-catalysed reductive aldol reaction of (X, P -unsaturated 
esters with ketones, affording five- and six-membered 3-hydroxylactones with high 
yields and very high syn-stereoselectivity (>95:5).66 
Initial efforts of this study focused on the cyclisation of a,13-unsaturated  esters 
tethered to a ketone utilising phosphine-stabilised copper hydride complexes as 
catalyst system. As it was described before (Scheme 3.25), the use of 
substoichiometric amounts of Stryker's reagent in the presence of stoichiometric 
siloxane had proved successful in promoting reductive aldol cyclisations in 
carbocycle synthesis. 105, 111 
In optimising the reaction, several copper salts were investigated (CuC1 2 2H20, 
CuF2, Cu(OAc) 2 H20, Cu(2-ethylhexanoate) 2, Cu(OBz)2, and Cu(acac) 2), also 
several siloxanes (PMHS and TMDS) and bisphosphine ligands [DPPE, DPPB, 
DPPF, rac-BINAP, and (SS)-Et-DuPhosj (Scheme 3.26). 
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R2 	0 
ligand (5 mol%) 
Cu(II)salt(5mol%) R2 	0 PMHS= 	Me3SiOSI—O IMe SiMe3 siloxane(1 eq) THE, rt H R1 O 





Ih 	 —PPh2 
Fe 
Ph2 P 	PPh2 PPh PPh2  
I 
Et 
265 DPPE 266 DPPB 267 (S,S)-Et-Duphos (rac)-268 (rac)-BINAP 	269 DPPF 
Scheme 3.26 Optimisation of the Cu-catalysed reductive a/do! cyc/isation 
Finally, it was identified that Cu(OAc)2+120, TMDS and either DPPF or 
rac-BINAP, in THF, promoted the cyclisation with good yields, and high 
diastereoselectivities (>95:5). Several (x,13-unsaturated ester components were 
tolerated (Table 3.4); methyl ketone or phenyl ketone were both permitted and the 
process could also be applied to the formation of five-membered lactones. 
PPh 
R2 	0 	SmoI% 	Fe 	 R2 	0 
R1.)1O 	269 	 PPh2 	R1' 
	
'O 
R}J) 	5 mol% Cu(OAc)2 'H 20 
1 eq TMDS 
270a-ni 	0 	 THF, rt 	 HO 271a-m 
Entry Subtrate R 	Product Yield (%) 




3 o 	o R 2-ryl fu 271c 63 
i-Bu 271d 73 









H  271g 71 
7 o 	o Me 	RO 271h 50 













10 Ph..) i-Bu 2711 65 
11 0 PhCH2CH2 	HO 271m 60 
Table 3.4 Copper-catalysed reductive a/do! cyc/isations 
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The use of nonracemic chiral bisphosphines (Figure 3.4) was also investigated 
and asymmetric cyclisations were performed with good enantioselectivities. The 
Roche MeO-BIPHEP Ligands (272-274) and SEGPHOS ligand 275 afforded slightly 
higher enantioselectivities than (S)-B1NAP 268 (Table 3.5). 
PPh 	MeO 	PPh 2 	MeO 	P(3,5-xyl) 2 
PPh 2 	MeO _ PPh 2 	MeO 	P(3,5-xyl) 2 
268 	 272 	 273 





MeO ' PAr2 <O pph2 
MeOJPAr2 
 0,LPPh2 
274 	 275 
Ar = 3,5-di-i-PrPh 	(S)-SEGPHOS 
(R)-3,5-di-i-Pr-MeO-BIPHEP 
Figure 3.4 Biphosphine ligands employed in asymmetric cyclisations 
0 
5 mol% ligand 
0 
R' 5 mol% Cu(OAC)2H20 R' 
R2 1 eq TMDS 
R2' THF, 
276a-m HO 277a-m 
entry 	Subtrate Ligand Yield (%) 	ee % 
1 268 72 277a 62 
2 Ph__ 	O %< 272 73 277b 73 
3 0 	o 273 69 277c 70 
274 64 277d 77 
5 275 62 277e 74 
6 268 79 277f 73 cl 
272 71 277g 76 
8 ° 	0 273 71 277h 83 
Me 'L) 275 73 2771 82 
10 / \ 268 60 277j 72 
O 272 60 277k 72 
12 0 	0 273 61 2771 80 
13 1 J 275 68 277m 80 
Table 3.5 Cu-catalysed asymmetric reductive a/do! cyclisations 
A catalytic cycle of the reaction was proposed (Scheme 3.27). This involves the 
generation of (bisphosphine)Cu-H species, from the reduction of the Cu(II) salt in the 
presence of bisphosphine and TMDS. Conjugate reduction occurs to generate the 
copper enolate, which is followed by aldol addition and finally, (T-bond metathesis 
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Cu(OAc)2 









P 	 0 
Cu Cu 
0 0 	 0 \0 
RI 
R2 	 R2 
	
0 
Iv 	'-.-----.------------,, 	III 
Aldol addition 
Scheme 3.27 Proposed catalytic cycle of the copper-catalysed reductive a/do! 
cyc/isation 
These results made a significant contribution to the copper-catalysed reductive 
aldol methodology, but since we were aiming to apply this approach into the 
synthesis of salinosporamide A, our interest was centred on the reductive aldol 
cyclisation of a,13-unsaturated  amides. Therefore, we were very pleased to see that 
the same copper catalyst system was also successfully applied to the reductive aldol 
cyclisation of a,J3-unsaturated amides, to form 4-hydroxypiperidin-2-ones in a highly 
diastereoselective fashion (>95: 5). 65 
The reaction was tolerant to wide variation in the ketone component, since alkyl, 
aromatic, and hetereoaromatic ketones were reacted in good yields (Table 3.6). 
However, the (t,13-unsaturated amide component did not allow much variety. 
Acryloyl amides were found to be the best substrates and crotonoyl amides were also 
cyclised but with lower reaction rates and conversions. Unfortunately, the formation 
of five-membered lactams was not possible. 
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PPh2 
0 	0 
5moI% Fe 	 0 
269 	7"2 
R111 _Ar 
I 	 5 mol% Cu(OAc)2 H20 
278a-k Ar 1 eq TMDS 	 HO 279a-k 
THF, rt 
Time Yield 
Subtrate R Product 
(h) (%) 
1 Me 279a 2.5 66 
2 o 	a Et 279b 5.5 61 
i-Bu MeT"_ N.PMP 	279c 24 64 
4 Ph R) 279d 21 69 
5 PMP 4-MeC6H4 HO 	 279e 24 64 




Me 	Et. 	PMP N 279g 22 55 












10 Me 	Et 	 OMP 279j 24 70 
11 Ph 279k 23 65 
OMP 
HO 
Table 3.6 Catalytic Cu-catalysed reductive a/dol cyclisation to form 
4-hydroxypiperidin-2-ones 
The effect on the diastereoselectivity of the cyclisation of pre-existing centres in 
the tether linking the amide and the ketone was also studied. Formation of C5- and 
C6- substituted 4-hydroxypiperidi-2-ones was achieved with moderate to excellent 
levels of diastereo selectivity, due to the 1,2- or 1,3-asymmetric induction in the 
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PPh2 
5mol% Fe 	 0 
0 R 1 0 	
269 	—PPh2 Me.l _PMP 
5 mol% Cu(OAc)2H20_ R" 
PMP R2 	 HO/ 12 R 1 eq TMDS 
280a-d 	 THF.rt 	 R 281a-d 
Substrate Product d.r. Yield (%) 
0 
o 	0 	Me 	u _PMP 
N 	 Ph 	Ph- 
•)) 	
8:1 	78 	281a 
PMP Me 	 HO 
Me 
O Ph 0 
N-"Me 	
MeJt.. PMP 
2 	i 	 1 	 >19:1 	65 	281b 
PMP 	 Mel- J.,, 
I  
85%ee 	 HO 	
Ph 
O 	CO2EtO 	 0 
3 	N 	
Me Me.}... - PMP 
>16:1 	68 	281c 
PMP 




Me 	I PMP 
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Table 3.7 Formation of C5- and C6-substituted 4-hydroxypiperidin-2-ones 
3.3.2. Cobalt-catalysed reductive aldol cyclisation 
The copper(I)-bisphosphine-catalysed reductive aldol cyclisation developed in 
our laboratories proved to be very efficient for the synthesis of 13-hydroxylactones 
and 3-hydroxylactams. The products were obtained with high diastereoselectivities 
and with moderate enantioselectivities in some cases. 
However, there were two main limitations in this methodology, first, that the 
yields were only moderate at best (60-70%) and second and more importantly 
regarding the synthesis of 1, that due to the lower electrophilicity of a,13-unsaturated 
amides, the range of amides permitted in this reaction was very limited, with acryloyl 
and crotonyl amides being the only competent substrates. Moreover, the cyclisation 
to five-membered lactams was not achieved. With this substrate limitation, the 
application of this methodology to the synthesis of salinosporamide A was not 
feasible. Therefore, a search for a new catalyst system that could overcome these 
limitations was initiated. 
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After trying different combinations of Cu(I) salts, hydrosilanes and ligands 
without any improvement of the reaction, the use of other metals was investigated. 
The combination of Co(II) salts and hydrosilanes, combinations that had been 
employed in intermolecular reductive aldol reactions, 93-95  also proved ineffective. 
Several methods had been reported in which organometallic reagents with 
p3-hydrogen-containing alkyl groups were employed as stoichiometric reductants for 
transition metal-catalysed reductive couplings. 112  Thus, the use of Et 3B and Et2Zn in 
the reaction was examined. In the presence of Co(acac) 2 2H20 (5 mol%), Et3B 
resulted in no reaction, but when Et 2Zn was employed, the desired product was 
obtained in 89% yield.67a 
The scope of the reaction with these new conditions was next explored. It was 
discovered that it allowed the cyclisation of substrates with a wide range of 
substitution at both the (t,-unsaturated amide and the ketone; to give five- and six-
membered rings -hydroxy1actams, in moderate to excellent yields and with high 
diastereoselectivities (Table 3.8). The standard conditions used Co(acac) 2 2H20 (5 
mol%) as the precatalyst (method A), but in some cases a combination of CoC1 2 (5 
mol%) and the electron-rich phosphine ligand Cy 2PPh (5.5 mol%) proved to be more 
efficient (method B). Most of these substrates were not cyclised under the copper 
conditions. 
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Co (cat) 	 o 
0 	0 	 ligand (cat) 
R2 Et2Zn(2eq) 	
, 	R 1 
THF, hexane 
R2 	 OCtort 
282a-k HO 283a-k 
Method A: Co(acac)2 2H20 (5 mol%) 
Method B: Cod 2 (5 mol%), Cy2PPh (5.5 mol%) 





283a 	12:1 	89 Me 	A 	Ph Y JN PMP 
2 
Ph 	




H A 0 283c 9:1 88 
4 II i-Pr A N >99 
 
283d >19:1 
Me Ph A 
R 	
Bfl 
Me 283e >19:1 97 
6 2-furyl A HO 283f >19:1 >99 
0 
7 Me A 283g >19:1 94 




10 	RN \ 	Me 	B 	
R 	 N 	
283j >19:1 	80 
CO2Et 	H B PMP 	283i 	9:1 56 
PMP 	I" 	 % 0tl 	 in i 	 00 
Table 3.8 Cobalt-catalysed reductive a/do! cyc/isations 
More importantly, the cyclisation to five-membered lactams -was also 
successfully achieved (Scheme 3.28), and although with slightly lower yields and 
diastereoselectivities. This was a very encouraging result towards the possible 
application of this methodology to form y-lactam 103, intermediate in the route to 1. 
Co (5 mol%) 	 o 0 
o 	o 	ligand (5.5 rnol%) 
R1 N Me 	
Et2Zn(2eq) 	
R1 N_PMP 	




PMP 282a-c 	 O°Ctort HO 285a 	






285a 47% 9:1 di 
0 
N - PMP 
Me" 
HO 
CoC12, Cy2 PPh 
285b 56% 8:1 dr 
OMeO - PMP 6--M N 
C0Cl2, Cy2PPh 
285c 74% >14:1 di 
Scheme 3.28 Cobalt-catalysed reductive a/dol cyc/isations to 5-membered 
!actams 
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The cyclisation to obtain five-membered lactams from (t,-unsaturated amides 
containing phenyl ketones was very low yielding (<20%) when using Et 2Zn. 
However, when the reaction was performed using Et 3Al instead, the desired cyclised 
products were obtained in modest yields (Scheme 3.29). 
0 






R 	0 	 0°C tort 
	Ph"._ 
HO 
286 R = PMP 	 28857% yield, >19:1 dr 
287 R = PMB 28953 % yield, 8:1 dr 
Scheme 3.29 Cyclisations to five-membered ring lactams using Et 3AI 
The mechanism for this Co-catalysed cyclisation reaction is explained in the next 
section, together with the Ni-catalysed methodology. 
3.3.3. Nickel-catalysed reductive aldol cyclisation 
In the search for new, and more efficient, catalyst systems for the reductive aldol 
cyclisation of (z,3-unsaturated esters and amides with ketones, the use of nickel was 
also contemplated. It was surprising that there is an extended development of 
catalytic reductive aldol couplings and cyclisations of a,f3-unsaturated carbonyl 
substrates mediated by other metals, but not using nickel. Only recently, 
Montgomery reported a Ni-catalysed reductive aldol addition of acrylates and 
aldehydes, using Et3B, Ni(COD)2 and in the presence of an aryl iodide, which was 
shown to be linked to an initiation step. 113 
However, it has been demonstrated in our laboratories that the use of the 
combination of Ni(acac)2 with Et 2Zn is not only as active as the cobalt catalyst 
system 67a  but also very efficient in the reaction of substrates that were completely 
inert or reacted inefficiently (Table 39)67b 
The substrates containing the fumaric acid ethyl esters were successfully reacted 
to give the bicyclic products due to lactonisation of the alkoxide produced into the 
pendant ester (Table 3.9, entries 14 and 15). 
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0 	 0 	M(acac)2 (5 mol%) 	
0 
Et2Zn(2eq)  0. RV& .R2 
R2 	 OCtort 	
R31L.) I 	 THF, hexane 
HO 291a-o 290a-o 
Subtrate R = Product dr 
Yield 
(%) 
1 Me o 	 291a >19:1 97 
3 










4 I Bn Ph 
Me" 	 291d >19:1 97 
5 2-fury! HO 291e >19:1 >99 
6 	 N 	 Me 
PMP 










291f 	>19:1 	75 
291g 	>19:1 	82 
0 






N 	 291h 	>19:1 	62 
OMP 
HO 
9 	 0 	 0 	 Me 	
0 2911 	9:1 	84 
10 RN Ph 	 i-Bu 291j 12:1 84 




R 	 N 	
CO2Et 	
Me 	R 	 N 	 2911 	>19:1 	62 - 
13 Ph 291m >19:1 50 
M P 
CO2Et 
14 	 0 	 0 	
R'=PMP 	 0 
291n 	>19:1 	79 R'= Ph 
EtO2CN R2  
2910 	>19:1 	89 
RBn 
15 	 R 	 R= Me 	 R2 
Table 3.9 Nickel-catalysed reductive a/dol cyc/isation to form 
4-hydroxypiperidin-2-ones 
Most encouragingly towards the synthesis of 1, the reaction was also possible for 
the synthesis of five-membered lactams (Scheme 3.30). 
77 
CHAPTER 3 	 Reductive A idol Cyclisation 
0 \ O 	0 	Ni(acac)2 (5moI%) 
Et2Zn (2 eq) 	R1 N_PMP 	




THF. hexane 	 Me 
292a -d PMP 	 	 0 C to r 	 HO 293a-d 	 103 HO CO2R / 
O 	 0 	 0 	 0 
PMP i.Prç 	PMP 	 PMP EtO2c-./7- PMP 
Me° 	 Me'J Me''i Me"J 
HO 	 HO 	 HO HO 
293a 42% 5:1 di 	293b 70% 5:1 dr 	 293c 56% >19:1 di 	 293d 76% >19:1 dr 
Scheme 3.30 Successful Ni-catalysed cyclisations to form lactams 
The cyclisations of esters was also performed using this new catalytic system. 
These substrates did not react under the cobalt conditions, but the Ni(acac) 2/Et2Zn 
combination gave productive cyclisations affording a range of -hydroxylactones in 




Ni(acac)2 (5 mol%) 
Et2Zn (2 eq) 	
IN 
THF, hexane 




Subtrate 	R = Product dr Yield (%) 
i-Bu o 295a 	>19:1 77 
O 	0 	CH2CH2Ph 295b 	>19:1 85 
3 RO Me 	4-MeOPh Me 295c 	>19:1 76 
4 2-furyl HO 295d 	>19:1 81 
0 
O 	0 	 i-Bu 
R'O''Ph 	CH2CH2Ph 
RYO 295e 	5.5:1 99 






295g >19:1 	88 
i-Pr 295h >19:1 74 
9 	 Ph 	 2951 >19:1 	73 
Table 3.10 Nickel-catalysed reductive a/dol cyclisation to form 
fl-hydroxylactones 
Several mechanistic possibilities have been proposed for the nickel-catalysed 
reductive couplings and cyclisations. 1 14  It is known that Ni(acac) 2 in the presence of 
Et2Zn is reduced from Ni(II) to Ni(0), forming what is accepted to be the active 
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catalytic species. It is believed that Co(acac) 2 2H20 or CoC12 in the presence of 
Et2Zn behave in a very similar manner. Two possible reactive pathways were 
proposed in our group in order to explain the nickel- and cobalt-catalysed reductive 
aldol reaction. 65b 
The oxidative cyclisation of Ni(0) with two it-components, forming metallacyclic 
intermediates, has been proposed as one of the possibles mechanisms for the 
three-components couplings of two it-components with a main-group organometallic 
complex. In this mechanism, oxidative cyclisation of Ni(0) with two it-components 
forms metallacycle II, which is followed by transmetallation with a metal alkyl MR 
to afford III and, finally, reductive elimination affords IV (Scheme 3.31)." 
	
L L 	 ,L 
NO 	 Ni 	MR 	 I 
ABC=O A,' N  D _____ _ A L 
L 




'B C' B-C 	
B-C R 
I 	 II II, 	 Iv 
Scheme 3.31 Oxidative cyclisation of Ni(0) with two .ir-components 
A possible catalytic cycle via the formation of metallacycles was proposed and is 
illustrated in Scheme 3.32. Oxidative cyclisation of M(0) with the alkene and the 
ketone of a,f3-unsaturated substrate I would form metallacycle II. Diethyizinc would 
facilitate oxidative cyclisation by Lewis acid activation of the ketone through binding 
with zinc and by Lewis basic activation of M(0) through a three-center-two-electron 
bridging of a zinc-ethyl bond.' 5 Transmetallation would cleave the metallacycle and 
would provide metal-ethyl species III, which undergo p-hydride elimination to 
generate metal hydride IV. Finally, reductive elimination affords alkoxide V, 
ethylene and M(0) which would reenter the catalytic cycle. Alkoxide V would be 
protonated during workup to give the desired product. 
With this reaction mechanism, the relative syn-stereochemistry of the major 
diastereomer obtained in the reaction could be explained by the preference for the 
formation of the bicyclic metallacycle II, containing a cis-ring junction. 
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M(acac)2 
0 	
R 1 	' X 




+ 	R2 )) 






RHH 0 	 R1 	H 
M-1,04 H..M Jx 	 Et 
EtZr' R2 
" 	 / 	R 2 	II 
 IV 
Ri H  H 0 	
Et 
Zn to  
/1-hydride El— M" X 
•_//1 
ethyl migration 
elimination 	 0 	 (transmetalation) 
EtZr( R2 
Ill 
Scheme 3.32 First possible reaction mechanism: via formation of 
metallacycles 
A second possible mechanism involving the formation of discrete enolates was 
proposed (Scheme 3.33). Interaction of M(0) and Et 2Zn forms intermediate I, a three-
centre-two-electron bridging interaction, product of an oxidative addition of M(0) 
with the ethyl-zinc bond. Coordination of this intermediate to substrate II would 
provide III, which undergoes n-hydride elimination to form metal hydride IV. 
Reorganization of IV provides V and M(0), that can reenter the cycle. Enolate V 
undergoes aldol cyclisation to form VII, which is protonated during workup to give 
the desired product. The syn-stereochemistry of the major diastereomer can be 
explained by preferential formation of the Z-zinc enolate and the chelated 
Zimmerman-Traxier transition state VT. 
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Scheme 3.33 Second possible reaction mechanism: via formation of a zinc 
enolate 
3.4. Retrosynthetic analysis 
The development in our group of the Cu-, Co- or Ni- catalysed reductive aldol 
cyclisation of a,3-unsaturated amides and esters has hugely contributed to the scope 
and strength of the reductive aldol methodology. 65-67  Regarding the application of 
these methodologies to the synthesis of salinosporamide A, the copper methodology 
was very substrate limited, showing poor reactivity with highly functionalised 
cLj-unsaturated amide substrates and the formation of y-lactams was not achieved. 
However, the Co- and mostly the Ni-catalysed methodology had a significantly 
expanded substrate scope. Most importantly towards the synthesis of 1, more 
examples of successful cyclisations affording 5-membered lactams were achieved 
(Scheme 3.28 and Scheme 3.30). 
The full retrosynthetic analysis for this approach devised towards the synthesis of 
the natural product is outlined in Scheme 3.34. Initial disconnections on 1 lead to 
y-lactam intermediate 296. The aldehyde group of 296 would arise from 
transformation of group X of 103, X representing an alcohol or an alcohol equivalent 
functionality. 
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We envisaged that y-lactam 103 could be synthesised from a,-unsaturated 
amide 102 via a reductive aldol cyclisation reaction. The objective was to find the 
optimal catalyst system that would allow this cyclisation with good yields and 
diastereoselectivities. Moreover, if the cyclisation reaction proved successful with 
several (L,3-unsaturated amides, the synthesis of derivatives of 1 would also be 
possible. Amide 102 could be constructed by coupling of an a,-unsaturated acid 
298, having a protected hydroxyl at the y-position, with an amine 297. 
Organomef al/ic 
	
Chlorination 	addition 	 Oxidation 
0 	I 	 0 
N CHO 	> 
CL_. H 
	





PGO CO2 R 	 HO CO2 R 
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coupling PGO IL N - PG 
MeyJ 
102 
Scheme 3.34 Retrosynthetic analysis for the reductive a/dol cydilsation 
approach 
The required functionalities of a,-unsaturated amide 102 to be converted into 
the final target 1 were then identified. Amide 299, with a methyl ester, PMB 
protected amide, and a CH 2 SiR3 group, was selected as a suitable substrate for this 
route (Scheme 3.35). This substitution of amide 299 was also chosen in order to 
avoid employing similar functionality to the one employed by Corey and co-workers 
in their reported synthesis of 1 (Scheme 1 .6).26  A synthetic route to amine 300 would 
be developed. 
0 	 0 
PG 	 PG 	PGO,-)i.. PMB 0 	 HN 
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OH 	 CO2Me 
102 o 	 299 o 	 298 	 0 300 
Scheme 3.35 Design of amide 102 
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After cyclisation of amide 299, the silyl group would be converted into the 
alcohol via a Tamao-Flaming oxidation (Scheme 3.36). Oxidation of alcohol 302 
would afford aldehyde. 303. We chose to have a PMB protecting group on the amide 
nitrogen because it was known that the insertion of the cyclohexenyl side chain at C5 
following Corey's procedure  26  worked best in the presence of a PMB group on that 
position. Ideally, it was desired to install also a PMB protecting group on the alcohol 
of the acid, so that deprotection of both PMB groups at a later stage could be 
performed simultaneously. However, the alcohol of the a,3-unsaturated acid could 
also be protected with other groups, in order to prepare several (x,-unsaturated 
amides and have a wider variety of substrates for the study of the reductive aldol 
cyclisation. If the preparation of triol 26 was achieved, this route would represent a 
formal synthesis of salinosporamide A, since 26 is a final intermediate in the 
synthesis of 1 reported by Corey  26and also in the one reported by Pattenden. 29 
0 
Reductive 	 Tamao-Fleming 	 0 aldol oxidation II 
PG0 l&...N_PMB 	cycllsation PGO ~_ N PMB 
 
Me _-L..—S1Me2Ph 	 Me......... SiMe2Ph 
CO2Me 
0 	 PGO CO2Me 
299 	 301  













Scheme 3.36 Main key steps after the cyclisation reaction 
It is worth pointing out that, with this approach, several steps to 26 are saved 
compared to Corey's synthesis. In the reported route, acrylamide 20 was prepared 
and successfully cyclised (Scheme 3.37). The y-!actam product of the cyclisation was 
then silylated, affording 21. A tributyltin-mediated radical-chain cyclisation was 
performed on 21 to obtain cis-fused y-lactam 22. This step introduced the ethyl chain 
at C2, setting up the desired stereochemical relationship at C2 and C3. In our route, 
the 'y-lactam obtained in the cyclisation (301) would already contain the side chain at 
C2. From intermediate 22, they prepared trio! 26 in further four steps. 
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0 
0 0 	 0 
	
)LN_PMB 	 tN_PMB 	
H 	




- OBn* CO2Me -- 	 Me......... 
Br 0 CO2Me 	Me 
Me 
M 	 'e CO2Me 	 HO CO2Et OH 
Me OBn 	
Mó ' Me 	
Me 
20 	 21 	 22 	 26 
Reagents and conditions: (a) 1) Ti(OiPr) 4, c-05H9MgC1, 'BuOMe, —40 °C, 30 
mm, 12,  —40 °C, 2 h then 0 °C, 2 h.; (ii) NEt 3 , CH2Cl2, 30 mm, 83%; (b) 
BrCH2Si(CH3)2C1, Et3N, DMAP, CH2Cl2, 0 °C, 30 mm, 95%; (c) Bu 3 SnH, 
AIBN, Benzene, reflux, 8 h, 89%. 
Scheme 3.37 Extra steps for the insertion of the C2 side chain in Corey's total 
synthesis of 1 
3.5. Results and discussion 
Our initial efforts focused on the synthesis of amine 300 and initially a racemic 
synthetic route was developed. Coupling of 300 with several acids would afford a 
range of a,13-unsaturated  amides that would allow us to study the feasibility of the 
cyclisation reaction with highly substituted substrates. If the cyclisation proved 
successful, this route would lead to the synthesis of (±)-l. We would then develop an 
asymmetric route to amine 300 and work towards the synthesis of 1. 
3.5.1. Preparation of amine 300 
Retrosynthetic analysis of 300 leads to the unprotected amine 305 (Scheme 3.38), 
which might be readily prepared via hydrogenolysis of 306. This intermediate is the 
product of the addition of dibenzylazodicarboxylate (DBAD) into 307, which arises 
from the alkylation of methyl acetoacetate 308 with chloromethyldimethylphenyl 
silane. 
/ PMB 
I 	 HN 
Ylc~o Me 
 S1Me2Ph = Me)LOMe 	> 	Me LOMe 
NHPMB 	 ~ NH 2  
0 	 Si 
300 	
PhMe2 	














308 	 307 	 306 
Scheme 3.38 Retrosynthetic route to amine 300 
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The synthesis of amine 300 began with the alkylation of methyl acetoacetate 308 
with (chloromethyl)dimethylphenyl silane. The reaction was first attempted via 
deprotonation of methyl acetoacetate with NaH, followed by addition of 
C1C112SiMe2Ph. Several attempts using different solvents, such as THF, DMF or 
Et20, were carried out. These were conducted at a range of temperatures varying 
from room temperature to reflux, and for a variety of reaction times. Unfortunately, 
no product was observed even after heating under reflux for several days. 
Formation of the desired product was only observed when an iodide source was 
added. Sequential addition of methyl acetoacetate and chloromethyl 
dimethylphenylsilane (1.1 eq) to a suspension of KI (0.6 eq) and NaH (1.1 eq) in 
DMF:THF (1:1) followed by heating under reflux for 14 h yielded the desired 
alkylated product in 45% The same procedure was repeated in THF only as 
solvent but product 307 was not formed. When a mixture of THF with other polar 
solvents (acetonitrile or DMSO) was employed, traces of product were obtained but 
the yield could not be improved. 
The number of equivalents and the source of iodide were also investigated. It was 
demonstrated that the optimal amount of KI was 0.6 equivalents. When B114NI was 
used, only traces of the desired alkylated product were formed. The use of NaT 
instead of KI also afforded the desired alkylated product but in slightly lower yield 
(40%). The yield of the reaction could finally be improved to 65% by increasing the 
amount of NaH (1.5 equivalents) and alkylating agent (1.2 equivalents) (Scheme 
3.39). 
0 0 




308 	 307 
Reagents and conditions: (a) NaH (1.5 eq), KI (0.6 eq), CICH 2 SiMe2Ph 
(1.2 eq), THF:DMF (1:1), reflux, 14 h, 65%. 
Scheme 3.39 Alkylation of methyl acetoacetate to afford 307 
The next step involved the amination of 307. Jorgensen reported in 2003 a 
catalytic enantioselective a-amination of a-substituted -ketoesters catalysed by a 
chiral copper(II)-bisoxazoline complex with azodicarboxylates as the nitrogen 
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fragment source. ' 7 With only 0.5 mol% of the catalyst, the corresponding products 
were obtained in high yields and excellent enantioselectivities (Table 3.11). 





N N CO2Bn 
310 
Me. 	Me 
N 	N çr>311 
Ph (s}Ph.BOx Ph 
Cu(OTf, CH2Cl2 
_COBn o 	FIN 
R1 CO2Bn 
R2  CO2 R3 
312 
10 mol% cat. 0.5 mol% cat. 
R' 	R2 R3 Yield (%) 	ee (%) Yield (%) 	ee (%) 
1 Me 	Me Et 312a 98 	98 91 	96 
2 Et 	Me Et 312b 94 	98 98 	98 
3 Ph 	Me Et 312c 85 	95 81 	87 
4 i-Pr 	Me t-Bu 312d 96 	98 89 	98 
5 Bn 	Me t-Bu 312e 84 	98 79 	98 
6 Me 	Ally! t-Bu 312f - 	 - 80 	98 
7 Me 	Me t-Bu 312g 86 	98 - 	 - 
8 (CH2)3 Et 312h 98 	99 96 	99 
9 (CH Et 312i 98 	99 96 	99 
10 (CH2)5 Et 312j 76 	98 70 	99 
Table 3.11 Jorgensen's (S)-Ph-Box-Cu(O TI) 2 catalysed enantioselective 
am/nation 
The newly formed stereogenic carbon centre was proved to be of R 
stereochemistry by X-ray crystallography of a derivative of one of the addition 
products. On the basis of this result, a reaction mechanism involving the approach of 
dibenzyl azodicarboxylate to the -ketoester coordinated to the catalyst was 
proposed (Figure 3.5). 
R02CR N _CO2R 
Me, 
OR  
Figure 3.5 Proposed reaction mechanism 
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Consequently, it was planned to apply this methodology in the synthesis of amine 
300, which also had a quaternary stereocentre with R stereochemistry (Scheme 3.40). 
N_CO2Bn 
0 	0 	 11 
	
)L.iL Bn02C_N 310 
Me OMe ---------------- 
) PhMe2SI 	 Cu(OTf)2 , CH 2Cl2 
307 
o o 
Me ' 0Me 
N—CO2 Bn 
PhMe2SV" '  
BnO2C NH 
306 
/ HN PMB 
I  
I Me 	—SIM82Ph 
CO2Me 
300 
Scheme 3.40 Possible application of Jorgensen's methodology to our system 
The need to test the feasibility of the key cyclisation step however, led us to first 
develop a simple and efficient route to racemic 300. Amination of 307 was carried 
out via a phosphine-catalysed addition of 307 to azodicarboxylates." 8 We were very 
pleased to see that when -keto ester 307 was reacted with a substoichiometric 
amount of tributylphosphine and with dibenzyl azodicarboxylate (310) in 
acetonitrile, the desired addition product 306 was easily prepared and isolated in 86% 
yield (Scheme 3.41). 
OMe 
N_CO2Bn 




OMe Me )L 
a 	





Reagents and conditions: (a) PBu 3 (0.2 eq), DBAD (310) (1.1 eq), 
MeCN, rt, 30 mm, 86%. 
Scheme 3.41 Phosphine catalysed a-amination of 307 
The proposed mechanism for this reaction is outlined in Scheme 3.42. The 
phosphine attacks the electronically deficient double bond of the azodicarboxylate, 
forming a phosphonium ylide intermediate 313 that deprotonates the dicarbonyl 
compound 314 generating its conjugate base (316). The conjugate base can now 
attack the nitrogen of the phosphonium cation 315, affording the addition product 
and releasing the phosphine (pathway A). Another alternative (pathway B) involves a 
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cyclic mechanism with attack of the conjugate base onto the double bond of the 
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Scheme 3.42 Proposed mechanism of the phosphine catalysed addition of 
/3-keto esters to azodicarboxylates 
We next looked at the hydrogenolysis of 306, to obtain the amine moiety. When 
compound 306 was treated with Pt0 2 or Pd/C as catalyst under a hydrogen 
atmosphere, no reaction was observed. The reaction with Ra-Ni was slow, it did not 
go to completion and it only afforded an inseparable mixture of products. However, 
the starting material was consumed when the reaction was performed in a high 
pressure reactor (45 bar) and using a large excess of Ra-Ni. Purification of the crude 
reaction mainly afforded a diastereomeric mixture of aminoalcohols 319a and 319b 
(approximately 2.4:1), arising from the reduction of both the N-N bond and the 
ketone of 306 (Scheme 3.43). Unfortunately, the yield of this reaction was 
inconsistent, ranging from 50 to 70%. This is a problem that would need to be 
addressed in the future. 
O 0 
OH 0 
Me 0Me 	a 	
Me OMe 
PhMe2SV" N—0O28n J NI-I2 
NH 	 PhMe2S1 
BnO2C 
306 	 3190 and 319b 
Reagents and conditions: (a) Ra-Ni, HOAc, MeOH, H 2 ,40 °C, 16 h, 50-70%. 
Scheme 3.43 Hydrogenolysis of 306 
88 
CHAPTER 3 	 Reductive A idol Cyclisation 
PMB protection on the nitrogen of 319a and 319b was first attempted using 
NaHCO3 and PMBC1, conditions that afforded some desired product but the yield 
was low and inconsistent (25-40%). Formation of the product protected both on the 
oxygen and on the nitrogen was problematic. Several attempts were carried out using 
different bases and different number of reagent equivalents, and also using iodide 
additives (KI, Nal), but in none of these was the yield of the reaction significantly 
improved. We were pleased to find that reductive amination with p-anisaldehyde 
gave the desired product in a consistent and good yield (65-70%) (Scheme 3.44). The 
reaction was performed on the mixture of both diastereomers 319a and 319b, which 
yielded a mixture of both diastereomers 320a and 320b. Oxidation to the 
aminoketone was achieved under Swern conditions.  6 ' The yield of this oxidation was 
good (>80%) when the reaction was performed on a small scale, but on scaling 
(>0.75 mmol), the yield was only moderate (60-70%). 
	
OH 0 	 OH 0 	 0 0 
a 	 b 
Me 	 OMe 	 Me 	 OMe 	 Mo 	 OMe ~ NH, 	 ~ NHPMB NHPMB 
PhMe2SI 	 PhMe2Si 	 PhMe2SI 
319a and 319b 	 320a and 320b 	 300 
Reagents and conditions: (a) NaCNBH3 (1.5 eq), p-anisaldehyde (1.2 eq), 
HOAc (2 eq), MeOH, II, 18 h, 65%; (b) (COd)2 (2.1 eq), DMSO (4.2 eq), 
Et3N (4.2 eq), CH2C12, —78 °C, 3h, 60-80%. 
Scheme 3.44 Final steps of the synthesis of amine 300 
The five step route shown in Scheme 3.45 allowed us to prepare sufficient 
amounts of amine 300 and studies on the reductive aldol reaction could be 
undertaken. However, a general improvement of the synthetic route, focusing on the 
hydrogenolysis of 306 and on the final oxidation step, was necessary. 
CO2Bn 
HN 	 - PMB 
Me(....rOMe a-b BnO2c 	
2Ph C 	
Me)Il.OM: 	d-e MeykMe2 
308 	 306 	 3l9a and 3l9b 	 300 
Reagents and conditions: (a) NaH, KI, CICH 2 SiMe2Ph, THF:DMF (1:1), 
reflux, 14 h, 65%; (b) PBu 3 , DBAD (310), MeCN, rt, 30 mm, 86%; (c) RaNi, 
HOAc, MeOH, H2, 40 °C, 16 h, 50-70%; (d) NaCNBH3, p-anisaldehyde, HOAc, 
MeOH, it, 18 h, 65%; (e) (Cod) 2, DMSO, Et3N, CH202, —78 °C, 3h, 60-80%. 
Scheme 3.45 Full synthetic route to amine 300 
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3.5.2. Studies on the amide coupling and reductive aldol cyclisation 
We next examined the preparation of the protected 4-hydroxy a,-unsaturated 
acid. Ideally, the 4-hydroxy group should be protected with a PMB group, so that it 
could be simultaneously deprotected with the PMB-protected amide nitrogen. It was 
envisaged that alcohol 322 could derive from ethyl trans-4-oxo-2-buteanoate 321 
(Scheme 3.46). Fortunately, Luche reduction 119  of 321 afforded alcohol 322 in 
excellent yield. PMB trichloroacetimidate 323 was next prepared 120  and reacted with 











321 	 322 	 324 	 325 
Reagents and conditions: (a) NaBH4 (I eq), CeCI3 (1 eq), EtOH, 0 °C to 
rt, 14 h, 95%; (b) acetimidate 323 (1.5 eq), CSA (1 eq), CH 2Cl2, 0 °C to 
ii, 14 h, 57%; (c)NaOH (1.1 eq), EtOH, rt, 14 h, 70%. 
Scheme 3.46 Preparation of PMB-protected acid 325 
The formation of the amide derived from acid 325 and amine 300 was attempted 
mainly via two methods: 1) formation of the acid chloride followed by coupling with 
the amine and 2) activation of the acid with a coupling agent followed by reaction 
with the amine. 
In the first method, the acid chloride of 325 was formed and then reacted with a 
solution of amine 300 in the presence of a base. Corey and co-workers have reported 
interesting results on the coupling reaction of structurally similar amine 327 and acid 
chlorides (Scheme 3•47)•121  They reported a novel reaction that produced bicyclic 
3-1actones 328 and 329, from the reaction of acryloyl chloride 326 and amino ketone 
327 with pyridine as base. However, this discovery originated from the study of the 
formation of the corresponding acrylamide, which proved to be unexpectedly 
troublesome. It was observed that the formation of the acrylamide was only achieved 
when highly hindered tertiary amines, like triisobutylamine or 
2,6-di-tert-butylpyridine, were employed as base. Instead, in the presence of less 
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hindered bases, like pyridine or triethylamine, the main products were the bicyclic 
13-lactones 328 and 329 (4:1 ratio). Due to the low basicity and high steric hindrance 
of amine 327, the reaction rate of the coupling with the acid chloride is so slow that 
the side reaction that affords the 13-lactones becomes dominant. 




Me 	 0 Me 
326 	 327 	 328 	 329 
Reagents and conditions: (a) Pyridine (3 eq), CH 2C12 , 80% (4:1). 
Scheme 3.47 Formation of /3-lactones 328 and 329 using a less hindered 
amine 
It was proposed that the most likely mechanism for the 3-lactone formation in the 
presence of pyridine involved the formation of an N-acryloylpyridinium complex 
331, which suffers an addition of the secondary amine 327 at the carbon 3 to the 
carbonyl group instead of at the carbonyl, probably due to steric reasons. Keto ketene 
332 is then formed and cyclises via an internal [2+2]-cycloaddition giving 3-1actones 
328 and 329 (Scheme 3.48). 
HN
_PMB 
Me 	—08n [ 	1 f 'CO2Me 
0 	
1I1 	 0 327 
+ LN cl ) [crQj 
326 	330 	 331 
[ 	CPMB 	1 
O8n HN 	I 
1+ 
 CO2Me 	01 O C
I 
[ 	332 0 
	
J 	330 
PMB 	 PMB 
.r— OBfl 
_..• 	 + o__., o-  
CO2Me 	 CO2Me 
Me 	 0 Me 
328 	 4:1 	 329 
Scheme 3.48 Proposed mechanism for the formation of /3-lactones 328 and 
329 
When more hindered bases are used, the activated N-acryloylammonium species 
is not formed and the amine is exclusively functioning as base, and N-acylation of 
amine 327 is the main reaction (Scheme 3.49). 
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Reagents and conditions: (a) Triisobutylamine (3 eq), CH 2Cl2 , 78%. 
Scheme 3.49 Acylation of amine 327 using hindered amines 
Bearing this example in mind, we proceeded to perform the amide coupling of 
our substrates. Acid 325 was reacted with oxalyl chloride and a substoichiometric 
amount of DMF and stirred for 6 h. The formation of the acid chloride was also 
carried out using thionyl chloride and allowing the reaction to stir at room 
temperature overnight. The solution containing the acid chloride was then 
concentrated in vacuo, redissolved in CH202 and transferred into a solution of the 
base and amine 300 (Scheme 3.50). This coupling reaction was initially attempted in 
the presence of 2,6-di-tert-butylpyridine or triisobutylamine as base, but without 
success. The reaction was also attempted at various temperatures, using different 
number of equivalents of both reagents and also using other bases (Na 2CO3 (aq) and 
pyridine). However, all efforts to obtain amide 334 were unsuccessful. 
The main reason of the failure of this reaction was the cleavage of the PMB 
protecting group of the alcohol during the formation of the acid chloride of 325, due 
to the acidic 'conditions produced in the reaction. This cleavage, combined with the 
low basicity and high steric hindrance of amine 300, did not allow the formation of 
amide 334. All reactions yielded a complex mixture of products and remaining 










0 	DMF 0 	
0 300 	PMBO..}.PMB 
I 	SIMe2Ph )L
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PMBO, -- 	 base 
325 - 	 333 	 334 	0 
Scheme 3.50 Preparation of 334 via formation of the acid chloride of 325 
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The use of peptide coupling agents was next investigated. In a peptide coupling 
reaction, the carboxylic acid is typically activated by an appropriate peptide coupling 
reagent followed by reaction with the amine of a second amino acid. Carbodiimide 
coupling reagents (335-337) have been extensively used in peptide synthesis because 
of their moderate activity and because they are relatively inexpensive (Figure 3.6). 
Additives like 1-hydroxybenzotriazole (HOBt) or DMAP are successfully used to 
enhance the reaction rate and reduce racernisation. Another coupling reagent 
extensively used is the imidazolium CDI. 
	
Me 	 Me 
K Me 	 Me 
335 DCC 	 336 DIC 
H3C N 






338 HOB1 	 339 DMAP 	 340 CDI 
Figure 3.6 Examples of coupling agents and additives 
Phosphonium reagents as C1oP and BroP were introduced in the early 1970s but 
they showed high racemisation in their reactions (Figure 3.7). After HOBt was 
discovered as an antiracemisation agent, a new CIoP-HOBt combined reagent (BOP) 
was introduced. Later, reagents like PyBroP were employed, in which the 
dimethylamine moiety has been replaced by a pyrrolidine. These reagents avoid the 
formation of the toxic hexamethyiphosphoramide (HMPA) in the reaction. 
Uronium reagents, like HBTU or TBTU, are also extensively used in peptide 
chemistry (Figure 3.7). Tetrafluoroborate or hexafluorophosphate anions are 
generally the non-nucleophilic counteranion used in these reagents. It has been 
reported that the active species of these reagents is the N-guanidium rather than the 
O-uronium salt. 
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341 X = Cl ClaP 	343 SOP 	 344 PyBroP 	 345 X = P176 HBTU 
342 X = Br BroP 346 X = BF4 TBTU 
Figure 3.7 Phosphonium and uranium coupling reagents 
We carried out different attempts using several coupling reagents, but all of them 
met with failure and no pure products could be isolated from the reactions. Table 
3.12 summarises the different conditions employed for this reaction. 
Attempts using DCC or EDC were performed in the presence of additives HOBt 
or DMAP (entries 1-4). These reactions were carried out in several solvents, under 
different temperatures, using different number of equivalents of the reagents and 
different reaction times. Even if under some conditions degradation of the starting 
material occurred, in every case unreacted amine 300 was recovered. An attempt was 
made using CDI in CH202 as solvent (entry 5), but no reaction was observed. 
Similarly disappointing results were obtained when HBTU, PyBrop or BOP was 















Coupling agent Solvent 
DCC, DMAP To! 
2 DCC, HOBt CH3CN 
3 EDC, DMAP CH2Cl 2 or DMF 
4 EDC, HOBt CH2Cl 2 or DMF 
5 CDT CI-1 2C!2 
6 HBTU,DIPEA DMF 
7 HBTU, HOBt, DIPEA DMF 
8 PyBrop, DIPEA CH2Cl2 
9 BOP, DIPEA CH2C!2 
Table 3.12 Attempts for the formation of amide 334 using coupling agents 
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In order to confirm that amine 300 is nucleophilic enough to couple with acid 
chlorides, reactions were repeated using commercially available acid chlorides. 
Amine 300 was successfully reacted with acroloyl or crotonoyl chloride (3 eq) in the 
presence of triisobutylamine,' 2 ' yielding amides 347 and 349, respectively, in good 
yields (Scheme 3.51). This suggests that decomposition of the acid was the main 











0 	 I 	SiMePh 
Me CI + 
Me 
0 














Reagents and conditions: (a) Triisobutylamine (3 eq), CH 20 2 , 0 °C to ii, 14 h. 
Scheme 3.51 Succesful coupling of amine 300 with commercially available 
acid chlorides 
Consequently, we decided to prepare another (t,13—unsaturated  acid, this time 
with a less acid-labile protecting group on the alcohol. We chose to use a benzyl 
protecting group, which is more stable under acidic conditions and should not cleave 
during the acid chloride formation. 
Protection of alcohol 322 with a benzyl group was performed using the same 
method employed in the PMB protection. Benzyl trichioroacetimidate 350 was easily 
prepared and it was then reacted with alcohol 322 in the presence of an acid (Scheme 
3.52). The first attempt was performed employing CSA but, although some desired 
product was formed, the reaction afforded a complex mixture of products and it did 
not go to completion, even when a large excess of acid was used. The use of triflic 
acid in a similar benzyl protection had been reported. 122  We were pleased to see that 
under these conditions, a fast and clean reaction afforded the desired ester 351 in 
moderate yield (60% to 70%). Hydrolysis of the ester using LiOH in H 20/THF' 23 
gave access to the desired protected acid 352 in 85% yield after purification (Scheme 
3.52). 
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NH. 350 
0 	BnO'CCI 3 	 0 	b 
a 	
BnO l 
322 	 351 	 352 
Reagents and conditions: (a) Benzyl acetimidate 350 (1.5 eq), TfOH (0.1 
eq), CH202, rt, 24 h, 60-70%, (b) LiOH (2 eq), H 20/THF, rt, 18 h, 85%. 
Scheme 3.52 Synthesis of benzyl protected acid 352 
The coupling of amine 300 with acid 352 was next attempted. After some 
experimentation, it was found that 4.5 equivalents of acid chloride were necessary in 
the reaction. Therefore, 4.5 equivalents of acid 352 were reacted with oxalyl chloride 
for 18 h and this solution was concentrated, redissolved in CH 202 and then added to 
a solution of amine 300 and triisobutylamine in CH 2C12 . Amide 354 was obtained in 
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COMe 





352 	 353 	 354 	0 
Reagents and conditions: (a) (COd) 2 (13.5 eq), CH202, 14 h, rt; (b) 
amine 300, triisobutylamine (4.5 eq), CH2Cl 2 , 0 °C to reflux, 14 h, 60%. 
Scheme 3.53 Successful amide coupling of 300 with acid 352 
We could now proceed to attempt the reductive aldol cyclisation of 354. For 
these trials we would screen the most effective catalyst systems discovered within 
the group. Therefore, amide 354 was treated with Et 2Zn as the stoichiometric 
reductant and either Co salts (Co(acac) 2 .2H20 or CoC1 2 and Cy2PPh) or Ni(acac) 2 as 
precatalyst. Unfortunately, in all cases the reaction only afforded a complex mixture 
of products, together with unreacted starting material (Scheme 3.54). The analysis of 
the reactions proved very difficult and desired products were never isolated. The 
reactions were also carried out using Et 3A1 instead of Et2Zn, but again a complex 
mixture of products was Obtained. 
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HO CO2R 
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Reagents and conditions: (a) Catalyst (10 mol%), ligand (11 mol%), 
Et2Zn or Et3AI (2 eq), THF. 
Scheme 3.54 Inconclusive cyclisation trials of amide 354 
As mentioned previously, amides 347 and 349 (Scheme 3.51) were synthesised to 
confirm whether amine 300 was nucleophilic enough to react with an acid chloride to 
form an amide. These substrates do not contain the 4-hydroxy functionality in the 
acyl moiety of the amide required for the synthesis of 1, but we questioned whether 
the cyclisation of these substrates would be possible. If these cyclisations were 
successful, more information about the optimal catalyst system and about the 
reaction conditions would be gained. Furthermore, we would learn that it was the 
functionalisation of the acyl part of the amide what was preventing the cyclisation of 
amide 354 from occurring. 
Cyclisation of 347 and 349 was attempted employing the same catalyst systems 
as previously. These substrates were treated with Et 2Zn as the stoichiometric 
reductant and either Co salts (Co(acac)22H20 or CoC1 2 and Cy2PPh) or Ni(acac) 2 as 
precatalyst (Scheme 3.55). In all cases the reaction resulted in a complex mixture of 
products and the desired product was never isolated. 
O 	 0 
	
a 	Me..,.hIN..PMB 	 Catalysts used: 
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HO CO2 R 
0 
349 	 357 
Reagents and conditions: (a) Catalyst (10 mol%), ligand (11 mol%), 
Et2Zn (2 eq), THF. 
Scheme 3.55 Inconclusive attempts of cyclisation of 347 and 349 
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In order to verify that the failure of the cyclisation could be attributed to the 
highly substituted amide, we decided to couple the simpler amine 359' with the 
benzyl protected acid 352 (Scheme 3.56). The formation of the acid chloride (2.5 eq) 
was achieved reacting acid 352 with oxalyl chloride, stirring at room temperature for 
14 h,' 23 followed by the reaction with a solution of the amide and triisobutylamine in 
CH202. Amide 360 was obtained in very good yield (>94%). The fact that the 
conditions needed for amide coupling with 359 were less harsh than for the coupling 
with amine 300 (where 4.5 equivalents of the acid chloride were needed), 






Me) 	 o 
a 	a 	 359 	Bno..APMP 
BnO )( 	 - 	 -,_!L
cl 
	 b 	 Met) 
352 	 358 	 360 	o 
Reagents and conditions: (a) (COd) 2 (12.5 eq), CH 202, 14 h, rt; (b) 
amine 359, triisobutylamine (3 eq), CH 202 , II, 12 h, 94%. 
Scheme 3.56 Preparation of amide 360 
When substrate 360 was treated with Et 2Zn and Co(acac) 2•2H20, some new 
products were formed, but most of the starting material remained unreacted. 
Surprisingly, exposure of 360 to Et2Zn and CoC12 and Cy2PPh as precatalyst 
afforded, in a very clean reaction, two cyclised products in a total conversion of 85% 
and in a 2:1 ratio (Scheme 3.57). The relative stereochemistry of each product was 
not assigned, although due to the known syn-selectivity of the cyclisation reaction, 67 
we assumed that the major diastereomer would be the syn-product. The reaction 
using Ni(acac)2 also afforded the two cyclised 'products, but with slightly lower 
conversions. 
Kindly donated by Dr. G. J. Murray 
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BnOz lL N _PMP 	a 	BnO_.,JL_PMP 
Me....(J 	 Me—)---1 
0 	 HO 
360 	 361aand361b (2:1) 
Reagents and conditions: (a) CoC1 2 (10 mol%), Cy 2PPh (11 mol%), 
Et2Zn (2 eq), THF, 0°C to rt, 18 h, 85 % (2:1). 
'Scheme 3.57 Successful cyclisation of amide 360 
We decided to prepare yet another substrate, containing a sorbyl acyl fragment. 124 
A substrate with the sorbyl functionality was potentially useful since ozonolysis of 
the double bond followed by a reductive work-up would reveal the ethyl hydroxyl 
side-chain at C2 needed for the synthesis of 1 (Scheme 3.58). 
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PGO CO2Me 	 PGO CO2Me 
362 	 363 
Scheme 3.58 Obtention of the ethyl hydroxyl chain at C2 via ozonolysis of 362 
Therefore, sorbyl chloride was readily prepared 125  and reacted in the first place 
with amine 359 (Scheme 3.59). The cyclisation of this simpler amide would be 
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Me OH 	 Me '- 	 Ci 	 b 	
Me 
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Reagents and conditions: (a) SOCl 2 (2 eq), DMF (cat), 1 h, reflux; (b) 
amine 359, triisobutylamine (3 eq), CH2Cl 2 , ii, 12 h, 62%. 
Scheme 3.59 Preparation of sorbyl am/do 366 
When substrate 366 was reacted using Co(acac) 2 •2H20 and Et2Zn, most of the 
starting material was recovered. Surprisingly, when the reaction was performed using 
Ni(acac)2 as precatalyst, the reaction went practically to completion and several 
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products were obtained. The crude mixture of this reaction was purified, and the 
major product isolated was a cyclisation product 367, in 20-25% yield. The relative 
stereochemistry of this compound was not known. Some traces of what was 
tentatively identified as the alternative diastereomer of 367 and also of the double 
bond isomer 368 were isolated. The overall conversion was approximately 50% 
(Scheme 3.60). The reaction employing CoC12 and Cy 2PPh also afforded 367 and the 
other isomers in a very similar reaction to the one with Ni(acac) 2 . 
Although the cyclisation of amide 366 had only afforded small amounts of 
cyclised product, this example demonstrated again that the cyclisation could take 
place with amides that were not prepared from amine 300. 
Me-':11, 	
PMP ONPM  	 Me 
Me 	
NMP 	Me 	
Me..e yJ Me—)—, 
	
366 o 	 367 HO 	 \ 	366 NO 	 ) 
Reagents and conditions: (a) Ni(acac) 2 , Et2Zn, THF, 0°C to rt, 18h, 25%. 
Scheme 3.60 Cyclisation of 366 
We then moved on to prepare amide 369 and attempt the cyclisation reaction. 
Sorbyl chloride was prepared and reacted with amine 300, employing the same 
procedure as for the coupling of amide 366. Unfortunately, although amide 369 was 
formed, the complete purification was not successfully achieved and therefore we 
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Reagents and conditions: (a) SOC1 2 (2 eq), DMF (cat), 1 h, reflux; (b) 
amine 300, triisobutylamine (3 eq), CH 2C1 2 , ii, 12 h. 
Scheme 3.61 The coupling of amine 300 with sorbyl chloride was not 
successful 
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3.6. Conclusions 
Due to the successful advances in the development of the reductive aldol 
cyclisation reaction within the group, especially some encouraging results in the 
synthesis of five-membered lactams, we decided to use this approach in the synthesis 
of salinosporamide A. 
Amide 354, containing the required substitution to be transformed into 1, was 
prepared and employed in several attempts of the cyclisation reaction. Unfortunately, 
in all cases only a complex mixture of products, together with unreacted starting 
material, was obtained and the isolation of cyclisation products proved impossible. 
Simpler amides 360 and 366 afforded cyclised products but all cyclisation attempts 
of highly substituted amides 354, 347 and 349 were unsuccessful. 
The failure of these cyclisations was attributed to the dense functionalisation of 
these substrates. Other side reactions, like conjugate reduction or reduction of the 
ketone, could be taking place, instead of the cyclisation reaction. Moreover, if some 
substrate had cyclised and the reaction was not diastereoselective, up to four cyclised 
products could be formed in similar ratios. All these factors could explain the 
formation of a complex mixture of compounds, from which the isolation of 
cyclisation products was not possible. 
Disappointingly, due to these negative results the use of amine 300 was 
abandoned and a new approach towards the synthesis of the natural product was 
investigated. 
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4. Reformatsky reaction approach in the synthesis of 
salinoporamide A 
The following chapter will concentrate on the route we adopted next. On this 
occasion we envisaged that the 7-lactam of 1 could be constructed via an 
intramolecular Reformatsky reaction. It was believed that the cyclisation could be 
achieved with high yield and high stereoselectivity. 
4.1. Retrosynthetic analysis 
The retrosynthetic plan adopted for this approach is outlined in Scheme 4.1. As 
described previously, initial disconnections of 1 lead to a y-lactam intermediate 
represented by 370 (Scheme 4.1). We envisaged that this y-lactam could be 
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Scheme 4.1 Retrosynthotic analysis using the Reformastky reaction approach 
Amide 371 could be readily prepared from the coupling of an a-halo acid 373 
with the corresponding amine (Scheme 4.2). For this route, it was decided not to 
employ amine 300, due to the unsuccessful results obtained when it was used in the 
reductive aldol approach (Chapter 3). It was decided to use amine 327 (Scheme 4.2), 
which had been utilised by Corey and co-workers in their synthesis of 1.26  Amine 
327 had proved successful in inducing diastereoselectivity in the cyclisation 
performed in Corey's synthesis. It was hoped that the quaternary stereocentre would 
also result in some internal asymmetric induction in the Reformatsky cyclisation of 
amide 372. Moreover, amine 327 could be prepared following reported methods and 
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since it was prepared from (L)-threonine, we would be already working on an 
asymmetric route to 1. 
0 	 0 
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Scheme 4.2 Retrosynthetic analysis of a-halo amide 372 
Amide 372 contains all the required functionalities for the synthesis of 
salinosporamide A. If 372 was successfully cyclised to afford y-lactam 374 (Scheme 
4.3), only a few operations would be necessary (transformation of the protected 
alcohol into the aldehyde, insertion of the cyclohexenyl chain, protecting group 
manipulations), to yield trio! 26. This intermediate is the same compound we were 
aiming to obtain via the reductive aldol approach (Chapter 3, Scheme 3.36), which is 
an intermediate in Corey's 26  and also in Pattenden's29 reported syntheses of!. 
PGO (&N PMB R%7 kY 
Me— 	CO2Me 	
HO CO2Me 	 HO CO2Me
OH 
372 	 374 	 26 
Scheme 4.3 Application of the Reformatsky reaction in the cyclisation to 
'lactam 374 and transformation to intermediate 26 
If the proposed route to intermediate 26 was successful, we would have 
developed a concise and effective formal synthesis of salinosporamide A. The 
challenge was to find the optimal conditions for the Reformatsky cyclisation of 
amide 372 to obtain f3-hydroxy y-lactam 374. In the next section, we will briefly 
review the Reformatsky reaction focusing on methodologies that have been 
successfully employed in intramolecular systems. 
103 
CHAPTER 4 	 Reformatsky Reaction 
4.2. The Reformatsky reaction 
The classical Reformatsky reaction, as it was reported for the first time in 
1887, 126  consisted of a zinc-induced formation of -hydroxy alkanoates from ethyl 
haloacetates and aldehydes or ketones (Scheme 4.4). However, since then the 
reaction has been found to be applicable to other alkyl 2-haloalkanoates, the scope of 
the reaction has also been extended beyond aldehydes and ketones as electrophiles 
and, moreover, other metals and catalysts have been found to promote the reaction in 
a similar way to zinc. 121-129 Therefore, a more general definition for the Reformatsky 
reaction was needed and it is now formulated as "all reactions resulting from metal 
insertions into carbon-halogen bonds activated by carbonyl or carbonyl-derived 
groups in vicinal or vinylogous positions with practically all kinds of 
electrophiles".' 27 
0 
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 .IL R2 	OZnX 	 H30 	OH 
XCH 2CO2 Et 	 XZnCH2COEt 
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375 	 376 	 377 378 
Scheme 4.4 Classical Reformatsky reaction 
The Reformatsky reaction has become a very important carbon-carbon bond 
formation method in organic synthesis. In the field of enolate chemistry, it represents 
an alternative to base-induced aldol reactions. A separate treatment is due mainly to 
the specific mode of metal enolate formation from halo carbonyl compounds, with 
the site of the reaction being strictly determined by the halogen substituent. This may 
be advantageous with polycarbonyl compounds, for which a regioselective enolate 
formation is difficult to achieve via proton abstraction with a base. 
The main disadvantage attributed to the Reformatsky reaction has been the lower 
yields and diastereoselectivities associated with it, compared to those of the aldol 
reaction. However, great improvements have been made in this area and there are 
now a great number of examples of highly diastereo- and enantio selective 
Reformatsky reactions. Therefore, it has become a perfectly suitable reaction for the 
synthesis of complex target molecules. 
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Several zinc-activation methods have been developed. 127  Activation is achieved 
either via effective removal of the zinc oxide layer from the metal surface or via a 
fine distribution of the metal, most efficiently accomplished by reduction of 
anhydrous zinc halides (e.g., Rieke zinc' 30  is obtained from the reduction of 
anhydrous zinc chloride by potassium). The most common depassivating procedures 
employ reagents such as iodine, 1 ,2-dibromoethane, copper(I) halides, 
chiorotrimethylsilane or simple acid washing of the zinc. 
Apart from the different available methods for zinc activation, there are 
numerous examples of additives or inductors in the Reformatsky reaction. 
Yamamoto and co-workers, in 1977, reported an aldol reaction of a-haloketones or 
a-haloesters with dialkylaluminium chloride and zinc. 13 1 An aluminium enolate was 
generated regiospecifically and then it was added to the carbonyl compounds 
affording the 3-hydroxy carbonyl compounds after workup (Scheme 4.5). 
• 	 R 
Al', 	 I 	 R 
R AI...R 	
R4CHO 	
'AI \ 	 0 	OK 
o H30 
	
o) _____ 	/ _____  
II 	R2 	 R'1)(R4 
R2 R3 R<.R3 
R2 R3 X 
R3 
379 	 380 	 381 	 382 
Scheme 4.5 Yamamoto dialky/aluminium chloride mediated Reformatsky reaction 
This methodology was employed in an intramolecular cyclisation of 383 which 
afforded diastereomer 384 as the major product (Scheme 4.6). 
132 
Me 	 HO Me 	 HO Me 
CI 	 C1 Br 	 CI + a 	 I Sol 
CI 	 CI 	
cI —J,.---J 
383 	 384 	 (3.5:1) 	 385 
Reagents and conditions: (a) Et2AICI, Zn, THF, 5 h, rt, 50%. 
Scheme 4.6 Intramolecular example of Yamamoto's methodology 
More recently, this procedure was applied to the synthesis of the BCD framework 
of richardianidins (Scheme 4.7). 133  Treatment of 386 with diethylaluminium chloride 
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and zinc in the presence of a substoichiometric amount of CuBr2SMe2 as zinc 
activator and at room temperature, afforded a diastereomeric mixture of 
syn-hydroxyester products 387 and 388 (1:20), due to the aluminium Z-enolate 
formation. 
	
0 	 o 	 o 





II 	 11 	 H"11 	
Fl 
386 387 	(1:20) 	388 	 389 
Reagents and conditions: (a) Et2AIC1, Zn, CuBr 2 SMe2 , THF, 15 h, 57%. 
Scheme 4.7 Synthesis of richardianidin 389 
Another relevant example of a zinc-mediated intramolecular Reformatsky 
reaction was reported by Heathcock and co-workers. During studies towards the 
synthesis of alkaloid daphnilactone A 
(393),134  they developed a one-pot process that 
involved treatment of keto amide 390 with activated zinc in THF at 0 °C. This was 
followed by treatment with HMPA, affording lactam ether 392 in 73% yield (Scheme 
4.8). This example was highly relevant, since the structure and cyclisation of a-halo 
amide 390 significantly resembles our system. 












392 73% 	 393 
Scheme 4.8 Synthesis of polycyclic lactam ether 392 via intramolecular 
Reform atsky reaction 
In 2000, Honda reported a rhodium-catalysed Reformatsky reaction using 
RhC1(PPh3)3 and Et 2Zn. 135  Surprisingly, prior to this work, there had been very few 
literature examples in the area of catalytic Reformatsky reactions. 136' 137  Honda and 
co-workers were especially encouraged by Ding's work, which employed zinc and a 
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catalytic amount of Cp 2TiC12 137, however, in this example it was thought that the 
active species was a titanium enolate. 
Aromatic and aliphatic aldehydes or ketones were reacted successfully with ethyl 
bromoacetate or 2-bromopropionate in the presence of Wilkinson's catalyst and 
Et2Zn to afford 3-hydroxy esters within 5 minutes in moderate to good yields. The 
formation of the ethyl adduct was not observed. More encouragingly for us, the 
intramolecular version of the reaction was also developed and secondary and tertiary 
cycloalkanols were obtained in good to excellent yields and with moderate 
diastereo selectivities. Some of the examples of the intramolecular reactions with 
methyl ketones are represented in Scheme 4.9. A transition state of the zinc enolate 
(400) was proposed to explain the obtention of cis-hydroxyesters. 
o 	CO2Et 	
a Me, 
OH CO2 Et 
+ 
OH CO2 Et 
Me —,, —Br 
394 395 (59%) 
Et 
396 (5%) 	 "Zn R 




OH CO2 EL 
Me 	 + 
OH CO2Et 	
[ 	
OEt if 	j 
400 
397 398 (65%) 399 (26%) 
Reagents and conditions: (a) Et 2Zn (2.2 eq), RhCI(PPh 3)3 (5 mol %), THF. 
Scheme 4.9 Intermolecular Rh-catalysed Reformatsky-type reaction 
The proposed mechanism for this reaction is shown in Scheme 4.10. Oxidative 
addition of ct-haloester I into Rh(I) forms a Rh(III) complex II that, after 
transmetallation with Et 2Zn, produces the ethylzinc enolate III and Rh(I), which can 
start the cycle again. The zinc enolate adds to the carbonyl compound forming zinc 
alkoxide IV that affords -hydroxy ester V after work-up. 
Rh(I) 
R 	 R 
R ,,. CO2Et Rh(I) 
R.T CO2Et 	J 	OZnEt R2 	
CO,Et 




OZnX 	 OH 
I 	 ii 	Et2Zn 	 iii 	 IV V 
Scheme 4.10 Mechanism of the Reformatsky reaction catalysed by 
RhCI(PPh3)3 and Et2Zn 
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This methodology was applied in the synthesis of 1 5-epi-haterumalide NA 
methyl ester 403, a cytotoxic macrolide from an Okinawan sponge (Scheme 4.1 1).138 
When the cyclisation of 401 was attempted using Honda's conditions, 
135  only 
decomposition of the starting material occurred. By monitoring the reaction it was 
observed that the 3-hydroxy lactone was being formed but it. was decomposing 
during workup. The addition of Ac20 to trap the intermediate allowed the isolation 
of the desired (3S,4Z)-402 in 9% yield, along with the (3R,4Z)- and (4K)- isomers. 
C1 	.0 	OMPM 	CI 	 .0 	OMPM 	
CO2Me 
J L' a 	 __ 
'CH0 	 Br 
0 Me 	 Me Me 
401 	- 	 402 	 403 
Reagents and conditions: (a) (i) Et2Zn, RhCI(PPh 3)3 , THF-hexane; 
(ii) Ac20, 9%. 
Scheme 4.11 Application of Honda's methodology in total synthesis 
In 1977, Kagan introduced samarium(II) diiodide as a reagent for organic 
synthesis. 139  Three years later, the first studies on its use in deoxygenation of 
epoxides and sulfoxides, the chemoselective reduction of aldehydes in the presence 
of ketones, dehalogenations, and coupling between ketones and alkyl halides were 
reported. 140, 141 Since then, this polyvalent reducing agent has been used in a 
multitude of important synthetic transformations and in the synthesis of natural 
products. 142  One important use of this reagent is the Sm1 2 mediated reaction of 
organic halides with an electrophile, including Sm1 2 mediated Reformatsky reactions. 
Sm12 is commercially available as a solution in THF, however it can be prepared 
from the metal and diiodomethane, diiodoethane or iodine, in THF.'40' 141  Sm12 is a 
single electron reducing agent, with Sm(II) wanting to revert to the more stable 
Sm(III) oxidation state. Therefore, the Sm1 2 promoted reactions of organic halides 
are achieved using 2 molar equivalents of Sm1 2 and occur by stepwise one-electron 
transfer to the halide. The most generally accepted mechanism for these reactions 
proceeds via organosamarium species which react with the electrophile (Scheme 
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4.12). These organosamarium species are formed via reduction of the alkyl halide to 
the radical by the first equivalent of Sm1 2 and then further reduction to 
alkyldiiodosamariums by the second equivalent of Sm1 2) 44 
Sm1 2 	 Sm1 2 




Scheme 4.12 Formation of organosamarium species 
Most of the reactions employing Sm12 are performed in THF, but other solvents 
employed have been tetrahydropyran (THP) and alkylnitriles.' 45 The use of additives 
and cosolvents has also shown a crucial effect on the Sm1 2 mediated reactions. The 
most commonly employed additive is the Lewis base HMPA.' 46 It was reported that 
the redox potential (E°) of Sm 2/Sm 3 in THF (vs. Ag/AgNO3 reference electrode in 
THF) increased from —1.33 V to —1.95 V with 3 equivalents of HMPA and reached 
-2.05 V with 4 equivalents, remaining constant with more equivalents. 
14' Hou and 
co-workers 148  isolated and characterised Sm1 2(HMPA)4, although it was suggested 
that the active species in solution are more closely represented by the formula {Sm-
(HMPA)4(THF)2]12. 149  When HMPA was replaced for the less toxic HMPU, there 
was also an increase in the reduction potential, although more equivalents were 
required to achieve a similar level of activation. 150  The use of TMEDA as an additive 
has also been reported. 151 
The rate of Sm12 mediated reactions can also be increased by the addition of 
inorganic salts like lithium chloride and bromide. 
152  The chemoselectivity was also 
altered by the addition of lithium halide salts. 153  These reactions have also been 
markedly improved by the addition of catalytic amounts of transition metal salts. 154 
Ferric salts (FeC1 3 , FeBr3 , Feb) have been extensively employed, Kagan, in his first 
paper, already observed the enhanced reactivity when substoichiometric amounts of 
FeC13 were used. 140  Cul and Nil 2  have also shown to be efficient additives. 154, 155 
 
Sm12 has efficiently been used to promote the Reformatsky-type reaction of 
a—halogenoesters, therefore becoming a useful alternative to the conventional 
Zn-mediated Reformatsky reactions. Due to the homogeneous conditions afforded by 
Sm12, the reaction can proceed with enhanced reactivity and reproducibility, under 
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milder conditions, with even better chemoselectivity and, in intramolecular 
examples, with better stereoselectivity. 
Intramolecular versions of the Reformatsky-like reactions have seen further 
developments and applications than their intermolecular versions. In fact, Sm12 is one 
of the most exploited reagents for intramolecular Reformatsky-like reactions, 
especially due to the yields and diastereoselectivities. It is believed that the reaction 
proceeds through a samarium (III) enolate and cyclisation occurs through a rigid 
cyclic transition structure enforced by chelation, where the large ionic radius, the 
flexible coordination and the high oxophilicity of samarium play an important 
role. 156 
Molander studied the 1,2-, 1,3-, and 1,4-asymmetric induction in intramolecular 
Sm12 mediated Reformatsky reactions. 157  The trends of diastereoselectivity observed 
could be all explained through an eight membered ring samarium chelate (405) 
(Scheme 4.13). The products were obtained in excellent yields and very high 
diastereoselectivities. 
0 
Br)L 	 2 eq. Sm12 




).5J<oH )5çOH t- Ph 	 Bu Ph 	 t-Bu 
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Scheme 4.13 Molander Sm!2 mediated intramolecular Reform atsky reactions 
The stereoselectivity of this reaction was also very high with y-bromoacetoxy 
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39-65% (>99% di) 
Scheme 4.14 Sm12 mediated cyclisations of bromoacetoxy ketones 
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Finally, it is worth highlighting a very interesting example due to the 
resemblance with our system, reported by Kocikowski in 1999.158  Treatment of 410 
and 412 with Sm12 afforded 1-lactams 411 and 413 as single diastereomers (Scheme 
4.15). No rationale was provided for the stereochemical outcomes of these reactions. 






-6L Z~11 	 tH 
	





411 91% 	Single 
413 80% diastereomer 
Reagents and conditions: (a) Sm1 2 , FeCI 3 (cat), THF-HMPA, rt. 
Scheme 4.15 Kocikowski Sm!2 mediated y4actam formation 
4.3. Results and discussion 
Initial efforts centred on the preparation of amine 327, using a slightly modified 
synthetic route from the one previously reported by Corey and co-workers. 
 26  Amine 
327 was then successfully coupled to a number of a-halo acids affording several 
substrates which were used in the investigation of the intramolecular Reformatsky 
reaction. 
4.3.1. Synthesis of amine 327 
Methyl ester 415 was readily prepared from reaction of (L)-tbreonine (414) with 
thionyl chloride in MeOH heated to reflux overnight, and it was used in the next step 
without further purification (Scheme 4.16). 4-Methoxybenzimidate hydrochloride 
(417) was obtained from an overnight reaction of p-methoxybenzonitrile (416) and 
acetyl chloride in MeOH. Purification of 417 only involved several washings with 
Et20. 
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HCI 
H 2N .CO2H 	
a 	H2N 	CO2Me 
HO 1 Me 	
1 Me HO 








Reagents and conditions: (a) SOCl 2 (1 eq), MeOH, 0°C to rt, 18 h, 
quantitative; (b) Acetyl chloride (8 eq), MeOH, rt, 18 h, 91%. 
Scheme 4.16 Preparation of compounds 415 and 417 
Reaction of methyl ester 415 with triethyl amine and hydrochloric acid salt 417 
in CH202 afforded oxazoline 418 (Scheme 4.17), in a moderate yield of 40%, due 
also to a difficult purification. The yield of this step was improved to 65% when 
K2CO3 was employed as base instead of triethyl amine.' Although the yield was a 
little low, the procedure was simpler and more convergent than the one reported by 
Corey, which involved acylation of methyl ester 415 with 4-methoxybenzoyl 
chloride followed by acid catalysed cyclisation (Scheme 1 .6).26  Moreover, it was 




HN 	,.CO2Me 	a 
N 	CO2Me 
MeO 1 
MeO HO1 Me 
Me 
417 415 418 
Reagents and conditions: (a) Et3N (2 eq), CH2Cl 2, reflux, 14 h, 40% 
Scheme 4.17 Oxazoline 418 formation 
We next examined the alkylation of oxazoline 418, an operation that introduces 
the CH20Bn group, and sets the stereochemistry of the quaternary centre C4 
(Scheme 4.18). In Corey's procedure 26  deprotonation was achieved using LDA in the 
presence of HMPA, and the enolate was reacted with chloromethyl benzyl ether 
affording the desired product in 69% yield. Using the commercially available base 
LHMDS instead of LDA, alkylated oxazoline 17 was obtained with an increased 75 
% yield. 
Step improved by Leszek Rupnicki 
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Reagents and conditions: (a) LHMDS (1.1 eq), HMPA (4.3 eq), 
CICH2OBn (1.2 eq), THF, —78 °C, 4 h, 75%. 
Scheme 4.18 SucOessful alternative procedure for the alkylation of 418 
Transformation of oxazoline 17 into amine 327 was successfully performed 
following Corey's reported procedure (Scheme 4.1 
9)26  Reductive opening of 
oxazoline 17 was achieved using sodium cyanoborohydride in acetic acid to give 
amino alcohol 18 in good yield (from 65 to 80%). Finally, amine 327 was readily 
obtained via Swern6 ' oxidation. 
	
CO2Me 	 HN _PMB 	
HN PMB 
- 




CO2Me 	 COMe 
OH 	 0 
17 	 18 327 
Reagents and conditions: (a) NaCNBH 3 (3.3 eq), HOAc, 50 °C, 18 h, 65%; (b) 
(COd) 2 (2.1 eq), DMSO (4.2 eq), Et 3N (4.2 eq), CH2Cl2, -78 °C, 3 h, 72%. 
Scheme 4.19 Final steps of the synthesis of amine 327 
4.3.2. Study of the Reformatsky cyclisation reaction 
To investigate the viability of the Reformatsky cyclisation in the proposed route 
to 1, an advanced model system was used. Ideally, this model substrate should be 
easily prepared and it should allow the optimisation of the reaction This way, once 
the optimal conditions had been found, they could be applied to the real system, the 
substrate with the required functionalities to be transformed into 1. 
With this in mind, we chose to couple amine 327 to the commercially available 
2-bromobutyryl bromide (419), to give a-bromo amide 420 (Scheme 4.20). This 
amide was an optimal compound to investigate the reaction, since it was readily 
prepared from a commercially available starting material and it was structurally 
similar to the real substrate, only lacking the hydroxyl group in the acyl fragment. 
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Scheme 4.20 Model studies for the Reformatsky cyclisation reaction 
As expected, treatment of amine 327 with the hindered base triisobutylamine' 2 ' 
followed by addition of 2-bromobutyryl bromide 419 afforded the two expected 
diastereomers of the amide in an excellent overall yield (93%) and approximately a 
3:2 ratio (Scheme 4.21). The diastereomers were differentiated on the basis of their 
polarity on the silica plate: the more polar and major diastereomer (57% yield) was 
referred to as 420a and the less polar and minor diastereomer (36% yield) as 420b; 
but the absolute stereochemistry of the bromine bearing carbon of each compound 
was not known. As the two diastereomers could differ in reactivity, they were 
separated by column chromatography and were used independently in the study of 
the cyclisation reaction. 
0 	 0 




Me 	 Br + Mey.._t\..OBn 
	a 	Me 	
I 	OBn + 	 I 	OBn 
Br 	 o 	 Me—i 
Br 
CO2Me 	
Br "'CO2Me 	 Me —i CO2Me 
419 	 327 	 0 	42Oa and 42Ob 
Reagents and conditions: (a) Triisobutytamine (1.3 eq), CH 202 , rt, 16 h, 
93% (420a 57% and 420b 36%). 
Scheme 4.21 Synthesis of amides 420a and 420b 
The initial studies on the reaction focused on the application of the conditions of 
the "classical" Reformatsky reaction. The substrates prepared would be reacted with 
activated zinc on its own and also in the presence of additives. For instance, bearing 
in mind the examples using Yamamoto's conditions (Scheme 4.6), 131-133  the reaction 
would also be attempted in the presence of Et 2A1C1. 
Although being an intermolecular system, it was found in the literature another 
interesting example of a Reformatsky reaction. It involved the addition of 
azetidin-2-ones (422) to aldehydes and nitrites, and the effect of the addition of 
Lewis acids was also investigated (Table. 4.1).159  The organozinc was prepared in 
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THF and when it was reacted with benzaldehyde at room temperature the 
condensation product was not obtained (entry 1). However, when A1Me 2C1 was 
added as an activator of the electrophile, both diastereomeric products, 423 and 424, 
were obtained within two hours and in good yield. The formation of the 
debrominated starting material (about 15%) was observed. The reaction was 
attempted also with several other Lewis acids. It was discovered that when the 
reaction was activated with BF 3 OEt2 or Ti(Oi-Pr)4, the products were obtained in 
good yields within two hours (entries 5 and 6) and, in the case of the titanium-
catalyzed reaction, some diastereoselectivity was observed. 




	 Ph + Et_.1 /h Et 	 Additive, Zn 
Ph 
422 	 423 - Ph 
	 424 Ph 
Additive Time (h) 
Yield of 423 + 424 
(%) (syn:anti) 
- 18 - 
2 AIMe2CI 2 63 (50:50) 
3 Sc(OT02 24 - 
4 ZrCL 6 30 (50:50) 
5 BF3 'OEt2 2 79 (50:50) 
6 Ti(Oi-Pr)4 2 76 (70:30) 
Table 4.1 Use of Lewis acids in the classical Hetormatsky reaction 
Several attempts of the cycliation employing the classical Reformatsky 
conditions were carried out. Unfortunately, no reaction was observed when 
a-bromoamides 420a and 420b were treated only with zinc, which had been 
activated either with HC1 washings or with 12,  and unreacted starting material 420 
was recovered (Scheme 4.22). 
The effect of the addition of Lewis acid additives was next investigated. Attempts 
were carried out in the presence of Et 3A1' 6° or Et2A1C1. These reactions were started 
at —40 °C and, since no reaction occurred at this temperature, they were then allowed 
to warm up slowly to room temperature over 4 hours, while monitoring the reaction 
by TLC. Disappointingly, amides 420a or 420b suffered quantitative debromination 
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to form 425. Other Lewis acids were also evaluated: the reaction with TiC1 4 or 
BF 3 .Et20 afforded the debrominated amide 425; Zn(OTf)2, Mg(OTf) 2 or AgOTf 





420a or 420b 






O°Cto 	 Me" 	
N08 
HO CO2Me 	 0 
421 	 425 
Additives employed: 
- Et3AI, Et2AICI, T04 , BF3 Et20 
(to give 425) 
- Zn(OTf) 2 , Mg(OTf), or AgOTf 
(recovered 420) 
Scheme 4.22 Failure of cyclisation trials using "classical" Reformatsky 
conditions 
Next, it was decided to attempt the cyclisation using Honda's conditions (Scheme 
4.9). 135  Substrates 420a and 420b were treated with Et 2Zn and RhCl(PPh3)3. 
Unfortunately, a complex mixture of products was obtained, from which it was only 
possible to identify unreacted starting material and debrominated 425 (Scheme 4.23). 
0 	 / 0 	
\\ 
Me 	
N - PMB 
OBn 	° x MeY" PMB 




Me"H ° \ j 
HO CO2Me 
420aor420b 	 421 	 \ 	425 	/ 
Reagents and conditions: (a) Et2Zn (2.2 eq), RhCI(PPh 3)3 (5 mol%), 
-78 °C to 0 °C, 5 h, THF. 
Scheme 4.23 Unsuccessful attempt of the cyclisation using Honda's 
methodology 
A related methodology was reported in 2003, which consisted of a Ni-catalysed 
Reformatsky-type three-component condensation reaction that combined an 
aldehyde, aniline and an a-bromocarbonyl affording 3-amino carbonyl compounds 
(Scheme 4.24).161  Using Et2Zn, several catalysts [RhC1(PPh 3)3, PdC12(PPh3)2 , 
Cr(acac)2, Co(acac)2-2H201 were surveyed for the reaction before discovering that 
Ni(acac)2 was a very effective catalyst and afforded the desired product in 95% yield. 
Further optimisation of the reaction revealed NiC1 2(PPh3)2 as a better catalyst and the 
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use of the less nucleophilic dimethyl zinc instead of diethyl zinc avoided the 
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Scheme 4.24 3-Component coupling Ni-catalysed Reformatsky reaction 
The proposed catalytic cycle of the reaction starts with the in situ generation of 
the active Ni(0), followed by formation of II via an oxidative addition to the (X-halo 
carbonyl (Scheme 4.25). Then, transmetallation with dimethyizinc forms the 
methylzinc enolate III and the Ni(II) complex IV, which undergoes reductive 
elimination liberating the active Ni(0) that can start the cycle again. Zinc enolate III 
reacts with the imine affording the p3-amino carbonyl (VII) after workup. 




0R2 	 XZfl _R2 
N 	0 N 
Ni° 	 JL..ZnX + 	II 
R3 	 Ri 2 	 R3 R1 




H0 	 R2 
VII 
Scheme 4.25 Proposed catalytic cycle for the nickel-catalysed Reformatsky- 
type reaction 
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This intermolecular methodology was applied to our model substrates (Table 
4.2). When amides 420a and 420b were exposed to Et 2Zn and Ni(acac) 2, the reaction 
went to completion but only to form a complex mixture of products, from which it 
was only possible to identify the debrominated amide 425. An intractable mixture of 
compounds was also obtained when using CoC12 and Cy2PPh (entry 2). When the 
reaction was carried out in the presence of Co(acac) 2 2H20 (entry 3), no reaction 
occurred and starting material 420a or 420b was recovered. 
0 	 EtZn 	 o 	7 	o 	\ 
Me''(N 	
Catalyst 
PMB 	'Me'N THF 
OBn Br )\OBn 	X Me Me 




0 	 0 	 I 




Ni(acac) 2 	 4 	 complex mixture 
2 	CoCl2, Cy2PPh 	 18 	complex mixture 
3 	Co(acac) 2 2H20 	 14 	 420 recovered 
Table 4.2 Reactions using Et2Zn as the zinc source 
The Cr-mediated Reformatsky reaction was then investigated, although this 
methodology had been developed on intermolecular systems. Since the 1970s, 
Nozaki and Hiyama were the pioneers of the use of organochronium reagents in 
organic synthesis. ' 3 ' They demonstrated the insertion of Cr(II) into allyl-, alkyl-, 
alkynyl-, propargyl- and aryl halides or sulfonates under aprotic conditions, forming 
the corresponding organochromium(III) reagents that can react as nucleophiles in 
organic transformations. In 1986, both Kishi and Nozaki independently discovered a 
catalytic effect of nickel salts in the reaction,, which improved the reproducibility of 
the reaction. 162  This was explained via the mechanism represented in Scheme 4.26. 
Ni(II) is reduced to Ni(0) with 2 equivalents of Cr 2C1. Then oxidative addition to the 
alkenyl halide occurs, followed by transmetallation with Cr(III), forming the 
alkenylcbromium (III) reagent, which is the species that reacts with the carbonyl. 
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Scheme 4.26 Explanation of the role of Ni(II) salts in the Cr(Il)-mediated 
coupling reaction 
The major drawback of the Nozaki-Hiyama-Kishi (NHK) reaction is that, since 
Cr(II) is a one-electron donor, at least 2 mole are needed per mole of halide and, in 
reality, huge excesses (4-16 eq) of Cr(II) are used in the reaction. Because of the 
toxicity of Cr and Ni salts, a catalytic version of the reaction was highly desirable. 
In 1995, Furstner and co-workers developed the Nozaki-Hiyama-Kishi (NHK) 
reaction catalytic in chromium (Scheme 4.27).163  They reasoned that, in the reaction,, 
the formation of the highly stable Cr(III) alkoxide drives the reaction to conversion 
but also traps the metal, impeding catalysis. It was hypothesised that if the chromium 
alkoxide (III) was reacted with a chlorosilane, a exchange of ligands (via bond 
metathesis) could occur, liberating the silyl ether of the desired product (IV) and 
liberating the second mole of Cr(III). The liberated Cr(III) species could be 
rereduced in situ by a non toxic reducing agent, this enabling the catalytic cycle. 
They found that use of the cheap and non-toxic Mn in combination with TMSC1 and 
catalytic amounts of CrC1 2 allowed the first NHK reactions catalytic in chromium. 
Me X 	 RCHO 
Me , , CrX2 
Me 	 j 11 	
OCrX2 Me 
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Scheme 4.27 Mechanism of the NHK reaction catalytic in chromium 
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a-Halo ketones, esters, amides, nitriles and other Reformatsky substrates 128, 
164 
have been reacted with Cr(II) salts, forming Cr(III) enolates via oxidative addition of 
the low valent metal salt into the carbon-halogen bond activated by the carbonyl 
group. In the presence of carbonyl compounds, the aldol products are obtained. For 
instance, intermolecular reaction of a-bromo ketones with aldehydes in the presence 
of CrC12 yielded the aldol products in good yields and with complete syn-
diastereoseletivity (Scheme 4.28).' 65 
0 	 0 OH 
a 
+ 	EtCHO 	 t-Bu Et 
Me 	 Me 
430 	 431 	 432 
Reagents and conditions: (a) CrCl 2, THF, 81%. 
Scheme 4.28 Intermolecular Cr-mediated Reformatsky reaction 
The Cr-mediated Reformatsky reactions tend to proceed in THF, DMF or 
acetonitrile. This reaction is highly chemoselective towards aldehydes, 166  although 
reactions with ketones as electrophiles are also possible. 167  However, when 
a-bromoamides 420a and 420b were subjected to standard catalytic NHK reaction 
conditions (Mn, TMSC1 and CrC1 3 doped with NiC12 in THF), debrominated product 
425 was obtained quantitatively (Scheme 4.29). The same result was obtained when 
the reaction was performed in DMF. Wessjohann reported increased yields in NHK 
reactions in the presence of a catalytic amount of Lii, due probably to a general 
Lewis acid effect and to its ability to solubilise and modify CrC1 2 . 168 A last attempt 
incorporating 10 mol% of Lii also failed, with 425 being again the only product of 
the reaction. With these results we concluded that the chromium enolate was being 
formed but it was not reacting with the methyl ketone and instead it was being 
immediately quenched. 
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Scheme 4.29 Unsuccessful Cr-mediated Reformatsky reaction 
At this point, the Reformatsky reaction had been attempted with several different 
metals but these were not successful in the formation of the cyclisation product and 
in most cases the debrominated starting material was obtained. The investigation 
next focused on the Sm1 2 mediated Reformatsky reaction. It was hoped that, in this 
case, the substrates would cyclise into the ketone due to the known chelating ability 
3+ of Sm 
Initially, both diastereomers 420a and 420b were treated with 2.2 equivalents of 
Sm12 (commercially available 0.1 M solution) in THF. The reaction did not proceed 
at —78 °C, but it quickly went to completion at room temperature (Scheme 4.30). We 
were very pleased to find that this reaction afforded the desired cyclised product 421 
(30% yield), although it was accompanied by amide 433, obtained in approximately 
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Reagents and conditions: (a) Sm1 2 (2.2 eq), THF, rt, 2 h. 
Scheme 4.30 Preliminary result for the Sm12 mediated Reformatsky reaction 
Although 421 was obtained in low yield, the good news was also that it was 
obtained as a single diastereomer (only one diastereomer of product was observed by 
'H NMR spectroscopy). Furthermore, the relative configuration was confirmed by a 
2D NOESY experiment (421 was not crystalline), which indicated that 421 was the 
desired diastereomer. Two cross peaks were observed to support this fact: the CH3 at 
C3 with CH20Bn at C4 and the same CH3 at C3 with the CH at C2 (Figure 4.1). 
121 
0 





0 	 [ Sn 3 
"0 
PMB __ I 
N—PMB 
Me 	N OB 	 Me 	
OBn 
Me .)—t 	Me OMe 
HO CO2 Me 
L 	436 421  
0 	 0 
Me-'N _PMB Sm12 Me N _ PMB 
M 	
OBn 	im OBn 
e—(c 
Sm1 2 
CO2 Me 	 MeCO2 Me 
434 0 	 435 	0 
OSmI2 
Me 	




435 0  
CHAPTER 4 	 Reformatsky Reaction 
0 




Figure 4.1 2D NOESY experiment 
A proposed mechanism for the cy.clisation to T-lactam 421 is represented in 
Scheme 4.31. A first equivalent of Sm1 2 reduces a-bromo amide 420 to form 434, 
which then receives another electron from a second equivalent of Sm1 2, to form 
enolate 435. Finally, this enolate is trapped by the methyl ketone, forming y-lactam 
421. A proposed transition state to explain the stereoselectivity of the reaction is 
represented by 436. 
Scheme 4.31 Proposed mechanism of the formation of 421 
A similar reductive mechanism is proposed for the formation of amide 433 
(Scheme 4.32). Probably after loss of the bromine atom of 421, the carbonyl of the 
ketone is reduced by a first equivalent of Sm1 2. Then, a second equivalent forms 
anion 438 which rearranges, facilitated by the anion-stabilising effect of the ester, 
causing the C-N bond cleavage and yielding 433. 
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Similar observations were made by Matsuda and co-workers, in an interesting 
example of an intramolecular Reformatsky cyclisation of 3-ketouridine derivatives 
promoted by Sm12. 169 When 439 was reacted with 2.0 equivalents of Sm1 2 in THF at 
room temperature, the Reformatsky reaction proceeded giving 440 in 71% yield 
(Scheme 4.33). The reaction performed at 0 °C afforded 440 in 75% yield and at —78 
°C the yield was 90%. When the reaction was performed at —78 °C but using HMPA 
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Scheme 4.33 Matsuda intramolecular cyclisation to 439 
When 439 was reacted with zinc as a reductant in toluene, 440 was not formed 
and only debrominated starting material (442) was isolated. To study the mechanism 
of the formation of 441, 442 was treated with Sm1 2 and HMPA in THF at room 
temperature, which produced 441 in 64% yield (Scheme 4.34). This could be 
explained via an electron transfer from Sm12 to the 3'-carbonyl of the 3 '-ketouridine 
derivative, followed by reductive cleavage of the carbon-oxygen bond at the 
4'-position. 
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Scheme 4.34 Proposed mechanism form the formation of 441 
They also reasoned that the ability of Sm12 in promoting the reaction was due to 
the ability of Sm3 to chelate to the 5 '-enolate and the 3'-carbonyl (Figure 4.2). It 
was because of the formation of this chelate that the enolate addition to the carbonyl 
123 
CHAPTER 4 	 Reformatsky Reaction 
occurred. That was the reason why, in the reaction with zinc as a reductant, the 
5 '-enolate was generated, but the addition into the 3'-carbonyl did not proceed, due 





Figure 4.2 Chelating ability of Sm 3 
Based on the encouraging preliminary result of the desired cyclised product, 
work proceeded on the optimisation of the reaction. When the reaction was 
performed using 2.2 equivalents of Sm1 2, but at 0 °C instead of at room temperature, 
the reaction was slowed down and did not go to completion; the main product 
obtained was debrominated amide 425. The reaction was repeated in other solvents, 
for example CH3CN and toluene, but THF remained the solvent of choice since it 
gave cleaner and better conversions. 
The use of additives did not afford any improvement in the reaction. In the 
presence of HMPA or DMPU the reaction was again slower and would not go to 
completion. The same result was obtained with the addition of substoichiometric 
amounts of FeC1 3 . Performing the reaction in the presence of Et 2A1C1 afforded 
debrominated amide 425 only, in a very fast reaction. This example resembled to the 
attempts of the cyclisation using other metals than Sm, where presumably chelation 
with the ketone was not occurring and debrominated amide 425 was the only product 
obtained. 
The amount of samarium iodide required was next revised. The number of 
equivalents employed was slowly raised from 2.2 to 12 equivalents. We discovered 
that when the reaction was performed using a large excess of Sm1 2 (10-12 
equivalents) at 0 °C, only traces of debrominated product 421 were obtained. The 
large excess of Sm12 resulted in a fast reaction (completed in a matter of minutes) 
which seemed to be beneficial since the debromination had been practically 
eradicated and, by TLC, the desired cyclised product seemed to be the major product. 
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However, when the crude reaction was purified and the products isolated by column 
chromatography, amide 433 was again obtained in 40% yield and the yield of 421 
had only increased slightly from 30% to 40% (Scheme 4.35). Under these conditions, 
the use of additives like HMPA, DMPU or FeCl3 , also resulted in lower conversions 
and more debrominated 425 was formed. There was no reaction when the 
temperature was lowered further (-40 °C or —20 °C). 
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Reagents and conditions: (a) Sm1 2 (10 eq), THF, 0°C, 40%. 
Scheme 4.35 Improved yield towards lactam 421 
A catalytic Sm1 2-mediated Reformatsky reaction had been reported in the 
literature, using Mg metal to carry out the reduction of Sm(III) to Sm(II).' 7° We 
speculated whether a catalytic procedure could favour the cyclisation at the expense 
of the C-N bond cleavage. However, little reaction occurred under these conditions. 
It is important to note that the formation of the cyclised product only occurred 
when reacting the major diastereomer 420a. Diastereomer 420b reacted slightly 
faster and at lower temperatures than 420a did, but to yield mainly debrominated 
amide 425 and amide 433, and only traces of the desired product. The fact that 420a 
was slightly less reactive turned out to be beneficial. However, being able to use only 
one diastereomer worsened the overall yield of a possible route to 1. 
In the next stages of the investigation, the a-iodo derivative was prepared, in 
order to determine if the nature of the halide had an effect on the cyclisation reaction. 
The synthesis of 2-iodo butanoic acid (448) was easily achieved from commercially 
available butanal (446) (Scheme 4.36). c-Iodo butanal (447) was prepared via a 
DL-proline catalysed a-iodination of 446 with NIS,' 7 ' which afforded 447 as a 
racemic mixture. Oxidation of 447 to acid 448 was successfully performed using 
KMn04 , in t-BuOH and a NaH2PO4 buffer to adjust the pH. 172  In a similar manner to 
that of the bromo-derivative preparation, from the racemic a-iodo carboxylic acid 
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both diastereomers of the amide would be obtained, they would be separated and the 
cyclisation reaction of each diastereomer would be studied independently. If one of 
the diastereomers were to react more efficiently, it could be selectively prepared with 
the same methodology but employing the chiral non-racemic organocatalyst. 
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Me 	 OH 
446 	 447 	 448 
Reagents and conditions: (a) DL-Proline (0.3 eq), NIS (1.3 eq), CH 2Cl 2 , 
0 00  to ii, 5 h, 42%; (b) KMn0 4 (6 eq), 5% NaH2PO4, t-BuOH, rt, 3 h, 95%. 
Scheme 4.36 Successful preparation of 2-iodo butanoic acid 448 
The amide coupling of amine 327 and 2-iodo butanoic acid 448 was successfully 
achieved using triisobutylamine' 2 ' as base, which yielded two diastereomers of the 
amide (449a and 449b) in 75% overall yield (Scheme 4.37). In this case both 
diastereomers were obtained in practically the same proportion (1.2:1 ratio). 
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Reagents and conditions: (a) Oxalyl Chloride (11 eq), DMF (cat), CH 2Cl 2 , ii, 
1 h; (b) amine 327, triisobutylamine (1.2 eq), CH 2C1 2, 0°C to ii, 14 h, 75%. 
Scheme 4.37 Successful amide coupling to ci-iodo amides 449 
The Reformatsky reaction with the iodo-derivatives was investigated, using from 
2.2 to 12 equivalents of Sm12 at different temperatures (from —40 °C to room 
temperature). In this case, neither the amount of Sm12 nor the temperature led to any 
significant variation in the reaction. In all cases, amide 433 was the main product, 
obtained in 40-50% yield, followed by the debrominated amide 425 in 15-30% yield. 
y-Lactam 421 was isolated only in a maximum yield of 10-15% (Scheme 4.38). The 
use of additives (HMPA, FeCI3 or Nib)  was again not beneficial in the reaction. 
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Scheme 4.38 Cyclisation reaction of iodo-derivative 449 
It was concluded that the iodo-derivative had a similar reactivity to the 
bromo-diastereomer 420b, which only afforded traces of the desired product. The 
reaction of 420b and the iodo derivatives 449 was faster and less controllable, and 
the cyclised product was formed in a lesser proportion than with the bromide 
diastereomer 420a. Consequently, only a-bromo amides were employed for the rest 
of the investigation. 
After this thorough study, an increase in the yield of the desired product had been 
achieved by reduction of the debromination of the starting material, but amide 433 
was still being formed as a major product. An ideal set of conditions were required 
that, without completely stopping the reaction, would favour the formation of the 
desired cyclised product 421 at the expense of the formation of 433. 
Since y-lactam 421 would only lead to the synthesis of salinosporamide B 
(Scheme 4.39), it was next decided to investigate further the optimisation of the 
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nation of Salinosporamide B 
For this purpose, amine 327 would be coupled to an cc-bromo acid such as 450, 
which contained a protected alcohol on the y-position (Scheme 4.40). If the amide 
obtained was successfully cyclised, the desired y-lactam 374 would be formed. 
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Scheme 4.40 Synthesis and cyclisation reaction of the real substrate 
The formation of the amide was initially attempted via the ring opening of 
ct-bromo-y-butyrolactone with amine 327 (Scheme 4.41). Amine 327 and 
butyrolactone 452 were reacted under reflux,' 73 but there was no reaction after 5 
days. The reaction was also attempted in the presence of several bases 
(triisobutylamine, pyridine, KHMDS), in several solvents (CH 3 CN, xylene, THF) 
and varying reaction times, but there was either no reaction or only a complex 
mixture of products was obtained. 
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Scheme 4.41 Failure of the ring opening of a-bromo-butyroIactone 452 
We centred then on the preparation of an a-bromo acid for acylation of amine 
327. As described previously in the reductive aldol approach (Scheme 3.36), ideally 
the alcohol would be protected with a PMB group. The PMB protected acid 456 was 
easily prepared in good yield from 1,4 butanediol (Scheme 174  





454 	 455 	 456 
Reagents and conditions: (a) PMBCI (0.49 eq), KOH (1.05 eq), DMSO, 
0°C to rt, 14 h, 85%; (b) PDC (3.5 eq), DMF, rt, 14 h, 71%. 
Scheme 4.42 Preparation of PMB protected acid 456 
Treatment of acid 456 with bromine ' 75or bromine and Pd 3 176 did not afford the 
desired ct-brominated acid (457). The cleavage of the PMB group occurred instead, 
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due to the HBr released in the reaction. a-Bromination of carboxylic acids can also 
be achieved via the formation of the acid chloride.177' 178  However, when acid 456 
was treated with thionyl chloride, followed by the addition of bromine, the cleavage 
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Scheme 4.43 Failure of the a-bromination of acid 456 
Acid 459, containing a TBDPS protecting group on the alcohol, was next 
prepared (Scheme 4.44). 179  Monoprotection of 1,4-butanediol (454) was followed by 
oxidation of 458 with PDC, which afforded acid 459 in moderate yield. The 
bromination was attempted employing the same procedures: acid 459 was reacted 
with bromine or bromine and PC1 3 in Et20 or CC14 and also via the formation of the 
acid chloride, followed by reaction with bromine or NBS. 177 All attempts to 





b TBDPSO OH X TBDPSO 
454 	 458 	 459 	 460 Br 
Reagents and conditions: (a) n-BuLi (0.33 eq), TBDPSCI (0.33 eq), THF, 
—78°C to ii, 2 h, 97%; (b)PDC (3.5 eq), DMF, 0°C to rt, 14 h, 51%. 
Scheme 4.44 Unsuccessful preparation of brominated acid 460 
Bromination of the acid was not being achieved; therefore, we decided to attempt 
the bromination on the aldehyde. Aldehyde 461 was prepared in good yield from 
alcohol 458 via a Swern oxidation (Scheme 445)61 
a 	 0 
TBDPSO-.--... 
458 	 461 
Reagents and conditions: (a) (COCI)2 (2.1 eq), DMSO (4.2 eq), Et 3N 
(4.2 eq), CH 2Cl2 , -78 °C, 3 h, 79%. 
Scheme 4.45 Swern oxidation of alcohol 458 
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Aldehyde 461 was reacted with bromine in Et20, CC1 4 or dioxane, but no 
reaction occurred. However, when the reaction was carried out in a mixture of Et 20 
and dioxane,' 8° brominated aldehyde 463 was successfully obtained (Scheme 4.46). 
This successful bromination procedure was also carried out with acid 459, so that the 
oxidation step would be avoided, but with no success. 
After bromination of 461, the crude product was employed without further 
purification in the oxidation reaction to acid 463, using KMn04, in t-BuOH and a 
NaH2PO4 buffer.  172  The yield of the oxidation was low due to partial cleavage of the 
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Reagents and conditions: (a) Br 2 (1 eq), dioxane, Et20, 0 °C to rt, 2 h; 
(b) KMn04 (6 eq), 5% NaH2PO4, t-BuOH, rt, 3 h, 38% in two steps. 
Scheme 4.46 Bromination and oxidation of aldehyde 461 
With acid 463 in hand, we next centred on the coupling with amine 327. The acid 
chloride of 463 was prepared and transferred into a solution of amine 327 and 
triisobutylamine (Scheme 4 . 47) . 121  The two expected diastereomers of the amide 
(464a and 464b) were obtained in an overall 73% yield, and in approximately a 1.2:1 
ratio. 
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Reagents and conditions: (a) (COd) 2 (11 eq), DMF (cat), CH 2Cl2, 0 °C 
to rt, I h; (b) amine 327, triisobutylamine (1.2 eq), CH 2C12, 0°C to rt, 14 
h, 73% (40% and -33%). 
Scheme 4.47 Synthesis of amides 464a and 464b 
The ct-bromo carboxylic acid containing an acetate protecting group (468) was 
also prepared, and it would be used in the study of the cyclisation reaction. The 
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acetate monoprotection of 454 was achieved, although in low yield, using Ac 20 and 
CeC1 3 .' 8 ' The yield of this reaction was not optimised. A PCC oxidation of 465 







454 	 465 	 466 
Reagents and conditions: (a) Ac 20 (10 eq), CeCI 3 (0.1 eq), THF, rt, 
16 h, 43%; (b) PCC (1.5 eq), CH 202, rt, 1.5 h, 65%. 
Scheme 4.48 Synthesis of aldehyde 466 
Aldehyde 466 was successfully brominated using DL-Proline and NBS in CH 202 
(Scheme 4.49). Oxidation to the carboxylic acid (468) was achieved in good yield 
using the same KMn0 4 protocol. 
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Reagents and conditions: (a) DL-Proline (0.3 eq), NBS (1.3 eq), CH 202 , 
rt, 4 h, 75%; (b) KMn04 (6 eq), 5% NaH2PO4 , t-BuOH, rt, 3 h, 70%. 
Scheme 4.49 Bromination and oxidation of 466 
The amide coupling was performed under the same conditions employed for the 
rest of amide couplings (Scheme 4.50). However, this reaction proved troublesome, 
because although amides 469 were obtained, complete purification of the two 
diastereomers was not achieved. Therefore, it was not possible to attempt the 
cyclisation reaction on these substrates. 
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Scheme 4.50 Unsuccessful amide coupling 
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The cyclisation reactions with the TDBPS derivatives 464a and 464b were then 
investigated. Each diastereomer was treated independently with Sm1 2 in THF, using 
from 2.2 to 12 equivalents, and at different temperatures (room temperature, 0 °C or 
—40°C). Both diastereomers had a similar and a reasonably high reactivity, since both 
substrates reacted at 0 °C and also at lower temperatures (-20 °C). However, the 
cyclisation product was not obtained and the only isolated product was amide 470 
(40%), as well as traces of a compound that was tentatively characterised by 'H 
NMR analysis as the debrominated starting material (471) (Scheme 4.51). 
The reactivity of these compounds was comparable to the most reactive 
diastereomer of the model substrate 420b or to the iodide derivatives, which reacted 
at lower temperatures than 420a but forming only traces of the cyclised product. 
Therefore, this example also contributed to the idea that a higher reactivity meant a 
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Scheme 4.51 Unsuccessful cyclisation of am/des 464a and 464b 
4.4. Conclusions 
In this approach we aimed to utilise a Reformatsky cyclisation of an cc-halo 
amide to obtain the y-lactam of 1, having the side chain at C2 already in place. 
Initially, a model system of the a-bromo amide substrate was prepared and employed 
in the investigation of the reaction. The Reformatsky cyclisation employing different 
metals (Zn, Rh, Ni, Co and Cr) was attempted but the cyclised product was not 
obtained. As the precedent in the literature indicated, Sm1 2 turned out to be the best 
reagent for this reaction, affording the desired cyclised product and as a single 
diastereomer, although in low yield. The fact that the cyclised product was formed 
only under the Sm12 conditions was attributed to the known chelating ability of Sm 3 , 
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which would make possible the enolate addition into the carbonyl of the methyl 
ketone. 
After a thorough optimisation study, the yield was slightly improved to 40 %, but 
the formation of the main by-product was not avoided. From the two diastereomers 
of the substrate, only one afforded the cyclisation product. The other one reacted 
faster and at lower temperatures, but to yield only traces of the cyclised product. The 
effect of the nature of the halide was also investigated, but the iodo- derivatives were 
slightly more reactive and therefore afforded the cyclised product in lower yield. 
The feasibility of the reaction with a substrate containing the required 
functionalities to obtain 1 was next studied. Efforts were made in the synthesis of 
several a-bromo amides. The cyclisation of the TBDPS derivative 464 was 
attempted, but the desired cyclised product was not obtained, and the amide resulting 
from a C-N bond cleavage was the only isolated product. 
We concluded that the Sm1 2 mediated Reformatsky reaction would either not 
progress at all at low temperatures or it would be too fast, yielding mainly the 
undesired by-product. At this stage, this approach was abandoned and work began on 
the next strategy. 
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5. Formal synthesis of salinosporamide A' 
5.1. Aims 
As described previously, our desire was to incorporate the reductive aldol 
methodology developed within our group 65-67  into a synthetic route to our natural 
product. We envisaged that a precursor such as 102 could be cyclised employing our 
methodology into y-lactam 178, and this intermediate could be converted into our 
final target 1 in only a few straightforward transformations. 
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Scheme 5.1 Application of the reductive aldol reaction into the synthesis of 1 
We had already undertaken investigations into the application of this approach 
into our synthetic route, which were described in Chapter 3. In these first studies, the 
a,13-unsaturated amide substrates for the cyclisation reaction were prepared from 
racemic amine 300 (Scheme 3.35). All attempts at the cyclisation reaction afforded a 
complex mixture of products and its analysis proved to be very difficult. 
It was decided to reinvestigate the reductive aldol approach. On this occasion, we 
would utilise amine 327 to prepare the a,-unsaturated substrates. This amine was 
utilised by Corey and co-workers in the synthesis of 1, forming part of the 
acrylamide substrate of the cyclisation step that successfully afforded the y-lactam 
core of 1, with very good yield and diastereoselectivity.22' 26  We had also employed 
amine 327 during the investigation of the Reformatsky cyclisation approach (Chapter 
4). In this study a positive influence of the stereocentre of amine 327 was also 
observed, in that the cyclised product of the model substrate was achieved as a single 
diastereomer. 
Work done in collaboration with Leszek Rupnicki, who developed the reductive aldol 
cyclisation-lactonisation reaction (Section 5.3). 
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We aimed to find out whether the use of amine 327 could also be beneficial in 
the reductive aldol methodology, facilitating the cyclisation and hopefully inducing 
diastereoselectivity in the reaction. In addition, unlike when this approach was first 
investigated, the Co- and Ni-catalysed methodologies were now completely 
developed, having been applied to a broader range of substrates. 65-67  Therefore we 
hoped to successfully utilise this reaction in our route to salinosporamide A. 
The Co- and Ni-catalysed methodologies have afforded promising results in the 
formation of 5-membered lactams. In particular we should highlight the cyclisation 
of amide 292d, containing the fumaric acid ethyl ester, which afforded y-lactam 293d 
in good yield and high syn-diastereoselectivity (Scheme 5.2). This example proved 
the high chemoselectivity of this methodology, because product 472, resulting from 
cyclisation a- to the ester instead of a- to the amide was not observed. The formation 
of 293d was especially encouraging, since the ethyl ester side chain could potentially 
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Scheme 5.2 Relevant examples of successful cyclisations to 5-membered ring 
lactams 
In conclusion, the reductive aldol approach was re-examined in order to employ 
in this occasion an a,-unsaturated amide prepared from amine 327. It was hoped 
that we could find the optimal substrate and catalyst which would allow cyclisation, 
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and hence provide the y-lactam core of our natural product in good yield and with the 
desired relative stereochemistry. 
5.2. Retrosynthetic analysis 
The retrosynthetic analysis in this new study incorporates amine 327 into the 
retrosynthetic analysis outlined in Chapter 3 (Scheme 3.34) and it is briefly outlined 
in Scheme 5.3. y-Lactam 374 represents the desired product of the reductive aldol 
cyclisation of a,13-unsaturated  amide 473. This amide could be obtained from the 
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Scheme 5.3 Retrosynthetic analysis of the reductive aldol cyclisation 
approach using amine 327 
If amide 473 cyclises to yield the desired y-lactam 374, this intermediate could be 
easily transformed into triol 26, the same intermediate we were aiming to obtain 
during the first investigation of the reductive aldol approach (Chapter 3, Scheme 
3.36), which is an advanced intermediate in Corey's synthesis 2 and also in 
Pattenden's synthesis. 29 Therefore, if the proposed route was successful, we would 
have developed a formal total synthesis of 1. 
5.3. Preliminary studies on the reductive aldol cyclisation 
reaction. 
Initial work focused on the synthesis of the amide represented by 473 (Scheme 
5.3). This amide would allow a thorough study of the reductive aldol cyclisation 
reaction, investigation that was carried out by another PhD student of the Lam group, 
Leszek Rupnicki and it is explained in this section. 
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Amine 327 was prepared following the method described in Chapter 4. The 
coupling of this amine with acid 325, containing a PMB protecting group on the 
alcohol (for synthesis see Chapter 3, Scheme 3.52) was attempted, but all efforts 
were unsuccessful. The attempts of formation of the acid chloride of 325 followed by 
coupling with amine 327 also resulted in cleavage of the PMB group. Investigations 
into the use of coupling reagents also proved fruitless, presumably due to the low 
nucleophilicity and bulkiness of amine 327 (Scheme 5.4). 
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Scheme 5.4 Unsuccessful preparation of amide 474 
Bearing in mind the successful cyclisation of 292d (Scheme 5.2), it was next 
decided to couple amine 327 to the commercially available fumaric acid monoethyl 
ester 479. However a potential problem was whether the ethyl ester on the C2 side 
chain of 476 could be, later in the synthesis, selectively reduced over the methyl ester 
at C4 (Scheme 5.5). 
selective 
0 	 0 	 ester 	 0 
HO _.'....,_)( PM  PMB 	 _-....)L reduction 
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475 	 476 	 478 
Scheme 5.5 Possibly problematic selective ethyl ester reduction 
In spite of this, it was decided to prepare the substrate and investigate the 
cyclisation reaction. Amide 481 was successfully obtained via addition of a solution 
of acid chloride 480 into a solution of amine 327 and diisopropylethyl amine in 
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Reagents and conditions: (a) (COd) 2 (1.2 eq), DMF (cat), CH2C12 , 0 °C 
to rt, 2 h; (b) 327, i-Pr 2EtN (1.7 eq), CH 202 , 0 °C to rt, 14 h, 95%. 
Scheme 5.6 Preparation of amide 481 
The cyclisation of amide 481 employing the reductive aldol methodology 
developed within the group was then investigated. The observed stereochemical 
outcome (syn-selectivity) of this methodology can be explained by preferential 
formation of the Z-enolate, along with a chelated chairlike Zimmerman-Traxler' 82 
transition state. 65-67  It was expected to observe a high syn-diastereoselectivity in the 
cyclisation of 481 and also to find out whether the quaternary stereocentre had an 
effect on the absolute configuration of the two newly formed stereocentres (Scheme 
5.7). 
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Scheme 5.7 Desired transition state of the cyclisation reaction 
The catalyst could potentially bind, as well as to the enolate and the methyl 
ketone oxygens, to the carbonyl of the methyl ester forming 485, which would yield 
the desired diastereomer 475 (Scheme 5.8). However, it could also bind to the benzyl 
ether (486) and therefore form the undesired diastereomer 484. Ideally, formation of 
chelate 485 would be preferred and therefore product 475 would be obtained as the 
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major diastereomer, at the expense of the alternative syn-diastereomer 484. However, 
the diastereoselectivity of this reaction was difficult to predict, since both proposed 
transition states could be formed in competition, or 486 could be the preferred one, 
and also neither of them could be occurring. 
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Scheme 5.8 Influence of the quaternary stereocentre 
Initially, the cyclisation reaction was attempted using the standard Co and Ni 
conditions, but when 481 was exposed to Et2Zn and Ni(acac) 2 or CoCl 2 and Cy2PPh 
only an inseparable mixture of compounds was obtained (Table 5.1, entry 1 and 2). 
When Co(acac) 2 2H20 was used, hardly any reaction was observed at all (entry 3). 
Et2Zn was replaced with Et 3A1 but again, a very complex mixture of compounds was 
obtained (entry 4 and 5). 
The influence of phosphine ligands was next investigated. The use of CoC1 2 and 
PPh3 proved unsuccessful, and unreacted starting material was recovered (entry 6). 
The combination of CoC12 and DPPF offered no improvement, since it afforded a 
complex mixture of compounds (entry 7). However, it was found that commercially 
available nickel—phosphine complexes were effective precatalysts. Complex 
(Ph3P)2NiBr2 was able to promote the reductive cyclisation of 481 under dilute 
conditions to give bicyclic fused 'y-lactone-y-lactam 489 containing the desired 
stereochemistry in 35% yield. Unfortunately, this compound was accompanied by a 
comparable amount of the alternative diastereoisomer 490 (entry 8). This result was 
slightly improved when using (Me 3P)2NiCl2 and performing the reaction at an initial 
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Metal salt/ligand Reductant Results/yields 
I Ni(acac) 2 Et2Zn intractable mixture 
2 CoCl2 , Cy2PPh Et2Zn intractable mixture 
3 Co(acac)2 2H20 Et2Zn <10% conversion 
4 Ni(acac) 2 Et3Al intractable mixture 
5 Co(acac)2 '2H20 Et3AI intractable mixture 
6 CoCl2 / PPh 3 Et2Zn 481 recovered 
7 CoCl2 / DPPF Et2Zn intractable mixture 
8 (Ph3P)2NiBr2 Et2Zn 35% of 489, 30% of 490 
9 (Me3P)2NiCl2 Et2Zn 42% of 489, 30% of 490 
Table 5.1 Conditions attempted in the cyclisation of 481 
The fact that both syn-diastereomers were obtained indicated that under these 
conditions, the pre-existing stereocentre in 327 was not effective in controlling the 
absolute configuration of the two new stereocentres formed in the reaction. The 
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Figure 5.1 X-ray crystallography of 490 
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The lactones of 489 and 490 were formed as a result of the tertiary zinc alkoxides 
formed in the aldol reaction cyclising with the pendant ethyl esters. This 
lactonisation occurred in the Ni-catalysed cyclisation of 6-membered lactams 290n 
and 290o (Scheme 5.9), but this cyclisation had been observed only as a minor 
product (<10%) in the cyclisation to the T-lactam 292d (Scheme 5.2). Therefore, the 
lactonisation was unexpected in the cyclisation of our substrate 481. However, it 
turned out to be a useful bonus because it protected the tertiary alcohol of 489 
towards subsequent transformations. 
0 	1 	 0 
0 	 0 	Et2Zn (2 eqthv) N R1 
Ni(acac)2 (5 mol %)  
TH F/hexane 	 2. 	
0:1: 
A1 	 O°Ct0RT EtZnO 	 j 	R2 290n RPMPR2 =Ph 	 491 	 291n >19:1dr,79% 
2900 R' = Bn, R2 = Me 492 2910 >19:1 dr, 89% 
Scheme 5.9 Sequential reductive cyclisation-lactonisation 
5.4. Completion of the formal synthesis 
Once the reductive aldol cyclisation of 481 to afford the desired cyclised product 
489 had been developed, we only needed to perform a few transformations to obtain 
intermediate 26. After separation of diastereomers 489 and 490 by column 
chromatography, the next step was the deprotection of the alcohol. This was 
achieved via a palladium-catalysed debenzylation, which afforded alcohol 493 in 
good yield (Scheme 5.10). This alcohol was crystalline and X-ray crystallography' of 
this compound allowed confirmation of its stereochemistry and therefore that of 489. 
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Me CO,Me 	 e CO,Me 
489 	 493 
Reagents and conditions: (a) PdJC (10%), EtOH, 23 °C, 12 h, 84% 
Scheme 5.10 Obtention of alcohol 493 and confirmation of its stereochemistry 
Crystal of 493 was obtained by Leszek Rupnicki 
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Oxidation of alcohol 493 to aldehyde 494 was performed using Dess-Martin 
periodinane reagent. 35  This aldehyde proved to be very unstable and therefore it had 
to be immediately reacted with 2-cyclohexenyizinc chloride, following Corey's 
procedure. 26  This step was readily performed, since we were already familiar with 
this transformation, which had been carried out during the first route we investigated 
for the synthesis of salinosporamide A (Chapter 2). Therefore, homoallylic alcohol 
495 was successfully obtained with high diastereoselectivity (only one observable 
diastereoisomer by 1H NMR analysis). The overall yield for this two-step sequence 
was 61% (Scheme 5.1 1). 
	
ZnCI
_ 	b 	 N' PMB0 'CH2OH 	a 	 N PMB CHO
Me CO2 Me Me CO2Me 	 Me CO2 Me 
493 	 494 	 495 
Reagents and conditions: (a) Dess-Martin periodinane (1.2 eq), CH 202 , 
rt, 1.5 h; (b) 24(2.5 eq), THF,-78 °C, 5 h, 61%. 
Scheme 5.11 Oxidation to the aldehyde and immediate insertion of the 
cyclohexenyl chain 
Alcohol 495 was also crystalline and X-ray crystallography showed that the 




C27 	 C29 
0 









CS 	 034 
C3 	C4 





C15 	 C20 
C21 
Figure 5.2 X-ray crystallography of 495 
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The last step to complete the formal synthesis involved the selective reduction of 
the lactone over reduction of the methyl ester. We were pleased to find out that the 
lactone of 495 was selectively reduced with NaBH 4 to give trio! 26 (Scheme 5.12), 
intermediate in the synthesis of Corey 26  and Pattenden29 groups. A vast excess of 
NaBH4 was necessary to obtain a satisfactory yield, otherwise, a small fraction of 
unreacted starting material was recovered. The conversion of 26 into 
salinosporarnide A is performed in four steps and has already been described by 
these groups. 




,PMB 	 CI 	
NH 
Me CO2Me CO2Me 
495 	 26 
Reagents and conditions: (a) NaBH4 (45 eq), EtOH, rt, 14h, 60%. 
Scheme 5.12 Final reductive ring-opening to trio! 26 
Interestingly, the NMR data we obtained for triol 26 displayed subtle but 
appreciable differences to those reported by Corey and co-workers for the same 
compound, 26 most notably in the ' 3C NMR chemical shifts."" However, comparison 
of our spectra with that obtained by Pattenden for the same compound 29  showed 
good agreement. The most likely explanation for this observation is that the values of 
the ' 3 C NMR chemical shifts for triol 26 are concentration-dependent; both our and 
that obtained by Pattenden group ' 3C NMR spectra were run at relatively low 
concentration, whereas the spectrum obtained by Corey was run at relatively high 
concentration." 
Both the Corey group and the Pattenden group had kindly supplied us with a copy of their ' 3C NMR 
spectrum 
"Both ' 3C NMR data and spectrum included in the experimental section. The higher concentration of 




In this chapter the reductive aldol approach was re-examined. On this occasion, 
we employed for the preparation of the a,13-unsaturated  amides the amine used by 
Corey and co-workers (327) in the synthesis of 1. a,3-Unsaturated amide 481 was 
prepared from monoethyl fumarate and amine 327, and it was discovered that it 
successfully cyclised when treated with (Me 3P) 2NiC12 and Et2Zn. The cyclisation 
reaction was followed by lactonisation due to the tertiary zinc alkoxide formed in the 
aldol reaction. The desired cyclised product was obtained in 42% yield and it was 
accompanied by a 30% yield of the alternative diastereomer. The lack of 
diastereoselectivity meant that the quaternary stereocentre of the amine was not 
effective in inducing stereoselection in the reaction. 
The lactonisation step turned out to be beneficial, because an extra step for the 
protection of the tertiary alcohol formed was not necessary. This approach achieved 
the formation of the y-lactam, installing the side-chain at C2 and with protection of 
the oxygen at CS simultaneously, therefore saving several steps over alternative 
routes. The desired cyclised product was successfully transformed in four steps to an 
intermediate in the synthesis of 1 by Corey and co-workers, which had been 
converted into salinosporamide A in a further four steps. Consequently, a formal 
synthesis of 1 had been achieved. 
Although very pleased with having been able to use the reductive aldol 
methodology developed in the group and with the success of the formal synthesis, 
the diastereoselectivity of the cyclisation reaction remains to be improved. Future 
work would involve more investigation to uncover alternative catalyst 
systems/reaction conditions that are able to promote the sequential reductive aldol 
cyclisation-lactonisation of 481, in the hope of obtaining a highly diastereoselective 
reaction to give 489 at the expense of 490. 
At this point, our synthetic route to intermediate 26 was achieved in a 2.5% 
overall yield and over eleven steps, which represents a total synthesis of 
salinosporamide A with an overall yield of 1.4% over fiftten steps. The comparison 
of synthetic routes is not completely obvious, since the starting materials employed 
and the compounds obtained in the reported syntheses can differ significantly. 
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However, if our route is compared to the other énantioselective syntheses reported 
(Danishefsky, Langlois or Macherla's), it is clear that our route is already more 
efficient, since it achieves the synthesis of 1 over less steps and with a better overall 
yield (Table 5.2, entries 3, 5, 7 and 8). 
If we compare our route with Corey's synthesis, which is the best reported 
synthesis of 1 so far, we observe that our synthetic route is 4 steps shorter, although 
the overall yield is notably lower (Table 5.2, entries 2 and 8). Nevertheless, if the 
diastereoselectivity of the key cyclisation step is improved, the overall yield of our 
route will increase significantly, and our synthesis of salinosporamide A will become 
as powerful as, if not more than, the one reported by Corey and co-workers. 









Corey 	 (8 steps to 29) 	(27.0% to 29) 
2 	 asymmetric 
(Kulinckovich) 22 	(14 steps to 26) 	(16.8% to 26) 
(10 steps from 18 to 26) (47.7% from 18-to 26) 
3 	Danishefsky 27 	28 (from 37) 	1.8% (from 37) 	asymmetric 
4 	Pattenden 29 	 14 (from 52) 	 11.5% (from 52) 	racemic 
Langlois (formal 8 (from 67 to 29) 11.8% (from 67 to 29) 
5 
synthesis)" (18 steps from 67 to 1) (4.0% from 67 to 1) 
asymmetric 
6 	Rom030 9 steps 1.2% racemic 
7 	Macherla 28 24 steps 0.2% asymmetric 
11 (to 26) 2.5% (to 26) 
HWL (formal 
8 (15 steps to 1) (1.4% to 1) asymmetric 
synthesis) 
(7 steps from 18 to 26) (8.8% from 18 to 26) 
Table 5.2 Comparison of the reported sIntesis of salinosporamide A with the 
HWL synthetic route 
Another step in the synthesis we wish to modify is the installation of the 
cyclohexenyl side-chain. Practically all total syntheses of salinosporamide A22' 26, 27, 
29-32 reported so far employ the allyizinc reagent, as described by Corey and co- 
workers. 26  Although this chemistry works very well, the preparation of this reagent 
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requires access to an allyistannane, which is then subjected to a tin—lithium—zinc 
transmetallation sequence. In addition to employing a toxic reagent, this chemistry is 
atom-inefficient and somewhat experimentally inconvenient. Therefore, we intend to 
seek alternative methods to this chemistry involving more user-friendly precursors 
and reaction conditions. Particularly, we are interested in investigating the 
application to our system of the methodology reported by Tamaru and co-workers. 183 
They developed a regio- and stereoselective Ni-catalysed homoallylation of aromatic 
and aliphatic aldehydes using Et3B. The use of Et 2Zn instead of Et3 B in the reaction 
with sterically congested aliphatic aldehydes and ketones afforded improved yields 
and similarly -high regio- and stereoselectivities (Scheme 5.13). 
Ni(acac)2 (10 mol%) 
Me 	 Et313 (240 mol%) 	 Me OH 
+ PhCHO 
Me 1 	 46 h, rt 	Me-'" Ph 
496 	 497 	 498 82% (exclusive 1,3 anti) 
	
Ni(acac)2 (10 mol%) 	Me OH 
Me 	OHC...<Me Et2Zn (240 mol%) Me + 	 Me 
Me 	 rt,lh 	 Me 
Me 
499 	 500 	 501 66% 20:1 (1,3 anti) 
Scheme 5.13 Ni-Catalysed homoallylation of aldehydes with 1,3-dienes 
The reaction with 1 ,3-cyclohexadiene was the only exception that resulted in an 
allylation, to yield 502 diastereoselectively and in good yield (Scheme 5.14). We 
therefore would like to investigate the application of this methodology to the 
insertion of the cyclohexenyl chain into aldehyde 494. 
Ni(acac)2 (10 mol%) 	OH 
PhCHO 
+ E2J 	
Et2Zn (240 mol%) 
Ph 
rt, 0.5 h 
497 	 142 	 502 61% 4:1 (1,2 anti) 
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6.1. General Information 
All reactions were carried out under a nitrogen atmosphere in oven-dried 
apparatus. Only in section 6.2.1, CH2C12 and MeCN were distilled from CaH 2 and 
Et20 and THF were distilled from sodium with benzophenone as an indicator. In the 
rest of sections, CH2C12, THF, MeCN and MeOH were dried and purified by passage 
through activated alumina columns using a solvent purification system from 
www.glasscontour.com . 'Petrol' refers to that fraction of light petroleum ether 
boiling in the range 40-60°C. Anhydrous DMF was purchased from Aldrich. 
Pyridine, Et3N and diisopropylamine were distilled from CaH 2. All other 
commercially available reagents were used as received. Thin layer chromatography 
(TLC) was performed on Merck DF-Alufoilien 60F 254 0.2 mm precoated plates. 
Product spots were visualized by UV light at 254 nm, and subsequently developed 
using vanillin, potassium permanganate or ceric ammonium molybdate solution as 
appropriate. The compounds were purified by wet flash column chromatography 
using silica gel (Fisher Scientific 60A particle size 3 5-70 micron) under a positive 
pressure. 184 Melting points were recorded on a Gallenkamp melting point apparatus 
and are uncorrected. Infra-red spectra were recorded on a Jasco FT/IR-460 Plus 
instrument as a thin film on sodium chloride plates. The wavelengths of maximum 
absorbance (V m ) are quoted in cm -1 . ' H NMR spectra were recorded on a Bruker 
DPX360 (360 MHz) spectrometer or a Bruker ARX250 (250 MHz) spectrometer. 
Chemical shifts () are quoted in parts per million (ppm) downfield of 
tetramethylsilane, using residual protonated solvent as internal standard (CDC13 at 
7.27 ppm). Abbreviations used in the description of resonances are: s (singlet), d 
(doublet), t (triplet), q, (quartet), app (apparent), b (broad), bs (broad singlet). 
Coupling constants (J) are quoted to the nearest 0.1 Hz. Proton-decoupled ' 3 C NMR 
spectra were recorded on a Bruker DPX360 (90.6 MHz) spectrometer or a Bruker 
ARX250 (62.9 MHz) spectrometer. Chemical shifts (ö) are quoted in parts per 
million (ppm) downfield of tetramethylsilane, using deuterated solvent as internal 
standard (CDC13 at 77.0 ppm). Assignments were made using the DEPT sequence 
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with secondary pulses at 900  and 1350.  High resolution mass spectra were recorded 
on a Finnigan MAT 900 XLT spectrometer using the electrospray (ES) positive ion 
mode at the EPSRC National Mass Spectrometry Service Centre, University of 
Wales Swansea, or on a Kratos MS50TC spectrometer using the electron ionization 
(El) technique in the mass spectrometry laboratory at the School of Chemistry, 
University of Edinburgh. Stated calculated mass values refer to that of the ion (i.e. 
the actual species being detected), not that of the neutral parent compound. Optical 
rotations were performed on an Optical Activity POLAAR 20 polarimeter with a 
path length of 0.5 dm at the sodium D line (589 run). 
6.2. Experimental Procedures 
6.2.1. Racemic approaches based on amidomalonate aldol cyclisations 
Diethyl 2-(4-methoxyphenylamino)malonate (1' 
Br 	 _PMP H2 N 
EtO1J... OEt + 
	
Et20 	
EtO HN OEt 
0 0 	 0 0 
116 	 117 
	
109 
To a stirred solution of p-anisidine 117 (26.9 g, 218 mmol) in THF (120 mL) at 
room temperature was added 3-diethyl-2-bromomalonate 116 (20 mL, 109 mmol) via 
syringe. The reaction was heated to reflux for 2 h and stirred for 14 h at room 
temperature. The solution was then concentrated in vacuo and then redissolved in 
Et20. The reaction mixture was filtered, washing the solids with Et20 and this 
solution was again concentrated in vacuo. This concentrate was now redissolved in 
EtOAc, filtered washing with EtOAc and concentrated in vacuo. A crystalline solid 
was formed and washed with petrol, obtaining pure amine 109 (26.2 g, 85%) as 
brown crystals. Rf (30% EtOAc in hexane) = 0.63; m.p. 65-67 °C, lit." 64-65 °C; 'H 
NMR (3 60 MHz, CDC1 3) ö 6.78 (2H, d, J = 9.1 Hz, ArH), 6.65 (2H, d, J = 9.1 Hz, 
ArH), 4.69 (1H, s, CH(CO 2Et)2), 4.58 (1H, bs, NH), 4.27 (4H, q, J = 7.1 Hz, 2 x 
CO2CH2CH3), 3.75 (3H, s, OCH 3), 1.28 (6H, t, J = 7.1 Hz, 2 x CO2CH2CH3); 13C 
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NMR (90 MHz, CDC1 3) 6 167.9 (2 x C), 153.1 (C), 139.4 (C), 115.1 (2 x CH), 114.8 
(2 x CH), 62.2 (2 x CH 2), 61.8 (CH), 55.6 (CH3), 14.0 (2 x CH3). 
'H spectroscopic data in good agreement with the literature. 51 
Diethyl 2-(4-methoxybenzylamino)malonate (119) 
Br .,PMB 
EtO....L.1.OEt + H2N__•i::LOMe Et3N,CH,CN 
	
EtO HN --ry OEt  
0 0 	 0 0 
116 	 118 	 119 
To a stirred solution of 4-methoxy benzylamine 118 (3.30 mL, 25.0 mmol) in 
MeCN (100 mL) at 0 °C, was added triethylamine (3:50 mL, 25.0 mmol), followed 
by the addition of 3-diethyl-2-bromomalonate 116 (4.60 mL, 25.0 mmol). The 
reaction was stirred for 14 h, allowed to warm up to room temperature, concentrated 
in vacuo and then redissolved in Et 20. It was then washed with water (2 x 20 mL) 
and with saturated aqueous NaHCO 3 solution (2 x 20 mL). The combined aqueous 
layers were extracted with Et20 0  x 20 mL), and the organic layers were combined, 
dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue by 
column chromatography (10% to 20% EtOAc/petrol) gave amine 119 (3.73 g, 52%) 
as a yellow oil. Rf (20% EtOAc in hexane) = 0.33; JR (film) 2981 (NH), 1752 (C=O), 
1734 (C0), 1612, 1513, 1465, 1369, 1302, 1248, 1031 cm'; 'H NMR (360 MHz, 
CDC13 ) 6 7.14 (21-1, d, J = 8.5 Hz, ArH), 6.74 (21-1, d, J= 8.5 Hz, ArH), 4.10 (41-1, q, 
J = 7.1 Hz, 2 x CO2CH2CH3), 3.92 (1H, s, CH(CO2Et)2), 3.67 (31-1, s, OCH 3), 3.63 
(211, s, CH2Ar), 2.33 (1H, bs, NH), 1.15 (61-1, t, J = 7.1 Hz, 2 x CO 2CH2CH3 ); 13 C 
NMR (90 MHz, CDC13) 6 166.4 (2 x C), 158.8 (C), 130.7 (C), 129.6 (2 x CH), 113.7 
(2 x CH), 63.8 (CH), 61.6 (2 x CH2), 55.1 (CH3), 50.9 (CH2), 13.9 (2 x CH 3); HRMS 
(ES) Exact mass calcd for C 15 1-121N05 [M+H]: 296.1492, found: 296.1494. 
Dimethyl 2-(4-methoxybenzylamino)malonate (121)' 
Br .PMB 
MeOJ.OMe + H2N1iJ 	
Et3N, CH,CN 	
MeO HN We 






To a stirred solution of 4-methoxybenzylamine 118 (8.00 g, 60.0 mmol) in 
MeCN (60 mL) at 0 °C was was added triethylamine (8.40 mL, 60.0 mmol), 
followed by the addition of 3-diethyl-2-bromomalonate 120 (8.80 mL, 60.0 mmol). 
The reaction was stirred for 14 h at room temperature, concentrated in vacuo and 
then redissolved in Et20 and saturated aqueous NaHCO 3 solution. This mixture was 
stirred for 30 mm. The aqueous layer was separated and extracted with Et 2 0 (3 x 60 
mL) and the combined organic layers were dried (MgSO 4), filtered and concentrated 
in vacuo. Purification of the residue by column chromatography (petrol/EtOAc, 10% 
to 30% in EtOAc) gave amine 121 (5.52 g, 35%) as a yellow oil. Rf (40% EtOAc in 
hexane) = 0.50; 'H NMR (360 MHz, CDC1 3) 6 7.25 (2H, d, J = 8.7 Hz, ArH), 6.86 
(2H, d, J = 8.7 Hz, ArH), 4.08 (1H, s, CH(CO 2M02), 3.80 (3H, s, OCH3), 3.77 (6H, 
s, 2 x CO2CH3), 3.75 (2H, s, CH 2Ar), 2.32 (1H, bs, NH); ' 3C NMR (90 MHz, 
CDCI3) 8  168.9 (2 x C), 158.9 (C), 130.6 (C), 129.6 (2 x CH), 113.8 (2 x CH), 63.6 
(CH), 55.2 (CH 3), 52.7 (CH3), 5 1. 0 (CH2). 
'H spectroscopic data in good agreement with the literature. 5 ' 
1 -(4-Methoxybenzyl)-3-hydroxy-3-methyl-5-oxopyrrolidine-2,2-dicarboxylic 
acid methyl ester (123) 
PMB 	 0 
o 	HN 	 PMB 




'Me 	 CH 2 Cl2 	Me'1— ... CO2Me 
HO CO2 Me 
122 	 121 	 123 
To a stirred solution of acetyl chloride 122 (2.75 mL, 38.4 mmol) in CH202 (30 
mL) at 0 °C, was added Et 3N (5.70 mL, 40.8 mmol) dropwise. After stirring for 1 h at 
0 9C, a solution of amine 121 (3.26 g, 12.0 mmol) and DMAP (293 mg, 2.40 mmol) 
in CH2C12 (30 mL) was added via cannula. The reaction was stirred for 14 h at room 
temperature and then quenched with pH 7 phosphate buffer (20 mL). The aqueous 
layer was separated and extracted with CH202 (3 x 20 mL) and the combined 
organic layers were dried (MgSO4), filtered and concentrated in vacuo. Purification 
of the residue by column chromatography (20% to 80% EtOAc/petrol) gave y-lactam 
123 (2.95 g, 70%) as a yellow powder. Rf (40% EtOAc in hexane) = 0.23; m.p. 
125-128 °C; JR (film) 2954 (OH), 2360, 1742 (CO), 1682 (CO), 1612 (C0), 
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1513, 1438, 1244, 1067 cm'; 'H NMR (3 60 MHz, CDC1 3) 8 7.16 (2H, d, J = 8.7 Hz, 
ArH), 6.79 (2H, d, J= 8.7 Hz, ArH), 4.79 (2H, s, CH2Ar), 3.76 (3H, s, OCH3), 3.62 
(3H, s, CO2CH3), 3.44 (3H, s, CO 2CH3), 2.74 (1H, d, J = 16.8 Hz, CHAHBCO), 
2:68 (1H, d, J= 16.8 Hz, CHAHBCO), 1.49 (3H, s, COHCH3); ' 3C NMR (90 MHz, 
CDC1 3) 8  174.8 (C), 168.1 (2 x C), 167.7 (C), 159.1 (C), 130.2 (2 x CH), 128.9 (C), 
113.9 (2 x CH), 79.5 (C), 55.6 (CH3), 53.1 (2 x CH 3), 45.5 (CH2), 45.3 (CH2), 23.8 
(CH3); HRMS (ES) Mass calcd. for C 17H22N07 [M+H]: 352.1391, found: 352.1393. 
3-Hydroxy-1-(4-methoxyphenyl)-3-methyl-5-oxopyrrolidine-2,2-dicarboxylic 
acid ethyl ester (110) 
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A stirred solution of dioxinone 129 (4.80 mL, 33.0 mmol) and amine 109 (8.44 g, 
30.0 mmol) in toluene (25 mL) in a round bottom flask with an air condenser was 
placed in an oil bath preheated at 150 °C. The reaction was heated to reflux for 6 h 
and then concentrated in vacuo. Purification of the residue by column 
chromatography (25% to 45% EtOAc/petrol) gave y-lactam 110 (8.72 g, 80%) as a 
yellow solid. Rf (50% EtOAc in hexane) = 0.17; m.p. 127-130 °C, lit 51  136-137 °C; 
JR (film) 2983 (OH), 1754 (CO), 1727 (CO), 1697 (CO), 1512, 1366, 1297, 
1250, 1031 cm'; 'H NMR (360 MHz, CDC1 3) 7.12 (2H, d, J= 9.1 Hz, Am), 6.86 
(2H, d, J = 9.1 Hz, ArH), 4.29 (2H, m, CO2CH2CH3), 4.13 (2H, m, CO2CH2CH3), 
3.88 (1H, bs, COH), 3.78 (3H, s, OCH3), 2.82 (1H, d, J = 16.7 Hz, CHAHBC=O), 
2.73 (1H, d, J= 16.7 Hz, CHAHBCO), 1.58 (3H, s, COHCH 3), 1.27 (3H, t, J= 7.1 
Hz, CO2CH2CH3), 1.07 (3H, t, J = 7.1 Hz, CO 2CH2CH3); ' 3 C NMR (90 MHz, 
CDC13) 174.2 (C), 167.6 (2 x C), 166.5 (C), 158.7 (C), 130.1 (C), 128.8 (2 x CH), 
113.8 (2 x CH), 80.9 (C), 62.4 (CH 2), 62.0 (CH2), 55.2 (CH3), 44.6 (CR2), 23.6 
(CH3), 13.8 (CR3), 14.4 (CH3). 




acid ethyl ester (131) 
Me 	Me 	 HN PMB 
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HO CO2 Et 
131 
1.30 mL, 8.80 mmol) and amine 119 (2.30 g, 
8.00 mmol) in toluene (25 mL) in a round bottom flask with an air condenser was 
placed in an oil bath preheated at 150 °C. The mixture was heated to reflux 14 h and 
then concentrated in vacuo. Purification of the residue by column chromatography 
(15% to 25% EtOAc/petrol) gave y-lactam 131 (2.65 g, 86%) as a brown oil. 
R(40% EtOAc in hexane) = 0.24; JR (film) 3392 (OH), 1738 (C0), 1683 (CO), 
1612 (C0), 1513, 1397, 1244, 1176,1032 cm -1  ; 1 HNMR(360 MHz, CDC13)67.16 
(2H, d, J= 8.7 Hz, ArH), 6.78 (2H, d, J= 8.7 Hz, ArH), 4.81 (1H, d, J= 14.9 Hz, 
CHAHBAr), 4.74 (1H, d, J = 14.9 Hz, CHAHBAr), 4.20-4.08 (1H, m, 
CO2CHCHDCH3), 4.05-3.95 (1H, m, CO 2CHC'HD'CH3), 3.95-3.86 (1H, m, 
CO2CHCHDCH3), 3.86-3.77 (1H, m, CO 2CHC'HD 'CH3), 3.75 (3H, s, OCH3), 2.72 
(1H, d, J= 16.5 Hz, CHAHBC=O), 2.65 (1H, d, J= 16.5 Hz, CHAHBCO), 1.51 (3H, 
s, COHCH3), 1.17 (3H, t, J = 7.1 Hz, CO2CH2CH3), 1.14 (3H, t, J = 7.1 Hz, 
CO2CH2CH3); ' 3C NMR (62.9 MHz, CDC13) 6 174.5 (C), 167.2 (C), 166.8 (C), 
158.6 (C), 129.4(2 x CH), 128.8 (C), 113.4(2 x CH), 79.1 (C), 76.4 (C), 62.2 (CH 2), 
62.1 (CH2), 55.2 (CH3), 45.1 (CH2), 44.9 (CH2), 23.4 (CH 3), 13.7 (2 x CH3); HRMS 
(ES) Exact mass calcd for C 19H26N07 [M+H]: 380.1704, found: 380.1703. 
1 -(4-Methoxy-phenyl)-3-methyl-5-oxo-3-trimethylsilanyloxy-pyrrolidine-2,2-
dicarboxylic acid ethyl ester (137) 
0 	 0 
N 	 N 
PMP TMSCI, DMAP, Et,N 	 PMP 
Me- .....CO,Et 	CH2C12 	Me ........CO,Et 
HO CO2 Et 	 TMSO CO,Et 
110 	 137 
To a stirred solution of lactam 110 (4.00 g, 10.9 mmol) and DMAP (540 mg, 
4.38 mmol) in CH202 (30 mL) at 0 °C, was added Et 3N (4.60 mL, 33 mmol) 
dropwise, followed by the addition of TMSC1 (2.15 mL, 16.4 mmol). The reaction 
152 
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was stirred for 30 min at 0 °C and then quenched with saturated aqueous NaHCO 3 
solution (20 mL). The aqueous layer was separated and extracted with CH 202 (3 x 
30 mL) and the combined organic layers were dried (MgSO 4), filtered and 
concentrated in vacuo. Purification of the residue by column chromatography (50% 
EtOAc/petrol) gave y-lactam 137 (4.27 g, 92%) as colourless crystals. Rf (50% 
EtOAc in hexane) = 0.80; m.p. 85-87 °C; IR (film) 2982, 1759 (C0), 1746 (CO), 
1721 (C=O), 1512, 1250, 1063, 845 cm'; 'H NMR (360 MHz, CDC1 3) 8 7.13 (2H, d, 
J = 8.9 Hz, ArH), 6.87 (2H, d, J = 8.9 Hz, ArH), 4.27 (2H, m, CO2CH2CH3), 4.17 
(2H, m, CO2CH2CH3), 3.79 (31-1, s, OCH 3), 2.97 (1H, d, J = 16.7 Hz, CHAHBCO), 
2.77 (1H, d, J = 16.7 Hz, CHAHBCO), 1.67 (3H, s, COTMSCH3), 1.27 (3H, t, J= 
7.1 Hz, CO2CH2CH3), 1.24 (3H, t, J = 7.1 Hz, CO2CH2CH3), 0.17 (9H, s, 3 x 
SiCH3); ' 3 C NMR (90 MHz, CDC13) ö 173.5 (C), 167.1 (2 x C), 164.9 (C), 157.8 
(C), 129.8 (C), 127.6 (2 x CH), 113.2 (2 x CH), 78.8 (C), 61.6 (CH 2), 60.8 (CH2), 
54.7 (CH), 45.2 (CH 2), 23.3 (CH3), 13.3 (2 x CH3), 1.2 (3 x CH3); HRMS (ES) 
Exact mass calcd. for C 21 H32NO7Si [M+H]: 438.1943, found: 438.1948 
1-(4-Methoxybenzyl)-3-methyl-5-oxo-3-(trimethylsilyloxy)pyrrolidine-2,2-
dicarboxylic acid ethyl ester (138) 
0 	 0 
TMSCI, DMAP, 
N 
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HO CO2Et 	 TMSO CO2Et 
131 	 138 
To a stirred solution of lactam 131 (2.50 g, 6.58 mmol) and DMAP (160 mg, 
1.31 mmol) in CH202 (120 mL) at 0 °C, was added Et 3N (2.80 mL, 19.8 mmol) 
dropwise, followed by the addition of TMSC1 (1.30 mL, 9.90 mmol) via syringe. The 
reaction was stirred for 14 h at room temperature and then quenched with saturated 
aqueous NaHCO 3 solution (40 mL). The aqueous layer was separated and extracted 
with CH202 (3 x 30 mL) and the combined organic layers were dried (MgSO4), 
filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (50% EtOAc/petrol) gave y-lactam 138 (2.50 g, 85%) as a brown 
solid. Rf(40% EtOAc in hexane) = 0.67; m.p. 68-71 °C; JR (film) 2958, 1736 (C=O), 
1707 (C=0), 1613 (C0), 1513, 1387, 1302, 1248, 1064, 844 cm'; 'H NMR (360 
153 
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MHz, CDC13) 6 7.19 (2H, d, J = 8.7 Hz, ArH), 6.76 (2H, d, J= 8.7 Hz, ArH), 5.01 
(1H, d, J = 14.9 Hz, CHAHBAr), 4.64 (1H, d, J = 14.9 Hz, CHAHBAr), 4.28-4.19 
(1H, m, CO2CHCHDCH3), 4.14-4.06 (1H, m, CO2CHCHDCH3), 3.75 (3H, s, OCH3), 
3.68-3.59 (2H, m, CO2CH2CH3), 2.80 (1H, d, J = 16.5 Hz, CHAHBCO), 2.61 (1H, 
d, J = 16.5 Hz, CHAHBCO), 1.57 (3H, s, COHCH3), 1.27 (3H, t, J = 7.1 Hz, 
CO2CH2CH3), 1.07 (3H, t, J = 7.1 Hz, CO2CH2CH3), 0.12 (9H, s, Si(CH3)3); 13 C 
NMR (62.9 MHz, CDC1 3) 6174.2 (C), 167.3 (C), 166.1 (C), 158.7 (C), 130.3 (2 x 
CH), 128.6 (C), 113.2 (2 x CH), 80.7 (C), 79.4 (C), 61.8 (CH 2), 61.4 (CH2), 55.2 
(CH3), 45.7 (CH2), 44.9 (CH 2), 23.5 (CH3), 13.9 (CH3), 13.6 (CH3), 1.9 (3 x CH3); 
HRMS (ES) Exact mass calcd for C 22H33NO7SiNa [M+Na]: 474.1918, found: 
474.1916. 
(2RS,3SR)-2-Formyl-1-(4-methoxy-phenyl)-3-methyl-5-oxo-3- 
trim ethylsilanyloxy-pyrrolidine-2-carboxylic acid ethyl ester (144) 
0 	 0 
II DIBAL-H, CH 2Cl2 	II 
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TMSO CO2Et TMSO CHO 
137 	 144 
To a stirred solution of lactam 137 (3.53 g, 9.00 mmol) in CH 202 (36 mL) at 
-78 °C, was added DIBAL—H (36 mL, 1 M in CH 202, 36 mmol) dropwise over 40 
mm. The reaction was stirred for 1.5 h at —78 °C and then quenched with EtOH (3 
mL), added dropwise. The mixture was stirred for 15 min and then it was poured into 
a solution of saturated Rochelle's salt (70 mL) and CH 2C12 (70 mL). The resulting 
solution was stirred for 1 h. The aqueous phase was then extracted with CH 2C12 (3 x 
30 mL) and the combined organic layers were dried (MgSO4), filtered and 
concentrated in vacuo. Purification of the residue by column chromatography (10% 
to 40% EtOAc/petrol) gave aldehyde 144 (2.16 g, 69%) as a yellow solid. Rf (40% 
EtOAc in hexane) = 0.65; m.p. 69-72'C; JR (film) 2959, 1754 (C0), 1719 (C0), 
1643 (C0), 1512, 1351, 1250, 1028, 844 cm t ; ' H NMR (360 MHz, CDC1 3) 6 10.01 
(1H, s, CHO), 7.11 (2H, d, J = 9.0 Hz, ArH), 6.81 (2H, d, J = 9.0 Hz, ArH), 4.23 
(2H, m, CO2CH2CH3), 3.74 (3H, s, OCH3), 2.77 (1H, d, J— 16.4 Hz, COCHAHB), 
2.65 (1H, d, J= 16.4 Hz, COCHAHB), 1.57 (3H, s, COTMSCH3), 1.19 (3H, t, J= 7.1 
154 
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Hz, CO2CH2CH3), 0.15 (9H, s, 3 x SiCH3); ' 3 C NMR (90 MHz, CDC1 3) 8  195.7 
(CH), 172.3 (C), 166.8 (C), 157.9 (C), 129.6 (C), 126.9 (2 x CH), 113.6 (2 x CH), 
81.9 (C), 80.8 (C), 62.0 (CH 2), 55.1 (CH3), 45.3 (CH2), 25.9 (CH3), 13.7 (CH3), 1.5 
(3 x CH3); HRMS (ES) Exact mass calcd. for C, 9H28NO6Si [M+H]: 394.1680, 
found: 394.1678. 







To a stirred solution of Pd2(dba)3 (65.2 mg, 71 pmo1) and PPh 3 (150 mg, 0.56 
mmol) in THF (45 mL), was added 1,3 cyclohexadiene (142) (4.2 mL, 42.7 mmol), 
followed by the slow addition of Bu 3 SnH (3.95 mL, 14.2 mmol) at room 
temperature. The reaction was stirred for 14 h and then the solvent was concentrated 
in vacuo. The catalyst was filtered off through silica plug, obtaining a cloudy 
colourless oil (4.7 g) that was distilled in vacuo to afford 2-cyclohexenyltributyltin 
143 (3.2 g, 85% purity assessed by 'H NMR spectroscopy, 52%). Rf (1% Et3N in 
hexane) = 0.75; 1 H NMR (360 MHz, CDCI3) ö 5.76 (1H, dm, J = 9.8 Hz, CH=CH), 
5.41 (1H, dm, J = 9.8 Hz, CHCH), 2.16 (1H, bs, SnCHCH2), 2.09-1.96 (3H, m, 
CH2CH2CH2), 1.85-1.76 (1H, m, CH 2CH2CH2), 1.72-1.63 (1H, m, CH2CH2CH2), 
1.60-1.42 (6H + 1H, m, 3 x SnCH 2CH2CH2CH3 + CH2CH2CH2), 1.31 (6H, m, 3 x 
SnCH2CH2CH2CH3), 0.88 (15H, m, 3 x SnCH2CH2CH2CH3); ' 3C NMR (90 MHz, 
CDC13) ö 131.6 (CH), 121.4 (CH), 29.2 (3 x CI-h),  27.5 (3 x CH2), 26.8 (CH2), 25.0 
(CH2), 23.2 (CH2), 13.7 (3 x CH3), 9.0 (3 x CH2). 
'H spectroscopic data in good agreement with the literature. 185 
155 
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(2SR,3SR)-2- [(66R)-(7R)-Cyclohex-2-enylhydroxym ethyl] - 1 -(4-m ethoxy-
phenyl)-3-methyl-5-oxo-3-trimethylsilanyloxy-pyrrolidine-2-carboxylic 	acid 
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To a stirred solution of cyclohexenyltributyltin 143 (3.40 mL, 6.37 mmol) in 
THF (12 mL) at-78 °C was added n-BuLi (3.10 mL, 2.1 M solution in hexanes, 6.37 
mmol). The reaction was stirred for 30 min stirring, ZnC1 2 (12.8 mL, 0.5 M solution 
in THF, 6.37 mmol) was added and stirring was continued for 30 min at —78 °C. To 
this solution was added a solution of aldehyde 144 (1.01 g, 2.55 mmol) in THF (20 
mL) at —78 °C via cannula. After stirring for 2.5 h at —78 °C the reaction mixture was 
quenched with water (20 mL), extracted with EtOAc (3 x 30 mL) and the combined 
organic layers were dried (MgSO4), filtered and concentrated in vacuo. Purification 
of the residue by column chromatography (20% to 40% EtOAc/petrol) gave 
homoallylic alcohol 145 (1.1 g, 83%) as a colourless solid. Rf (40% EtOAc in 
hexane) = 0.69; m.p. 124-126 °C; JR (film) 2953 (OH), 1688 (C0), 1644 (C0), 
1510, 1375, 1295, 1250, 1148, 1028, 844 cm -1 ; ' H NMR (360 MHz, CDC1 3) ö 7.06 
(2H, d, J = 9.0 Hz, ArH), 6.61 (2H, d, J = 9.0 Hz, ArH), 5.28 (1H, dm, J 10.4 Hz, 
CH=CH), 4.57 (1H, dm, J = 10.4 Hz, CH=CH), 4.03 (2H, q, J = 7.1 Hz,, 
CO2CH2CH3), 3.88 (1H, t, J 3.9 Hz, CHOH), 3.52 (3H, s, OCH3), 3.21 (1H, s, J= 
3.9 Hz, CHOH), 2.45 (1H, d, J— 16.7 Hz, CHAHBCO), 2.38 (1H, d, J = 16.7 Hz, 
CHAHBCO), 2.02-1.96 (1H, m, CHOHCH), 1.65-1.53 (2H, m, CHCH 2CH2), 1.36-
1.28 (2H, m, CH2CH2CH2), 1.25 (3H, s, COTMSCH3), 1.21-1.13 (2H, m, CH 2CH2), 
1.10 (3H, t, J = 7.1 Hz, CO 2CH2CH3), -0.01 (9H, s, 3 x SiCH3); ' 3C NMR (90 MHz, 
CDC13) 8  172.1 (C), 169.0 (C), 156.9 (C), 128.8 (CH), 128.2 (C), 126.2 (CH), 125.4 
(2 x CH), 112.1 (2 x CH), 80.9 (C), 79.5 (C), 73.8 (CH), 59.7 (CH2), 53.3 (CH3), 
43.9 (CH2), 36.4 (CH), 28.1 (CH 2), 23.4 (CH3), 22.9 (CH2), 19.1 (CH2), 11.9 (CH3), 





(trim ethylsilyloxy)pyrrolidine-2-carboxylic acid ethyl ester (147) 
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To a stirred solution of diester 137 (106 mg, 0.242 mmol) in THF (1 mL) at 0 °C 
was added anhydrous lithium chloride (57.3 mg, 1.33 mmol) and sodium 
borohydride (51.4 mg, 1.33 mmol), followed by the addition of EtOH (2 mL).The 
reaction was stirred for 14 h at room temperature, then quenched with saturated 
aqueous NH4C1 solution (1 mL) and the THF removed in vacuo. The solution was 
extracted with CH 202 (3 x 10 mL) and the combined organic layers were dried 
(MgSO4), filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (50 % EtOAc/petrol) gave alcohol 147 (86.2 mg, 90%) as a 
colourless solid. Rf (50% EtOAc in hexane) = 0.56; m.p; 143-144 °C; JR (film) 3389 
(OH), 2958, 1756 (C0), 1685 (C0), 1511, 1392, 1250, 1102, 1047, 916 cm; 1 H 
NMR (3 60 MHz, CDC1 3) ö 7.08 (2H, d, J= 8.9 Hz, ArH), 6.89 (2H, d, J= 8.9 Hz, 
ArH), 4.29 (2H, q, J = 7.1 Hz, CO2CH2CH3), 3.96 (1H, d, J = 11.6 Hz, 
CHACHBOH), 3.79 (4H, s + d, J = 11.6 Hz, OCH3 + CHACHBOH), 3.04 (1H, d, J= 
16.1 Hz, CHCHDCO), 2.56 (1H, d, J = 16.1 Hz, CHCHDC=O), 1.36 (3H, s, 
COTMSCH3), 1.36 (3H, t, J = 7.1 Hz, CO 2CH2CH3), 0.16 (9H, s, 3 x SiCH3); 13 C 
NMR (90 MHz, CDC1 3) 5  172.3 (C), 169.5 (C), 157.2 (C), 127.3 (2 x CH), 126.7 
(C), 112.5 (2 x CH), 76.6 (C), 75.2 (C), 60.3 (CH2), 59,7(CH2), 53.4 (CH3), 44.9 
(CH2), 22.8 (CH3), 12.3 (CH3), 0.0 (3 x CH3); HRMS (ES) Mass calcd. for 
C 19H30N06Si [M+H]: 396.1837, found: 396.1837. 
(2SR,3SR)-2-Formyl-1-(4-methoxy-phenyl)-3-methyl-5-oxo-3- 
trim ethylsilanyloxy-pyrrolidine-2-carboxylic acid ethyl ester (148) 
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157 
ental 
To a stirred solution of oxalyl chloride (0.047 mL, 0.52 mmol) in CH 2C12 (2 mL) 
at —78 °C was added DMSO (0.075 mL, 1.1 mmol) dropwise over 1 mm. After 
stirring for 15 minutes a solution of alcohol 147 (99.0 mg, 0.25 mmol) in CH 202 
(1.5 mL) was added via cannula. This reaction was stirred at —78 °C for 1 h and Et3N 
(0.15 mL, 1.1 mmol) was then added. The reaction was stirred at —78 °C for 2 h and 
then was quenched with saturated aqueous NH4C1 solution (3 mL). The aqueous 
layer was separated and extracted with CH 2Cl2 (3 x 10 mL), and the combined 
organic layers were dried (MgSO4), filtered and concentrated in vacuo. Purification 
of the residue by column chromatography (30 % EtOAc/petrol) gave aldehyde 148 
(88 mg, 90%) as a yellow oil. R f (40% EtOAc in hexane) = 0.54; JR (film) 3418, 
2959, 1722 (C0), 1644 (C°0), 1512, 1351, 1249, 1159,1024, 844 cm 1 ; 1 HNMR 
(3 60 MHz, CDC13) ö 10.18 (1H, s, CHO), 7.12 (2H, d, J = 9.1 Hz, ArH), 6.84 (2H, 
d, J= 9.1 Hz, ArH), 4.31-4.23 (2H, m, CO 2CH2CH3), 3.79 (3H, s, OCH 3), 2.94 (1H, 
d, J 16.4 Hz, CHAHBCO), 2.60 (1H, d, J = 16.4 Hz, CHAHBC=O), 1.52 (3H, s, 
COTMSCH3), 1.26 (3H, t, J = 7.2 Hz, CO 2CH2CH3), 0.19 (9H, s, 3 x SiCH3); 13C 
NMR (90 MHz, CDC13) ö 195.3 (CH), 171.0 (C), 165.5 (C), 156.3 (C), 128.2 (C), 
125.6 (2 x CH), 112.1 (2 x CH), 82.8 (C), 78.2 (C), 60.4 (CH 2), 53.5 (CH3), 43.7 
(CH2), 23.5 (CH3), 12.2 (CH3), 0.0 (3 x CH3); HRMS (ES) Mass calcd. for 
C 19H28NO6Si [M+H]: 394.1680, found: 394.1682. 
(2RS,3SR)-2- [( 6S)-(7S)-Cycloh ex-2-enylhydroxym ethyl] -1-(4-methoxy-phenyl)-
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143 	 24 	 149 
To a stirred solution of cyclohexenyltributyltin 143 (1.30 g, 3.35 mmol) in THF 
(7 mL) at —78 °C was added n-BuLi (1.3 mL, 2.5 M solution in hexanes, 3.2 mmol). 
The reaction was stirred for 30 mm, ZnC1 2 (6.70 mL, 0.5 M solution in THF, 3.35 
mmol) was added and stirring was continued for 30 min at —78 °C. To this solution 
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was added a —78 °C solution of the aldehyde 148 (0.53 g, 1.34 mmol) in THF (6 mL) 
via cannula. After stirring for 2.5 h at —78 °C the reaction mixture was quenched with 
water (20 mL), extracted with Et20 (3 x 30 mL) and the combined organic layers 
were dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue 
by column chromatography (30% to 40% EtOAc/petrol) gave homoallylic alcohol 
149 (543 mg, 84%) as a colourless solid. Rf (40% EtOAc in hexane) = 0.16; m.p. 
175-177 °C; JR (film) 3406 (OH), 2932, 1755 (CO), 1683 (CO), 1509, 1456, 
1382, 1250, 1137, 841 cm'; 'H NMR (360 MHz, CDC1 3) ö 7.53 (2H, d, J= 9.0 Hz, 
ArH), 6.87 (2H, d, J = 9.0 Hz, ArH), 5.79 (1H, dm, J = 10.2 Hz, CH=CH), 5.35 (1H, 
dm, J = 10.2 Hz, CH=CH), 4.25-4.13 (2H, m, CO 2CH2CH3), 4.01 (1H, t, J = 5.7 Hz, 
CHOH), 3.80 (3H, s, OC113), 2.84 (1H, d, J = 16.5 Hz, CHAHBCO), 2.67 (1H, d, J 
= 16.5, CHAHBCO), 2.25-2.19 (1H, bs, CHOHCH), 1.94-1.84 (3H, bs, 
CHCH2CH2), 1.70 (3H, s, COTMSCH3), 1.63-1.59 (2H, m, CH 2CH2CH2), 1.55-1.47 
(1H, m, CH2CH2), 1.34 (3H, t, J = 7.2 Hz, CO 2CH2CH3), 0.16 (9H, s, 3 x SiCH3); 
' 3C NMR (90 MHz, CDC1 3) ö 172.2 (C), 167.4 (C), 156.8 (C), 130.1 (CH), 128.9 
(C), 128.5 (CH), 124.8 (2 x CH), 111.5 (2 x CH), 81.9 (C), 78.7 (C), 73.9 (CH), 58.7 
(CH2), 53.3 (CH 3), 44.4 (CH2), 36.5 (CH), 24.8 (CH 2), 22.9 (CH 2), 22.2 (CH3), 18.3 
(CH2), 11.9 (CH 3), 0.0 (3 x CH3); LRMS (ES) Mass calcd. for C 25H38NO6Si [M+H]+ : 
476.2463, found: 476.2465. 
(2RS,3SR)2(Hydroxymethyl)-1-(4-methoxybenZYl)-3-IflethYl-5-OXO-3-
(trimethylsilyloxy)pyrrolidine-2-CarbOXYliC acid ethyl ester (503) 
0 	 0 
PMB 
L1CI, NaBH4 , EtOH 
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138 	 503 
To a stirred solution of diester 138 (6.16 g, 13.6 mmol) in THF (38 mL) at 0 °C, 
was added anhydrous lithium chloride (1.20 g, 27.3 mmol) and sodium borohydride 
(1.03 g, 27.3 mmol), followed by the addition of EtOH (76 mL). The reaction was 
stirred for 14 h at room temperature, then quenched with saturated aqueous NH 4C1 
solution (40 mL) and the THF removed in vacuo. The solution was extracted with 
CH2C12 (3 x 50 mL) and the combined organic layers were dried (MgSO4), filtered 
159 
Experimental 
and concentrated in vacuo. Purification of the residue by column chromatography 
(30% EtOAc/petrol) gave alcohol 503 (3.82 g, 68%) as a colourless solid. Rf (40% 
EtOAc in hexane) = 0.20; m.p. 112-114 °C; IR (film) 3453 (OH), 2957, 2348, 1734 
(C0), 1678 (C0), 1513, 1248, 1176, 1034, 841 cm'; 'HNMR (360 MHz, CDC13) 
7.29 (2H, d, J= 8.9 Hz, ArH), 6.80 (2H, d, J= 8.9 Hz, ArH), 4.73 (1H, d, J = 15.0 
Hz, CHAHBOH), 4.38 (111, d, J = 15.0 Hz, CHAHBOH), 4.12-4.02 (111, m, 
CO2CHcH0CH3), 3.96-3.88 (1H, m, CO2CHCHDCH3), 3.87 (1H, d, J = 12.5 Hz, 
CHEHFAr), 3.77 (311, s, OCH3), 3.72 (1H, d, J= 12.5 Hz, CHEHFAr), 2.76 (1H, d, J 
= 16.2 Hz, CHAHBCO), 2.47 (1H, d, J= 16.2 Hz, CHAHBCO), 2.25 (1H, bs, OH), 
1.47 (3H, s, COTMSCH3), 1.19 (311, td, J = 7.1, 2.6 Hz, CO 2CH2CH3), 0.09 (9H, s, 
Si(CH3)3); ' 3 C NMR (62.9 MHz, CDC13) 8  174.2 (C), 170.4 (C), 158.9 (C), 129.8 
(C), 129.7 (2 x CH), 114.0 (C), 113.8 (2 x CH), 78.2 (C), 62.1 (CH 2), 61.3 (CH2), 
55.2 (CH3), 46.6 (CH2), 44.1 (CH 2), 24.3 (CH3), 14.0 (CH3), 1.8 (3 x CH3); HRMS 
(ES) Exact mass calcd for C 20H32NO6Si [M+H]+: 410.1993, found: 410.1994. 
(trimethylsilyloxy)pyrrolidine-2-carboxylic acid ethyl ester (150) 
0 	 0 
	




CH20H 	 Me.T_ CHO 
TMSO CO2Et 	 TMSO CO2Et 
503 	 150 
To a stirred solution of oxalyl chloride (0.74 mL, 8.46 mm.ol) in CH 2C12 (40 mL) 
at —78 °C was added DMSO (1.20 mL, 16.9 mmol) dropwise over 1 min and this 
solution was stirred for 15 mm. A solution of alcohol 503 (1.65 g, 4.03 mmol) in 
CH2C12 (40 mL) at —78 °C, was treated with Et 3N (2.40 mL, 16.9 mmol), followed by 
the addition of the Swern reagent via cannula. The reaction was stirred at —78 °C for 
3 h and then quenched with NH 4CI (30 mL). The aqueous layer was separated and 
extracted with CH 202 (3 x 20 mL) and the combined organic layers were washed 
with saturated aqueous NaHCO3 solution (2 x 30 mL), dried (MgSO4), filtered and 
concentrated in vacuo. Purification of the residue by column chromatography (30% 
EtOAc/petrol) gave aldehyde 150 (1.28 g, 78%) as a yellow oil. Rf (30% EtOAc in 
hexane) = 0.45; IR (film) 2957, 1756 (C0), 1724 (CO), 1612 (C0), 1513, 1378, 
Experimental 
1282, 1250, 1025, 845 cm'; 'H NMR (360 MHz, CDC1 3) 6 9.91 (1H, s, CHO), 7.09 
(2H, d, J = 8.6 Hz, ArH), 6.75 (2H, d, J = 8.6 Hz, ArH), 4.89 (1H, d, J = 14.4 Hz, 
CHAHBAr), 4.34 (1H, d, J = 14.4 Hz, CHAHBAr), 3.96-3.87 (1H, m, 
CO2CHAHBCH3), 3.82-3.75 (1H, m, CO2CHAHBCH3), 3.74 (3H, s, OCH3), 2.89 (1H, 
d, J = 16.0 Hz, CHAHBCO), 2.41 (1H, d, J = 16.2 Hz, CHAHBC=O), 1.35 (3H, s, 
COTMSCH3), 1.11 (3H, t, J = 7.1 Hz, CO2CH2CH3), 0.10 (9H, s, Si(CH3)3); 13C 
NMR (62.9 MHz, CDC13) 6 196.6 (CH), 172.6 (C), 167.0 (C), 158.4 (C), 130.5 (2 x 
CH), 126.9 (C), 112.9 (2 x CH), 80.5 (C), 78.9 (C), 61.2 (CH 2), 54.6 (CH3), 45.3 
(CH2), 43.9 (CH2), 25.1 (CH3), 13.3 (CH3), 1.2 (3 x CH3); HRMS (ES) Exact mass 
calcd for C 20H30NO6Si [M+H]: 408.1837, found: 408.1836. 
(2RS,3SR)-2- [(6S)-(75)-Cyclohex-2-enylhydroxymethyl] -1-(4-methoxybenzyl)-3-
methyl-5-oxo-3-(trimethylsilyloxy)pyrrolidine-2-carboxyliC acid ethyl ester (151) 
SnBu3 ) n-BuLl, -78°C ZnCI 
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TMSO CO2 Et 
151 
To a stirred solution of cyclohexenyltributyltin 143 (2.78 g, 6.44 mmol, 85%) in 
THF (5 mL) at —78 °C was added n-BüLi (2.50 mL, 2.5 M solution in hexanes, 6.31 
rnmol). The reaction was stirred for 30 min,ZnC12 (12.8 mL, 0.5 M solution in THF, 
6.44 mmol) was added and stirring was continued for 30 min at —78 °C. To this 
solution was added a —78 °C solution of aldehyde 150 (1.05 g, 2.57 mmol) in THF (6 
mL) via carmula. After stirring for 1.5 h at —78°C the reaction mixture was quenched 
with water (15 mL), extracted with Et 20 (3 x 20 mL) and the combined organic 
layers were dried (MgSO4), filtered and concentrated in vacuo. Purification of the 
residue by column chromatography (20% to 30% EtOAc/petrol) gave homoallylic 
alcohol 151 (892 mg, 71%) as a colourless solid. Rf (40% EtOAc in hexane) = 0.31; 
m.p. 169-171 °C; JR (film) 3429 (OH), 2923, 2666, 1748 (CO), 1681 (CO), 1513, 
1442, 1247, 1034, 841 cm'; 1 H NMR (3 60 MHz, CDC13) 6 7.29 (2H, d, J = 8.8 Hz, 
ArH), 6.81 (2H, d, J= 8.8 Hz, ArH), 5.95 (1H, dm, J = 10.4 Hz, CH=CH), 5.69 (1H, 
dm, J = 10.4 Hz, CH=CH), 4.82 (1H, d, J— 15.2 Hz, CHAHBAr), 4.47 (1H, d, J= 
161 
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15.2 Hz, CHAHBAr), 4.11-4.05 (2H, m, CO2CH2CH3 + CHOH), 3.78 (3H, s, OC113), 
2.85 (1H, d, J = 16.6 Hz, CHAHBCO), 2.45 (1H, bs, CHOH), 2.39 (1H, d, J = 16.6 
Hz, CHAHBCO), 2.32-2.26 (1H, m, CHOHCH), 2.03-1.98 (211, m, CHCH 2CH2), 
1.75-1.68 (3H + 211, m, COTMSCH3 + CH2CH2CH2), 1.57-1.44 (211, m, CH2CH2), 
1.11 (3H, t, J= 7.0 Hz, CO2CH2CH3), 0.16 (9H, s, Si(CH3)3); ' 3C NMR (90 MHz, 
CDC13) 6 175.1 (C), 168.9 (C), 157.9 (C), 133.7 (CH), 130.6 (C), 127.6 (2 x CH), 
124.4 (CH), 113.2 (2 x CH), 82.8 (C), 82.0 (C), 76.5 (CH), 60.9 (CH 2), 55.2 (CH3), 
47.5 (CH), 46.7 (CH 2), 38.0 (CH), 29.0 (CH2), 25.0 (CH2), 22.6 (CH3), 20.5 (C112), 
13.7 (C113), 2.1 (3 x CH 3); HRMS (ES) Exact mass calcd for C 26H40NO6Si [M+H]+ : 
490.2619, found: 490.2616. 
(2RS,3SR)-2- [(65)-(7S)-Cyclohex-2-enylhydroxymethyll-3-hydroxy-1 -( 4-




TMSO CO2Et 	 HO CO2EI 
149 	 156 
To a stirred solution of alcohol 149 (2.00 g, 4.80 mmol) in EtOH (10 mL) was 
added camphor sulfonic acid (245 mg, 1.03 mrnol) at room temperature. This 
solution was stirred for 3 h and then quenched with Et 3N (0.14 mL, 1.04 mmol). The 
solution was concentrated in vacuo. Purification of the residue by column 
chromatography (60% to 80% EtOAc/petrol) gave diol 156 (1.92 g, 95%) as a 
colourless solid. Rf (50% EtOAc in hexane) = 0.16; m.p. 184-186 °C; JR (film) 3393 
(OH), 2933, 2359, 2341, 1753 (C0), 1682 (C0), 1509, 1372, 1249, 1030 cm 1 ; 1 H 
NMR (360 MHz, CDC1 3) 6 7.57 (211, d, J= 9.0 Hz, ArH), 6.86 (211, d, J= 9.0 Hz, 
ArH), 5.77 (111, dm, J = 10.3 Hz, CHCH), 5.41 (111, dm, J = 10.4 Hz, CHCH), 
4.41-4.28 (111, m, CO2CHAHBCH3), 4.24-4.12 (2H, m, CO2CHAHBCH3), 4.12-4.06 
(1H, m, CHOH), 3.81 (31-I, s, OCH3), 2.95 (1H, d, J= 16.8 Hz, CHCHDCO), 2.93 
(1H, s, CHOH), 2.55 (lI-I, d, J = 16.8 Hz, CHCHDCO), 2.26-2.14 (2H, m, 
CHCH2CH2), 1.91-1.82 (2H, m, CHCH 2CH2), 1.65 (3H, s, COHCH 3), 1.52-1.43 
(111, m, CHOHCH), 1.39 (3H, t, J = 7.1 Hz, CO2CH2CH3), 1.19-1.07 (2H, m, 
CHCH2CH2); ' 3 C NMR (90 MHz, CDC13) 6 175.9 (C), 170.0 (C), 158.8 (C), 131.5 
162 
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(2 x CH), 130.9 (CH), 130.6 (C), 126.2 (CH), 113.6 (2 x CH), 82.9 (C), 77.5 (C), 
75.9 (CH), 61.4 (CH 2), 55.3 (CH3), 46.6 (CH2), 38.3 (CH), 26.9 (CH2), 25.3 (CH2), 
23.2 (CH3), 20.7 (CH 2), 14.4 (CH3); HRMS (ES) Exact mass calcd for C 22H3 0N06 
[M+H]: 404.2068, found: 404.2063. 
(2RS,3SR)-2-(6S)-Acetoxy- [(78)-cyclohex-2-enyl] methyl}-1-(4-methoxybenzyl)-
3-methyl-5-oxo-3-(trimethylsilyloxy)pyrrolidine-2-carboxylic acid ethyl ester 
(158) 
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151 	 158 
To a stirred solution of alcohol 151 (100 mg, 0.2 mmol) and DMAP (20.0 mg, 
0.16 mmol) in CH202 (1.5 mL) at 0 °C, was added Et 3N (0.14 mL, 1.02 mmol) 
dropwise, followed by the addition of Ac 20 (0.058 mL, 0.61 mmol) via syringe. The 
reaction was stirred for 14 h and then quenched with saturated aqueous NaHCO3 
solution (3 mL). The aqueous layer was separated and extracted with CH 202 (3 x 10 
mL) and the combined organic layers were dried (MgSO4), filtered and concentrated 
in vacuo. Purification of the residue by column chromatography (30% EtOAc/petrol) 
gave acetate protected homoallylic alcohol 158 (96 mg, 90%) as a pale yellow solid. 
Rf (50% EtOAc in hexane) = 0.63; m.p. 146-148 °C; JR (film) 2938, 1748 (CO), 
1708 (C=O), 1613 (C0), 1513, 1247, 1221, 1175, 1032, 842 cm 1 ; 1 H NMR (360 
MHz, CDC13) 5 7.31 (2H, d, J— 8.6 Hz, ArH), 6.81 (2H, d, J = 8.6 Hz, ArH), 5.76 
(1H, dm, J = 10.4 Hz, CHCH), 5.43 (1H, dm, J = 10.4 Hz, CHCH), 5.36 (1H, d, J 
= 3.8 Hz, CHOAc), 4.79 (1H, d, J = 15.3 Hz, CHAHBAr), 4.56 (1H, d, J = 15.3 Hz, 
CHAHBAr), 4.19-4.10 (2H, m, CO 2CH2CH3), 3.78 (3H, s, OCH3), 2.53-2.47 (1H, m, 
CHOHCH), 2.47 (1H, d, J = 16.8 Hz, CHCHDCO), 2.41 (1H, d, J = 16.8 Hz, 
CHCHDC=O), 2.05 (3H, s, COCH3), 1.99-1.92 (2H, m, CHCH 2CH2), 1.80-1.72 (2H 
+ 1H, m, CH2CH2CH2), 1.57 (3H, s, COTMSCH3), 1.52-1.39 (1H, m, CH 2CH2), 
1.18 (3H, t, J— 7.0 Hz, CO 2CH2CH3), 0.16 (9H, s, Si(CH3)3); ' 3 C NMR (90 MHz, 
CDC13 ) 8  173.9 (C), 169.5 (C), 167.9 (C), 157.9 (C), 130.4 (C), 130.1 (CH), 127.7 
(2 x CH), 124.4 (CH), 113.2 (2 x CH), 82.0 (C), 81.1 (C), 77.1 (CH), 61.4 (CH2) 3  
163 
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55.2 (CU3), 47.6 (CH2), 46.2 (CU2), 37.8 (CH), 29.4 (CH2), 24.5 (CH2), 22.6 (CH 3), 
21.4 (CH2), 21.1 (CH3), 13.8 (CU3), 2.0 (3 x CH3); HRMS (ES) Exact mass calcd for 
C28H42NO7 Si [M+H]: 532.2725, found: 532.2721. 
(2RS,3SR)-2- {(6S)-Acetoxy- [(7S)-cyclohex-2-enyll m ethyl) -3-hydroxy-1-(4-
methoxybenzyl)-3-methyl-5-oxopyrrolidine-2-carboxylic acid ethyl ester (159) 
	




TMSO CO2Et 	 HO CO2Et 
158 	 159 
To a stirred solution of the lactam 158 (253 mg, 0;48 mmol) in EtOH (5 mL) was 
added camphor sulfonic acid (220 mg, 0.95 mmol). The reaction was stirred for 30 
min and it was then quenched with Et 3N (0.13 mL, 0.95 mmol). The solvent was 
concentrated in vacuo and purification of the residue by column chromatography 
(80% EtOAc/petrol) gave /3-hydroxy-1actam 159 (195 mg, 91%) as a colourless 
solid. Rf (50% EtOAc in hexane) = 0.22; m.p. 182-184 °C; JR (film) 3468 (OH), 
2922, 1748 (C=O), 1703 (C0), 1687 (C0), 1513, 1220, 1032, 522 cm'; 'H NMR 
(3 60 MHz, CDCI 3) 8 7.36 (2H, d, J = 8.5 Hz, ArH), 6.84 (2H, d, J = 8.5 Hz, ArH), 
5.74 (1H, dm, J = 10.3 Hz, CHCH), 5.38-5.31 (2H, m, CH=CH + CHOAc), 4.77 
(1H, d, J = 15.1 Hz, CHAHBAr), 4.57 (1H, d, J = 15.1 Hz, CHAHBAr), 4.32-4.29 
(1H, m, CO2CHCHDCH3), 4.21-4.11 (1H, m, CO2CHcHCH3), 3.78 (3H, s, OCH 3), 
2.69 (1H, bs, OH) 2.53-2.48 (1H, m, CHOHCH), 2.47 (1U, d, J = 17.2 Hz, 
CHEHFC=O), 2.39 (1H, d, J = 17.2 Hz, CHEHFCO), 2.07 (3H, s, COCH 3), 1.99-
1.92 (2H, m, CHCH2CH2), 1.79-1.69 (2H + 1H, m, CH2CH2CH2), 1.49 (3H, s, 
COTMSCH3), 1.49-1.41 (1H, m, CH2CH2), 1.23 (3H, t, J = 7.1 Hz, CO2CH2CH3); 
' 3c NMR (90 MHz, CDCI 3) 8 174.2 (C), 169.4 (C), 168.2 (C), 158.2 (C), 130.2 
(CH), 130.1 (C), 128.3 (2 x CH), 128.2 (C), 124.3 (CH), 113.4 (2 x CU), 80.9 (C), 
77.1 (CH), 61.8 (CH2), 55.2 (CU3), 47.6 (CU2), 46.1 (CH2), 37.7 (CU), 29.1 (CU2), 
24.5 (CU2), 22.1 (CU3), 21.2 (CH2), 21.1 (CU3), 13.9 (CH3); HRMS (ES) Exact mass 
calcd for C25H34N07 [M+H]: 460.2330, found: 460.2329. 
164 
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(2RS,3SR)-2- [(1S)-Hydroxy-2-methylallyl] -1-(4-m ethoxybenzyl)-3-methyl-5-oxo-
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To a stirred solution of aldehyde 150 (1.26 mg, 3.10 mmol), in THF (150 mL) at 
-78 °C was added TMSC1 (2.0 mL, 15.5 mrnol), followed by the addition of 
isopropenylmagnesium bromide (18.6 mL, 0.5 M solution in THF, 9.31 mmol) via 
syringe. The reaction was stirred at —78 °C for 3 h and then slowly quenched with 
saturated aqueous NH4C1 solution (30 mL). After warming up to room temperature 
and stirring for 30 mm, the aqueous layer was extracted with EtOAc (2 x 30 mL) and 
the combined organic layers were washed with water (1 x 30 mL), saturated NaCl 
aqueous solution (lx 30 mL) and then were dried (Na 2 SO4), filtered and concentrated 
in vacuo. Purification of the residue by column chromatography (25% EtOAc/petrol) 
gave alcohol 164 (1.06 g, 76%) as a colourless solid. Rf (40% EtOAc in hexane) = 
0.14; m.p. 171-173 °C; IR (film) 3318 (OH), 2957, 2359, 1751 (C=O), 1680 (C=O), 
1513, 1246, 1174, 1034, 841 cni'; 'H NMR (360 MHz, CDC13) 8 7.21 (2H, d, J= 
8.8 Hz, ArH), 6.78 (2H, d, J = 8.8 Hz, ArH), 5.24 (1H, s, CHOH), 5.24 (1H, s, 
C=CHAHB), 5.08 (1H, s, CCHAHB), 4.63 (1H, d, J = 15.7 Hz, CHAHBAr), 4.31 
(1H, d, J = 15.7 Hz, CHAHBAr), 4.14-4.00 (2H, m, CO2CH2CH3), 3.77 (3H, s, 
0CH3), 2.91 (1H, d, J = 16.6 Hz, CHAHBCO), 2.40 (1H, d, J 16.5 Hz, CHAHB 
CO), 2.23 (1H, bs, CHOH), 1.81 (3H, s, CCH3), 1.76 (3H, s, COTMSCH 3), 1.12-
1.06 (3H, m, CO 2CH2CH3), 0.16 (9H, s, Si(CH3)3); ' 3 C NMR (90 MHz, CDC1 3) 
174.9 (C), 168.7 (C), 157.8 (C), 144.5 (C), 131.1 (C), 127.5 (2 x CH), 115.1 (CH 2), 
113.1 (2 x CH), 82.1 (C), 82.0 (C), 75.7 (CH), 61.0 (CH 2), 55.2 (CH3), 48:5 (CH2), 
46.8 (CH2), 22.3 (CH3), 21.2 (CH3), 13.6 (CH 3), 2.1 (3 x CH3); HRMS (ES) Exact 
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164 	 165 
To a stirred solution of alcohol 164 (1.32g, 2.92 mmol) and DMAP (71 mg, 0.58 
mmol) in CH202 (10 mL) at 0 °C, was added pyridine (0.83 mL, 10.2 mmol) 
dropwise, followed by Ac 20 (1.70 mL, 17.6 mmol) via syringe. The reaction was 
stirred for 14 h at room temperature and then quenched with saturated aqueous 
NH4C1 solution (10 nL). The aqueous layer was separated and extracted with 
CH202 (3 x 10 mL) and the combined organic layers were dried (MgSO 4), filtered 
and concentrated in vacuo. Purification of the residue by column chromatography 
(40% EtOAc/petrol) gave acetate protected allylic alcohol 165 (1.32 g, 92%) as a 
pale yellow oil. Rf (40% EtOAc in hexane) = 0.38; IR (film) 2957, 2359, 1749 
(C=O), 1707 (C0), 1614 (C0), 1513, 1247, 1222, 1175, 1033, 912 cm'; 'HNMR 
(3 60 MHz, CDC13) 8 7.23 (2H, d, J = 8.8 Hz, ArH), 6.79 (2H, d, J = 8.8 Hz, ArH), 
5.65 (1 H, s, CHOAc), 5.09 (2H, s, CCH2), 4.68 (1H, d, J = 15.7 Hz, CHAHBAr), 
4.42 (1H, d, J = 15.7 Hz, CHAHBAr), 4.22-4.01 (2H, m, CO 2CH2CH3), 3.77 (3H, s, 
OCH3), 2.68 (1H, d, J = 16.7 Hz, CHCHDCO), 2.49 (1H, d, J = 16.7 Hz, 
CHCHDC=O), 2.13 (3H, s, C=OCH3), 1.77 (3H, s, CH3COTMS), 1.60 (3H, s, 
CCH3), 1.14 (3H, t, J = 7.1 Hz, CO2CH2CH3), 0.18 (9H, s, Si(CH3)3); ' 3 C NMR (90 
MHz, CDC13) 6 179.9 (C), 168.8 (C), 167.6 (C), 157.8 (C), 139.8 (C), 130.6 (C), 
127.4 (2 x CH), 116.1 (CH 2), 113.1 (2 x CH), 81.4 (C), 81.1 (C), 77.2 (CH), 61.4 
55.1 (CH3), 48.6 (CH2), 46.4 (CH 2), 22.1 (CH3), 21.2 (CH3), 20.9 (CH3), 13.6 
2.0 (3 x CH3); HRMS (ES) Exact mass calcd for C 25H38NO7Si [M+H]: 




methyl-5-oxopyrrolidine-2-carboxylic acid ethyl ester (166) 
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165 	 166 
To a stirred solution of 165 (710 mg, 1.43 mmol) in EtOH (10 mL) was added 
camphor sulfonic acid (1.30 g, 5.70 mmol). The reaction was stirred for 14 h and 
then quenched with Et3N (0.80 mL, 5.70 mmol) and extracted with CH 2C1 2 (3 x 15 
mL). The combined organic layers were concentrated in vacuo and purification of the 
residue by column chromatography (50% EtOAc/petrol) gave /3-hydroxy-1actam 
166 (536 mg, 83%) as a colourless 'solid. Rf (50% EtOAc in hexane) = 0.22; m.p. 
194-196 °C; JR (film) 3386 (OH), 2922, 2663, 2347, 1749 (CO), 1711 (CO), 1682 
(C0), 1224, 1032 cm -1 ; ' H NMR (360 MHz, CDC13) 8 7.28 (2H, d, J = 8.7 Hz, 
ArH), 6.81 (2H, d, J = 8.7 Hz, ArH), 5.65 (1H, s, CHOAc), 5.08 (2H, s, CCH2), 
4.67 (1H, d, J= 15.4 Hz, CHAHBAr), 4.38 (1H, d, J= 15.4 Hz, CHAHJ,Ar), 4.28-
4.19 (1H, m, CO2CHcH0CH3), 4.15-4.06 (1H, m, CO2CHcHCH3), 3.76 (3H, s, 
OCH3), 2.64 (1H, d, J = 17.1 Hz, CHEHFCO), 2.38 (1H, d, J = 17.1 Hz, 
CHEHFC=O), 2.14 (3H, s, C=OCH3), 1.78 (3H, s, CCH3), 1.49 (3H, s, C11 3COH), 
1.17 (3H, t, J = 7.1 Hz, CO 2CH2CH3); ' 3 C NMR (90 MHz, CDC13) 6 174.1 (C), 
168.7 (C), 167.9 (C), 158.0 (C), 139.7 (C), 130.5 (C), 127.9 (2 x CH), 116.1 (CH 2), 
113.3 (2 x CH), 80.0 (C), 77.8 (CH), 77.2 (C), 61.8 (CH2), 55.1 (CH3), 48.6 (CH2), 
46.2 (CH2), 21.9 (CH3), 21.1 (CH 3), 21.0 (CH3), 13.7 (CH3); HRMS (ES) Exact mass 
calcd for C 22H29NO 7Na [M+Na]: 442.1836, found: 442.1837. 
(2RS,3SR)-2- [(1S)-Acetoxy-2-methylpropyl]-3-hydroxy-1-(4-methoxybenzyl)-3-
methyl-5-oxopyrrolidine-2-carboxylic acid ethyl ester (167) 
PMB 	H,, Pd-C 	
MB
1 Me 
Me-, 	 Me Me.)—t--_<Thle 
OAC 
HO CO2Et 	 HO CO2 Et 
166 	 167 
A mixture of alcohol 166 (180 mg, 0.43 mmol) and 10% Pd/C (23.0 mg, 0.22 
mmol) in EtOH (4 mL) at room temperature was evacuated and flushed with H 2 (3 
167 
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times) and then stirred vigorously under an atmosphere of H2 (1 atm, H 2 balloon) at 
room temperature for 18 h. The reaction mixture was filtered through celite and 
concentrated in vacuo. Purification of the residue by column chromatography (50% 
EtOAc/petrol) gave alcohol 167 (91 mg, 50%) as a white powder. Rf (50% EtOAc in 
hexane) = 0.36; m.p. 182-184 °C; IR (film) 3365 (OH), 2359, 2341, 1749 (C=O), 
1702 (C0), 1682 (C0), 1512, 1223, 1175, 1025 cm'; 'H NMR (360 MHz, 
CDC13) 6 7.34 (2H, d, J = 8.7 Hz, ArH), 6.83 (2H, d, J= 8.7 Hz, ArH), 5.30 (1H, d, 
J= 6.5 Hz, CHOAc), 4.74 (1H, d, J= 15.2 Hz, CHAHBAr), 4.62 (1H, d, J = 15.2 Hz, 
CHAHBAr), 4.31-4.21 (1H, m, CO2CHCHDCH3), 4.18-4.09 (1H, m, 
CO2CHcHDCH3), 3.77 (3H, s, OCH3), 2.47 (1H, d, J = 17.1 Hz, CHEHFCO), 2.36 
(1H, d, J = 17.1 Hz, CHEHFCO), 2.11 (3H, s, C=OCH 3), 2.04-1.94 (1H, m, 
CHOHCH), 1.47 (3H, s, CH3COH), 1.23 (3H, t, J= 7.1 Hz, CO2CH2CH3), 1.05 (3H, 
d, J = 6.7 Hz, CHCH3), 0.76 (3H, d, J = 6.7 Hz, CHCH3); ' 3 C NMR (90 MHz, 
CDC13) 6 174.4 (C), 169.9 (C), 168.4 (C), 158.2 (C), 130.1 (C), 128.3 (2 x CH), 
113.4 (2 x CH), 80.6 (C), 78.6 (CH), 77.6 (C), 61.7 (CH 2), 55.1 (CH3), 47.7 (CH 2), 
46.1 (CH2), 30.6 (CH), 22.0 (CH 3), 21.9 (CH3), 2 1. 0 (CH 3), 18.7 (CH3), 13.8 (CH 3); 
HRMS (ES) Exact mass calcd for C 22H31N07Na [M+Na]: 444.1993, found: 
444.1989. 
6.2.2. Reductive aldol cyclisation approach 
Methyl 2- I(dimethylphenylsilyl)methyll -3-oxobutanoate (307) 
KI, NaH 	 0 	0 
0 	0 	CICH2SiMe2Ph 	
Me('0Me 
Me OMe 	DMF:THF 
SiMe2 Ph 
3 308 	 07 
To a suspension of KI (9.90 g, 60.0 mmol) and NaH (6.00 g, 60% dispersion in 
mineral oil, 150 mmol) in a mixture of DMF:THF (1:1, 200 mL) at room 
temperature, was added methyl acetoacetate (308) (11.5 mL, 100 mmol) dropwise 
over 25 mm. This solution was stirred for 30 mm, until the effervescence stopped, 
when chioromethyl dimethylphenyl silane (22.0 mL, 120 mmol) was added and the 
solution was heated to reflux for 14 h. The reaction mixture was then diluted with 
Et20, washed with 2 M HC1 (2 x 50 mL) and with saturated NaCl aqueous solution 
168 
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(2 x 50 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification of the 
residue by column chromatography (2% to 6% EtOAc/petrol) gave alkylated product 
307 (17 g, 65%) as a colourless oil. Rf (40% EtOAc in hexane) = 0.50; JR (film) 
3070, 2953, 1744 (C0), 1717 (C0), 1428, 1357, 1249, 1113, 836, 701 cm 1 ; ' H 
NMR (360 MHz, CDC1 3) 6 7.51-7.45 (2H, m, ArH), 7.39-7.34 (3H, m, ArH), 3.58 
(3H, s, CO 2CH3), 3.41 (1H, dd, J = 9.1, 6.0 Hz, CHCH2Si), 2.11 (3H, s, CH3C=O), 
1.43-1.27 (2H, m, SiCH2), 0.31 (3H, s, CH3Si), 0.30 (3H, s, CH3Si); ' 3 C NMR (62.9 
MHz, CDC13) 6 203.4 (C), 171.0 (C), 137.5 (C), 133.6 (2 x CH), 129.2 (CH), 127.8 
(2 x CH), 55.3 (CH), 52.2 (CH3), 27.9 (CH3), 14.5 (CH 2), —2.9 (CH3), —3.0 (CH3); 
HRMS (ES) Exact mass calcd for C 14H2002SiNa [M+Na]: 287.1074, found: 
287.1077. 



















To a stirred solution of -ketoester 307 (2.28 g, 8.62 mmol) in dry acetonitrile 
(60 mL) at room temperature was added tributylphosphine (0.12 mL, 1.72 mmol), 
followed by the addition of dibenzyl azodicarboxylate (3.15 g, 9.48 mmol). The 
solution was stirred for 30 min and then concentrated in vacuo. Purification of the 
residue by column chromatography (20% EtOAc/petrol) gave addition product 306 
(4.16 g, 86%) as a colourless oil. Rf (30% EtOAc in hexane) = 0.43; JR (film) 3297 
(NH), 3033, 1722 (4 x CO), 1497, 1394, 1338, 1216, 1111, 979, 830 cm'; 'H NMR 
(360 MHz, CDCI 3) 6 7.51 (2H, bs, ArH), 7.37 (10H, bs, 2 x ArH), 7.30 (3H, bs, 
ArH), 6.53 (1H, bs, NH), 5.17 (4H, bs, 2 x CO 2CH2Ar), 3.57 (3H, bs, OCH3), 2.38 
(3H, s, CH3CO), 1.66 (2H, bs, SiCH 2), 0.35 (3H, bs, CH3Si), 0.31 (3H, bs, CH3Si); 
' 3 C NMR (62.9 MHz, CDC1 3) 6 199.7 (C), 169.4 (C), 156.1 (2 x C), 138.8 (2 x C), 
135.2 (2 x C), 133.48 (2 x CH), 129.0 (2 x CH), 128.6 (4 x CH), 128.5 (4 x CH), 
128.1 (CH), 127.8 (2 x CH), 68.7 (CH2), 68.1 (CH 2), 52.4 (CH3), 24.7 (CH 3), 20.6 
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(CH2), -0.9 (Cl-I3), -2.0 (CH 3); HRMS (ES) Exact mass calcd for C 30H38N307 Si 
[M+NH4]+ : 580.2474, found: 580.2475. 
Methyl 2-amino-2- [(dimethylphenylsilyl)methyl] -3-hydroxybutanoate (319a and 
319b) 
o o 
RaNi HOAc, MeOH 	 °N 0 
Me 	 OMe 	 H2 	
OMe Met~<NH~  
	
PhMe2S L 	
hMe2Si  NH 	 P 
BnO2C 
306 	 319a and 319b 
Raney nickel (17 g, suspension in MeOH) was pre-washed with methanol (3 x 10 
mL). 306 (2.10 g, 3.72 mmol) was placed in the reaction vessel of the parr 
hydrogenator and then it was added a suspension of the catalyst in MeOH (100 mL), 
followed by HOAc (40 drops). The reaction mixture was stirred at 40 °C under 
hydrogen (45 bar) for 16 h. The reaction mixture was filtered over celite, the solids 
were washed with EtOAc and the combined organic layers were concentrated in 
vacuo. Purification of the residue by column chromatography (20% to 30% 
EtOAc/petrol) afforded the two aminoalcohols 319a (3 86 mg, 40%) and 319b (182 
mg, 17%) as colourless oils. - 
Data for 319a: R (40% EtOAc in hexane) = 0.15; JR (film) 3404 (NH + OH), 
2359, 2341, 1637 (C0), 669, 524, 509 cm'; 'H NMR (360 MHz, CDC1 3) S 7.53-
7.50 (2H, m, ArH), 7.38-7.35 (3H, m, ArH), 3.68 (1H, q, J = 6.4 Hz, CH3 CHOH), 
3.51 (3H, s, CO 2CH3), 2.41 (2H, bs, OH + NH), 1.52 (1H, d, J 14.9 Hz, 
SiCHAHB), 1.41 (1H, d, J = 14.9 Hz, SiCHAHB), 0.97 (3H, d, J = 6.4 Hz, 
CH3CHOH), 0.33 (3H, s, CH3Si), 0.32 (3H, s, CH3Si); ' 3 C NMR (62.9 MHz, 
CDC13) 5 176.3 (C), 138.3 (C), 133.6 (2 x CH), 129.2 (CH), 127.9 (2 x CH), 73.1 
(CH), 63.3 (C), 51.9 (CH3), 24.6 (CH 2), 18.1 (CH3), —1.8 (CH3), —2.4 (CH 3); HRMS 
(ES) Exact mass calcd for C 1 4H24NO3Si [M+H]: 282.1520, found: 282.1520. 
Data for 319b: Rf (40% EtOAc in hexane) = 0.10; JR (film) 3382 (NH + OH), 
1730 (C0), 1587, 1427, 1249, 1112, 835, 701, 521 cm'; 'H NMR (360 MHz, 
CDC1 3) S 7.52-7.48 (2H, m, ArH), 7.37-7.34 (3H, m, ArH), 3.83 (1H, q, J= 6.3 Hz, 
CH3CHOH), 3.47 (3H, s, CO 2CH3), 2.20 (2H, bs, OH + NH), 1.33 (1H, d, J= 14.7 
Hz, SiCHAHB), 1.14 (3H, d, J = 6.3 Hz, CH3CHOH), 1.13 (1 H, d, J = 14.7 Hz, 
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SiCHAHB), 0.33 (6H, s, (CH3)2 S1); ' 3 C NMR (62.9 MHz, CDC13) 8  176.5 (C), 138.3 
(C), 133.5 (2 x CH), 129.1 (CH), 127.8 (2 x CH), 73.0 (CH), 63.5 (C), 51.9 (CH3), 
23.6 (CH 2), 16.6 (CH3), —1.9 (CH 3), —2.1 (CH3); HRMS (ES) Exact mass calcd for 
C 14H24NO3Si [M+H]: 282.1520, found: 282.1521. 
Methyl 2-(4-methoxybenzylamino)-2- I(dimethylphenylsilyl)methyll-3-
hydroxybutanoate (320a and 320b) 
OH 0 	




J NH2 ~ NHPMB 
PhMe2Si 	 PhMe2Si 
319a and 319b 	 320a and 320b 
To a solution of a mixture of alcohols 319a and 319b (1.27 g, 4.50 mmol) in 
MeOH (40 mL) at room temperature was added HOAc (0.52 mL, 9.00 mmol), and 
the reaction flask was placed in a water bath. NaBH 3 CN (450 mg, 6.77 mmol) was 
then added, followed by p-anisaldehyde (0.70 mL, 5.40 mmol). The reaction was 
stirred at room temperature for 18 h and it was then quenched with saturated aqueous 
NaHCO3 solution. The suspension was concentrated in vacuo, and the crude mixture 
was partitioned between H 20 and CH2C12 . The aqueous layer was extracted with 
CH2C12, and the combined organic extracts were dried (Na2SO4), filtered and 
concentrated. Purification of the residue by column chromatography (10% 
EtOAc/petrol) gave the mixture of aminoalcohols 320a and 320b (1.16 g, mixture of 
both diastereomers, 65%) as a colourless oil. 
This reaction was typically performed on a mixture of both diastereomers 319a 
and 319b and it was isolated a mixture of both diastereomers of 320a and 320b. Only 
on one occasion was the reaction performed individually on each diastereomer for 
characterisation purposes 
Data for 320a: R f (30% EtOAc in hexane) = 0.48; JR (film) 2950 (NH + OH), 
2348, 1727 (C=O), 1612, 1512, 1462, 1247, 1111, 1033, 833 cm; 1 H NMR (360 
MHz, CDC13) ö 7.56-7.53 (2H, m, ArH), 7.36-7.34 (3H, m, ArH), 7.12 (2H, d, J 
8.6 Hz, ArH), 6.84 (2H, d, J = 8.6 Hz, ArH), 3.99 (1H, q, J = 6.4 Hz, CH3 CHOH), 
3.81 (3H, s, ArOCH3), 3.58 (3H, s, CO2CH3), 3.55 (1H, d, J = 11.6 Hz, 
NHCHACHBAr), 3.46 (1 H, d, J= 11.6 Hz, NHCHACHBAr), 3.23 (1 H, bs, NH), 1.92 
(1H, bs, OH), 1.57 (lH, d, J = 15.2 Hz, SiCHACHB), 1.33 (1H, d, J = 15.2 Hz, 
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SiCHACHB), 1.17 (3H, d, J = 6.4 Hz, CH3CH), 0.39 (6H, s, (CH 3)2Si); ' 3 C NMR 
(62.9 MHz, CDC1 3) 8  175.9 (C), 158.7 (C), 139.4 (C), 133.6 (2 x CH), 131.9 (C), 
129.2 (2 x CH), 128.9 (CH), 127.8 (2 x CH), 113.8 (2 x CH), 70.2 (CH), 68.1 (C), 
55.2 (CH3), 51.6 (CH 3), 47.1 (CH2), 20.2 (CH2), 17.3 (CH3), —1.2 (CH3), —1.4 (CH3); 
FIRMS (ES) Exact mass calcd for C 22H32NO4Si [M+H]: 402.2095, found: 402.2096. 
Data for 320b: Rf (30% EtOAc in hexane) = 0.48; JR (film) 2951 (NH + OH), 
2348, 1729 (C=O), 1612, 1512, 1427, 1246, 1173, 1111, 832 cm'; 'H NMR (360 
MHz, CDC13) 5 7.55-7.51 (2H, m, ArH), 7.36-7.32 (3H, m, ArH), 7.07 (2H, d, J= 
8.6 Hz, ArH), 6.81 (2H, d, J = 8.6 Hz, ArH), 4.04 (1H, q, J= 6.4 Hz, CH3CHOH), 
3.80 (3H, s, ArOCH3), 3.61 (1H, d, J = 11.6 Hz, NHCHACHBAr), 3.58-3.52 (3H, s, 
CO2CH3 + 1H, d, J = 11.6 Hz, NHCHACHBAr), 3.31 (1H, bs, NH), 1.60 (1H, bs, 
OH), 1.43 (1H, d, J— 15.0 Hz, SiCHACHB), 1.33 (1H, d, J= 15.0 Hz, SiCHACHB), 
1.23 (3H, d, J= 6.3 Hz, CH3CHOH), 0.38 (3H, s, CH3Si), 0.36 (3H, s, CH3 Si); ' 3C 
NMR (62.9 MHz, CDC13) 8  175.5 (C), 158.7 (C), 138.9 (C), 133.6 (2 x CH), 131.8 
(C), 129.2 (2 x CH), 129.0 (CH), 127.8 (2 x CH), 113.8 (2 x CH), 70.2 (CH), 68.0 
(C), 55.3 (CH3), 51.7 (Cl3), 47.5 (CH2), 20.5 (CH2), 17.3 (CH 3), —1.2 (CH3), —1.3 
(CH3); HRMS (ES) Exact mass calcd for C22H32NO4Si [M+H]: 402.2095, found: 
402.2095. 
Methyl 2-(4-methoxybenzylamino)-2- [(dimethylphenylsilyl)methyl] -3-
oxobutanoate (300) 




Me5<"OMe ~ NHPMBOM. NHPMB 
PhMe2 Si 	 PhMe2Si 
320a and 320b 	 300 
To a stirred solution of oxalyl chloride (0.51 mL, 5.76 mmol) in CH202 (12 mL) 
at —78 °C was added DMSO (0.82 mL, 11.5 mmol) dropwise. After stirring for 15 
minutes, a solution of the mixture of alcohols 320a and 320b (1.10 g, 2.74 mmol) in 
CH2C12 (12 mL) was added via cannula. The reaction was stirred at —78 °C for 1 h 
and Et3N (1.61 mL, 11.5 mmol) was then added. The reaction was stirred at —78 °C 
for 1 h, allowed to warm up to —40 °C over 2 h and then quenched with saturated 
aqueous NH4C1 solution (10 mL). The aqueous layer was separated and extracted 
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with CH202 (3 x 20 mL) and the combined organic layers were dried (MgSO4), 
filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (10% to 20% EtOAc/petrol) gave amino ketone 300 (886 mg, 81%) 
as a yellow oil. Rf(30% EtOAc in hexane) = 0.53; IR (film) 2952 (NH), 2359, 1739 
(C0), 1717 (C0), 1612, 1512, 1247, 1172, 1035, 832 cm; 'H NMR (360 MHz, 
CDC13) 6 7.56-7.52 (2H, m, ArH), 7.36-7.33 (3H, m, ArH), 7.09 (2H, d, J= 8.5 Hz, 
ArH), 6.83 (2H, d, J= 8.5 Hz, ArH), 3.80 (3H, s, ArOCH3), 3.52 (3H, s, CO 2CH3), 
3.40 (1H, d, J = 12.0 Hz, NHCHACHBAr), 3.32 (1H, d, J = 12.0 Hz, 
NHCHACHBAr), 2.28 (1H, bs, NH), 2.11 (3H, s, CH3C=O), 1.73 (1H, d, J= 15.4 
Hz, SiCHACHB), 1.63 (1H, d, J= 15.4 Hz, SiCHACHB), 0.35 (3H, s, CH3Si), 0.34 
(3H, s, CH3Si); ' 3C NMR (62.9 MHz, CDC13) 6 204.6 (C), 172.1 (C), 158.7 (C), 
138.7 (C), 133.7 (2 x CH), 131.5 (C), 129.2 (2 x CH), 129.0 (CH), 127.7 (2 x CH), 
113.7 (2 x CH), 73.6 (C), 55.3 (CH 3), 52.3 (CH3), 46.8 (CH2), 24.9 (CH3), 19.2 
(CH2), —2.0 (CH3), —2.1 (CH 3); HRMS (ES) Exact mass calcd for C 22H30NO4SiNa 
[M+H]: 400.1939, found: 400.1933. 
(E)-Ethyl 4-hydroxybut-2-enoate (322) 186 
CeCI3 7H 20 
0 	NaBN4 , EtOH 	 0 
-.. 	 OEt 
321 	 322 
To a stirred solution of aldehyde 321 (5.60 mL, 44.6 mmol) in EtOH (200 mL) at 
0 °C was added CeC1 3 7H20 (16.6 g, 44.6 mmol) followed by NaBH4 (1.72 g, 44.6 
mmol), added portionwise over 20 minutes. The reaction was allowed to warm up to 
room temperature and stirred for 14 h and then quenched with saturated aqueous 
NH4C1 solution. This mixture was concentrated in vacuo and the remaining mixture 
was taken up with Et 20. The ether phase was washed with water (2 x 40 mL) and the 
combined aqueous layers were extracted with Et 20 (2 x 30 mL). The combined 
organic layers were dried (MgSO4), filtered and concentrated in vacuo to afford 
alcohol 322 (5.5 g, 95%) as a colourless oil which was used in the next step without 
further purification. Rf (30% EtOAc in hexane) = 0.26; 'H NMR (250 MHz, CDC1 3) 
6 6.99 (1H, dt, J = 3.9, 15.7 Hz, CHCHCO), 6.05 (1H, dt, J = 2.1, 15.7 Hz, 
CHCHCO), 4.29 (2H, bs, HOCH 2), 4.16 (2H, q, J = 7.1 Hz, CH2CH3), 3.06 (1H, 
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bs, OH), 1.25 (3H, t, J= 7.1 Hz, CH2CH3); ' 3 C NMR (62.9 MHz, CDCI3) 8  166.6 
(C), 147.2 (CH), 119.8 (C), 61.5 (CH 2), 60.4 (CH2), 14.1 (CH3). 
'H spectroscopic data in good agreement with the literature. 186 






322 CSA, CH2Cl2 	PMBo 
MeO ' 	
...,)LOE 
504 323 324 
To a stirred suspension of sodium hydride (80 mg, 60% dispersion in mineral oil, 
2.0 mmol) in Et20 (25.0 mL) at 0 °C was added 4-methoxybenzyl alcohol 504 (2.50 
mL, 20.0 mmol) dropwise over 3 mm. The reaction was stirred at 0 °C for 5 min and 
trichioroacetonitrile (2.00 mL, 21.0 mmol) was added over 2 mm. The reaction was 
allowed to warm up to room temperature, stirred for 12 h and then concentrated in 
vacuo to give crude p-methoxybenzyl trichloroacetimidate 323 (6.10 g), which was 
used in the next step without further purification. 120 
To a stirred solution of alcohol 322 (4.35 g, 33.3 mmol) in CH 202 (80 mL) at 
0°C was added a solution of p-methoxybenzyl trichioroacetimidate (14.1 g, 49.9 
mmol) in CH202 (30 mL) via cannula, followed by the addition of CSA (780 mg, 
3.33 mmol) in one portion. The reaction was allowed to warm up to room 
temperature, stirred for 14 h and then filtered through celite. The solids were washed 
with CH202 (3 x 30 mL) and the combined organic layer was washed with NaHCO3 
(2 x 30 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification of the 
residue by column chromatography (10% to 20% EtOAc/petrol) gave ester 324 (4.73 
g, 57%, reaction not optimised) as a yellow oil. Rf (10% EtOAc in hexane) = 0.26; 
'H NMR (250 MHz, CDC1 3) 6 7.20 (2H, d, J = 8.3 Hz, ArH), 6.94 (1H, dt, J = 15.5, 
4.2 Hz, CH=CHC=O), 6.85 (2H, d, J = 8.3 Hz, ArH), 6.10 (1H, dt, J = 15.5, 2.3 Hz, 
CHCHCO), 4.50 (2H, s, ArCH 20), 4.18 (2H, q, J = 7.1 Hz, CH2CH3), 4.10 (2H, 
dd, J = 4.2, 2.3 Hz, CH2CHCH), 3.8 (3H, s, CH30), 1.28 (3H, t, J = 7.1 Hz, 
CH2CH3). 
'H spectroscopic data in good agreement with the literature. 187 
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(E)-4-(4-Methoxybenzyloxy)but-2-enoic acid (325) 
NaOH 
0 	 EtOH 	 0 
PM8O-A. 	 - 	
"-")(OH 
 
324 	 325 
To a stirred solution of ester 324 (5.17 g, 20.6 mmol) in EtOH (100 mL) was 
added a 0.5 M NaOH aqueous solution (45 mL). The reaction was stirred at room 
temperature for 14 h, concentrated in vacuo, dissolved in water (40 mL) and washed 
with CHC12 0  x 30 mL). The pH of the aqueous layer was. taken to pH = 4 and it 
was then extracted with CH 202 (3 x 30 mL). The combined organic layers were 
dried (MgSO4), filtered and concentrated in vacuo, to give acid 325 as a colourless 
solid (3.1 g, 70%), which was used in the next step without further purification. Rf 
(30% EtOAc in hexane) = 0.23; m.p. 83-85 °C; IR (film) 2838 (OH), 2360, 1685 
(C0), 1515, 1425, 1311, 1251, 1180, 1029, 821 cm'; 'HNMR (250 MHz, CDCI 3) 
ö 7.43 (2H, d, J = 8.1 Hz, ArH), 7.24 (1H, dt, J = 15.7, 4.1 Hz, CHCHCO), 7.05 
(2H, d, J = 8.1 Hz, ArH), 6.29 (1H, dt, J = 15.7, 2.0 Hz, CHCHCO), 4.67 (2H, s, 
ArCH20), 4.33 (2H, dd, J = 4.1, 2.0 Hz, CH 2CHCH), 3.97 (3H, s, OCH3); 13 C 
NMR (62.9 MHz, CDC1 3) 8  171.4 (C), 159.3 (C), 147.1 (CH), 129.5 (C), 129.3 (2 x 
CH), 120.3 (CH), 113.8 (2 x CH), 72.5 (CH 2), 68.1 (CH2), 55.2 (CH3); HRMS (ES) 
Exact mass calcd for C 12H 18N04 [M+NH4]: 240.1230, found: 240.1232. 




_PMB 	Trilsobutylamine 	_ft. PMB 
I + Me 	 SiMePh 
SIMe2Ph 	CH2Cl2 	 N 
Me 
326 	 300 	 347 0 
To a stirred solution of amine 300 (652 mg, 1.63 mmol) in CH202 (10 mL) at 
0 °C, was added triisobutylamine (1.20 mL, 4.89 mmol). The reaction was stirred at 
0 °C for 10 min and acryloyl chloride (0.44 mL, 4.89 mmol) was then added. The 
reaction was stirred for 14 h and then quenched with 1 M HC1 (10 mL). The aqueous 
layer was separated and extracted with CFI 202 (2 x 10 mL) and the combined 
organic layers were dried (MgSO4), filtered and concentrated in vacuo. Purification 
of the residue by column chromatography (10% to 20% EtOAc/petrol) gave amide 
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347 (452 mg, 65%) as a pale yellow oil. Rf (30% EtOAc in hexane) = 0.46; IR (film) 
2952, 1741 (C=O), 1716 (C=O), 1652 (C=O), 1513, 1415, 1249, 1174, 829, 734 
cm'; 'H NMR (360 MHz, CDC13) ö 7.48-7.44 (2H, m, ArH), 7.37-7.33 (3H, m, 
ArH), 7.30 (2H, d, J = 8.4 Hz, ArH), 6.95 (2H, d, J = 8.4 Hz, ArH), 6.37 (111, dd, J 
= 3.2, 16.7 Hz, CH AHB CH), 6.34 (1H, dd, J = 9.1, 16.7 Hz, CH2=CHC=O), 5.67 
(1H, dd, J = 9.1, 3.2 Hz, CHAHB=CH), 4.62 (1H, d, J = 18.3 Hz, NHCHAHBAr), 
4.53 (1H, d, J = 18.3 Hz, NHCHAHBAr), 3.86 (3H, s, ArOCH3), 3.42 (3H, 5, 
CO2CH3), 2.38 (3H, s, CH3C=O), 1.79 (1H, d, J = 13.7 Hz, SiCHCHD), 1.47 (1H, d, 
J = 13.7 Hz, SiCHCHD), 0.30 (6H, s, (CH3)2Si); ' 3 C NMR (62.9 MHz, CDC1 3) 
201.9 (C), 169.9 (C), 168.2 (C), 158.9 (C), 138.9 (C), 133.7 (2 x CH), 130.1 (CH 2), 
129.7 (C), 128.8 (CH), 128.2 (CH), 127.6(2 x CH), 127.2(2 x CH), 114.1 (2 x CH), 
73.9 (C), 55.3 (CH 3), 52.1 (CH3), 47.9 (CH2), 28.0 (CH3), 21.3 (CH2), —1.2 (CH 3), 
-2.0 (CH3); HRMS (ES) Exact mass calcd for C 25H32NO5 Si [M+H]+ : 454.2044, 
found: 454.2044. 
(E)-Methyl 2- [N-(4-methoxybenzyl)but-2-enamidol -2-
[(dim ethylphenylsilyl)methyl]-3-oxobutanoate (349) 
0 
HN




CoSiMe2Ph 	CH2Cl2 	Me 	 N 
I 	SiMe2 Ph 
Me 
348 	 300 	 349 0 
To a stirred solution of amine 300 (400 mg, 1.00 mmol) in CH 202 (10 ML) at 
0 °C, was added triisobutylamine (0.73 mL, 3.00 mmol). The reaction was, stirred at 
0 °C for 10 min and crotonoyl chloride (0.29 mL, 3.00 mmol) was then added. The 
reaction was stirred for 15 h and then quenched with 1 M HC1 (10 mL). The aqueous 
layer was separated and extracted with CH 2C12 (2 x 10 mL) and the combined 
organic layers were dried (MgSO4), filtered and concentrated in vacuo. Purification 
of the residue by column chromatography (10% to 20% EtOAc/petrol) gave amide 
349 (413 mg, 88%) as a yellow oil. Rf (30% EtOAc in hexane) = 0.50; IR (film) 
2952, 1740 (C=O), 1715 (C=O), 1660 (C=O), 1616, 1512, 1398, 1248, 1173, 829 
cm'; 'H NMR (360 MHz, CDC1 3) 8 7.44-7.40 (2H, m, ArH), 7.32-7.28 (3H, m, 
ArH), 7.26 (2H, d, J= 8.5 Hz, ArH), 6.98-6.88 (1H, m, CHCHCO), 6.92 (2H, d, J 
= 8.5 Hz, ArH), 6.00 (1H, dd, J = 15.0, 1.6 Hz, CHCHCO), 4.56 (1H, d, J = 18.3 
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Hz, NHCHAHBAr), 4.49 (1H, d, J= 18.3 Hz, NHCHAHBAr), 3.83 (3H, s, ArOCH3), 
3.36 (3H, s, CO2CH3), 2.33 (3H, s, CH3CO), 1.79 (3H, dd, J = 6.9, 1.6 Hz, 
CH3CH=CH), 1.73 (1H, d, J = 13.8 Hz, SiCHCHD), 1.42 (1H, d, J = 13.8 Hz, 
SiCHCHD), 0.26 (3H, s, CH3Si), 0.25 (3H, s, CH3Si); ' 3 C NMR (62.9 MHz, CDC1 3) 
ö 201.8 (C), 170.0 (C), 168.4 (C), 158.8 (C), 144.3 (CH), 139.0 (C), 133.7 (2 x CH), 
129.9 (C), 128.7 (CH), 127.5 (2 x CH), 127.3 (2 x CH), 122.3 (CH), 114.1 (2 x CH), 
73.8 (C), 55.3 (CH3), 52.0 (CH3), 47.9 (CH2), 28.0 (CH3), 21.3 (CH2), 18.2 (CH3), 
-1.2 (CH3), —1.9 (CH3); HRMS (ES) Exact mass calcd for C 26H34NO5Si [M+H]: 
468.2201, found: 468.2204. 
(E)-Ethyl 4-(benzyloxy)but-2-enoate (351)' 88 
0 
CI3CCN  
NaH 	 NH 	HO. _)LOE 
322 	
BnO CrOH 	Et20 CSA, CH2Cl2 	
3 505 	 51 
To a stirred suspension of sodium hydride (256 mg, 60% dispersion in mineral 
oil, 6.40 mmol) in Et20 (40.0 mL) at 0 °C was added benzyl alcohol 505 (6.6 mL,64 
mmol) dropwise over 4 mm. The reaction was stirred at 0 °C for 5 min and 
trichioroacetonitrile (13.2 mL, 128 mmol) was added over 3 mm. The reaction was 
allowed to warm up to room temperature, stirred for 12 h and concentrated in vacuo 
to give crude benzyl trichioroacetimidate (350) (15.5 g, 95%), which was used in the 
next step without further purification. 120 
To a stirred solution of alcohol 322 (2.40 g, 18.4 mmol) in CH2Cl2 (40 thL) and 
toluene (20 mL) at room temperature was added a solution of benzyl 
trichioroacetimidate (350) (7.80 g, 27.6 mmol) in CH 202 (20 mL) and toluene (10 
mL), followed by addition of a catalytic amount of triflouromethanesulfonic acid 
(0.16 mL, 1.84 mmol). The reaction was stirred for 24 h and then filtered. The 
filtrates were washed with CH 202 and the combined organic layers were washed 
with saturated aqueous NaHCO 3 solution (2 x 30 mL), water (1 x 30 mL) and then 
were dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue 
by column chromatography (12 % EtOAc/petrol) gave ester 351 (2.5 g, 63%) as a 
pale yellow oil. Rf (30% EtOAc in hexane) = 0.57; 'H NMR (250 MHz, CDC1 3) 
7.46-7.40 (5H, m, ArH), 7.06 (1H, dt, J = 15.7, 4.3 Hz, CH=CI-IC=O), 6.22 (1H, dt, 
177 
Experimental 
J= 15.7, 1.9 Hz, CH=CHCO), 5.09 (2H, dd, J = 4.3, 1.9 Hz, CH2CH=CH), 4.65 
(2H, s, ArCH20), 4.32 (2H, q, J = 7.1 Hz, CH2CH3), 1.38 (3H, t, J = 7.1 Hz, 
CH2CH3); ' 3 C NMR (62.9 MHz, CDC13) 6 166.2 (C), 144.1 (CH), 137.7 (C), 128.4 
(2 x CH), 127.8 (CH), 127.6 (2 x CH), 121.4 (CH), 72.7 (CH2), 68.6 (Cl2), 66.6 
(CH2), 14.2 (CH3). 
'H and 13 C spectroscopic data in good agreement with the literature. 188 
(E)-4-(Benzyloxy)but-2-enoic acid (352)123 
NaOH 
0 	EtOH 	 0 
	
- 	OH 
351 	 352 
To a stirred solution of ester 351 (9.20 mg, 4.17 mmol) in THF (12 mL) and 
water (2 mL), was added LiOH (351 mg, 8.34 mmol). The reaction was stirred at 
room temperature for 18 h, diluted in water (6 mL) and concentrated in vacuo. This 
mixture was dissolved in water (40 mL) and washed with Et20 (2 x 10 mL). The pH 
of the aqueous was taken to pH = 4 and it was then extracted with Et 20 (3 x 15 mL). 
The combined organic layers were dried (MgSO4), filtered and concentrated in 
vacuo. Purification of the residue by column chromatography (20 % EtOAc/petrol) 
gave acid 352 (690 mg, 85%) as a pale yellow solid, which was used in the next step 
without further purification. Rf (30% EtOAc in hexane) = 0.17; m.p. 46-48 °C, lit. 123 
46-47 °C; 'H NMR (3 60 MHz, CDC1 3) 67.39-7.34 (5H, m, ArH), 7.12 (1 H, dt, J 
15.7, 4.0 Hz, OCH2CHCHCO), 6.18 (1H, dt, J = 15.7, 2.1 Hz, 
OCH2CHCHCO), 4.60 (2H, s, ArCH 20), 4.24 (1H, d, J = 2.1 Hz, 
OCHAHBCHCHCO), 4.24 (1H, d, J = 2.1 Hz, OCHAHBCHCHCO); ' 3C NMR 
(62.9 MHz, CDC1 3) 6 171.6 (C), 147.1 (CH), 137.5 (C), 128.5 (2 x CH), 127.9 (CH), 
127.6 (2 x CH), 120.4 (CH), 72.8 (CH 2), 68.4 (CH2). 
'H and 13 C spectroscopic data in good agreement with the literature. 123 
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(E)-Methyl 2- 14-(benzyloxy)-N-(4-methoxybenzyl)but-2-enamidol -2- 

















To a stirred solution of acid 352 (865 mg, 4.50 mmol) in CH202 (10 rnL) was 
added oxalyl chloride (1.16 mL, 13.5 mmol) at room temperature. The reaction was 
stirred for 14 h, concentrated in vacuo, redissolved in CH2C1 2 (8 mL) and then 
transferred via cannula into a stirred solution of amine 300 (400 mg, 1.00 mmol) in 
CH2C12  (10 mL) and triisobutylamine (1.10 mL, 4.50 mmol) at 0 °C. The reaction 
mixture was stirred for 1 h at room temperature, heated to reflux for 14 h, and then 
quenched with saturated aqueous NH 4C1 solution (10 mL). The aqueous layer was 
separated and extracted with CH 202 (3 x 15 mL) and the combined organic layers 
were dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue 
by column chromatography (20% EtOAc/petrol) gave amide 354 (331 mg, 60%) as a 
pale yellow oil. Rf (30% EtOAc in hexane) = 0.25; IR (film) 2952, 1741, 1718, 1654, 
1513, 1249, 1174, 1033, 829 cm'; 'H NMR (3 60 MHz, CDC1 3) ö 7.46-7.42 (2H, m, 
ArH), 7.33-7.26 (8H, m, ArH), 7.17-7.14 (2H, m, ArH), 6.98-6.90 (2H + 1H, m, 
ArH + CH=CHCO), 6.34 (1H, d, J = 15.1 Hz, CHCHCO), 4.58 (1H, d, J = 18.2 
Hz, NHCHAHBAr), 4.52 (1 H, d,J= 18.2 Hz, NHCHAHBAr), 4.42 (2H, s, ArCH20), 
4.12-4.09 (2H, m, OCH2CH=CHC=O), 3.82 (3H, s, ArOCH3), 3.38 (3H, s, 
CO2CH3), 2.34 (3H, s, CH3C=O), 1.75 (1H, d, J = 13.7 Hz, SiCHCHD), 1.45 (1H, d, 
J = 13.7 Hz, SiCHCHD), 0.27 (6H, s, (CH3)2Si); ' 3 C NMR (62.9 MHz, CDC13) 
201.8 (C), 169.9 (C), 168.1 (C), 158.8 (C), 144.0 (CH), 138.9 (C), 137.6 (C), 133.7 
(2 x CH), 129.8 (C), 128.8 (CH), 128.3 (2 x CH), 127.6 (CH), 127.5 (2 x CH), 127.4 
(2 x CH), 127.3 (2 x CH), 120.7 (CH), 114.0 (2 x CH), 73.9 (C), 72.5 (CH2), 68.8 
(CH2), 55.2 (CH3), 52.0 (CH3), 47.9 (CH2), 28.0 (CH3), 21.3 (CH2), —1.2 (CH 3), —1.9 
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To a stirred solution of acid 352 (723 mg, 3.76 mmol) in CH 202 (10 mL), was 
added oxalyl chloride (1.70 mL, 18.8 mmol) at room temperature. The reaction was 
stirred for 14 h, concentrated in vacuo, redissolved in CH202 (8 mL) and then 
transferred via cannula into a stirred solution of amine 359 (270 mg, 1.50 mmol) in 
CH202  (10 mL) and triisobutylamine (1.10 mL, 4.51 mmol) at 0 °C. The reaction 
mixture was stirred for 12 h at room temperature, and then quenched with saturated 
aqueous NH4C1 solution (10 mL). The aqueous layer was separated and extracted 
with CH202 (3 x 15 mL) and the combined organic layers were dried (MgSO4), 
filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (20% EtOAc/petrol) gave amide 360 (497 mg, 94%) as a pale 
yellow solid. Rf (30% EtOAc in hexane) = 0.19; m.p. = 94-96 °C; JR (film) 2989, 
2867, 1731 (C0), 1666 (C0), 1511, 1380, 1249, 1170, 1029 cm 1 ; 1 HNMR (360 
MHz, CDC13) 8 7.24-7.06 (7H, m, ArH), 6.86 (1H, dt, J = 15.3, 4.4 Hz, 
CHCHCO), 6.82 (2H, d, J = 8.8 Hz, ArH), 6.04 (1H, dt, J = 15.3, L9 Hz, 
CHCHCO), 4.40 (2H, s, CH2), 4.35 (2H, s, CH2), 4.02 (2H, dd, J = 4.4, 1.9 Hz, 
OCH2CHCH), 3.74 (3H, s, OCH3), 2.11 (3H, s, CH 3CO); ' 3 C NMR (62.9 MHz, 
CDC13) ö 202.4 (C), 165.8 (C), 159.0 (C), 141.9 (CH), 137.7 (C), 135.1 (C), 129.2 (2 
x CH), 128.3 (2 x CH), 127.6 (CH), 127.4 (2 x CH), 120.6 (CH), 114.6 (2 x CH), 
72.3 (CH2), 68.8 (CH2), 59.7 (CH2), 55.4 (CH), 27.2 (CH3); HRMS (ES) Exact mass 
calcd for C 21 H24N04 [M+H] + : 354.1700, found: 354.1703. 
3-(2-Benzyloxyethyl)-4-hydroxy-1-(4-m ethoxyphenyl)-4-methylpyrrolidin-2-one 
(361a and 361b) 
O 	 C0Cl2 	 0 
BnO JL
PMP Cy2PPh 
N 	 THF 
	
BnO._.. tt N _ PMP 
Me,.) 	 Me 
HO 0 
360 	 361a and 361b (2:1) 
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A solution of a,3-unsaturated amide 360 (53 mg, 0.15 mmol), CoC12 (2.0 mg, 15 
j.imol) and Cy2PPh (4.5 mg, 16 pmo1) in THF (1 mL) was stirred at room 
temperature for 30 min and then cooled to 0 °C. Et2Zn (0.3 mL, 1 M solution in 
THF, 0.3 mmol) was then added. The reaction was allowed to warm slowly to room 
temperature over 18 h, and then quenched carefully with saturated aqueous NH 4C1 
solution (2 mL) and extracted with EtOAc (3 x 30 mL). The combined organic layers 
were dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue 
by column chromatography (10% to 20% EtOAc/petrol) gave the two diastereomers 
of the cyclised products 361a (14.8 mg, 29%) . and 361b (29.8 mg, 55%) as pale 
yellow oils. 
Data for 361a: Rf (30% EtOAc in hexane) = 0.50; JR (film) 3434 (OH), 2929, 2360, 
1694 (C=O), 1511, 1397, 1246, 1102, 1030, 829 cm'; 'H NMR (360 MHz, CDC13) 
7.46 (2H, d, J = 9.1 Hz, ArH), 7.39-7.32 (5H, m, ArH), 6.90 (2H, d, J = 9.1 Hz, 
ArH), 4.62 (1H, d, J = 11.5 Hz, CHAHBPh), 4.57 (1H, d, J = 11.5 Hz, CHAHBPh), 
3.89-3.72 (1H, m, OCHcH0CH2), 3.80 (3H, s, OCH3), 3.79 (1H, d, J = 9.0 Hz, 
NCHEHF), 3.63-3.52 (1H, m, OCHcHCH2), 3.79 (1H, d, J = 9.0 Hz, NCHEHF), 
2.68 (1H, dd, J = 10.8, 2.4 Hz, CH2CHC=O), 2.25 (1H, dm, J = 15.3 Hz, 
CH2CHGHHCH), 2.05-1.8 (lH, m, CH 2CHcHHCH), 1.34 (3H, s, CH3COH); 2D 
COSY experiment showed cross peak between: CHEHF and CHGHH; CHGHH and 
CHCO; 13C NMR (62.9 MHz, CDC13) 5  172.1 (C), 156.5 (C), 136.9 (C), 132.4 (C), 
128.6 (2 x CH), 128.1 (CH), 127.9 (2 x CH), 121.5 (2 x CH), 114.0 (2 x CH), 73.7 
(CH2), 73.1 (C), 70.7 (CH2), 59.6 (CH2), 55.6 (CH), 55.4 (CH3), 24.5 (CH2), 23.7 
(CH3); HRMS (El) Exact mass calcd for C 21 H25N04 [M]: 355.1778, found: 
355.1780. 
Data for 361b: Rf (30% EtOAc in hexane) = 0.38; JR (film) 3425 (OH), 2931, 2868, 
1682 (C=O), 1511, 1397, 1247, 1103, 829, 699 cm - 1 ; 1 H NMR (360 MHz, CDC13) ö 
7.48 (2H, d, J = 9.2 Hz, ArH), 7.36-7.29 (5H, m, ArH), 6.89 (2H, d, J = 9.2 Hz, 
ArH), 4.58 (1H, d, J = 11.6 Hz, CHAHBPh), 4.57 (1H, d, J = 11.6 Hz, CHAHBPh), 
3.87-3.79 (lH, m, OCHCHDCH2), 3.80 (3H, s, OCH3), 3.71 (1H, d, J = 10.2 Hz, 
NCHEHF), 3.66 (lH, d, J = 10.2 Hz, NCHEHF), 3.69-3.60 (1H, m, OCHCHDCH2), 
2.61 (1H, dd, J = 8.7, 4.3 Hz, CH2CHC=O), 2.30-2.09 (2H, m, CH2CH2CH), 2.05 
(3H, s, CH3COH); 2D COSY experiment showed cross peak between: CHCHDCH2 
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and CH2CH; CH2CH and CH2CH; 13C NMR (62.9 MHz, CDC1 3 ) 5 172.1 (C), 156.5 
(C), 136.9 (C), 132.4 (C), 128.6 (2 x CH), 128.1 (CH), 127.9 (2 x CH), 121.5 (2 x 
CH), 114.0(2 x CH), 73.7 (CH2), 73.1 (C), 70.7 (CH2), 59.6 (CH2), 55.6 (CH), 55.4 
(CH3), 24.5 (CH2), 23.7 (CH3); HRMS (El) Exact mass calcd for C 21 H25N04 [M]': 





0 	SOCl2 ,DMF 	 0 	 Me-- 	 N 
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Sorbic acid (5.00 g, 44.6 mmol) was heated to reflux with thionyl chloride (6.50 
mL, 89.2 mmol) and DMF (15 tL, 0.13 mmol) for 1 h. The reaction mixture was 
distilled under reduced pressure to give acid chloride 365 in quantitative yield. 125 
To a stirred solution of amine 359 (500 mg, 2.79 mmol) and triisobutylamine 
(2.00 mL, 8.37 mmol) in CH202 (15 mL) at 0 .°C was transferred via cannula a 
solution of sorbyl chloride (1.1 g, 8.37 mmol) in CH 202 (10 mL) at 0 °C. The 
reaction mixture was stirred for 1 h at 0 °C, allowed to warm up to room temperature, 
stirred for 12 h and then quenched with saturated aqueous NH 4C1 solution (15 mL). 
The aqueous layer was separated and extracted with CH 202 (3 x 15 mL) and the 
combined organic layers were dried (MgSO4), filtered and concentrated in vacuo. 
Purification of the residue by column chromatography (20% to 45% EtOAc/petrol) 
gave amide 366 (470 mg, 62%) as a brown oil. Rf (40% EtOAc in hexane) = 0.32; JR 
(film) 2975, 1729 (C=O), 1652 (C=O), 1511, 1384, 1249, 1170, 1029, 840, 561 cm'; 
'H NMR (250 MHz, CDC1 3) 8 7.21 (2H, d, J = 8.9 Hz, ArH), 6.89 (2H, d, J = 8.9 
Hz, ArH), 6.02 (2H, m, CH=CH), 5.73 (2H, m, CH=CH), 4.46 (2H, s, Cl 2), 3.83 
(3H, s, OCH3), 2.17 (3H, s, CH3C=O), 1.77 (3H, d, J = 5.4 Hz, CH3CH); ' 3C NMR 
(62.9 MHz, CDC1 3) ö 202.7 (C), 192.4 (C), 166.8 (C), 158.9 (C), 142.9 (CH), 133.0 
(CH), 130.1 (CH), 129.2 (2 x CH), 118.6 (CH), 114.5 (2 x CH), 59.7 (CH 2) 55.4 
(CH3), 27.2 (CH 3), 18.5 (CH 3); HRMS (ES) Exact mass calcd for C 16H20NO3 
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A solution of cx,f3-unsaturated amide 366 (50 mg, 0.18 mmol) and Ni(acac)2 (4.8 mg, 
18 p.mol) in THF (1 mL) was stirred at room temperature for 30 min and then cooled 
to 0 °C. Et2Zn (0.37 mL, 1 M solution in THF, 0.36 mmol) was then added. The 
reaction was allowed to warm slowly to room temperature over 18 h, and then 
quenched carefully with saturated aqueous NH 4C1 solution (2 mL) and extracted with 
EtOAc (3 x 30 mL). The combined organic layers were dried (MgSO 4), filtered and 
concentrated in vacuo. Purification of the residue by column chromatography (5% to 
10% EtOAc/petrol) gave cyclised product 367 (13.5 mg, 25%) as a yellow oil. Rf 
(30% EtOAc in hexane) = 0.52; IR (film) 3404 (OH), 2934, 1674 (C=O), 1511, 
1400, 1248, 1180, 1033, 829 cm'; 1 H NMR (250 MHz, CDC1 3) S 7.45 (2H, d, I = 
9.2 Hz, ArH), 6.89 (2H, d, J = 9.2 Hz, ArH), 5.79-5.37 (2H, m, CH=CH), 3.79 (3H, 
s, OCH3), 3.72 (1H, d, J = 9.6 Hz, NCHAHB), 3.55 (1H, d, J = 9.6 Hz, NCHAHB), 
2.67 (1H, dd, J = 9.0, 5.0 Hz, CHC=O), 2.62-2.48 (1H, m, CHCH DCHC=O), 2.40-
2.22 (1H, m, CHCHDCHC=O), 1.67 (3H, d, J = 5.3 Hz, CH3CH), 1.42 (3H, s, 
CH3COH); 2D COSY experiment showed cross peak of CH=CH protons with 
CHACHB , CH2CH and CH3; 2D NOESY experiment showed cross peak of CH3 at 
C3 with CHC=O proton and with CHCHDCHC=O protons; 13C NMR (62.9 MHz, 
CDC13) 3 172.9 (C), .156.6 (C), 132.2 (C), 127.9 (CH), 127.8 (CH), 121.7 (2 xCH), 
114.0 (2 x CH), 74.3 (C), 60.5 (CH2), 55.4 (CH), 54.7 (CH 3), 29.4 (CH2), 22.8 (CH3), 




6.2.3. Reformatsky reaction approach 
(L)-Threonine methyl ester (415) 189 
S02C1 	HCI 





To a stirred solution of SOC1 2 (11.0 mL, 150 mmol) in MeOH (115 mL) at 0°C 
was added (L)-threonine (18.2 g, 150 mmol) in portions. After stirring for 30 min at 
room temperature, the reaction was heated to reflux for 14 h and then concentrated in 
vacuo, to obtain a thick colourless oil. Methyl ester 415 was used in the next step 
without further purification. 'H NMR (360 MHz, CD 3 0D) 8 5.11 (3H, bs, NH2 + 
OH), 4.52 (1H, dq, J = 6.5, 4.2 Hz, CHCH3), 4.19 (1H, d, J = 4.2 Hz, CHCHOH), 
4.08 (3H, s, OCH3), 1.56 (3H, d, J = 6.5 Hz, CH3CH); ' 3C NMR (62.9 MHz, 
CD30D) 8 170.1 (C), 66.8 (CH), 60.3 (CH), 54.2 (CH 3), 20.9 (CH3). 
1 H and 13C spectroscopic data in good agreement with the literature. 189 







416 	 417 
To a stirred solution of p-methoxybenzonitrile 416 (22.4 g, 168.6 mmol) in 
MeOH (85 mL, 2.0 mol) at 0 °C was added acetyl chloride (96.0 mL, 1.34 mol) 
slowly via syringe. The solution was stirred for 14 h at room temperature and then 
concentrated in vacuo which afforded 417 as a colourless solid. This solid was 
washed with Et20 (5 x 30 mL), dried and used without further purification in the 
next step (30.5 g, 91%). m.p. 165-167 °C; 'H NMR (3 60 MHz, CDC1 3) ö 11.60 (1H, 
bs, NH), 8.39 (2H, d, J = 9.0 Hz, ArH), 7.02 (2H, d, J- 9.0 Hz, ArH), 4.51 (3H, s, 
OCH3), 3.88 (3H, s, OCH3); ' 3 C NMR (62.9 MHz, CDC13) 8  171.1 (C), 165.5 (C), 
132.1 (2 x CH), 116.7 (C), 114.6 (2 x CH), 60.8 (CH 3), 55.6 (CH3). 
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To a stirred solution of threonine methyl ester 415 (25.5 g, 150 mmol) in CH202 
(175 mL) at room temperature was added Et 3N (41.0 mL, 300 mmol) slowly via 
syringe, followed by the addition of 417 in one portion. The reaction was stirred for 
1 h at room temperature, heated to reflux for 14 h, then it was quenched with 
saturated aqueous NH 4CL solution (150 mL) and extracted with CH 202 (3 x 70 mL). 
The combined organic layers were dried (MgSO4), filtered and concentrated in 
vacuo. Purification of the residue by column chromatography (15% to 40% 
EtOAc/petrol) afforded oxazoline 418 (12.8 g, 40%) as a pale yellow solid. Rf (30% 
EtOAc in hexane) = 0.29; m.p. 87-88 °C, lit. 26 86-87 °C; [a] +76.5 (c 1.98, CHC1 3), 
lit.26 +69.4 (c 2.0, CHC13); 'H NMR (3 60 MHz, CDC1 3) 8 7.86 (2H, d, J = 8.9 Hz, 
ArH), 6.83 (2H, d, J = 8.9 Hz, ArH), 4.89 (1H, dq, J = 7.4, 6.3 Hz, OCHCH3), 4.38 
(1H, d, J= 7.4 Hz, NCH), 3.75 (3H, s, OCH 3), 3.73 (3H, s, OCH3), 1.45 (3H, d, J 
6.2 Hz, CHCH3); ' 3 C NMR (62.9 MHz, CDC1 3) 8  171.4 (C), 165.0 (C), 162.1 (C), 
130.0 (2 x CH), 119.4 (C), 113.4(2 x CH), 78.4 (CH), 74.8 (CH), 55.0 (CH 3), 52.2 
(CH3), 20.7 (CH3). 
'H and 13C spectroscopic data in good agreement with the literature. 26 
(4R,5R)-Methyl 4- I(benzyloxy)methyl] -4,5-dihydro-2-(4-methoxyphenyl)-5-
methyloxazole-4-carboxylate (17) 26 
C 	OBn 





418 	 17 
To a stirred solution of LHMDS (56.6 mL, 1 M solution in THF, 56.5 mmol), in 
THF (200 mL) at —78 °C was added HMPA (30.0 mL, 221 mmol), followed by the 
transfer of a solution of oxazoline 418 (12.8 g, 51.3 mmol) in THF (100 mL) via 
185 
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cannula. This solution was stirred at —78 °C for 1 h to allow enolate formation. 
Benzyloxy chioromethyl ether (14.3 mL, 61.7 mmol) was then added and the 
reaction was stirred at —78 °C for 3 h, when it was quenched with saturated aqueous 
NH4C1 solution (150 mL) and warmed up to room temperature for 30 minutes. The 
aqueous layer was extracted with EtOAc (4 x 80 mL) and the combined organic 
layers were dried (MgSO4), filtered and concentrated in vacuo. Purification of the 
residue by column chromatography (15% to 20% EtOAc/petrol) afforded alkylated 
oxazoline 17 (14.8 g, 75%) as a pale yellow oil. Rf (30% EtOAc in hexane) = 0.53; 
[x]-6.0 (c 1.0, CHC13 , lit. 26 —6.3 (c 1.0, CHC13); 'H NMR (360 MHz, CDC1 3 ) 
7.97 (2H, d, J = 9.0 Hz, ArH), 7.29-7.24 (5H, m, ArH), 6.90 (2H, d, J = 9.0 Hz, 
ArH), 4.78 (1H, q, J = 6.6 Hz, OCHCH 3), 4.61 (2H, s, OCH 2Ar), 3.87 (1H, d, J= 
9.9 Hz, CHAHBO), 3.81 (1H, d, J = 9.9 Hz, CHAHBO), 3.80 (3H, s, OCH3), 3.73 
(3H, s, 0CH3), 1.35 (3H, d, J = 6.6 Hz, CHCH3); ' 3 C NMR (62.9 MHz, CDC1 3) 
170.8 (C), 165.0 (C), 162.2 (C), 137.8 (C), 130. 2 (2 x CH), 128.0 (2 x CH), 127.4 (2 
x CH), 127.3 (CH), 119.7 (C), 113.4 (2 x CH), 8 1. 0 (C), 79.5 (CH), 73.5 (CH 2), 73.0 
(CH2), 55.1 (CH 3), 52.0 (CH3), 16.5 (CH3). 
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To a stirred solution of oxazoline 17 (14.8 g, 40.0 mmol) in HOAc (50 mL) at 
room temperature was added NaCNBH3 (8.80 g, 132 mmol) in small portions over 
2 h. The reaction mixture was stirred for 16 h at 50 °C, when it was diluted in water 
(100 mL), neutralised with solid Na2CO3 and the aqueous layer was extracted with 
ethyl acetate (5 x 60 mL). The combined organic layers were dried (MgSO 4), filtered 
and concentrated in vacuo. Purification of the residue by column chromatography 
(10% to 25% EtOAc/petrol) afforded aminoalcohol 18 (9.3 g, 65%) as a pale yellow 
oil. Rf (30% EtOAc in hexane) = 0.21; [aJ-5.8 (c 1.03, CHC1 3), lit. 26 —9.1 (c 1.0, 
CHCI3); 'H NMR (360 MHz, CDC1 3) 8 7.54-7.44 (5H, m, ArH), 7.43 (2H, d, J= 8.7 
186 
Experimental 
Hz, ArH), 7.02 (2H, d, J = 8.7 Hz, ArH), 4.71 (2H, s, OCH2Ph), 4.15 (1H, q, J = 6.4 
Hz, HOCHCH3), 4.03 (1H, d, J = 9.8 Hz, NCHAHBAr), 3.98 (1H, d, J = 9.8 Hz, 
NCHAHBAr), 3.95 (3H, s, OCH3), 3.92 (3H, s, OCH 3), 3.87 (1H, d, J = 11.8 Hz, 
CHCHDOBn), 3.79 (1H, d, J= 11.8 Hz, CHCHDOBn), 2.28 (1H, bs, OH), 1.35 (3H, 
d, J = 6.6 Hz, CHCH3); 13 C NMR (62.9 MHz, CDC1 3) 6 172.8 (C), 158.8 (C), 137.5 
(C), 131.7 (C), 129.5(2 x CH), 128.4(2 xCH), 127.8 (CH), 127.7(2 x CH), 113.8(2 
x CH), 73.5 (CH2), 69.8 (C), 69.5 (CH2), 69.4 (CH), 55.2 (CH3), 52.1 (CH 3), 47.3 
(CH2), 17.9 (CH3). 
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To a stirred solution of oxalyl chloride (1.70 mL, 18.8 mmol) in CH 2 C12 (40 mL) 
at —78 °C, was added DMSO (2.10 mL, 37.6 mmol) dropwise over 3 mm. After 
stirring for 15 mm, a solution of alcohol 18 (3.34 g, 8.94 mmol) in CH 2C12 (30 mL) 
was added via cannula over 5 mm. The reaction stirred at —78 °C for 1 h and Et 3N 
(5.25 mL, 37.6 mmol) was then added over 1 mm. The reaction was stirred at —78 °C 
for 1 h, allowed to warm up to —40 °C over 2 h, and then quenched with saturated 
aqueous NH4C1 solution (40 mL). The aqueous layer was separated and extracted 
with CH202 (3 x 20 mL) and the combined organic layers were dried (MgSO4), 
filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (10% to 20% EtOAc/petrol) gave amino ketone 327 (2.39 g, 72%) 
as a pale yellow solid. Rf (30% EtOAc in hexane) = 0.55; m.p. = 60-62 °C; 
[a] 2 -127 (c 1.02, CHC13); JR (film) 3347 (NH), 2952, 2836, 1741 (C=O), 1718 
(C0), 1511, 1245, 1178, 1033, 700 cm -1 ; ' H NMR (250 MHz, CDC1 3 ) 67.39-7.28 
(5H, m, ArH), 7.25 (2H, d, J = 8.7 Hz, ArH), 6.85 (2H, d, J = 8.7 Hz, ArH), 4.59 
(1H, d, J = 12.4 Hz, OCHAHBPh), 4.53 (1H, d, J = 12.4 Hz, OCHAHBPh), 4.02 (1H, 
d, J = 10.1 Hz, NHCHCHD), 3.90 (1H, d, J = 10.1 Hz, NHCHCHD), 3.80 (3H, s, 
OCH3), 3.74 (3H, s, OCH3), 3.59 (1H, d, J= 12.3 Hz, CHEHFOBn), 3.46 (1H, d, J= 
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12.3 Hz, CHEHFOBn), 2.53 (11-1, br s, NH), 2.21 (3H, s, CH3C=O); ' 3 C NMR (62.9 
MHz, CDC13) 8 203.3 (C), 169.8 (C), 158.7 (C), 137.6 (C), 131.7 (C), 129.3 (2 x 
CH), 128.4 (2 x CH), 127.8 (3 x CH), 113.7 (2 x CH), 74.8 (C), 73.4 (CH 2), 68.1 
(CH2), 55.3 (CH3 ), 52.7 (CH3), 46.7 (CH 2), 25.7 (CH3); HRMS (ES) Exact mass 
calcd for C 21 H26N05 [M+H] +: 372.1805, found: 372.1804. 
(R)-Methyl 2-benzyloxymethyl-2-[2-bromo-N-(4-methoxybenzyl)butanamidol -3-
oxobutanoate (420a and 420b) 
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To a stirred solution of amine 327 (1.25 g, 3.36 mmol) in CH 202 (15 mL) at 
room temperature was added triisobutylamine (1.10 mL, 4.37 mmol). The reaction 
was stirred for 10 min and 2-bromobutyryl bromide (0.55 mL, 4.04 mmol) was then 
added. The reaction was stirred for 16 h and then quenched with saturated aqueous 
NH4C1 solution (10 mL). The aqueous layer was separated and extracted with 
CH2C12 (2 x 15 mL) and the combined organic layers were dried (MgSO4), filtered 
and concentrated in vacuo. Purification of the residue by column chromatography 
(10 % to 15% EtOAc/petrol) gave the two diastereomers of the amide, the more polar 
diastereomer 420a (990 mg, 57%) and the less polar diastereomer 420b (627 mg, 
36%), as yellow oils. 
Data for 420b: Rf (30% EtOAc in hexane) = 0.46; [a]-63.3 (c 1.03, CHC13); 
IR(film) 2972, 1741 (C0), 1709 (C0), 1657 (C0), 1513, 1433, 1246,1177,741, 
510 (C-Br) cm'; 'H NMR (250 MHz, CDC13) 8 7.31 (211, d, J = 8.7 Hz, ArH), 7.22-
7.17 (3H, m, ArH), 7.07-7.01 (2H, m, ArH), 6.84 (2H, d, J = 8.7 Hz, ArH), 5.01 
(1H, d, J = 18.7 Hz, OCHAHBPh), 4.75 (1H, d, J= 18.7 Hz, OCHAHBPh), 4.27 (1H, 
d, J = 11.8 Hz, NHCHCHD), 4.19 (1H, d, J = 11.8 Hz, NHCHCHD), 4.00 (1H, dd, J 
8.6, 6.1 Hz, CHBr), 3.76 (3H, s, OCH3), 3.75 (3H, s, OCH3), 3.63 (2H, s, CH20Bn), 
2.42 (3H, s, CH 3CO), 2.16-1.96 (111, m, CHBrCHEHFCH3), 1.90-1.76 (1H, m, 
CHBrCHEHFCH3), 0.71 (3H, t, I = 7.3 Hz, CHAHBCH3); 13 C NMR (62.9 MHz, 
CDC13) 6 198.1 (C), 171.4 (C), 168.6 (C), 158.8 (C), 136.6 (C), 130.2 (C), 128.3 (2 x 
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CH), 127.9 (CH), 127.4 (2 x CH), 126.7 (2 x CH), 114.2 (2 x CH), 77.2 (C), 73.8 
(CR2), 70.3 (CH2), 55.3 (CH3), 52.9 (CH3), 48.5 (CH2), 44.5 (CH), 28.6 (Cl-I2), 28.1 
(CH3), 12.0 (CH3); HRMS (ES) Exact mass calcd for C 25R3079BrNO6Na [M+Na]: 
542.1149, found: 542.1155. 
Data for 420a: Rf(30% EtOAc in hexane) 0.35; [a]+41.0 (c 0.925, CHC1 3); 
IR (film) 2971, 2359, 1744 (CO), 1735 (CO) 1660 (CO), 1513, 1413, 1247, 
1176, 1095, 740, 503 (C-Br) cm'; 'H NMR (250 MHz, CDC1 3) 8 7.38 (2H, d, J= 
8.7 Hz, ArH), 7.34-7.30 (3H, m, ArH), 7.21-7.18 (2H, m, ArH), 6.95 (2H, d, J= 8.7 
Hz, ArH), 4.95 (1H, d, J = 18.4 Hz, OCHAHBPh), 4.86 (1H, d, J 18.4 Hz, 
OCHAHBPh), 4.42 (1H, d, J 11.8 Hz, NHCHCHD), 4.38 (1H, d, J = 11.8 Hz, 
NHCHCHD), 4.22 (1H, dd, J = 8.5, 6.1 Hz, CHBr), 3.87 (1H, d, J = 10.5 Hz, 
CHEHFOBn), 3.93 (1H, d, J = 10.5 Hz, CHEHFOBn), 3.87 (3H, s, OCH3), 3.80 (3H, 
s, OCH3), 2.43 (3H, s, CH3C=O), 2.28-2.15 (1H, m, CHBrCHGHHCH3), 2.00-1.88 
(1H, m, CHBrCHGHHCH3), 0.88 (3H, t, J 7.3 Hz, CHGHHCH3); ' 3C NMR (62.9 
MHz, CDCI3) ö 197.5 (C), 171.6 (C), 167.6 (C), 158.8 (C), 136.6 (C), 130.0 (C), 
128.4 (2 x CH), 127.9 (CH), 127.6(2 x CH), 126.9 (2 x CH), 114.1 (2 x CH), 77.8 
(C), 73.8 (CR 2), 70.2 (CH2), 55.3 (CR3), 52.8 (CH3), 49.7 (CR2), 44.7 (CH), 28.6 
(CH2), 27.5 (CR3), 12.0 (CH3); RRMS (ES) Exact mass calcd for C 25H3079BrN06Na 
[M+Na]: 542.1149, found: 542.1153. 
(2R,3S,4R)-2-Benzyloxymethyl-4-ethyl-3-hydroxy-1-(4-methoxybenzyl)-3-
methyi-5-oxopyrrolidine-2-carboxylic acid methyl ester (421), N-(4-
methoxybenzyl)butyramide (433) and (R)-methyl 2-benzyloxymethyl-2- [N-(4-
methoxybenzyl)butyramido] -3-oxobutanoate (425) 
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To a stirred solution of amide 420a (more polar diastereomer, 30 mg, 57 tmol) in 
THF (3 mL) at 0 °C was added Sm1 2 (0.1 M solution in hexanes, 6.90 mL, 0.69 
mmol). The reaction was stirred at 0 °C for 1 h and then quenched with saturated 
aqueous NR4C1 solution (5 mL). The aqueous layer was separated and extracted with 
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EtOAc (2 x 15 mL) and the combined organic layers were dried (Na2SO4), filtered 
and concentrated in vacuo. Purification of the residue by column chromatography 
(10 % to 15% EtOAc/petrol) gave 241actam 421 (9.5 mg, 38%), amide 433 (4.5 mg, 
40%) and debrominated amide 425 (2.6 mg, 10%). 
Data for 421: Rf (30% EtOAc in hexane) = 0.10; [a] 22 -24.6 (c 0.73, CHC13); IR 
(film) 3424 (OH), 2956, 1749 (CO), 1670 (CO), 1511, 1454, 1245, 1176, 1058, 
736, 511 (C-Br) cmi; 111  NMR (360 MHz, CDC13) 67.30-7.20 (5H, m, ArH), 7.07 
(21-1, d, J = 8.6 Hz, ArH), 6.69 (2H, d, J = 8.6 Hz, ArH), 4.97 (1H, d, J= 15.2 Hz, 
OCHAHBPh), 4.19 (1H, d, J = 15.2 Hz, OCHAHBPh), 3.89 (1H, d, J = 11.8 Hz, 
NHCHCHD), 3.83 (1H, d, J 11.8 Hz, NHCHCHD), 3.73 (1H, d, J = 10.3 Hz, 
CHEHFOBn), 3.70 (3H, s, OCH 3), 3.69 (3H, s, OCH3), 3.17 (1H, d, J = 10.3 Hz, 
CHEHFOBn), 2.44 (1H, t, J = 6.9 Hz, CHGHHCH), 1.83-1.71 (1H, m, CHGHHCH), 
1.60-1.48 (1H, m, CHGHHCH), 1.40 (3H, s, CCH30H), 1.11 (3H, t, J = 7.5 Hz, 
CH3CHGHH); 2D NOESY experiment showed cross peak between: CCH 30H and 
CHEHFOBn and between CCH 30H and CHGHHCH; ' 3 C NMR (62.9 MHz, CDC1 3) 6 
176.5 (C), 169.3 (C), 158.7 (C), 137.2 (C), 130.4 (C), 130.0 (2 x CH), 128.3 (2 x 
CH), 127.7 (2 x CH), 127.2 (CH), 113.5 (2 x CH), 78.4 (C), 77.2 (C), 72.8 (CH 2), 
68.5 (CH2), 55.2 (CH3), 52.7 (CH), 52.4 (CH 3), 44.9 (CH 2), 21.1 (CH3), 17.8 (CH2), 
13.4 (CH3); HRMS (ES) Exact mass calcd for C 25H32N06 [M+H]: 442.2224, found: 
442.2227. 
Data for 433: Rf (30% EtOAc in hexane) = 0.13; JR (film) 3289 (NH), 2930, 1632 
(C0), 1556, 1512, 1434, 1253, 1029, 813, 754 cm'; 'H NMR (250 MHz, CDC1 3) 6 
7.20 (2H, d, J 8.7 Hz, ArH), 6.86 (2H, d, J = 8.7 Hz, ArH), 5.75 (1H, bs, NH), 
4.36 (2H, d, J = 5.6 Hz, OCH2Ph), 3.79 (3H, s, OCH3), 2.17 (2H, t, J = 7.6 Hz, 
CH2CO), 1.68 (2H, qt, J = 7.6, 7.3 Hz, CH3 CH2CH2), 0.95 (2H, t, J = 7.3 Hz, 
CH3CH2CH2); ' 3 C NMR (62.9 MHz, CDC13) 6 172.6 (C), 158.9 (C), 130.5 (C), 
129.1 (2 x CH), 114.0 (2 x CH), 55.2 (CH3), 43.0 (CH 2), 38.6 (CH 2), 19.1 (CH2), 
13.7 (CH3); HRMS (El) Exact mass calcd for C 12H, 7NO2 [M]': 207.1254, found: 
207.1253. 
Data for 425: Rf (30% EtOAc in hexane) = 0.32; JR (film) 2959, 2924, 2853, 1740 
(C=O), 1716 (C0), 1651 (C0), 1513, 1247, 1096, 1029 cm'; 'H NMR (250 MHz, 
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CDC13) 5 7.34 (21-1, d, J= 8.7 Hz, ArH), 7.30-7.26 (31-1, m, ArH), 7.15-7.10 (21-1, m, 
ArH), 6.91 (21-1, d, J = 8.7 Hz, ArH), 4.89 (1H, d, J= 18.3 Hz, OCHAHBPh), 4.71 
(1H, d, J= 18.3 Hz, OCHAHBPh), 4.32 (1H, d, J = 11.9 Hz, NHCHCHD), 4.26 (1H, 
d, J = 11.9 Hz, NHCHCHD), 3.83 (31-1, s, OCH3), 3.79 (31-1, s, OCH3), 3.73 (21-1, s, 
CH2013n), 2.42 (31-1, s, CH3C=O), 2.26 (21-1, t, J= 11.9 Hz, CH 2C=O), 1.62 (21-1, m, 
CH3 CH2CH2), 0.85 (31-1, t, J = 7.4 Hz, CH3CH2); ' 3C NMR (62.9 MHz, CDC13) 
197.9 (C), 176.0 (C), 168.7 (C), 158.6 (C), 136.7 (C), 130.5 (C), 128.3 (2 x CH), 
127.8 (CH), 127.4 (2 x CH), 126.9 (2 x CH), 114.0 (2 x CH), 77.2 (C), 73.7 (CH2), 
70.3 (CH2), 55.2 (CH3), 52.7 (CH3), 48.6 (CH2), 34.9 (CH2), 28.0 (CH 3), 18.3 (CH2), 








446 	 447 
To a stirred solution of butanal 446 (1.80 mL, 20.0 mmol) in CH 2 C12 (20 mL) at 
0 °C was added DL-proline (690 mg, 6.00 mmol), followed by the addition of NIS 
(5.80 g, 10.1 mmol). This reaction mixture was stirred for 30 minutes at 0 °C, 
allowed to warm up to room temperature and then stirred for another 5 h. Hexane 
was added to the reaction mixture and the precipitated NIS, succinimide and catalyst 
were filtered off. The solvents were concentrated in vacuo and purification of the 
residue by column chromatography (10 % EtOAc/hexane) gave a-iodoaldehyde 446 
(1.66 g, 42%) as a light pinkoil. Rf (30% EtOAc in hexane) = 0.55; 'H NMR (250 
MHz, CDC13) 6 9.27 (11-1, s, CHO), 4.46-4.37 (11-1, m, CHICHO), 2.09-1.86 (21-1, m, 
CH3CH2CHI), 1.09-1.00 (31-1, m, CH3CH2); ' 3 C NMR (62.9 MHz, CDC13) 8 191.7 
(C), 38.6 (CH), 25.6 (CH2), 14.0 (CH3). 
1 H and 13C spectroscopic data in good agreement with the literature. 191  
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2-lodobutanoic acid (448) 
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To a solution of the cx-iodoaldehyde 447 (1.27 g, 6.40 mmol) in t-BuOH (38 mL) 
and 5% NaH2PO4 solution (26 mL) at room temperature was added KMN04 (38 mL, 
1 M solution). The reaction mixture was stirred for 3 h and then quenched by the 
addition of solid Na2SO3 until the solution turned dark brown from the original 
purple colour. 1 M HC1 (30 mL) was added to the reaction mixture until acidic pH. 
The reaction was then extracted with Et 20 (4 x 40 mL) and the combined organic 
layers were dried (MgSO4), filtered and concentrated in vacuo. Purification of the 
residue by column chromatography (50% EtOAc/petrol) gave a-iodoacid 448 (1.31 
mg, 95%) as a light pink oil. Rf (30% EtOAc in hexane) = 0.26; JR (film) 2970 (OH), 
1705 (C=O), 1456, 1417, 1271, 1218, 1143, 930, 783, 506 (C-I) cm'; 'H NMR (250 
MHz, CDC13) 8  10.3 (1H, bs, OH), 4.27 (1H, t, J= 7.5 Hz, CHICO 2H), 2.00 (2H, dq, 
J = 7.5, 7.3 Hz, CH3 CH2CHI), 1.01 (3H, t, J = 7.2 Hz, CH3CH2); ' 3 C NMR (62.9 
MHz, CDC13) 8  177.6 (C), 29.2 (CH), 21.9 (CH2), 13.9 (CH 3); HRMS (El) Exact 
mass calcd for C 4H7021 [M]: 213.9485, found: 213.9489. 
(2R)-Methyl 2-benzyloxymethyl-2- [2-iodo-N-(4-methoxybenzyl)butanamido] -3- 
oxobutanoate (449a and 449b) 
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449a and 449b 0 
To a stirred solution of acid 448 (615 mg, 1.46 mmol) in CH 202 (8 mL) at 0 °C, 
was added oxalyl chloride (0.74 mL, 8.30 mmol) followed by DMF (1 drop). The 
reaction was stirred 5 min at 0 °C and then allowed to warm up to room temperature 
and stirred for another 30 mm. The solution containing the acid chloride was 
concentrated in vacuo, redissolved in CH202 (8 mL) and then transferred via cannula 
into a stirred solution of amine 327 (270 mg, 0.73 mmol) in CH 202 (10 mL) and 
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triisobutylamine (0.22 mL, 0.87 mmol) at 0 °C. The reaction mixture was allowed to 
warm up to room temperature, stirred for 14 h and then quenched with saturated 
aqueous NH4C1 solution (10 mL). The aqueous layer was separated and extracted 
with CH2C12 (3 x 15 mL) and the combined organic layers were dried (MgSO4), 
filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (10% EtOAc/petrol) afforded the two diastereomers of amide, the 
more polar diastereomer 449a (226 mg, 40%) and the less polar diastereomer 449b 
(189 mg, 35%), as yellow oils. 
Data for 449b: Rf(30% EtOAc in hexane) = 0.62; [a]-62.9 (c 0.985, CHC13); 
JR (film) 2952, 2360, 1741 (CO), 1708 (C0), 1650 (C0), 1513, 1358, 1246, 
1097, 738, 504 (C-I) cm'; 'H NMR (250 MHz, CDC13) 8 7.34 (21-1, d, J = 8.6 Hz, 
ArH), 7.25-7.19 (31-1, m, ArH), 7.10-7.04 (2H, m, ArH), 6.87 (21-1, d, J = 8.6 Hz, 
ArH), 5.03 (11-1, d, J = 18.7 Hz, OCHAHBPh), 4.59 (11-1, d, J = 18.7 Hz, 
OCHAHBPh), 4.31 (11-1, d, J = 11.7 Hz, NCHCHD), 4.22 (11-1, d, J = 11.7 Hz, 
NCHCHD), 4.03 (lI-I, dd, J = 8.9, 5.9 Hz, CHI), 3.80 (31-1, s, OCH 3), 3.78 (31-1, s, 
OCH3), 3.65 (21-1, s, CH20Bn), 2.45 (31-1, s, CH3CO), 2.15-1.95 (11-1, m, 
CHICHEHFCH3), 1.95-1.75 (111, m, CHICHEHFCH3), 0.67 (31-1, t, J = 7.2 Hz, 
CHEHFCH3); ' 3 C NMR (62.9 MHz, CDC13) ö 198.4 (C), 173.0 (C), 169.4 (C), 159.3 
(C), 137.0 (C), 130.6 (C), 128.8 (2 x CH), 128.3 (CH), 127.9 (2 x CH), 127.1 (2 x 
CH), 114.6 (2 x CH), 77.6 (a), 74.3 (CH2), 70.8 (CH2), 55.7 (CH3), 53.2 (CH3), 49.7 
(CH2), 30.9 (CH2), 28.5 (CH 3), 22.3 (CH), 14.3 (CH 3); FIRMS (ES) Exact mass calcd 
for C25H31 1N06 [M+H]: 568.1191, found: 568.1194. 
Data for 449a: Rf (30% EtOAc in hexane) = 0.52; [a] 22  +28.0 (c 0.57, CHC13); 
JR (film) 2953 (OH), 2360, 1743 (C0), 1730 (CO), 1653 (CO), 1513, 1410, 
1247, 1094, 736, 503 (C-I) cm'; 'H NMR (250 MHz, CDC1 3) 5 7.29 (21-1, d, J = 8.6 
Hz, ArH), 7.27-7.20 (311, m, ArH), 7.14-7.08 (211, m, ArH), 6.86 (2H, d, J= 8.6 Hz, 
ArH), 4.78 (1H, d, J = 18.4 Hz, OCHAHBPh), 4.67 (1H, d, J = 18.4 Hz, 
OCHAHBPh), 4.36 (111, d, J 11.8 Hz, NCHCHD), 4.30 (11-1, d, J = 11.8 Hz, 
NCHCHD), 4.13 (11-1, dd, J = 8.9, 5.8 Hz, CHI), 3.93 (11-1, d, J = 10.4 Hz, 
CHEHFOBn), 3.85 (1H, d, J = 10.4 Hz, CHEHFOBn), 3.77 (31-1, s, OCH3), 3.70 (3H, 
s, OCH3), 2.33 (3H, s, CH3CO), 2.17-1.97 (1H, m, CHJCHGHHCH3), 1.96-1.75 
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- (1H, m, CHICHGHHCH3), 0.70 (3H, t, J = 7.2 Hz, CHGHHCH3); ' 3 C NMR (62.9 
MHz, CDC13) 8  197.5 (C), 172.8 (C), 167.5 (C), 158.8 (C), 136.7 (C), 130.1 (C), 
128.3 (2 x CH), 127.8 (CH), 127.6 (2 x CH), 126.9 (2 x CH), 114.2 (2 x CH), 78.0 
(C), 73.8 (CH 2), 70.1 (CH2), 55.3 (CH3), 52.8 (CH3), 50.6 (CH2), 30.5 (CH2), 27.5 
(CH3), 22.0 (CH) 13.9 (CH3); HRMS (ES) Exact mass calcd for C 25H31 1N06 
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To a stirred solution of 1,4-butanediol (55.0 mL, 61.4 mmol) and KOH (powder, 
4.16 g, 63.0 mmol) in DMSO (12 mL) at 0 °C was addedp-(methoxy)benzyl chloride 
(4.15 mL, 30.0 mmol). The reaction was stirred at 0 °C for 2 h, allowed to warm up 
to room temperature, stirred then for 12 h and quenched with saturated aqueous 
NH4C1 solution (30 mL). The aqueous layer was extracted with Et 20 (4 x 40 mL) and 
the combined organic layers were washed with saturated aqueous NaCl solution (1 x 
60 mL), dried (Mg504), filtered and concentrated in vacuo. Purification of the 
residue by column chromatography (30% to 40% EtOAc/petrol) gave monoalcohol 
455 (5.32 g, 85%) as a colourless oil. Rf (30% EtOAc in hexane) = 0.50; 'H NMR 
(360 MHz, CDC13) ö 7.25 (2H, d, J = 8.6 Hz, ArH), 6.73 (2H, d, J = 8.6 Hz, ArH), 
4.41 (2H, s, ArCH20), 3.75 (3H, s, OCH3), 3.59 (2H, t, J = 5.1 Hz, OCH2CH2), 3.48 
(2H, t,J = 5.3 Hz, CH2CH20H), 2.30 (1H, bs, OH), 1.70-1.58 (4H, m, CH 2CH2); 13 C 
NMR (62.9 MHz, CDC1 3) 8  159.1 (C), 130.1 (C), 129.2 (2 x CH), 113.7 (2 x CH), 
72.5 (CH2), 69.9 (CH2), 62.4 (CH2), 55.1 (CH 3), 29.9 (CH2), 26.5 (CH2). 
'H and 13C spectroscopic data in good agreement with the literature. 174 
4-(4-Methoybenzyloxy)butyric acid (456)1 74 
PDC 




455 	 456 
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To a stirred solution of alcohol 455 (5.32 g, 25.3 mmol) in DMF (125 mL) at 
room temperature was added PDC (34.0 g, 88.5 mmol) portionwise. The reaction 
was stirred for 14 h and then quenched with water (250 mL) and extracted with Et20 
(5 x 50 mL). The combined organic layers were dried (MgSO4), filtered and 
concentrated in vacuo. Purification of the residue by column chromatography (10% 
EtOAc/petrol) afforded acid 456 (4.0 g, 71%) as a colourless oil. Rf (30% EtOAc in 
hexane) = 0.25; 'H NMR (360 MHz, CDC13) 8  10.5 (1H, bs, OH), 7.22 (2H, d, J 
8.7 Hz, ArH), 6.84 (2H, d, J = 5.6 Hz, ArH), 4.40 (2H, s, ArCH 20), 3.76 (3H, s, 
OCH3), 3.46 (2H, t, J = 6.1 Hz, OCH2CH2), 2.43 (2H, t, J = 7.3 Hz, CH2C=O), 1.89 
(2H, quint, J= 7.3, 6.1 Hz, CH2CH2CH2); ' 3 C NMR (62.9 MHz, CDCI 3) 8  178.9 (C), 
159.0 (C), 130.2 (C), 129.1 (2 x CH), 113.7 (2 x CH), 72.4 (CH2), 68.6 (CH 2), 55.1 
(CH3), 30.9 (CH 2), 24.7 (CH2). 
'H and 13C spectroscopic data in good agreement with the literature. 174 
4(tert-Buty1dipheny1si1y1oxy)butafl-1-Ol (458)179 
n-BuLi, TBDPSCI 





To a vigorously stirred solution of 1 ,4-butanediol (4.0 mL, 45 mmol) in THF (24 
mL) at —78 °C was added n-BuLi (9.4 mL, 1.6 M in hexanes, 15 mmol) dropwise 
over -10 mm. The reaction was stirred for 5 min and TBDPSC1 (4.0 mL, 15 mmol) 
was then added dropwise. The reaction was allowed to warm up to room temperature 
(a white suspension was formed), stirred for 1.5 h and then quenched with water (20 
mL) and saturated aqueous NH 4C1 solution (20 mL). The aqueous layer was 
separated and extracted with Et 20 (3 x 30 mL) and the combined organic layers were 
dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue by 
column chromatography (10 % to 20% EtOAc/petrol) gave mono-protected alcohol 
458 (4.78 g, 97%) as a colourless oil. Rf (30% EtOAc in hexane) = 0.50; 'H NMR 
(360 MHz, CDC13) 8 7.72-7.68 (4H, m, ArH), 7.48-7.38 (6H, m, ArH), 3.73 (2H, t, J 
= 5.6 Hz, CH20H), 3.68 (2H, t, J = 5.7 Hz, TBDPSOCH2), 1.74-1.65 (4H, m, 
CH2CH2), 1.09 (9H, s, C(CH3)3); ' 3C NMR (62.9 MHz, CDC1 3) 8  135.5 (4 x CH), 
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133.6 (2 x C), 129.6 (2 x CH), 127.6 (4 x CH), 63.9 (CH2), 62.7 (Cl2), 29.7 (CH2), 
29.2 (CH2), 26.8 (3 x CH 3), 19.1 (C). 
'H spectroscopic data in good agreement with the literature. 179 
4-(tert-Butyldiphenylsilyl)oxy butyric acid (459) 179 
PDC 
TBDPSO - 	DMF 	
TBDPSO_.Ji... 
458 	 459 
To a stirred solution of alcohol 458 (4.40 g, 13.3 mmol) in DMF (35 mL) at 0 °C 
was added PDC (18.0 g, 46.8 mmol) portionwise. The reaction was allowed to warm 
to room temperature, stirred for 14 h and then quenched with water (250 mL). The 
aqueous layer was extracted with Et20 (5 x 50 mL) and the combined organic layers 
were dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue 
by column chromatography (10% EtOAc/petrol) afforded acid 459 (2.4 g, 51%) as a 
colourless solid. Rf (30% EtOAc in hexane) = 0.20; m.p. 68-70 °C; 'H NMR (360 
MHz, CDC13) ö 7.70-7.65 (4H, m, ArH), 7.45-7.36 (6H, m, ArH), 3.71 (2H, t, J = 
5.9 Hz, OCH2), 2.53 (2H, t, J = 7.3 Hz, CH2CO2H), 1.90 (2H, q, J= 7.3, 5.9 Hz, 
CH2CH2CH2), 1.06 (9H, s, C(CH3)3); 13 C NMR (62.9 MHz, CDC1 3) 8 179.4 (C), 
135.5 (4 x CH), 133.5 (2 x C), 129.6 (2 x CH), 127.6 (4 x CH), 62.7 (CH 2), 30.7 
(CH2), 27.4 (CH 2), 26.8 (3 x CH3), 19.1 (C). 
'H and 13 C spectroscopic data in good agreement with the literature. 179 
4-(tert-Butyldiphenylsilyl)oxy-1-butanal (461)' 92 
(COd)2 , DMSO, 
Et,N, CH 2Cl2 
458 	 461 
To a stirred solution of oxalyl chloride (1.10 mL, 12.7 mmol) in CH 2C12 (30 mL). 
at —78 °C, was added DMSO (1.80 mL, 25.6 mmol) dropwise. After stirring for 15 
minutes, a solution of alcohol 458 (2.0 g, 6.1 mmol) in CH202 (30 mL) was added 
via cannula. The reaction stirred at —78 °C for 1 h and then Et 3N (3.60 mL, 25.6 
mmol) was added. The reaction was stirred at —78 °C for 1 h, allowed to warm up to 
—40 °C for 2 h and then quenched with NH 4C1 (40 mL). The aqueous layer was 
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separated and extracted with CH 202 (3 x 20 mL) and the combined organic layers 
were dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue 
by column chromatography (20% EtOAc/petrol) gave aldehyde 461 (1.57 g, 79%) as 
a colourless oil. Rf (30% EtOAc in hexane) = 0.70; 'H NMR (360 MHz, CDC1 3) 
9.80 (1H, d, J = 1.6 Hz, CHO), 7.67 (4H, d, J = 7.9 Hz, ArH), 7.45-7.37 (6H, m, 
ArH), 3.71 (2H, t, J = 6.0 Hz, 0CH2CH2), 2.56 (2H, dt, J = 7.1, 1.6 Hz, CH 2CHO), 
1.94-1.87 (2H, m, CH2CH2CH2), 1.07 (9H, s, C(CH 3)3); 13 C NMR (62.9 MHz, 
CDC13) ö 202.5 (C), 135.5 (2 x CH), 135.2 (C), 134.8 (4 x CH), 133.6 (C), 129.7 
(CH), 127.7(4 x CH), 62.9 (CH 2), 40.7 (CH2), 26.6 (3 x CH 3), 25.2 (CH2), 19.2 (C). 
'H and 13C spectroscopic data in good agreement with the literature. 192 
2-Bromo-4-(tert-butyldiphenylsilyl)oxy-1-butanoic acid (463) 
Br2 	 1MKMn04 





Br 	 Br 
461 	 462 	 463 
To a stirred solution of aldehyde 461 (1.47 g, 4.52 mmol) and dioxane (1.20 mL) 
in dry Et20 (18 mL) at 0 °C, was added bromine (0.23 mL, 4.52 mmol) dropwise 
over 1 mm. The reaction was stirred for 30 minutes at 0 °C and then 1 h at rt when it 
was quenched with saturated aqueous NaHCO3 solution. The aqueous layer was 
extracted with Et 20 (2 x 20 mL) and the combined organic layers were dried 
(MgSO4), filtered and concentrated in vacuo. The crude residue was used in the 
oxidation step without further purification. 
To a stirred solution of the a-bromoaldehyde 462 in t-BuOH (29 mL) and 5% 
NaH2PO4 solution (19.5 mL) at room temperature was added KMN04 (1 M solution, 
29 mL). The reaction was stirred for 3 h and then quenched by the addition of solid 
Na2SO3 until the solution turned dark brown from the original purple colour. 1 M 
HCl (30 mL) was added to the reaction mixture until acidic pH. The reaction was 
then extracted with Et 20 (4 x 40 mL) and the combined organic layers were dried 
(MgSO4), filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (15% to 20% EtOAc/petrol) gave a-bromoacid 463 (0.72 g, 38% in 
two steps) as a colourless solid. R f (30% EtOAc in hexane) = 0.20; m.p.= 73-75 °C; 
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JR (film) 2957 (OH), 2931, 2857, 1718 (CO), 1428, 1277, 1111, 737, 701, 505 (C-
Br) cm'; 'H NMR (360 MHz, CDC1 3) 6 7.72-7.66 (4H, m, ArH), 7.49-7.39 (6H, m, 
ArH), 4.66 (1H, dd, J = 8.1, 6.1 Hz, CHBr), 3.87-3.77 (2H, m, OCH 2CHAHB), 2.46-
2.37 (1H, m, OCH2CHAHB), 2.22-2.12 (1H, m, OCH2CHAHB), 1.08 (9H, s, 
C(CHI)3); ' 3 C NMR (62.9 MHz, CDC1 3) 6 175.6 (C), 135.5 (4 x CH), 133.1 (2 xC), 
129.8 (2 x CH), 127.7 (4 x CH), 60.6 (CH 2), 42.6 (CH), 37.2 (CH 2), 26.8 (3 x CH3), 
19.1 (C); HRMS (ES) Exact mass calcd for C 20H2979BrNO3Si [M+NH4]: 438.1095, 
found: 438.1093. 
(R)-Methyl 2-benzyloxymethyl-2- 12-bromo-4-(tert-butyldiphenylsilyloxy)-N-(4-














TBDPSO 	 OBn 
OH 
Br 	 Br 	
Trilsobutylamine 	 Br 
Me 	CO2Me 
463 507 464a and 464b 0 
To a stirred solution of acid 463 (615 mg, 1.46 mmol) in CH 2 C12 (8 mL) at 0 °C, 
was added oxalyl chloride (0.74 mL, 8.30 mmol) followed by DMF (1 drop). The 
reaction was stirred 5 min at 0 °C and then allowed to warm up to room temperature 
and stirred for another 30 mm. The solution containing the acid chloride was 
concentrated in vacuo, redissolved in CH 202 (8 mL) and then transferred via cannula 
into a stirred solution of amine 327 (271 mg, 0.73 mmol) in CH 2C12 (10 mL) and 
triisobutylamine (Q.22 mL, 0.87 mmol) at 0 °C. The reaction mixture was stirred for 
14 h at room temperature and then quenched with saturated aqueous NH 4C1 solution 
(10 mj). The aqueous layer was separated and extracted with CH 2C12 (3 x 15 mL) 
and the combined organic layers were dried (MgSO 4), filtered and concentrated in 
vacuo. Purification of the residue by column chromatography (10% EtOAc/petrol) 
afforded the two diastereomers of amide, the more polar diastereomer 464a (226 mg, 
40%) and the less polar diastereomer 464b (189 mg, 33%), as yellow oils. 
Data for 464b: Rf (30% EtOAc in hexane) = 0.48; [a]" —19.8 (c 0.98, CHC13); 
IR (film) 2929, 2856, 2360, 1741 (CO), 1708 (C=O), 1654 (CO), 1513, 1247, 
1106, 701, 505 (C-Br) cm'; 'H NMR (250 MHz, CDC1 3) 6 7.87-7.81 (4H, m, ArH), 
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7.70-7.52 (11H, m, ArH), 7.40 (2H, d, J= 8.5 Hz, ArH), 7.11 (2H, d, J= 8.5 Hz, 
ArH), 5.38 (1H, d, J = 18.7 Hz, OCHAHBPh), 5.21 (1H, d, J = 18.7 Hz, 
OCHAHBPh), 4.99 (1H, dd, J = 8.3, 5.8 Hz, CHBr), 4.61 (lI-I, d, J = 11.7 Hz, 
NHCHCHD), 4.54 (1H, d, J= 11.7 Hz, NHCHcH0), 4.11 (3H, s, OCH3), 4.01-3.98 
(3H+2H+2H, m, OCH3+CH2OBn+OCH2CH2), 2.76 (3H, s, CH3CO), 2.50-2.40 
(2H, m, CHBrCH2), 1.13 (9H, s, C(CH3) 3); 13 C NMR (62.9 MHz, CDC13) S 197.8 
(C), 171.5 (C), 168.5 (C), 158.7 (C), 136.5 (C), 135.3 (4 x CH), 133.3 (C), 133.2 (C), 
129.5 (2 x CH), 128.3 (2 x CH), 127.8 (CH), 127.6 (2 x C), 127.5 (4 x CH), 127.4 (2 
x CH), 126.5 (2 x CH), 114.2 (2 x CH), 73.8 (CH 2), 70.1 (CH2), 60.3 (CH2), 55.1 
(CH3), 52.8 (CH3), 48.7 (CH 2), 41.5 (CH), 37.3 (CH 2), 28.0 (CH3), 26.6 (3 x CHA 
18.9 (C); HRMS (ES) Exact mass calcd for C 41 H49 79BrNO7Si [M+H]: 774.2456, 
found: 774.2460. 
Data for 464a: Rf (30% EtOAc in hexane) = 0.35; [a] 21  +4.4 (c 0.905, CHC13); 
JR (film) 2931, 2857, 2360, 1745 (CO), 1721 (CO), 1660 (C0), 1513, 1247, 
1108, 701, 505 (C-Br) cm'; 'H NMR (250 MHz, CDC1 3) 5 7.70-7.64 (4H, m, An-I), 
7.51-7.35 (11H, m, ArH), 7.24 (2H, d, J = 8.6 Hz, ArH), 6.94 (2H, d, J = 8.6 Hz, 
ArH), 5.12 (2H, d, J = 18.7 Hz, OCH2Ph), 4.98 (1 H, dd, J = 8.7, 5.6 Hz, CHBr), 
4.23 (2H, s, NHCH2Ar), 3.93 (2H, s, CH 20Bn), 3.88-3.84 (2H, m, OCH2CH2), 3.83 
(3H, s, OCH3), 3.81 (3H, s, OCH3), 2.49 (3H, s, CH3CO), 2.42-2.23 (2H, m, 
CHBrCH2), 0.99 (9H, s, C(CH3)3); ' 3 C NMR (62.9 MHz, CDC1 3) 5 197.5 (C), 171.7 
(C), 167.6 (C), 158.7 (C), 136.5 (C), 135.3 (4 x CH), 133.3 (C), 133.1 (C), 129.5 (2 x 
CH), 129.3 (2 x C), 128.3 (2 x CH), 127.8 (CH), 127.6 (4 x CH), 127.5 (2 x CH), 
126.7 (2 x CH), 114.1 (2 x CH), 73.7 (CH 2), 70.1 (CH2), 60.4 (CH2), 55.1 (CH3), 
52.7 (CH3), 49.2 (CH2), 41.6 (CH), 37.7 (CH 2), 27.7 (CH3), 26.6 (3 x CH 3), 18.9 (C); 
HRMS (ES) Exact mass calcd for C41 H4979BrNO7Si [M+H]: 774.2456, found: 
774.2457. 
4-Hydroxybutyl acetate 	 113  
Ac,O, CeCI3 
HO 	 THF 	AcO 
454 	 465 
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To a stirred solution of 1,4-butanediol (5.30 mL, 60.0 mmol) and CeC137H20 
(2.2 g, 6.0 mmol) in THF (170 mL) at room temperature was added acetic anhydride 
(57.0 mL, 600 mmol). The reaction was stirred for 16 h, diluted with Et20 (100 mL) 
and then washed with a saturated aqueous NaHCO3 solution (2 x 60 mL) and with 
saturated NaCl aqueous solution (1 x 60 mL). The combined organic layers were 
dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue by 
column chromatography (30% EtOAc/hexane) gave monoacetate 465 (3.35 g, 43%) 
as a colourless oil. Rf (30% EtOAc in hexane) = 0.20; 'H NMR (250 MHz, CDC13) 6 
4.09 (2H, d, J = 6.3 Hz, CH20Ac), 3.67 (2H, d, J = 6.3 Hz, CH20H), 2.04 (3H, s, 
CH3CO), 1.79 (1H, bs, OH), 1.78-1.58 (4H, m, CH 2CH2); ' 3C NMR (62.9 MHz, 
CDC13) 6 171.2 (C), 64.2 (CH 2), 62.3 (CH2), 29.1 (CH2), 25.0 (CH2), 21.0 (CH3). 
'H and 13C spectroscopic data in good agreement with the literature. 193 
4-Oxobutyl acetate (466)' 94 
Pcc 
CH2Cl2 	 0 
AcO 	 AcO 
465 	 466 
To a stirred solution of PCC (8.20 g, 38.0 mmol) in CH202 (70 mL) at room 
temperature was added a solution of monoalcohol acetate 465 (3.35 g, 25.3 mmol) in 
CH2C12 (7 mL) via cannula. The reaction was stirred for 1.5 h, when Et20 (70 mL) 
was added. The solution was filtered through celite and the organics were 
concentrated in vacuo. Purification of the residue by column chromatography (10% 
to 30% EtOAc/hexane) gave aldehyde 466 (2.13 g, 65%) as a colourless oil. Rf (30% 
EtOAc in hexane) = 0.47; 'H NMR (360 MHz, CDC1 3) 6 9.77 (1H, t, J= 1.3 Hz, 
CHO), 4.10 (2H, dt, J = 6.3, 4.8 Hz, AcOCH2), 2.54 (1H, td, J = 7.1, 1.3 Hz, 
CH2CHAHBCHO), 2.43 (1H, td, J = 14.0, 7.1 Hz, CH2CHAHBCHO), 2.18 (3H, s, 
CH3CO), 2.17-2.05 (2H, m, CH2CH2CH2); ' 3 C NMR (62.9 MHz, CDC13) 6 201.2 
(CH), 170.9 (C), 63.4 (CH 2), 40.4 (CH 2), 21.3 (CH2), 20.8 (CH3). 
'H spectroscopic data in good agreement with the literature.' 94 
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4-Acetyloxy-2-bromobutanal (467)' 95 
NBS 





466 	 467 
To a stirred solution of aldehyde 466 (2.40 g, 18.4 mmol) in CH 202 (25 mL) at 
0 °C was added DL-proline (640 mg, 5.53 mmol), followed by the addition of NBS 
(4.60 g, 25.8 mmol). The reaction was stirred for 30 minutes at 0 °C and then allowed 
to warm up to room temperature and stirred for another 4 h. Hexane was added to the 
reaction mixture and the precipitated NBS, succinimide and catalyst were filtered off. 
The solvents were concentrated in vacuo and purification of the residue by column 
chromatography (15% to 20% EtOAc/hexane) gave a-bromoaldehyde 467 (2.92 g, 
75%) as a colourless oil. Rf (30% EtOAc in hexane) = 0.30; 'H NMR (360 MHz, 
CDC13) ö 9.47 (1H, d, J = 2.0 Hz, CHO), 4.42-4.34 (1H, m, CHBrCHO), 4.31-3.98 
(2H, m, OCH2CH2), 2.48-2.31 (1H, m, CH2CHAHBCHBr), 2.24-2.07 (1H, m, 
CH2CHAHBCHBr), 2.04 (3H, s, CH 3C=O); ' 3 C NMR (62.9 MHz, CDC1 3) ö 191.7 
(CH), 176.3 (C), 61.0 (CH2), 51.3 (CH), 30.5 (CH 2), 20.6 (CH3). 
'FL spectroscopic data in good agreement with the literature. 195 
4-Acetyloxy-2-bromobutanoic acid (468) 
1M KMnO4 
5% NaH2PO 	 0 
f-BuOH 
AcO_)( 	 AcO (l(OH 
Br 	 Br 
467 468 
To a solution of a-bromoaldehyde 467 (500 mg, 2.38 mrnol) in t-BuOH (14 mL) 
and 5% NaH2PO4 solution (9.5 mL) at room temperature was added KMN04 (14 
mL, 1 M solution). The reaction was stirred for 3 h and then quenched by the 
addition of solid Na 2 SO3 until the solution turned dark brown from the original 
purple colour. 1 M HCl (10 mL) was added to the reaction mixture until acidic pH. 
The reaction was then extracted with Et 20 (4 x 20 mL) and the combined organic 
layers were dried (MgSO4), filtered and concentrated in vacuo. Purification of the 
residue by column chromatography (15% to 20% EtOAc/petrol) gave ci-bromoacid 
468 (386 mg, 70%) as a colourless oil. Rf (30% EtOAc in hexane) = 0.12; JR (film) 
201 
Experimental 
2967 (OH), 1738 (2 x C=O), 1428, 1390, 1368, 1244, 1040, 806, 666, 607, 503 
(C-Br) cm'; 'H NMR (3 60 MHz, CDC1 3) 6 10.3(1H, bs, 01-I), 4.40 (1H, dd, J = 8.3, 
6.1 Hz, CHBrCO2H), 4.29 (1H, td , J = 10. 9, 5.4 Hz, AcOCHAHB), 4.20 (1H, ddd, J 
= 11.6, 8.1, 4.7 Hz, AcOCHAHB), 2.51-2.41 (1H, m, CH2CHAHBCHBr), 2.34-2.25 
(1H, m, CH2CHAHBCHBr), 2.07 (3H, s, CH3CO); ' 3 C NMR (62.9 MHz, CDC13) 6 
173.9 (C), 171.2 (C), 61.4 (CH 2), 41.5 (CH), 33.5 (CH2), 20.7 (CH3); HRMS (El) 
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464aor464b 	 470 
To a stirred solution of amide 464a or 464b (28 mg, 36 j.tmol) in THF (1 mL) at 
0 °C, was added Sm12 (3.6 mL, 0.1 M solution in hexanes, 0.36 mmol). The reaction 
was stirred at 0 °C for 1 h and then quenched with saturated aqueous NH 4C1 solution 
(3 mL). The aqueous layer was separated and extracted with EtOAc (2 x 5 mL) and 
the combined organic layers were dried (Na 2 SO4), filtered and concentrated in vacuo. 
Purification of the residue by column chromatography (10% to 15% EtOAc/petrol) 
gave amide 470 (10 mg, 40%) as a pale yellow oil. Rf (30% EtOAc in hexane) = 
0.39; JR (film) 3287 (NH), 2930, 2857, 1644 (CO), 1512, 1428, 1248, 1110, 822, 
701 cm'; 'H NMR (250 MHz, CDC1 3) 6 7.67-7.61 (4H, m, ArH), 7.44-7.33 (6H, m, 
ArH), 7.18 (2H, d, J = 8.7 Hz, ArH), 6.85 (2H, d, J = 8.7 Hz, ArH), 5.77 (1H, bs, 
NH), 4.34 (2H, d, J = 5.6 Hz, NHCH 2Ar), 3.83 (3H, s, OCH3), 3.71 (2H, t, J = 5.9 
Hz, OCH2CH2), 2.35 (2H, t, J = 7.3 Hz, CH2CO), 1.96-1.85 (2H, m, CH 2CH2CH2); 
' 3 C NMR (62.9 MHz, CDC13) 172.5 (C), 158.9 (C), 135.4 (4 x CH), 133.6 (2 x C), 
130.4 (C), 129.6 (2 x CH), 129.1 (2 x CH), 127.6 (4 x CH), 114.0 (2 x CH), 63.0 
(CH2), 55.2 (CH3), 43.0 (CH2), 33.1 (CH 2), 28.4 (CH2), 26.8 (3 x CH3), 19.2 (C); 
HRMS (El) Exact mass calcd for C 28H35NO3 Si [M]': 461.2381, found: 461.2382. 
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6.2.4. Formal synthesis 
























To a stirred solution of fumaric acid monoethyl ester (858 mg, 5.65 mmol) in 
CH2 C12 (10 mL) at 0 °C was added oxalyl chloride (0.56 mL, 6.40 mmol) followed 
by DMF (one drop). This solution was stirred at room temperature for 1 h, and then 
transferred via cannula to a solution of the amine 327 (1.34 g, 3.60 mmol) and 
diisopropylethyl amine (1.10 mL, 6.40 mmol) in CH202 (10 mL). The reaction 
mixture was stirred at 0 °C for 10 mill and then at room temperature for 18 h, when it 
was quenched with saturated aqueous NH 4C1 solution (20 mL). The aqueous layer 
was separated and extracted with CH 2Cl2 (3 x 20 mL), and the combined organic 
layers were dried (MgSO4), filtered and concentrated in vacuo. Purification of the 
residue by column chromatography (20% EtOAc/petrol) gave amide 481 (1.7 g, 
95%) as a pale yellow oil. Rf (30% EtOAc in hexane) = 0.45; [a]-18.2 (c 1. 18, 
CHC13); JR (film) 2953, 2837, 1722 (C0),1658 (C=O), 1513, 1408, 1294, 1175, 
1032, 974 cm'; 'H NMR (360 MHz, CDC13) ö 7.35-7.27 (5H, m, ArH), 7.22 (1H, d, 
J = 15.3 Hz,. =CH), 7.17-7.12 (2H, m, ArH), 6.95-6.89 (2H, dm, J = 8.8 Hz, ArH), 
6.80 (1H, d, J 15.3 Hz, CH), 4.95 (1H, d, J = 18.4 Hz, OCHAHBAr), 4.81 (1 H, d, 
J = 18.4 Hz, OCHAHBAr), 4.32 (lH, d, J = 11.9 Hz, NCHCHDAr), 4.28 (1H, d, J = 
11.9 Hz, NCHcHnAr), 4.19 (2H, q, J 7.1 Hz, OCH2CH3), 3.83 (3H, 5, OCH3), 3.80 
(3H, s, OCH3), 3.78 (2H, s, CH20Bn), 2.45 (3H, s, CH3CO), 1.26 (3H, t, J = 7.1 
Hz, OCH2CH3); ' 3 C NMR (62.9 MHz, CDC13) 8  197.6 (C), 168.0 (C), 167.5 (C), 
165.2 (C), 158.9 (C), 136.5 (C), 133.3 (CH), 133.1 (CH), 129.7 (C), 128.4 (2 x CH), 
127.9 (CH), 127.5 (2 x.CH), 127.1 (2 x CH) 114.2 (2 x CH), 77.5 (C), 73.7 (CH 2), 
70.1 (CH2), 61.1 (CH2), 55.2 (CH3), 52.9 (CH 3), 48.9 (CH2), 27.9 (CH3), 14.0 (CH3); 




dioxohexahydrofuro 12,3-cl pyrrole-6-carboxylic acid methyl ester (489) and 
dioxohexahydrofuro 12,3-cl pyrrole-6-carboxylic acid methyl ester (490) 
o 	 0 	 0 
	
PMB 	 PMB 
IN 	
0
Me 	C.- . 




N 	 Et2Zn 
OBn 




489 	 490 
A solution of amide 481 (875 mg, 1.75 mmol) and (Me3P)2NiC12 (115 mg, 0.175 
mmol) in THF (75 mL) was stirred at room temperature for 30 min and then cooled 
to —15 °C (ice-salt bath). Et 2Zn (3.52 mL, 1 M solution in THF, 3.52 mmol) was then 
added via syringe. The reaction was allowed to warm slowly to room temperature 
over 18 h, and then quenched carefully with saturated aqueous NH 4C1 solution (50 
mL) and extracted with EtOAc (3 x 30 mL). The combined organic layers were dried 
(MgSO4) and concentrated in vacuo. Purification of the residue by column 
chromatography (20% to 35 % EtOAc/petrol) gave the duble cyclization product 
489 (3 54 mg, 42%) as a pale yellow oil, followed by the double cyclization product 
490 (253 mg, 30%) as a colourless solid. Recrystallization of 490 from EtOAc/petrol 
gave colourless crystals that were suitable for X-ray crystallography. 
Data for desired 489: Rf (30% EtOAc in CHC13) = 0.19; [a] —33.3 (c 1.02, CHC13); 
IR (film) 2955, 1789 (CO), 1733 (C0), 1699 (C0), 1612, 1513, 1439, 1404, 
1248, 1178 cni'; 'H NMR (250 MHz, CDC13) ö 7.27-7.18 (3H + 2H, m, ArH), 7.04- 
6.99 (2H, m, ArH), 6.69 (2H, d,J = 8.7 Hz, ArH), 4.97 (1H, d, J = 15.2 Hz, 
OCHAHBPh), 4.21 (1H, d, J = 15.2 Hz, OCHAHBPh), 3.83 (1H, d, J = 11.5 Hz, 
NCHcH0Ar), 3.75 (1H, d, J = 10.4 Hz, CHEHFOBn), 3.73 (1H, d, J = 11.5 Hz, 
NCHCHDAr), 3.73 (3H, s, OCH3), 3.66 (3H, s, OCH3), 3.13 (1H, d, J = 10.4 Hz, 
CHEHFOBn), 2.97 (1H, dd, J = 9.3, 1.5 Hz, CHGHHCH), 2.88 (1H, dd, J= 18.3, 1.5 
Hz, CHGHHCH), 2.72 (1H, dd, J = 18.3, 9.3 Hz, CHGHHCH), 1.53 (3H, s, CH3 ); 13 C 
NMR (62.9 MHz, CDC1 3) 8  173.5 (C), 172.9 (C), 166.9 (C), 159.0 (C), 136.7 (C) 
130.0 (2 x CH), 129.4 (C), 128.4(2 x CH), 127.9 (CH), 127.3 (2 x CH), 113.6 (2 x 
CH), 88.4 (C), 75.8 (C), 72.8 (CH 2), 67.7 (CR2), 55.2 (CR 3), 52.8 (CH3), 47.5 (CH), 
RMI 
Experimental 
45.1 (CH2), 30.7 (CH2), 19.4 (CH3); HRMS (ES) Exact mass calcd for C 25H28N07 
[M+H]: 454.1860 , found: 454.1856. 
Data for undesired 490: Rf (30% EtOAc in CHC1 3) = 0.08; m.p. = 105 °C; [a] -17.9 
(c 1.0 1, CHC13); JR (film) 2952, 2870, 1789 (CO), 1743 (C=O), 1703 (C=O), 1613, 
1512, 1434, 1246, 1128 cm-1; 'H NMR (250 MHz, CDC13) 5 7.38-7.21 (5H, m, 
ArH), 7.12 (2H, d, J = 8.7 Hz, Art!), 6.82 (2H, d, J = 8.7 Hz, ArH), 4.72 (1H, d, J= 
15.2 Hz, OCHAHBPh), 4.40 (1H, d, J= 15.2 Hz, OCHAHBPh), 4.34 (1H, d, J= 11.7 
Hz, NCHCHDAr), 4.27 (1H, d, J = 11.7 Hz, NCHcHDAr), 3.94 (1H, d, J = 10.1 Hz, 
CHEHFOBn), 3.82 (3H, s, OCH3), 3.74 (1H, d, J = 10.1 Hz, CHEHFOBn), 3.67 (3H, 
s, OCH3), 3.07 (1H, dd, J= 9.7, 1.8 Hz, CHGHHCH), 3.04 (1H, dd, J= 18.3, 1.9 Hz, 
CHGHHCH), 2.88 (1H, dd, J = 18.3, 9.7 Hz, CHGHHCH), 1.51 (3H, s, CH 3); 13 C 
NMR (62.9 MHz, CDC13) 8  173.4 (C), 173.2 (C), 169.2 (C) 158.7 (C) 137.1 (C) 
129.2 (2 x CH), 129.0 (C), 128.3 (2 x CH), 127.7 (3 x CH), 113.6 (2 x CH), 86.6 (C), 
75.3 (C), 73.6 (CH2), 68.7 (CH2), 55.2 (CH3), 52.8 (CH3), 46.9 (CH), 45.1 (CH2), 
30.9 (CH2), 21.3 (CH3); FIRMS (ES) Exact mass calcd for C 25H28N07 [M+H]: 
454.1860, found: 454.1858. 
(3aR,6R,6aS-6-Hydroxymethyl-5-(4-methoxybenzyl)-6a-methYl-2,4-
dioxohexahydrofuro 12,3-cl pyrrole-6-carboxylic acid methyl ester (493) 
0 	 0 
a4 PMB PMB 0eN08 OH CO2Me Me CO2Me 
489 	 493 
A mixture of benzyl ether 489 (354 mg, 0.78 mmol) and 10% Pd/C (99 mg, 0.093 
mmol) in EtOH (5 mL) at room temperature was evacuated and flushed with H 2 (3 
times) and then stirred vigorously under an atmosphere of H 2 (1 atm, H2 balloon) at 
room temperature for 18 h. The reaction mixture was filtered through celite and 
concentrated in vacuo. Purification of the residue by column chromatography (50% 
EtOAc/petrol) gave alcohol 493 (240 mg, 84%) as a white powder. Rf (100% 
EtOAc) = 0.52; m.p. 144-146 °C; [a] —30.1 (c 0.95, CHC13); JR (film) 3437 (OH), 
2955, 2253, 1787 (C=O), 1757 (C=O), 1692 (CO), 1613, 1513, 1247, 1035, 
951cm 1 ; ' H NMR (250 MHz, CDC13) 6 7.37 (2H, d, J = 8.6 Hz, ArH), 6.87 (2H, d, J 
205 
Experimental 
= 8.6 Hz, ArH), 5.22 (1H, d,.J = 15.2 Hz, NCHAHBAr), 4.24 (1H, d, J = 15.2 Hz, 
NCHAHBAr),3.95 (1H, dd, J = 13.0, 8.9 Hz, CHCHDOH), 3.83 (3H, s, OCH 3), 3.80 
(3H, s, OCH3), 3.43 (1H, dd,J= 13.0, 5.5 Hz, CHCHDOH), 3.04 (1H, dd,J 9.1, 1.7 
Hz, CHEHFCH), 2.96 (1H, dd, J = 18.1, 1.7 Hz, CHEHFCH), 2.85 (1H, dd, J= 18. 1, 
9.1 Hz, CHEHFCH), 1.69 (3H, s, CH3); ' 3 C NMR (62.9 MHz, CDC1 3) 6 173.7 (C), 
172.7 (C), 167.1 (C), 159.5 (C), 129.6(2 x CH + C), 114.6 (2 x CH), 88.3 (C), 77.3 
(C), 60.9 (CH 2), 55.3 (CH3), 52.8 (CH3), 47.6 (CH), 44.9 (CH 2), 30.5 (CH2), 19.8 
(CH3); HRMS (ES) Exact mass calcd for C 1 8H25N207 [M+NH4] + : 381.1656, found: 
381.1660. 
(3aR,6R,6aS)-6-Formyl-5-(4-methoxybcnzyl)-6a-methyl-2,4-
dioxohexahydrofuro [2,3-c] pyrrole-6-carboxylic acid methyl ester (494) 





Me CO2Me 	 Me CO,Me 
493 	 494 
To a solution of alcohol 493 (30 mg, 0.082 mmol) in CH 202 (0.8 mL) at room 
temperature was added Dess-Martin periodinane (43 mg, 0.099 mmol). The reaction 
mixture was stirred for 1.5 h, quenched with water and extracted with EtOAc (3 x 
mL). The combined organic layers were dried (Na 2SO4) and concentrated in vacuo as 
an oil. This aldehyde proved to be unstable and was generally used immediately in 
the next step without purification. On one occasion, purification of a small amount of 
crude product by column chromatography (50% EtOAc/petrol) was performed for 
characterisation purposes. Rf (100% EtOAc) = 0.34; JR (film) 2956, 1788 (C0), 
1760 (C=O), 1728 (C0), 1687 (C0), 1513, 1438, 1246, 1176, 949 cm'; 'HNMR 
(250 MHz, CDC13) 6 9.47 (1H, s, CHO), 7.05 (2, d, J = 8.7 Hz, ArH), 6.81 (2H, d, J 
= 8.7 Hz, ArH), 4.86 (1H, d, J = 14.4 Hz, NCHAHBAr), 4.39 (1H, d, J = 14.4 Hz, 
NCHAHBAr), 3.90 (3H, s, OCH3), 3.78 (3H, s, OCH3), 3.08 (1H, dd, J= 9.7, 1.8 Hz, 
CHCHDCH), 2.99 (1H, dd, J= 18.4, 1.8 Hz, CHCHDCH), 2.85 (1H, dd, J= 18.4, 9.7 
Hz, CHCHDCH), 1.52 (3H, s, CH');  ' 3 C NMR (62.9 MHz, CDC1 3) 6 195.5 (CH), 
172.7 (C), 172.0 (C), 165.7 (C), 159.6 (C), 131.1 (2 x CH), 126.8 (C), 114.2 (2 x 
CH), 87.3 (C), 79.0 (C), 55.2 (CH3), 53.4 (CH), 46.8 (CH), 45.6 (CH 2), 30.6 (CH2), 
FM 
Experimental 
20.5 (CH3); LRMS (El) Mass calcd. for C, 8H 19N07Na [M+Na]: 384.3, found: 
383.7. 
(3aR,6R,6aS)-6- [(7S)-(8S)-Cyclohex-2-enylhydroxym ethyl] -5-(4-
methoxybenzyl)-6a-methyl-2,4-dioxohexahydrofuro [2,3-c] pyrrole-6-carboxylic 
acid methyl ester (495) 
0 
SnBu3 i)n-BuLi, -78°C 	ZnCI 	
N_ 
CHO6 PMB 6 
	ii)ZnCl2 , -78°C 





Me CO2 Me 
495 
To a solution of cyclohexenyltributyltin (143)36  (89.6 mg, 0.206 mmol) in THF 
(0.6 mL) at —78 °C was added n-BuLi (130 pL mL, 1.6 M solution in hexanes, 0.206 
mmol). After stirring at —78 °C for 1 h, ZnC1 2 (0.42 mL, 0.5 M solution in THF, 0.21 
mmol) was added and stirring was continued at this temperature for another 1 h. A 
solution of the crude aldehyde 494 from the above experiment (theoretically 0.082 
mmol) in THF (0.4 mL) was then added via cannula, and after stirring for 3 h at —78 
°C, the reaction was quenched with H 20 (5 mL) and extracted with EtOAc (3 x 5 
mL). The combined organic layers were dried (MgSO4) and concentrated in vacuo, 
and purification of the residue by column chromatography (50% EtOAc/petrol) gave 
the homoallylic alcohol 495 (22.4 mg, 61% over two steps) as a colourless solid. Rf 
(100% EtOAc) = 0.61; Rf (70% EtOAc in CHC1 3) = 0.45; m.p. = 114-116 °C; 
[a]+3.0 (c 1.47, CHC13); IR (film) 3438 (OH), 2931, 2359, 1790 (C=O), 1755 
(C0) 1687 (C0), 1512, 1440, 1246, 1175, 807 cm'; 'H NMR (250 MHz, CDC1 3) 
ö 7.18 (2H, d, J = 8.7 Hz, ArH), 6.84 (2H, d, J = 8.7 Hz, ArH), 5.91 (1H, dm, J 
10.2 Hz, CH=CH), 5.68 (1H, dm, J 10.2 Hz, CH=CH), 4.79 (1H, d, J 14.9 Hz, 
NCHAHBAr), 4.54 (1H, d, J = 14.9 Hz, NCHAHBAr), 4.12 (1H, t, J = 7.1 Hz, 
CHOH), 3.78 (6H, s, 2 x OC113), 3.13 (1H, dd, J = 6.8, 3.3 Hz, CH2CHCO), 2.92 
(1H, br s, OH), 2.82-2.79 (2H, m, CH2CHCO), 2.32 (1H, bs, CHOHCH), 2.02 (2H, 
bs, CH2), 1.81 (3H, s, C113CO), 1.76-1-66 (2H, m, CH2), 1.57-1.46 (1H, m, CH 2), 
1.44-1.33 (1H, m, CH 2); ' 3C NMR (62.9 MHz, CDC1 3) 6 174.8 (C), 173.0 (C), 167.8 
(C), 158.3 (C), 131.8 (CH), 129.3 (C), 127.6(2 x CH), 125.2 (CH), 113.7(2 x CH), 
207 
Experimental 
91.1 (C), 79.0 (C), 76.9 (CH), 55.2 (CH 3), 52.4 (CH3), 47.9 (CH2), 47.8 (CH), 38.3 
(CH), 30.9 (CH 2), 27.0 (CH2), 24.9 (CH2), 20.6 (CH2), 19.6 (CH3); HRMS (ES) 
Exact mass calcd for C 24H33N207 [M+NH4]: 461.2282, found: 461.2283. 
(2R,3S,4R)-2- I(6S)-(7S)-Cyctohex-2-enylhydroxym ethyl] -3-hydroxy-4-(2-
hydroxyethy1)-1-(4-methoxybenzyl)3-methyl-5-oxopyrrolidine-2-CarbOXYliC 
acid methyl ester (26) 
MeOH 	HO 
0 0 	 OH 	 OH 




To a solution of the lactone 495 (19.3 mg, 0.043 nimol) in MeOH (0.6 mL) at 
room temperature was added NaBH4 (75 mg, 2.0mmol) portionwise over 2 mm. The 
solution was stirred for 18 h, quenched with H 20 (4 mL) and extracted with EtOAc 
(3 x 4 mL). The combined organic layers were dried (Na 2 504) and concentrated in 
vacuo. Purification of the residue by column chromatography (70% EtOAc/petrol) 
gave triol 26 (11.7 mg, 60%) as a white foam. Rf (70% EtOAc in CHC13) = 0.12; 
m.p. = 82-83 °C, lit. 26  83-84 °C; [a]+3.5 (c 0.56, CHC13), lit- 26 +5.2 (c 0.60, 
CHC13); JR (film) 3331(OH), 2925, 2853, 1752 (CO), 1670 (CO), 1512, 1441, 
1245, 1175, 1034 cm 1 ; ' H NMR (250 MHz, CDC13) ö 7.29 (2H, d, J= 8.7 Hz, ArH), 
6.85 (2H, d, J= 8.7 Hz, ArH), 5.93 (1H, dm, J= 10.2 Hz, CH=CH), 5.62 (1H, dm, J 
10.2 Hz, CH=CH), 4.76 (1H, d, J = 15.2 Hz, NCHAHBAr), 4.39 (1H, d, J= 15.2 
Hz, NCHAHBAr), 4.15 (1H, t, J 6.3 Hz, CHOH), 3.87-3.81 (1H, m, 
HOCHCHDCH2), 3.80-3.75 (1H, m, HOCH cH0CH2), 3.79 (3H, s, OCH3), 3.71 (3H, 
s, OCH3), 3.02 (1H, dd, J= 8.1, 4.8 Hz, COCH), 2.20 (1H, bs, CHOHCH), 2.01 (2H, 
bs, CH2), 1.93- 1.78 (2H, m, C112), 1.76-1.65 (2H, m, CH2), 1.64 (3H, s, CH3CO), 
1.54-1.41 (2H, m, CH2); ' 3 C NMR (62.9 MHz, CDC1 3) 8  178.5 (C), 169.7 (C), 158.2 
(C), 132.9 (CH), 130.2 (C), 128.0(2 x CH), 124.8 (CH), 113.6 (2 x CH), 81.8 (C), 
80.6 (C), 77.2 (CH), 61.7 (CH 2), 55.2 (CH3), 51.9 (CH), 51.3 (CH 3), 47.8 (CH2), 38.6 
(CH), 28.2 (CH 2), 26.8 (CH2), 25.0 (CH2), 21.2 (CH 3), 20.6 (CH 2); HRMS (ES) 
Exact mass calcd for C 24H33NO7Na [M+Na]: 470.2149, found: 470.2150. 
208 
Experimental 
Comparison of ' 3 C NMR data (HWL, Corey and Pattenden's) for 26 
HWL 13 C NMR 
data (CDC1 3 
referenced at 
77.0 ppm) 
Corey ' 3 C NMR data with 
CDC13 referenced at 77.38 
ppm (data with CDC1 3 
referenced at 77.0 ppm) 
Appm 
Pattenden 
' 3C NMR data with 
CDC13 referenced 
at 77.03 ppm 
Appm 
178.5 178.99 (178.61) -0.11 178.8 -0.3 
169.7 170.12 (169.74) -0.04 169.7 0 
158.2 158.27 (157.89) +0.31 158.2 0 
132.9 131.30 (130.92) +1.98 132.6 +0.3 
130.2 130.55 (130.17) +0.03 130.7 -0.5 
128.0 128.13 (127.75) +0.25 128.2 -0.2 
124.8 126.39 (126.01) -1.21 125.1 -0.3 
113.7 113.74 (113.36) +0.34 113.7 0 
81.8 81.93 (81.55) +0.25 81.8 0 
80.6 80.75 (80.37) +0.23 80.6 0 
77.2 76.87 (76.49) +0.71 77.2 0 
61.7 61.61 (61.23) +0.47 61.6 +0.1 
55.2 55.45 (55.07) +0.13 55.2 0 
51.9 51.97 (51.59) +0.31 51.9 0 
51.3 51.32 (50.94) +0.36 51.3 0 
47.8 48.07 (47.69) +0.11 47.9 -0.1 
38.6 39.17 (38.22) +0.38 38.7 -0.1 
28.2 27.71 (27.82) +0.38 28.0 +0.2 
26.8 27.13 (26.75) +0.05 26.8 0 
25.0 25.22 (24.84) +0.16 25.0 0 
21.2 21.35 (20.97) +0.23 21.1 +0.1 
20.6 21.22 (20.84) -0.62 20.7 -0.1 
FM 
Experimental 
6.2.5. NMR spectra 
(R)-Ethyl (E)-3- IN(1benzy1ox1m ethyl- 1-carbomethoxy-2-oxoProPY1)-N-(4-
methoxybenzyl)carbamoyl]acrylate (481) 
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dioxohexahydrofuro 12,3-cl pyrrole-6-carboxylic acid methyl ester (489) 
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dioxohexahydrofuro [2,3-c] pyrrole-6-carboxylic acid methyl ester (490) 
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dioxohexahydrofuro [2,3-cl pyrrole-6-carboxylic acid methyl ester (493) 
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dioxohexahydrofuro [2,3-cl pyrrole-6-carboxylic acid methyl ester (494) 
9.0 	 8.0 	 7.0 	 6.0 	 5.0 	 4.0 	 3.0 	 2.0 	 1.0 
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(3aR,6R,6aS)-6- [(S)-(S)-Cyclohex-2-enylhydroxym ethyl] -5-(4-methoxyben7yl)-
6a-methyl-2,4-dioxohexahydrofuro 12,3-cl pyrrole-6-carboxylic acid methyl ester 
(495) 
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acid methyl ester (26) 
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Experimental 
' 3C NMR Spectrum of triol 26 obtained by the Corey group 
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